data_2nda_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nda _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HA ' HD21 ' A' ' 48' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 1.16 111.518 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.76 109.993 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 1.17 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.16 116.878 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 1.03 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.59 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.78 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 1.13 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.35 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 1.03 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 1.05 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 1.03 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.478 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.81 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 1.03 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 1.36 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 1.03 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.499 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.84 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.754 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.64 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.633 ' CG2' HG23 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.03 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 1.03 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.94 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.17 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.37 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.43 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 1.03 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 1.05 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.673 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.99 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.449 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.83 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.664 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.99 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.673 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.17 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.15 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 1.03 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.22 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 1.02 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.93 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 1.01 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.573 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 1.03 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.95 108.22 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 1.07 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.484 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 1.2 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 3.35 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 1.12 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 3.06 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.97 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 1.0 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 1.05 109.296 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 66' ' ' TYR . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.604 ' HA ' HD22 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 82' ' ' LEU . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.86 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 1.04 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 10' ' ' MET . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 1.01 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.455 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 2.05 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 HG23 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 1.03 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.16 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.588 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 1.03 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.52 HG22 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 1.02 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t30 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.47 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HG22 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.8 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' HD13 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.95 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.528 ' CG ' HG23 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 1.03 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.88 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HG3' HD21 ' A' ' 90' ' ' LEU . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 1.21 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.542 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.13 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 1.04 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.97 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD21 ' HG3' ' A' ' 84' ' ' LYS . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 1.03 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.19 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.633 HG23 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 1.0 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 1.02 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.57 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.5 t30 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.61 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.36 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.565 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 1.08 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 1.04 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 1.46 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.24 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 1.05 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 48' ' ' LEU . 21.5 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.655 0.613 . . . . 1.16 112.655 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.435 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.742 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.623 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.17 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.16 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 1.03 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.59 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.78 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 1.13 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.35 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 1.03 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 1.05 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.593 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 1.03 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.482 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.81 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 1.03 110.126 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 1.36 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 1.03 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.84 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.64 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 1.03 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 1.03 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.94 114.258 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.17 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.635 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.43 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 1.05 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.661 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.99 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.578 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.578 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.466 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.83 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.99 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.17 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.596 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.15 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 1.03 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.691 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.22 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 1.02 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.93 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.691 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 47' ' ' VAL . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 1.01 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.633 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 1.03 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.95 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 1.07 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.633 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 1.2 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 3.35 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 1.12 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.443 ' NE ' HG22 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 3.06 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.97 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 1.0 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.405 ' H ' ' HB ' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 1.05 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.596 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.441 ' CD1' HD21 ' A' ' 82' ' ' LEU . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.86 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 1.04 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 1.01 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 2.05 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 1.03 112.432 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.16 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD12 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 1.03 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 1.02 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.47 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.469 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.8 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.95 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.515 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 1.03 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.88 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 1.21 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.13 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 1.04 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.97 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 1.03 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.19 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 1.02 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.61 106.671 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.596 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.36 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 1.08 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 1.04 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 1.46 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.24 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 1.05 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' HA ' HD22 ' A' ' 48' ' ' LEU . 39.0 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 1.16 113.032 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.76 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.608 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 1.17 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.16 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 1.03 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.59 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.78 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 1.13 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.35 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 1.03 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 1.05 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 1.03 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.502 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.81 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 1.03 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 1.36 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 1.03 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.532 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.84 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.64 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' CG2' HG23 ' A' ' 92' ' ' THR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 1.03 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 1.03 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.94 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.17 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.37 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.43 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 1.03 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.604 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 1.05 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.663 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.99 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.83 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.99 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.663 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.17 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.15 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 1.03 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.22 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 1.02 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.93 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 1.01 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 1.03 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.95 108.203 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 1.07 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.49 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 1.2 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 3.35 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 1.12 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 3.06 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.49 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.97 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 1.0 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 1.05 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.612 ' HA ' HD23 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.86 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 1.04 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 1.01 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 2.05 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.59 HG23 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 1.03 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.16 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 1.03 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 1.02 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.47 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.8 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.53 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.95 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 1.03 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.88 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' HD23 ' A' ' 90' ' ' LEU . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 1.21 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.13 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 1.04 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.97 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD23 ' HG3' ' A' ' 84' ' ' LYS . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 1.03 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.19 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 1.0 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 1.02 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.61 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.36 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 1.08 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 1.04 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 1.46 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.24 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 1.05 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 48' ' ' LEU . 47.5 t . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 1.16 111.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.437 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.76 110.699 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.597 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 1.17 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.16 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 1.03 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.59 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.78 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 1.13 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.35 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 1.03 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 1.05 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 1.03 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.428 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 34.0 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.81 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 1.03 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 1.36 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 1.03 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.493 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.84 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.705 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.64 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.615 ' CG2' HG21 ' A' ' 92' ' ' THR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 1.03 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.727 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 1.03 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.94 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.17 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.37 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.43 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 1.03 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.791 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.99 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.604 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.83 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.615 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.99 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.791 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.17 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.15 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 1.03 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.22 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 1.02 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.93 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 1.01 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.562 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 1.03 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.95 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 1.07 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.473 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 1.2 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 3.35 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 1.12 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 3.06 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.97 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.678 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 1.05 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.86 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 1.04 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 1.01 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 2.05 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 1.03 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.846 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.16 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.635 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 1.03 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 1.02 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.47 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.8 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.95 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' CG ' HG22 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.621 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.88 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 1.21 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.13 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 1.04 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.97 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD21 ' HG3' ' A' ' 84' ' ' LYS . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 1.03 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.19 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.615 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 1.0 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 1.02 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.61 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.667 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.36 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 1.08 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 1.04 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.24 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 1.05 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.575 ' HA ' HD21 ' A' ' 48' ' ' LEU . 44.6 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.301 0.572 . . . . 1.16 112.294 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 48' ' ' LEU . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.76 110.577 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 1.17 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.16 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD22 ' HA ' ' A' ' 65' ' ' GLN . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 1.03 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.59 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.78 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 1.13 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.35 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 1.03 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 1.05 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 1.03 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.81 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 1.03 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 1.36 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 1.03 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.494 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.84 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.64 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.626 ' CG2' HG22 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 1.03 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 1.03 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.94 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.861 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.17 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.602 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.37 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.43 110.727 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 1.03 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.876 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.99 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.83 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.606 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.99 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.876 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.17 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.652 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.15 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 1.03 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.22 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 1.02 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 8' ' ' VAL . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.93 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 1.01 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.549 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 1.03 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.95 108.143 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 1.07 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.475 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 1.2 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 3.35 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 1.12 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 3.06 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.97 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 1.05 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 66' ' ' TYR . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.576 ' HA ' HD22 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.86 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 1.04 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.639 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 1.01 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 2.05 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 1.03 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.861 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.16 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 1.03 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 1.02 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.47 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.8 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.513 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.95 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 1.03 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.88 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 1.21 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.13 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 1.04 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.97 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 HD21 ' HG3' ' A' ' 84' ' ' LYS . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 1.03 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.19 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.626 HG22 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 1.0 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 1.02 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.61 107.069 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.652 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.36 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 1.08 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 1.04 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 1.46 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.24 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 1.05 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HA ' HD21 ' A' ' 48' ' ' LEU . 76.8 t . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 1.16 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.411 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.76 109.913 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.621 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 1.17 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.16 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 1.03 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.59 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG11 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.78 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 1.13 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.35 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 14' ' ' SER . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 1.03 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 1.05 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.6 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 1.03 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.81 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.438 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 1.03 110.672 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 1.36 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 1.03 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.84 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG3' HG21 ' A' ' 101' ' ' VAL . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.64 111.487 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.594 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 1.03 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 1.03 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.94 113.68 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.17 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.37 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.43 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.782 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 1.03 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 1.05 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.687 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.99 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.577 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.436 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.83 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.99 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.17 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.687 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.15 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 1.03 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.22 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 1.02 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.93 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 1.01 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.677 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 1.03 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.95 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 1.07 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.677 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 1.2 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 3.35 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 1.12 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 3.06 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.483 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.97 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 55' ' ' SER . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 1.0 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 1.05 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.595 ' HA ' HD22 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' ASP . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 1.04 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 1.01 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 2.05 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.554 HG23 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 1.03 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.869 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.16 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 1.03 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 1.02 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.47 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.8 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.95 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.554 ' CG ' HG23 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 1.03 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.88 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 1.21 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.13 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 1.04 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.97 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 84' ' ' LYS . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 1.03 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' CZ ' HD13 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.19 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.594 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 1.02 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.61 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.687 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.36 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 1.08 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.04 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.5 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 1.46 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.24 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' A' ' 25' ' ' ARG . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 1.05 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' HD22 ' A' ' 48' ' ' LEU . 41.1 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.32 0.581 . . . . 1.16 112.502 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.76 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.627 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 1.17 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.16 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 1.03 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.59 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.534 ' O ' HG13 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.78 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 1.13 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.35 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 14' ' ' SER . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 1.03 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 1.03 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.536 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.81 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 1.03 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 1.36 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.457 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.84 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 101' ' ' VAL . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.64 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' CG2' HG23 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 1.03 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 1.03 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.94 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.17 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.37 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.43 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 1.03 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 1.05 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.99 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.83 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.99 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.17 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.641 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.15 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 1.03 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.22 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 1.02 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 8' ' ' VAL . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.93 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 1.01 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.509 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 1.03 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.95 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 1.07 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 1.2 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 3.35 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 1.12 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 3.06 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.97 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 1.0 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 1.05 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD23 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 64' ' ' ASP . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.86 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 1.04 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 1.01 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 2.05 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 HG23 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 1.03 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.16 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 HD13 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 1.03 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 1.02 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.47 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.8 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.95 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CG ' HG23 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 1.03 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.88 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HG3' HD23 ' A' ' 90' ' ' LEU . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 1.21 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.13 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 1.04 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.97 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 84' ' ' LYS . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 1.03 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.19 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.576 HG23 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 1.0 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 1.02 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.61 106.619 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.641 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.36 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 1.08 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 1.04 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.24 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.55 ' O ' HG21 ' A' ' 101' ' ' VAL . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 1.05 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 48' ' ' LEU . 44.9 t . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 1.16 112.117 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.76 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.599 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 1.17 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.16 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 1.03 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.59 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.78 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 1.13 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.35 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 1.03 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 1.05 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 1.03 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.81 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 23' ' ' ALA . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 1.36 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 21' ' ' ARG . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 1.03 110.312 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.597 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.84 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.64 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.603 ' CG2' HG23 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 1.03 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.719 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 1.03 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.94 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.845 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.17 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.62 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.37 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.43 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 1.03 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.62 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 1.05 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 37' ' ' ASN . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.868 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.99 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.49 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.83 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.99 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.868 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.17 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.704 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.15 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 1.03 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.22 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 1.02 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 8' ' ' VAL . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.93 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 47' ' ' VAL . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.01 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 1.03 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.95 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.476 HG22 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 1.07 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.464 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 1.2 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 3.35 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 1.12 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.476 ' NE ' HG22 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 3.06 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.97 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 1.0 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 1.05 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HA ' HD23 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 82' ' ' LEU . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.86 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 1.04 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 1.01 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.642 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 2.05 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 1.03 112.04 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.845 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.16 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 1.03 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.02 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.47 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.8 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.95 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 1.03 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.88 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 1.21 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.581 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.13 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 1.04 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.97 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 84' ' ' LYS . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 1.03 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.19 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 1.0 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 1.02 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.61 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.704 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.36 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 1.08 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 1.04 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 1.46 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.24 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 1.05 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' A' ' 48' ' ' LEU . 45.7 t . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 1.16 111.867 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.714 ' SD ' HD21 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 1.17 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.16 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 1.03 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.59 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.78 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 1.13 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.35 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 14' ' ' SER . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 1.03 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 1.05 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 1.03 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.81 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 1.03 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 1.36 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 1.03 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.84 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.64 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 1.03 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 1.03 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.94 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.858 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.17 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.37 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.43 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 1.03 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.613 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 1.05 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.757 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.99 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.583 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.83 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.99 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.757 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.17 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.15 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 1.03 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.22 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 1.02 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.93 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 1.01 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 1.03 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.95 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.479 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 1.07 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.648 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 1.2 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 3.35 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 1.12 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.479 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 3.06 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.97 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 1.05 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.86 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 1.04 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.714 HD21 ' SD ' ' A' ' 10' ' ' MET . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 1.01 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 2.05 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 1.03 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.858 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.16 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.638 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 1.03 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 1.02 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.47 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CD1' HG23 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.8 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.95 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' CG ' HG22 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 1.03 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.88 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 1.21 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.13 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 1.04 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.97 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 1.03 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.19 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 1.0 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 1.02 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.61 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.643 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.36 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 1.08 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 1.04 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 1.46 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.24 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 1.05 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' HA ' HD21 ' A' ' 48' ' ' LEU . 49.4 t . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 1.16 111.858 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.76 110.695 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.602 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 1.17 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.16 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 1.03 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.59 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.78 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 1.03 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 1.05 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 1.03 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.81 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.403 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 1.03 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 1.36 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 1.03 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.652 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.84 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.64 111.981 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.632 ' CG2' HG23 ' A' ' 92' ' ' THR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 1.03 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.742 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 1.03 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.94 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.875 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.17 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.37 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.43 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 1.03 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 1.05 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.734 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.99 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.489 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.83 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.99 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.734 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.17 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.15 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 1.03 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.22 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 1.02 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 8' ' ' VAL . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.93 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 1.01 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 1.03 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.95 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 1.07 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 1.2 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 3.35 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 1.12 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 3.06 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.97 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 1.0 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 1.05 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.607 ' HA ' HD23 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.86 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 1.04 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 1.01 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.605 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 2.05 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 1.03 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.875 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.16 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 1.03 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 1.02 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.466 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.47 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.8 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.95 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.544 HD21 ' HH ' ' A' ' 83' ' ' TYR . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 1.03 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.88 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 1.21 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.13 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 1.04 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.97 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.549 HD23 ' HG3' ' A' ' 84' ' ' LYS . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 1.03 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.19 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.632 HG23 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 1.0 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 1.02 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' C ' HD13 ' A' ' 93' ' ' LEU . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.61 107.127 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.646 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.36 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 1.04 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.49 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 1.46 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.24 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 1.05 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 48' ' ' LEU . 77.0 t . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 1.16 111.881 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.76 109.879 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.705 ' SD ' HD21 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 1.17 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.16 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 65' ' ' GLN . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 1.03 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.59 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG13 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.78 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 1.13 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.35 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 14' ' ' SER . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 1.03 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 1.05 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 1.03 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.81 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 1.03 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 1.36 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 1.03 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.669 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.84 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.64 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 1.03 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.756 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 1.03 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.94 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.844 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.17 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.43 109.838 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.76 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 1.03 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.604 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 1.05 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.717 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.99 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.625 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.83 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.99 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.717 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.17 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.615 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.15 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 1.03 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.22 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 1.02 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 8' ' ' VAL . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.93 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 47' ' ' VAL . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 1.01 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 1.03 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.95 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 1.07 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.492 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 1.2 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 3.35 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 1.12 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 3.06 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.97 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 1.0 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 1.05 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.586 ' HA ' HD22 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 64' ' ' ASP . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.86 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 1.04 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.705 HD21 ' SD ' ' A' ' 10' ' ' MET . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 1.01 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 2.05 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 1.03 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.844 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.16 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.6 HD12 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 1.03 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 1.02 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.47 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.8 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.501 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.95 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.806 HD21 ' HH ' ' A' ' 83' ' ' TYR . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 1.03 107.891 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.806 ' HH ' HD21 ' A' ' 81' ' ' ASN . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.88 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 1.21 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.13 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 1.04 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.97 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.534 HD21 ' HG3' ' A' ' 84' ' ' LYS . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 1.03 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.19 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 1.0 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 1.02 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.61 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.36 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 1.08 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 1.04 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 1.46 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.24 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 1.05 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HA ' HD21 ' A' ' 48' ' ' LEU . 94.8 t . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 1.16 110.393 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.627 ' ND2' ' HH ' ' A' ' 66' ' ' TYR . 4.3 p-10 -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.76 110.4 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.585 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 1.17 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.16 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 1.03 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.59 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.548 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.78 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 1.13 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.35 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 14' ' ' SER . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 1.03 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 1.05 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 1.03 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.416 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.81 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 1.03 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 1.36 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 1.03 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.619 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.84 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.676 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.64 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.636 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 1.03 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 1.03 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' HA ' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.94 113.476 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.86 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.17 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.37 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.43 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 1.03 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 1.05 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.688 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.99 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.589 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.83 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.99 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.688 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.17 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.626 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.15 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 1.03 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.22 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 1.02 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.93 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 1.01 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 1.03 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.95 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.416 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 1.07 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.479 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 1.2 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 3.35 110.715 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 1.12 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.416 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 3.06 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.97 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 1.0 111.7 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 1.05 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.58 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' HH ' ' ND2' ' A' ' 9' ' ' ASN . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.86 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 1.04 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 1.01 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 2.05 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 1.03 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.86 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.16 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.587 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 1.03 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 1.02 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.47 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG23 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.8 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.95 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.696 HD21 ' HH ' ' A' ' 83' ' ' TYR . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 1.03 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' HH ' HD21 ' A' ' 81' ' ' ASN . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.88 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' HD22 ' A' ' 90' ' ' LEU . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 1.21 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.13 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 1.04 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.97 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 84' ' ' LYS . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 1.03 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.19 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.636 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 1.02 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.61 106.607 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.626 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.36 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 1.08 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 1.04 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.24 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 1.05 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 48' ' ' LEU . 75.3 t . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 1.16 111.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 48' ' ' LEU . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.76 110.306 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.622 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 1.17 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.16 116.53 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 1.03 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.59 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.549 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.78 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 1.13 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 1.03 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 1.05 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 1.03 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.81 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 1.03 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 1.36 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 1.03 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.522 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.84 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.64 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 1.03 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 1.03 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' HA ' HG13 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.94 113.213 177.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.861 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.17 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.37 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.43 109.994 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.764 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 1.03 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 1.05 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.76 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.99 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.64 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.595 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.99 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.17 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.734 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.15 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 1.03 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.22 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 1.02 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.93 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 mm100 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.56 ' CD1' HD11 ' A' ' 93' ' ' LEU . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 1.01 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 1.03 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.95 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.637 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 1.07 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 1.2 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 3.35 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 1.12 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 3.06 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.97 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 55' ' ' SER . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 1.0 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 1.05 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.86 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 1.04 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 1.01 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 2.05 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.557 HG23 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 1.03 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.861 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.16 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.622 HD12 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 1.03 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 1.02 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.423 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.47 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.8 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.95 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.557 ' CG ' HG23 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.444 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 1.03 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.88 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.582 ' HG3' HD22 ' A' ' 90' ' ' LEU . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 1.21 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.13 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 1.04 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.531 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.97 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD22 ' HG3' ' A' ' 84' ' ' LYS . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 1.03 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.19 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 26' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 1.0 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 1.02 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.61 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.734 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.36 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 1.08 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 1.04 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 1.46 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.24 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 1.05 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 1.16 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.527 ' ND2' ' HH ' ' A' ' 66' ' ' TYR . 2.4 p-10 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.76 110.174 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.609 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 1.17 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.16 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 1.03 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.59 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.529 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.78 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 1.13 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.35 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 14' ' ' SER . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 1.03 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 1.05 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 1.03 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.447 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.81 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 1.03 111.217 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 1.36 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 1.03 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.84 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.64 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' CG2' HG23 ' A' ' 92' ' ' THR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 1.03 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 1.03 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.94 114.436 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.854 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.17 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.37 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.43 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 1.03 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 1.05 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.867 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.99 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.83 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.661 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.99 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.17 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.15 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 1.03 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.22 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 1.02 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.93 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 47' ' ' VAL . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 1.01 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 1.03 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 1.07 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.507 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 1.2 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 3.35 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 1.12 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 3.06 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.97 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 1.0 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 1.05 109.629 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HA ' HD22 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.527 ' HH ' ' ND2' ' A' ' 9' ' ' ASN . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.86 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 1.04 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 1.01 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 2.05 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 1.03 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.854 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.16 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.64 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 1.03 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 1.02 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.47 110.929 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.8 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.95 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 1.03 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.88 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.548 ' HG3' HD21 ' A' ' 90' ' ' LEU . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 1.21 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.13 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 1.04 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.748 ' HH ' ' HG1' ' A' ' 92' ' ' THR . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.97 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.548 HD21 ' HG3' ' A' ' 84' ' ' LYS . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 1.03 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.19 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.748 ' HG1' ' HH ' ' A' ' 89' ' ' TYR . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 1.02 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.61 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.67 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.36 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 1.08 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 1.04 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 1.46 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.24 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 1.05 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t . . . . . 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 1.16 112.395 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.76 110.578 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.602 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 1.17 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.16 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 1.03 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.59 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.78 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 1.13 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.35 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 14' ' ' SER . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 1.03 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 1.05 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 1.03 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 30.2 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.81 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 1.03 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 1.36 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 1.03 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.511 ' CB ' HD22 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.84 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.64 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.605 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 1.03 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 1.03 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.94 113.569 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.17 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.37 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.43 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 1.03 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 1.05 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.616 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.99 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.533 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.83 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.99 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.647 ' NE1' HD13 ' A' ' 73' ' ' ILE . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.17 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.705 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.15 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 1.03 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.22 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.566 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 1.02 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 8' ' ' VAL . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.93 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 47' ' ' VAL . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 1.01 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 1.03 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.95 108.202 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 1.07 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.457 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 1.2 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 3.35 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 1.12 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 3.06 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HB3' HD12 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.97 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 1.0 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 1.05 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 66' ' ' TYR . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.579 ' O ' ' HG3' ' A' ' 85' ' ' PRO . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.86 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 1.04 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 1.01 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 2.05 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 1.03 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.878 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.16 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.647 HD13 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 1.03 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 1.02 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.412 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.47 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.434 ' HD1' HG23 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.8 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.518 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.95 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.602 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 1.03 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.88 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.532 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 1.21 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.579 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.13 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.532 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 1.04 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.97 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 1.03 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.19 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.605 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 1.02 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.61 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.705 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.36 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 1.08 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 1.04 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 1.46 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.24 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 1.05 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.574 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 1.16 110.326 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.535 HD22 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.76 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.769 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 1.17 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' HA2' HD22 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.16 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 1.03 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.59 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' HG11 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.78 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 1.13 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.35 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 14' ' ' SER . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 1.03 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 1.05 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 1.03 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.81 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 1.03 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 1.36 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 1.03 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.536 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.84 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.64 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.626 ' CG2' HG23 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 1.03 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 1.03 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.94 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.856 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.17 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.37 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.43 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 1.03 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 1.05 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.665 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.99 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.611 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.83 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.99 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.665 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.17 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.63 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.15 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 1.03 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.22 112.755 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 1.02 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.93 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 47' ' ' VAL . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 1.01 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.486 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 1.03 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.95 108.56 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 1.07 110.695 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.485 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 1.2 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 3.35 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 1.12 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 3.06 110.764 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.97 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 1.0 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 1.05 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 64' ' ' ASP . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.86 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 1.04 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.769 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 2.05 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 1.03 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.16 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.589 HD13 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 1.03 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 1.02 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.456 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.47 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.8 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.95 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.581 ' CG ' HG23 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.88 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 1.21 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.13 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 1.04 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.97 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 84' ' ' LYS . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 1.03 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.19 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.626 HG23 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 1.0 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 1.02 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.61 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.63 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.36 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 1.08 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 1.04 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 1.46 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.24 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 1.05 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HA ' HD21 ' A' ' 48' ' ' LEU . 80.1 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 1.16 110.969 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.76 110.425 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.747 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 1.17 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.16 116.822 172.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 1.03 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.59 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.625 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.78 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 1.13 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.35 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 1.03 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 1.05 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 1.03 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.81 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 1.03 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 1.36 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 1.03 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.84 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.64 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 1.03 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 1.03 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.94 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.17 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.37 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.43 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.768 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 1.03 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.593 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 1.05 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.99 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.522 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.83 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB1' ' OD1' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.99 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.17 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.693 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.15 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.455 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 1.03 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.22 112.568 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 1.02 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.93 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 47' ' ' VAL . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 1.01 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 1.03 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.95 108.347 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 1.07 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.492 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 1.2 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 3.35 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 1.12 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 3.06 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.97 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 1.05 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 66' ' ' TYR . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.86 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 1.04 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.747 HD23 ' SD ' ' A' ' 10' ' ' MET . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 1.01 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 2.05 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG22 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 1.03 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.16 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.664 HD13 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.03 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 1.02 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.47 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' HG22 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.8 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.95 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' CG ' HG22 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 1.03 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.88 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HG3' HD21 ' A' ' 90' ' ' LEU . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 1.21 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.13 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 1.04 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.97 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD21 ' HG3' ' A' ' 84' ' ' LYS . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 1.03 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.19 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 1.02 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.61 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.693 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.36 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 1.08 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 1.04 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 1.46 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.24 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 1.05 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD22 ' A' ' 48' ' ' LEU . 84.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.224 0.535 . . . . 1.16 112.403 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.44 ' O ' HD21 ' A' ' 48' ' ' LEU . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.76 109.697 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.608 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 1.17 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.16 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 65' ' ' GLN . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 1.03 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.59 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.569 ' O ' HG11 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.78 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.35 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.569 HG11 ' O ' ' A' ' 14' ' ' SER . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 1.03 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 1.05 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 1.03 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.464 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 32.9 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.81 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 1.03 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 1.36 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 1.03 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.606 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.84 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.64 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 1.03 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 1.03 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.94 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.17 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.598 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.37 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.43 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.788 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 1.03 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 1.05 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.99 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.466 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.83 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.99 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.627 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.15 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 1.03 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.22 112.288 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.585 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 1.02 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 8' ' ' VAL . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.93 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 47' ' ' VAL . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 1.01 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 1.03 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.95 108.417 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 1.07 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 1.2 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 3.35 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 1.12 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 3.06 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.97 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 1.0 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 1.05 109.532 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' HD23 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HB2' HD21 ' A' ' 82' ' ' LEU . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.86 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 1.04 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 1.01 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 2.05 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 1.03 111.836 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.16 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 1.03 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 1.02 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.47 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.462 ' CD1' HG22 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.8 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.95 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.88 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 1.21 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.13 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 1.04 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.97 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 1.03 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.19 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.596 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 1.0 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 1.02 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.61 106.675 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.627 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.36 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 39' ' ' SER . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 1.08 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 1.04 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 1.46 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.24 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 1.05 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 1.16 112.065 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.76 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 1.17 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.16 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 1.03 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.59 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG13 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.78 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 1.13 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.35 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 1.03 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 1.05 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 1.03 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.4 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.81 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 1.03 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 1.36 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 1.03 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.626 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.84 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.663 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.64 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.614 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 1.03 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 1.03 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.94 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.17 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.619 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.37 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.43 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 1.03 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 1.05 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.718 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.99 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.83 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.99 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.718 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.17 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.15 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.498 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 1.03 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.22 112.427 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 1.02 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.93 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 47' ' ' VAL . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 1.01 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 1.03 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.95 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 1.07 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.486 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 1.2 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 3.35 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 1.12 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 3.06 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.97 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 1.0 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 1.05 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.86 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 1.04 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 1.01 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 2.05 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 1.03 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.869 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.16 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.6 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 1.03 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 1.02 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.47 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.498 ' CD1' HG23 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.8 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.503 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.95 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 1.03 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.88 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.639 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 1.21 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.13 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 1.04 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.97 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 84' ' ' LYS . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 1.03 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.19 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.614 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 1.0 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 1.02 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.61 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.624 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.36 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 1.08 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 1.04 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 1.46 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.24 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 1.05 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.5 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 1.16 111.887 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.76 110.956 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.638 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 1.17 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.16 115.762 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 1.03 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.59 110.24 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.78 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 1.13 110.607 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.35 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.51 HG11 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 1.03 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 1.05 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 1.03 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.486 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.81 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 1.03 111.264 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 1.36 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 1.03 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.647 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.84 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.64 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 1.03 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.717 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 1.03 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.94 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.866 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.17 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.37 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.43 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.773 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 1.03 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.617 ' HA ' ' CZ2' ' A' ' 41' ' ' TRP . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 1.05 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.654 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.99 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.83 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.99 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.745 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.17 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.15 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 1.03 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.22 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 1.02 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.93 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 1.01 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 1.03 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.95 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 1.07 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.472 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 1.2 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 3.35 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 1.12 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 3.06 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.97 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 62' ' ' THR . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 1.0 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 61' ' ' ILE . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 1.05 109.876 172.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.614 ' HA ' HD22 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 82' ' ' LEU . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.86 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 1.04 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 1.01 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 2.05 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 1.03 112.589 -169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.866 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.16 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD13 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 1.03 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 1.02 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.47 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.8 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' HD12 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.95 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 1.03 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.88 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 90' ' ' LEU . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 1.21 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.13 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 1.04 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.97 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 84' ' ' LYS . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 1.03 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.19 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.596 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 1.02 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.61 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.72 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.36 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 1.08 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 1.04 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 1.46 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.24 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.165 -0.374 . . . . 9.71 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -133.89 -58.84 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.593 0.235 . . . . 9.67 110.699 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -64.38 -68.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 8.44 111.23 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 p -170.88 -69.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.186 -0.461 . . . . 6.12 109.977 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -152.4 140.73 20.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 6.53 110.084 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.4 m 62.8 94.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.014 0.822 . . . . 2.03 111.543 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.86 -57.41 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.955 -1.021 . . . . 2.01 112.081 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HA ' HD21 ' A' ' 48' ' ' LEU . 98.2 t 62.36 107.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 1.16 111.518 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.76 109.993 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 1.17 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.16 116.878 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 1.03 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.59 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.78 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 1.13 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.35 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 1.03 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 1.05 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 1.03 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.478 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.81 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 1.03 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 1.36 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 1.03 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.499 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.84 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.754 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.64 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.633 ' CG2' HG23 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.03 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 1.03 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.94 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.17 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.37 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.43 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 1.03 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 1.05 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.673 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.99 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.449 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.83 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.664 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.99 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.673 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.17 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.15 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 1.03 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.22 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 1.02 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.93 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 1.01 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.573 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 1.03 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.95 108.22 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 1.07 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.484 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 1.2 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 3.35 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 1.12 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 3.06 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.97 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 1.0 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 1.05 109.296 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 66' ' ' TYR . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.604 ' HA ' HD22 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 82' ' ' LEU . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.86 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 1.04 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 10' ' ' MET . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 1.01 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.455 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 2.05 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG23 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 1.03 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.16 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.588 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 1.03 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.52 HG22 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 1.02 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t30 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.47 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HG22 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.8 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' HD13 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.95 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.528 ' CG ' HG23 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 1.03 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.88 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HG3' HD21 ' A' ' 90' ' ' LEU . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 1.21 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.542 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.13 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 1.04 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.97 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD21 ' HG3' ' A' ' 84' ' ' LYS . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 1.03 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.19 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.633 HG23 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 1.0 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 1.02 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.57 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.5 t30 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.61 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.36 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.565 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 1.08 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 1.04 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 1.46 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.24 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 110' ' ' ASP . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 1.05 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.93 178.24 28.23 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -124.35 159.54 30.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.41 . . . . 1.18 111.039 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.19 -140.77 3.11 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.757 -0.656 . . . . 2.58 111.911 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.57 62.04 6.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.835 0.35 . . . . 3.93 111.309 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.12 49.2 73.53 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.144 -0.551 . . . . 2.52 112.609 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -136.2 157.11 47.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.466 . . . . 5.52 110.682 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -82.45 100.82 10.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.516 0.674 . . . . 1.4 110.015 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -64.45 -62.31 1.68 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.614 -1.176 . . . . 2.21 110.083 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.564 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 17.6 m-20 -117.54 3.97 12.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.623 -0.717 . . . . 2.37 110.223 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 25' ' ' ARG . 2.1 mm? -83.16 170.54 14.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.725 -0.67 . . . . 1.23 111.024 -170.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -157.76 -34.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.07 -0.968 . . . . 1.68 109.978 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 114.994 -1.003 . . . . 3.87 111.127 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.078 -0.409 . . . . 9.71 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -140.95 149.65 42.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.539 . . . . 9.67 109.543 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt 68.13 96.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.868 0.73 . . . . 8.44 110.284 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m 66.42 -175.53 0.19 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.693 -0.685 . . . . 6.12 110.533 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -150.24 130.5 13.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.315 -0.254 . . . . 6.53 110.315 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -82.0 126.49 32.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.961 -0.385 . . . . 2.03 109.961 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 41.9 mt-10 -145.04 -47.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.057 -0.52 . . . . 2.01 111.354 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 48' ' ' LEU . 21.5 t 48.12 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.25 0.62 . . . . 1.16 112.655 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.742 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.623 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.17 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.16 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 1.03 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.59 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.78 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 1.13 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.35 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 1.03 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 1.05 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.593 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 1.03 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.482 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.81 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 1.03 110.126 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 1.36 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 1.03 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.84 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.64 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 1.03 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 1.03 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.94 114.258 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.17 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.635 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.43 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 1.05 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.661 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.99 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.578 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.578 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.466 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.83 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.99 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.17 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.596 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.15 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 1.03 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.691 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.22 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 1.02 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.93 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.691 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 47' ' ' VAL . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 1.01 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.633 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 1.03 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.95 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.443 HG22 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 1.07 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.633 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 1.2 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 3.35 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 1.12 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.443 ' NE ' HG22 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 3.06 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.97 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 1.0 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.405 ' H ' ' HB ' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 1.05 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.596 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.441 ' CD1' HD21 ' A' ' 82' ' ' LEU . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.86 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 1.04 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 1.01 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 2.05 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 1.03 112.432 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.16 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD12 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 1.03 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 1.02 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.47 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.469 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.8 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.95 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.515 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 1.03 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.88 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 1.21 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.13 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 1.04 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.97 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 1.03 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.19 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 1.02 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.61 106.671 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.596 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.36 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 1.08 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 1.04 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 1.46 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.24 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 1.05 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.42 -173.29 33.86 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -138.01 91.77 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.564 0.697 . . . . 1.18 111.326 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.74 -32.41 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.71 -0.757 . . . . 2.58 112.564 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.3 57.99 4.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.47 . . . . 3.93 111.382 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.06 -132.97 11.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 2.52 112.653 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -92.9 -46.97 7.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.135 0.493 . . . . 5.52 110.446 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.09 86.95 2.58 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.216 0.531 . . . . 1.4 111.262 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.94 -58.38 8.13 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.178 -0.919 . . . . 2.21 110.57 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.63 -14.54 11.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.115 -0.948 . . . . 2.37 110.158 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.3 mm? -73.65 162.88 28.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.616 -1.175 . . . . 1.23 112.04 -162.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -146.94 -25.96 0.4 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.501 -1.227 . . . . 1.68 110.851 -171.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.556 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 21.6 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.447 -0.787 . . . . 3.87 111.223 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.859 -0.496 . . . . 9.71 111.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 m170 58.48 33.07 22.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.99 0.424 . . . . 9.67 111.449 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.7 ttm -74.13 -33.94 63.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 8.44 110.559 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.41 28.82 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.75 -0.659 . . . . 6.12 110.554 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 5' ' ' ARG . 13.1 mmm180 -124.37 101.29 7.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.513 0.561 . . . . 6.53 112.513 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 p 40.13 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.929 1.393 . . . . 2.03 114.315 172.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.95 -46.13 18.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.857 -1.065 . . . . 2.01 111.653 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' HA ' HD22 ' A' ' 48' ' ' LEU . 39.0 t 41.39 88.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 1.16 113.032 -176.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.76 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.608 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 1.17 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.16 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 1.03 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.59 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.78 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 1.13 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.35 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 1.03 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 1.05 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 1.03 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.502 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.81 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 1.03 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 1.36 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 1.03 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.532 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.84 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.64 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.703 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 1.03 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 1.03 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.94 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.17 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.37 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.43 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 1.03 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 1.05 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.663 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.99 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.481 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.83 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.99 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.663 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.17 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.15 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 1.03 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.22 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 1.02 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.93 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 1.01 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 1.03 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.95 108.203 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 1.07 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.49 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 1.2 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 3.35 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 1.12 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 3.06 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.49 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.97 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 1.0 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 1.05 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.612 ' HA ' HD23 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.86 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 1.04 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 1.01 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 2.05 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG23 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 1.03 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.16 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 1.03 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 1.02 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.47 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.8 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.53 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.95 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.59 ' CG ' HG23 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 1.03 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.88 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' HD23 ' A' ' 90' ' ' LEU . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 1.21 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.13 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 1.04 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.97 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD23 ' HG3' ' A' ' 84' ' ' LYS . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 1.03 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.19 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 1.0 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 1.02 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.61 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.36 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 1.08 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 1.04 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 1.46 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.24 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 1.05 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.84 179.53 31.48 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -124.96 171.44 10.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.253 0.526 . . . . 1.18 110.083 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.71 -143.45 7.54 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.658 -0.782 . . . . 2.58 112.056 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.78 100.4 12.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 3.93 110.961 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.37 -163.92 26.34 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.816 -0.706 . . . . 2.52 112.259 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.45 -35.89 9.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.857 0.36 . . . . 5.52 111.178 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.428 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -135.69 121.85 20.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.578 . . . . 1.4 112.168 -173.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.99 -60.19 2.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.022 -0.99 . . . . 2.21 110.055 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 15.8 m-20 -114.31 -1.43 13.57 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.128 -0.942 . . . . 2.37 110.286 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 108' ' ' ALA . 2.4 mm? -81.03 162.24 23.87 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.274 -0.876 . . . . 1.23 110.979 -167.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -142.3 -23.46 0.67 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.72 -1.127 . . . . 1.68 110.749 -171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.703 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p90 . . . . . 0 C--O 1.252 1.202 0 CA-C-N 115.718 -0.674 . . . . 3.87 111.008 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.235 -0.346 . . . . 9.71 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 55.07 76.78 0.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.312 0.645 . . . . 9.67 111.19 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ttt 55.22 61.57 2.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.619 -0.719 . . . . 8.44 110.535 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -68.84 154.98 41.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.465 -0.789 . . . . 6.12 110.933 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -79.31 62.1 3.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.493 -0.929 . . . . 6.53 108.493 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 m -151.26 89.93 1.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.558 -0.746 . . . . 2.03 111.07 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -96.24 -56.66 2.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 2.01 111.218 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 48' ' ' LEU . 47.5 t 56.8 92.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 1.16 111.913 -176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.437 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.76 110.699 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.597 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 1.17 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.16 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 1.03 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.59 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.78 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 1.13 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.35 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 1.03 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 1.05 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 1.03 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.428 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 34.0 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.81 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 1.03 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 1.36 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 1.03 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.493 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.84 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.705 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.64 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.688 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 1.03 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.727 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 1.03 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.94 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.17 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.37 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.43 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 1.03 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.791 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.99 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.604 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.83 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.615 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.99 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.791 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.17 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.15 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 1.03 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.22 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 1.02 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.93 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 1.01 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.562 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 1.03 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.95 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 1.07 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.473 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 1.2 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 3.35 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 1.12 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 3.06 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.97 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.678 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 1.05 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.86 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 1.04 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 1.01 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 2.05 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 1.03 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.846 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.16 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.635 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 1.03 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 1.02 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.47 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.8 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.95 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' CG ' HG22 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.621 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.88 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 1.21 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.13 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 1.04 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.97 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD21 ' HG3' ' A' ' 84' ' ' LYS . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 1.03 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.19 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.615 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 1.0 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 1.02 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.61 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.667 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.36 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 1.08 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 1.04 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.24 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 1.05 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.54 38.88 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -134.68 24.92 3.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.27 0.535 . . . . 1.18 110.446 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.75 85.54 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.623 -0.717 . . . . 2.58 112.346 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.11 -21.77 49.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.225 0.536 . . . . 3.93 110.298 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.34 -81.46 1.55 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.551 -0.75 . . . . 2.52 112.567 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -67.26 93.39 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.336 0.255 . . . . 5.52 110.465 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.419 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . 46.41 71.39 0.3 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.476 0.655 . . . . 1.4 111.261 -173.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -51.93 -55.76 18.27 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.464 -1.244 . . . . 2.21 110.415 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -117.88 -12.99 10.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.44 -0.8 . . . . 2.37 110.007 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 108' ' ' ALA . 1.9 mm? -73.96 162.02 29.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.945 -1.025 . . . . 1.23 112.241 -161.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.93 -24.23 2.96 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.927 -1.488 . . . . 1.68 110.363 -173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.688 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 17.7 p90 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.586 -0.734 . . . . 3.87 110.608 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.321 -0.312 . . . . 9.71 112.321 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -85.6 -30.99 22.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 9.67 110.254 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 tpt -98.85 -48.93 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.126 0.488 . . . . 8.44 110.499 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -85.93 76.88 9.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.235 0.541 . . . . 6.12 109.942 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -76.87 125.98 30.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.596 -0.729 . . . . 6.53 109.918 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -143.03 88.31 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.885 0.85 . . . . 2.03 111.706 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.6 -48.3 6.15 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.431 -1.258 . . . . 2.01 111.017 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.575 ' HA ' HD21 ' A' ' 48' ' ' LEU . 44.6 t 48.97 89.02 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 123.839 0.712 . . . . 1.16 112.294 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 48' ' ' LEU . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.76 110.577 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 1.17 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.16 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD22 ' HA ' ' A' ' 65' ' ' GLN . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 1.03 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.59 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.78 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 1.13 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.35 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 1.03 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 1.05 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 1.03 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.81 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 1.03 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 1.36 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 1.03 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.494 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.84 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.64 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.626 ' CG2' HG22 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 1.03 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 1.03 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.94 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.861 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.17 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.602 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.37 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.43 110.727 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 1.03 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 1.05 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.876 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.99 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.83 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.606 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.99 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.876 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.17 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.652 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.15 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 1.03 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.22 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 1.02 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 8' ' ' VAL . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.93 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 1.01 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.549 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 1.03 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.95 108.143 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 1.07 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.475 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 1.2 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 3.35 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 1.12 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 3.06 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.97 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 1.05 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 66' ' ' TYR . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.576 ' HA ' HD22 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.86 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 1.04 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.639 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 1.01 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 2.05 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 1.03 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.861 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.16 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 1.03 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 1.02 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.47 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.8 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.513 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.95 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 1.03 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.88 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 1.21 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.13 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 1.04 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.97 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 HD21 ' HG3' ' A' ' 84' ' ' LYS . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 1.03 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.19 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.626 HG22 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 1.0 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 1.02 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.61 107.069 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.652 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.36 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 1.08 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 1.04 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 1.46 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.24 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 1.05 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -99.48 -163.19 29.32 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.49 35.77 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.545 0.688 . . . . 1.18 110.138 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.68 -31.35 7.48 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.365 -0.834 . . . . 2.58 112.276 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 109' ' ' ASP . . . -80.1 -43.33 21.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 3.93 111.19 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.87 -156.46 27.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.662 -0.78 . . . . 2.52 112.087 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -52.52 -41.87 63.85 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.431 0.292 . . . . 5.52 111.655 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 111' ' ' LEU . . . -120.22 75.23 1.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.648 0.737 . . . . 1.4 110.532 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 105' ' ' ALA . 17.5 t70 -54.69 -56.56 17.93 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.354 -1.294 . . . . 2.21 109.677 173.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 9.6 m-20 -119.98 -2.84 10.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.364 -0.835 . . . . 2.37 110.42 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 108' ' ' ALA . 2.2 mm? -75.89 167.36 22.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.775 -0.648 . . . . 1.23 111.475 -167.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.13 -27.32 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.16 -0.927 . . . . 1.68 110.432 -172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.44 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 23.6 p90 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.866 -1.061 . . . . 3.87 111.678 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 111.786 -0.525 . . . . 9.71 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 58.1 73.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 9.67 110.915 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptm -94.48 -10.82 31.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.764 -0.458 . . . . 8.44 109.764 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 m 67.73 117.42 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.106 -0.952 . . . . 6.12 112.123 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -90.51 39.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.462 0.649 . . . . 6.53 109.916 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -140.92 69.04 1.34 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.295 1.045 . . . . 2.03 110.445 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -91.64 -56.53 3.07 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.745 -1.571 . . . . 2.01 111.985 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HA ' HD21 ' A' ' 48' ' ' LEU . 76.8 t 56.71 97.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 1.16 112.002 -173.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.411 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.76 109.913 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.621 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 1.17 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.16 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 1.03 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.59 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG11 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.78 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 1.13 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.35 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 14' ' ' SER . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 1.03 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 1.05 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.6 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 1.03 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.81 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.438 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 1.03 110.672 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 1.36 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 1.03 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.84 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.627 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.64 111.487 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.622 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 1.03 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 1.03 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.94 113.68 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.17 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.37 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.43 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.782 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 1.03 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 1.05 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.687 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.99 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.577 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.436 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.83 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.99 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.17 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.687 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.15 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 1.03 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.22 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 1.02 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.93 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 1.01 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.677 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 1.03 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.95 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 1.07 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.677 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 1.2 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 3.35 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 1.12 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 3.06 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.483 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.97 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 55' ' ' SER . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 1.0 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 1.05 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.595 ' HA ' HD22 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' ASP . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 1.04 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 1.01 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 2.05 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.554 HG23 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 1.03 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.869 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.16 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 1.03 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 1.02 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.47 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.8 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.95 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.554 ' CG ' HG23 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 1.03 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.88 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 1.21 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.13 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 1.04 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.97 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 84' ' ' LYS . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 1.03 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' CZ ' HD13 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.19 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.594 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 1.02 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.61 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.687 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.36 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 1.08 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 1.04 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.5 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 1.46 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.24 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HG3' ' A' ' 25' ' ' ARG . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 1.05 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.02 176.29 33.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.627 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 30.2 p-10 -132.44 -4.04 3.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.65 0.725 . . . . 1.18 111.889 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.93 68.53 2.25 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.24 -0.505 . . . . 2.58 113.076 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.86 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.851 0.46 . . . . 3.93 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.78 -174.58 42.87 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.715 -0.755 . . . . 2.52 111.668 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 52.48 -96.24 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.327 0.651 . . . . 5.52 112.401 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.71 125.19 4.66 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.896 0.855 . . . . 1.4 110.187 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' HB2' HH21 ' A' ' 25' ' ' ARG . 51.1 t0 -83.77 -64.16 1.22 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.337 -1.301 . . . . 2.21 110.845 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -116.69 -5.3 11.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 2.37 111.226 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.24 163.65 27.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.708 0.766 . . . . 1.23 111.94 -166.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.81 -30.99 0.35 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.452 -1.249 . . . . 1.68 110.642 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.622 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 12.1 p90 . . . . . 0 C--O 1.246 0.909 0 CA-C-N 115.522 -0.763 . . . . 3.87 110.971 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.171 -0.372 . . . . 9.71 112.171 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -154.3 68.29 0.74 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.221 0.534 . . . . 9.67 109.614 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.03 -33.91 70.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 8.44 111.014 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.5 t -93.75 113.38 25.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.917 -0.583 . . . . 6.12 109.93 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 3.2 mpt_? -82.48 -38.26 24.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.439 -0.948 . . . . 6.53 108.439 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t 61.35 103.84 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.93 -1.032 . . . . 2.03 112.04 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -109.5 -42.05 4.43 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.79 -1.095 . . . . 2.01 111.018 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' HD22 ' A' ' 48' ' ' LEU . 41.1 t 46.01 86.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 123.766 0.666 . . . . 1.16 112.502 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.76 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.627 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 1.17 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.16 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 1.03 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.59 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.534 ' O ' HG13 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.78 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 1.13 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.35 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 14' ' ' SER . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 1.03 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 1.03 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.536 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.81 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 1.03 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 1.36 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 1.03 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.457 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.84 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.64 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' CG2' HG23 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 1.03 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 1.03 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.94 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.17 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.37 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.43 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 1.03 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 1.05 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.99 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.83 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.99 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.17 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.641 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.15 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 1.03 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.22 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 1.02 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 8' ' ' VAL . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.93 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 1.01 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.509 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 1.03 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.95 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 1.07 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 1.2 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 3.35 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 1.12 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 3.06 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.97 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 1.0 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 1.05 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD23 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 64' ' ' ASP . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.86 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 1.04 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 1.01 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 2.05 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG23 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 1.03 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.16 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 HD13 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 1.03 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 1.02 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.47 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.8 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.95 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CG ' HG23 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 1.03 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.88 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HG3' HD23 ' A' ' 90' ' ' LEU . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 1.21 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.13 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 1.04 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.97 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 84' ' ' LYS . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 1.03 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.19 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.576 HG23 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 1.0 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 1.02 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.61 106.619 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.641 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.36 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 1.08 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 1.04 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.24 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.55 ' O ' HG21 ' A' ' 101' ' ' VAL . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 1.05 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.65 -168.34 33.85 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -138.35 178.93 6.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.171 -0.307 . . . . 1.18 110.171 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.58 -48.6 0.92 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.712 -0.756 . . . . 2.58 111.902 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.07 89.42 7.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.691 0.281 . . . . 3.93 111.146 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.45 -141.9 48.07 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 2.52 112.248 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.14 -50.32 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.817 -0.438 . . . . 5.52 109.817 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.07 87.01 5.99 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.438 0.637 . . . . 1.4 110.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -64.26 -53.3 51.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.885 -1.052 . . . . 2.21 109.916 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -115.91 -17.22 11.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.317 -0.856 . . . . 2.37 110.18 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -80.84 167.89 19.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.901 -1.045 . . . . 1.23 112.391 -162.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -126.79 1.95 6.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.539 -1.664 . . . . 1.68 107.527 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.469 ' HH ' HD11 ' A' ' 111' ' ' LEU . 5.4 p90 . . . . . 0 N--CA 1.438 -1.052 0 CA-C-N 113.734 -1.575 . . . . 3.87 110.615 -172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.068 -0.413 . . . . 9.71 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -86.71 112.0 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.343 -0.243 . . . . 9.67 110.343 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.4 mmm 70.15 128.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.937 0.773 . . . . 8.44 111.733 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m 62.08 88.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.334 -0.848 . . . . 6.12 111.266 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.45 110.11 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.866 -0.607 . . . . 6.53 110.043 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -128.37 92.53 3.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.552 0.691 . . . . 2.03 111.074 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.77 -49.33 11.27 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.972 -1.013 . . . . 2.01 111.159 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 48' ' ' LEU . 44.9 t 42.71 79.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 1.16 112.117 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.76 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.599 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 1.17 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.16 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 1.03 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.59 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.78 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 1.13 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.35 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 1.03 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 1.05 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 1.03 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.81 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 23' ' ' ALA . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 1.36 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 21' ' ' ARG . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 1.03 110.312 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.597 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.84 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.64 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' CG2' HG23 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 1.03 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.719 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 1.03 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.94 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.845 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.17 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.62 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.37 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.43 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 1.03 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.62 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 1.05 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 37' ' ' ASN . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.868 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.99 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.49 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.83 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.99 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.868 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.17 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.704 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.15 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 1.03 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.22 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 1.02 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 8' ' ' VAL . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.93 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 47' ' ' VAL . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.01 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 1.03 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.95 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.476 HG22 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 1.07 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.464 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 1.2 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 3.35 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 1.12 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.476 ' NE ' HG22 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 3.06 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.97 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 1.0 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 1.05 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HA ' HD23 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 82' ' ' LEU . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.86 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 1.04 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 1.01 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.642 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 2.05 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 1.03 112.04 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.845 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.16 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 1.03 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.02 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.47 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.8 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.95 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 1.03 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.88 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 1.21 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.581 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.13 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 1.04 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.97 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 84' ' ' LYS . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 1.03 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.19 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 1.0 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 1.02 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.61 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.704 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.36 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 1.08 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 1.04 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 1.46 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.24 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 1.05 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.6 -118.43 0.38 Allowed Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -155.27 -68.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.628 -0.508 . . . . 1.18 109.628 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.98 -144.14 42.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.218 -0.515 . . . . 2.58 112.853 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.82 169.39 8.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.571 0.225 . . . . 3.93 110.612 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.26 34.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.83 -0.7 . . . . 2.52 112.421 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -117.84 -9.46 10.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 5.52 110.984 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -134.25 119.98 19.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.846 0.831 . . . . 1.4 112.552 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.11 -54.07 3.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.211 -1.359 . . . . 2.21 109.742 171.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.513 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 8.9 m-20 -115.85 -1.17 12.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.335 -0.848 . . . . 2.37 109.525 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 108' ' ' ALA . 2.6 mm? -81.4 164.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.159 -0.928 . . . . 1.23 111.514 -165.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.38 5.46 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.586 -1.188 . . . . 1.68 109.757 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-N 114.909 -1.041 . . . . 3.87 111.344 -167.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.678 -0.569 . . . . 9.71 111.678 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 58.24 67.38 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.93 0.395 . . . . 9.67 110.747 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -79.76 119.88 23.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.872 -0.418 . . . . 8.44 109.872 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -68.54 118.89 12.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.2 -0.454 . . . . 6.12 109.81 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.01 141.39 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 6.53 111.066 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 p -96.02 87.34 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.908 0.861 . . . . 2.03 110.821 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.7 mm-40 -89.83 -61.59 1.66 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.675 -1.148 . . . . 2.01 111.997 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' A' ' 48' ' ' LEU . 45.7 t 57.69 90.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 1.16 111.867 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.714 ' SD ' HD21 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 1.17 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.16 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 1.03 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.59 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.78 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 1.13 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.35 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 14' ' ' SER . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 1.03 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 1.05 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 1.03 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.81 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 1.03 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 1.36 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 1.03 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.84 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.64 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 1.03 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 1.03 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.94 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.858 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.17 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.37 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.43 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.781 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 1.03 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.613 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 1.05 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.757 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.99 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.583 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.83 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.99 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.757 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.17 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.15 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 1.03 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.22 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 1.02 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.93 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 1.01 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 1.03 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.95 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.479 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 1.07 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.648 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 1.2 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 3.35 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 1.12 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.479 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 3.06 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.97 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 1.05 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.86 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 1.04 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.714 HD21 ' SD ' ' A' ' 10' ' ' MET . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 1.01 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 2.05 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 1.03 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.858 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.16 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.638 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 1.03 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 1.02 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.47 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CD1' HG23 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.8 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.95 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' CG ' HG22 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 1.03 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.88 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 1.21 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.13 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 1.04 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.97 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 1.03 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.19 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 1.0 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 1.02 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.61 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.643 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.36 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 1.08 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 1.04 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 1.46 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.24 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 1.05 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.01 -159.79 23.51 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.91 -20.86 15.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.109 0.48 . . . . 1.18 109.968 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.31 -129.78 49.62 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.367 -0.833 . . . . 2.58 112.543 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.54 21.6 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.339 0.59 . . . . 3.93 109.762 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.82 158.63 14.68 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.348 -0.842 . . . . 2.52 111.943 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 62.99 -138.63 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.701 0.4 . . . . 5.52 111.233 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.07 106.68 16.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.4 0.619 . . . . 1.4 111.869 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.47 -64.15 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.191 -0.913 . . . . 2.21 110.315 171.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' H ' HD23 ' A' ' 111' ' ' LEU . 27.2 t70 -116.24 0.7 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.13 -0.941 . . . . 2.37 109.161 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 110' ' ' ASP . 1.9 mm? -85.71 175.23 8.84 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 1.23 112.73 -163.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.65 -30.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.595 -1.639 . . . . 1.68 106.843 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.927 0 CA-C-N 112.889 -1.959 . . . . 3.87 110.408 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.771 -0.531 . . . . 9.71 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -96.7 147.41 23.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.843 0.322 . . . . 9.67 110.329 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -120.32 154.88 34.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.175 -0.676 . . . . 8.44 109.175 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 p -94.69 144.62 25.47 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.516 -0.55 . . . . 6.12 109.516 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -82.96 -175.56 5.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.021 -0.363 . . . . 6.53 110.021 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.0 p -70.93 87.36 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.641 0.734 . . . . 2.03 110.416 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 23.1 mm-40 -85.73 -58.97 2.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.803 -1.089 . . . . 2.01 112.097 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' HA ' HD21 ' A' ' 48' ' ' LEU . 49.4 t 53.32 92.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 1.16 111.858 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.76 110.695 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.602 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 1.17 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.16 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 1.03 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.59 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.78 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 1.03 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 1.05 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 1.03 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.81 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.403 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 1.03 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 1.36 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 1.03 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.652 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.84 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.64 111.981 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.781 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 1.03 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.742 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 1.03 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.94 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.875 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.17 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.37 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.43 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 1.03 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 1.05 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.734 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.99 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.489 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.83 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.99 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.734 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.17 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.15 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 1.03 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.22 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 1.02 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 8' ' ' VAL . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.93 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 1.01 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 1.03 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.95 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 1.07 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 1.2 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 3.35 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 1.12 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 3.06 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.97 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 1.0 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 1.05 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.607 ' HA ' HD23 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.86 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 1.04 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 1.01 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.605 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 2.05 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 1.03 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.875 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.16 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 1.03 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 1.02 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.466 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.47 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.8 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.95 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.544 HD21 ' HH ' ' A' ' 83' ' ' TYR . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 1.03 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.88 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 1.21 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.13 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 1.04 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.97 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.549 HD23 ' HG3' ' A' ' 84' ' ' LYS . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 1.03 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.19 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.632 HG23 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 1.0 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 1.02 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' C ' HD13 ' A' ' 93' ' ' LEU . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.61 107.127 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.646 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.36 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 1.04 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.49 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 1.46 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.24 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 1.05 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.98 179.92 27.55 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.476 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 31.7 p-10 -129.82 15.82 5.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.2 0.5 . . . . 1.18 110.861 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.94 -32.9 34.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.868 -0.682 . . . . 2.58 112.232 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.41 -29.75 62.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.918 0.39 . . . . 3.93 111.103 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.14 173.03 49.12 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 2.52 112.243 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.2 m80 57.26 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.426 0.69 . . . . 5.52 111.569 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.0 97.48 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.092 0.472 . . . . 1.4 109.845 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.96 -60.48 3.51 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.172 -0.922 . . . . 2.21 110.95 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -12.37 11.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.597 0.713 . . . . 2.37 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 25' ' ' ARG . 1.4 mm? -75.84 161.57 28.88 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.237 -0.892 . . . . 1.23 112.262 -162.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.39 -29.1 0.16 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.93 -1.486 . . . . 1.68 110.253 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.781 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 3.6 p90 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.382 -0.827 . . . . 3.87 111.338 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.966 -0.453 . . . . 9.71 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -127.24 30.9 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 9.67 110.705 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -60.15 132.73 54.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 8.44 110.68 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 t -137.92 -99.17 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 6.12 110.082 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 5' ' ' ARG . 23.5 mtp180 56.14 -168.52 0.1 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.534 0.683 . . . . 6.53 111.719 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -135.11 91.71 2.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.619 -0.719 . . . . 2.03 109.571 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.1 mm-40 -117.07 -59.41 1.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.861 -1.063 . . . . 2.01 111.751 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 48' ' ' LEU . 77.0 t 61.67 105.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 1.16 111.881 -175.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.76 109.879 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.705 ' SD ' HD21 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 1.17 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.16 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 65' ' ' GLN . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 1.03 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.59 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG13 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.78 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 1.13 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.35 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 14' ' ' SER . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 1.03 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 1.05 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 1.03 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.81 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 1.03 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 1.36 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 1.03 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.669 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.84 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.64 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 1.03 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.756 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 1.03 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.94 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.844 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.17 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.43 109.838 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.76 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 1.03 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 1.05 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.717 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.99 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.625 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.83 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.99 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.717 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.17 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.615 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.15 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 1.03 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.22 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 1.02 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 8' ' ' VAL . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.93 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 47' ' ' VAL . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 1.01 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 1.03 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.95 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 1.07 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.492 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 1.2 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 3.35 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 1.12 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 3.06 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.97 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 1.0 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 1.05 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.586 ' HA ' HD22 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 64' ' ' ASP . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.86 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 1.04 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.705 HD21 ' SD ' ' A' ' 10' ' ' MET . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 1.01 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 2.05 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 1.03 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.844 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.16 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.6 HD12 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 1.03 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 1.02 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.47 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.8 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.501 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.95 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.806 HD21 ' HH ' ' A' ' 83' ' ' TYR . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 1.03 107.891 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.806 ' HH ' HD21 ' A' ' 81' ' ' ASN . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.88 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 1.21 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.13 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 1.04 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.97 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.534 HD21 ' HG3' ' A' ' 84' ' ' LYS . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 1.03 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.19 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 1.0 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 1.02 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.61 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.36 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 1.08 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 1.04 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 1.46 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.24 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 1.05 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.48 -172.71 32.24 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -137.28 159.62 41.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.071 0.436 . . . . 1.18 110.328 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.72 -141.04 3.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 2.58 112.264 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.92 -13.53 55.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.83 0.348 . . . . 3.93 111.468 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.89 -158.36 30.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.843 -0.694 . . . . 2.52 112.035 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -110.59 -58.72 2.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 5.52 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 111' ' ' LEU . . . -104.24 91.76 4.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.456 0.646 . . . . 1.4 111.65 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.61 -61.1 2.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.694 -1.139 . . . . 2.21 109.753 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 6.3 m-20 -118.04 -5.07 10.99 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.208 -0.906 . . . . 2.37 110.21 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 25' ' ' ARG . 1.9 mm? -69.5 165.07 21.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.399 -0.818 . . . . 1.23 111.657 -167.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.99 -30.55 0.12 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.81 -1.086 . . . . 1.68 110.809 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.501 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 14.6 p90 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.294 -0.866 . . . . 3.87 111.294 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.673 -0.571 . . . . 9.71 111.673 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -77.46 -57.86 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.872 -0.418 . . . . 9.67 109.872 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -68.6 111.51 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.107 -0.701 . . . . 8.44 109.107 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 m -100.25 -85.56 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 6.12 111.22 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.3 107.81 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.915 -0.402 . . . . 6.53 109.915 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m 56.61 81.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.853 0.835 . . . . 2.03 110.977 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 43.1 mt-10 -101.5 -61.36 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.828 -1.078 . . . . 2.01 113.555 -171.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HA ' HD21 ' A' ' 48' ' ' LEU . 94.8 t 69.08 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 1.16 110.393 -170.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.627 ' ND2' ' HH ' ' A' ' 66' ' ' TYR . 4.3 p-10 -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.76 110.4 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.585 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 1.17 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.16 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 1.03 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.59 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.548 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.78 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 1.13 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.35 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 14' ' ' SER . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 1.03 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 1.05 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 1.03 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.416 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.81 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 1.03 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 1.36 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 1.03 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.619 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.84 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.676 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.64 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.636 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 1.03 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 1.03 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' HA ' HG12 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.94 113.476 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.86 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.17 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.37 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.43 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 1.03 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 1.05 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.688 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.99 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.589 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.83 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.99 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.688 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.17 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.626 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.15 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 1.03 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.22 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 1.02 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.93 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 47' ' ' VAL . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 1.01 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 1.03 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.95 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.416 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 1.07 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.479 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 1.2 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 3.35 110.715 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 1.12 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.416 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 3.06 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.97 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 1.0 111.7 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 1.05 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.58 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' HH ' ' ND2' ' A' ' 9' ' ' ASN . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.86 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 1.04 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 1.01 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 2.05 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 1.03 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.86 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.16 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.587 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 1.03 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 1.02 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.47 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG23 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.8 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.95 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.696 HD21 ' HH ' ' A' ' 83' ' ' TYR . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 1.03 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' HH ' HD21 ' A' ' 81' ' ' ASN . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.88 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' HD22 ' A' ' 90' ' ' LEU . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 1.21 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.13 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 1.04 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.97 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 84' ' ' LYS . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 1.03 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.19 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.636 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 1.02 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.61 106.607 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.626 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.36 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 1.08 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 1.04 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.24 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 1.05 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.04 175.82 20.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -141.04 47.91 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.618 0.723 . . . . 1.18 109.242 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.09 -22.2 78.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.614 -0.721 . . . . 2.58 113.604 -173.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.13 6.58 5.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 3.93 111.89 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.89 79.48 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.778 -0.725 . . . . 2.52 112.065 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -117.91 158.61 24.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.349 -0.611 . . . . 5.52 109.349 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -63.86 92.47 0.07 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.52 0.676 . . . . 1.4 110.186 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.38 -62.01 2.2 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.39 -1.277 . . . . 2.21 110.337 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -117.62 0.42 12.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.529 -0.76 . . . . 2.37 110.987 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 25' ' ' ARG . 2.3 mm? -82.11 161.72 22.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.671 0.748 . . . . 1.23 111.555 -167.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.31 -33.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.295 -1.32 . . . . 1.68 110.513 -170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 10.7 p90 . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.976 -1.011 . . . . 3.87 111.708 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 CA-C-O 120.177 -0.235 . . . . 9.71 112.805 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.4 m80 60.77 43.9 11.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.621 0.368 . . . . 9.67 111.707 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.9 ttp -129.65 87.64 2.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.926 0.393 . . . . 8.44 110.415 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.6 t -74.56 112.31 10.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.47 -0.567 . . . . 6.12 109.47 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -98.65 166.94 11.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 6.53 111.163 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.8 m 65.61 77.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.132 0.968 . . . . 2.03 110.773 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -85.28 -61.35 1.79 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.037 -1.438 . . . . 2.01 112.273 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 48' ' ' LEU . 75.3 t 58.22 99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 1.16 111.87 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 48' ' ' LEU . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.76 110.306 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.622 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 1.17 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.16 116.53 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 1.03 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.59 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.549 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.78 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 1.13 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 1.03 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 1.05 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 1.03 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.81 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 1.03 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 1.36 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 1.03 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.522 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.84 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.64 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 1.03 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 1.03 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' HA ' HG13 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.94 113.213 177.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.861 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.17 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.37 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.43 109.994 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.764 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 1.03 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 1.05 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.76 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.99 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.64 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.595 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.99 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.17 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.734 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.15 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 1.03 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.22 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 1.02 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.93 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 mm100 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.56 ' CD1' HD11 ' A' ' 93' ' ' LEU . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 1.01 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 1.03 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.95 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.637 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 1.07 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 1.2 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 3.35 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 1.12 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 3.06 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.97 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 55' ' ' SER . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 1.0 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 1.05 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.86 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 1.04 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 1.01 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 2.05 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.557 HG23 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 1.03 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.861 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.16 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.622 HD12 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 1.03 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 1.02 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.423 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.47 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.8 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.95 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.557 ' CG ' HG23 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 1.03 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.88 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.582 ' HG3' HD22 ' A' ' 90' ' ' LEU . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 1.21 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.13 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 1.04 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.531 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.97 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD22 ' HG3' ' A' ' 84' ' ' LYS . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 1.03 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.19 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 26' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 1.0 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 1.02 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.61 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.734 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.36 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 1.08 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 1.04 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 1.46 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.24 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 1.05 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -102.28 176.54 25.61 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -113.67 177.5 4.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.421 0.611 . . . . 1.18 109.948 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.87 -35.69 2.07 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.698 -0.763 . . . . 2.58 112.012 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.26 -167.48 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.547 0.213 . . . . 3.93 110.87 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.45 -90.47 1.49 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.249 -0.977 . . . . 2.52 112.295 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -60.51 -51.55 68.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.624 0.25 . . . . 5.52 111.116 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 111' ' ' LEU . . . -164.05 127.59 2.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.36 0.6 . . . . 1.4 111.199 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.945 -1.025 . . . . 2.21 111.055 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.3 -19.4 12.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.571 0.7 . . . . 2.37 110.432 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.524 HD11 ' OH ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -80.16 166.01 21.88 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.888 -1.051 . . . . 1.23 111.488 -166.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.86 3.51 4.11 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.01 -1.45 . . . . 1.68 108.213 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.524 ' OH ' HD11 ' A' ' 111' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 113.948 -1.478 . . . . 3.87 111.017 -175.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.442 -0.663 . . . . 9.71 111.442 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -62.34 120.33 10.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.169 -0.678 . . . . 9.67 109.169 175.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttm -71.16 80.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 8.44 111.285 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.7 m -161.83 -54.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.157 -0.929 . . . . 6.12 108.735 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.681 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 18.5 tpp180 70.76 119.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.143 0.902 . . . . 6.53 110.42 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 112.15 11.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.137 0.494 . . . . 2.03 111.916 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.09 -50.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 2.01 111.696 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t 58.49 101.08 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 1.16 112.138 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.527 ' ND2' ' HH ' ' A' ' 66' ' ' TYR . 2.4 p-10 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.76 110.174 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.609 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 1.17 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.16 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 1.03 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.59 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.529 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.78 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 1.13 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.35 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 14' ' ' SER . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 1.03 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 1.05 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 1.03 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.447 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.81 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HH ' ' A' ' 28' ' ' TYR . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 1.03 111.217 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 1.36 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 1.03 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.84 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.64 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.711 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 1.03 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 1.03 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HH ' ' HD3' ' A' ' 21' ' ' ARG . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.94 114.436 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.854 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.17 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.37 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.43 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 1.03 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 1.05 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.867 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.99 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.83 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.661 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.99 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.17 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.15 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 1.03 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.22 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 1.02 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.93 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' OE1' ' HG3' ' A' ' 5' ' ' ARG . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 47' ' ' VAL . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 1.01 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 1.03 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 1.07 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.507 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 1.2 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 3.35 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 1.12 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 3.06 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.97 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 1.0 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 1.05 109.629 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HA ' HD22 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.527 ' HH ' ' ND2' ' A' ' 9' ' ' ASN . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.86 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 1.04 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 1.01 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 2.05 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 1.03 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.854 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.16 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.64 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 1.03 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 1.02 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.47 110.929 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.8 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.95 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 1.03 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.88 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.548 ' HG3' HD21 ' A' ' 90' ' ' LEU . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 1.21 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.13 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 1.04 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.748 ' HH ' ' HG1' ' A' ' 92' ' ' THR . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.97 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.548 HD21 ' HG3' ' A' ' 84' ' ' LYS . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 1.03 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.19 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.748 ' HG1' ' HH ' ' A' ' 89' ' ' TYR . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 1.02 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.61 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.67 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.36 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 1.08 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 1.04 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 1.46 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.24 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 1.05 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -93.01 -173.5 40.76 Favored Glycine 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -139.08 -170.88 2.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.598 0.699 . . . . 1.18 111.635 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.38 -128.06 1.27 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.059 -0.817 . . . . 2.58 111.059 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.48 58.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.869 0.366 . . . . 3.93 110.077 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.95 2.11 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.401 -0.904 . . . . 2.52 113.621 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.69 145.65 54.58 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.258 0.529 . . . . 5.52 110.628 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.39 93.77 1.18 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.14 0.495 . . . . 1.4 110.561 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.14 -63.36 1.17 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.99 -1.004 . . . . 2.21 110.693 174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -116.26 -12.74 11.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.5 -0.773 . . . . 2.37 110.188 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.32 160.12 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.961 -1.018 . . . . 1.23 111.827 -164.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.23 -30.92 0.92 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.032 -1.44 . . . . 1.68 110.033 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.5 p90 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.421 -0.808 . . . . 3.87 111.008 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.042 -0.423 . . . . 9.71 112.042 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -113.29 -19.18 11.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.726 -0.279 . . . . 9.67 111.082 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 4' ' ' SER . 53.5 tpp -86.25 -78.0 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.057 -0.349 . . . . 8.44 110.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 3' ' ' MET . 36.4 t 170.93 140.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.184 -0.673 . . . . 6.12 109.184 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -111.63 34.22 4.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.011 0.91 . . . . 6.53 109.255 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -125.64 115.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.888 -1.051 . . . . 2.03 110.417 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 46.0 mt-10 -134.45 -49.64 0.78 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.62 -0.718 . . . . 2.01 111.183 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t 54.72 92.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 1.16 112.395 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.76 110.578 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.602 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 1.17 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.16 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 1.03 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.59 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.78 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 1.13 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.35 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 14' ' ' SER . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 1.03 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 1.05 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 1.03 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 30.2 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.81 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 1.03 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 1.36 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 1.03 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.511 ' CB ' HD22 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.84 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.656 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.64 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.605 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 1.03 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 1.03 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.94 113.569 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.17 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.37 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.43 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 1.03 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 1.05 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.616 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.99 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.533 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.83 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.99 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.647 ' NE1' HD13 ' A' ' 73' ' ' ILE . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.17 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.705 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.15 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 1.03 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.22 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.566 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 1.02 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 8' ' ' VAL . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.93 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 47' ' ' VAL . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 1.01 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 1.03 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 49' ' ' GLU . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.95 108.202 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 1.07 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.457 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 1.2 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 3.35 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 1.12 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 3.06 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HB3' HD12 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.97 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 1.0 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 1.05 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 66' ' ' TYR . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.579 ' O ' ' HG3' ' A' ' 85' ' ' PRO . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.86 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 1.04 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 1.01 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 2.05 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 1.03 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.878 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.16 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.647 HD13 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 1.03 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 1.02 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.412 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.47 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.434 ' HD1' HG23 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.8 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.518 ' OH ' ' HB3' ' A' ' 41' ' ' TRP . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.95 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.602 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 1.03 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.88 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.532 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 1.21 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.579 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.13 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.532 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 1.04 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.97 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 1.03 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.19 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.605 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 1.02 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.61 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.705 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.36 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 1.08 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 1.04 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 1.46 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.24 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 1.05 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.3 -176.78 36.01 Favored Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -130.18 23.16 5.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.114 0.483 . . . . 1.18 110.521 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.12 -37.39 91.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.081 -0.807 . . . . 2.58 111.081 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.01 139.57 48.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.888 -0.412 . . . . 3.93 109.888 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.7 69.46 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.835 -0.621 . . . . 2.52 113.388 -174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -131.76 -78.07 0.51 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.762 0.281 . . . . 5.52 110.574 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.33 107.5 14.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.654 0.74 . . . . 1.4 112.004 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.96 -68.83 0.34 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.578 -1.192 . . . . 2.21 110.279 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.26 0.78 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.376 1.084 . . . . 2.37 108.483 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -71.39 150.77 44.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 1.23 112.57 -166.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.72 -0.05 0.84 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.958 -1.474 . . . . 1.68 108.739 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.436 -1.256 . . . . 3.87 110.374 -173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.747 -0.541 . . . . 9.71 111.747 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -124.34 74.42 1.31 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.132 0.492 . . . . 9.67 109.806 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -148.67 155.11 40.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.051 -0.522 . . . . 8.44 110.936 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -155.68 -74.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 6.12 109.753 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.432 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 74.6 mtp180 51.76 -158.45 0.12 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.18 0.514 . . . . 6.53 110.912 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -146.33 107.12 4.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.251 -0.648 . . . . 2.03 109.251 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 42.1 mt-10 -119.18 -45.93 2.53 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 2.01 110.891 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.574 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t 53.52 91.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 1.16 110.326 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.535 HD22 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.76 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.769 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 1.17 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' HA2' HD22 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.16 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 1.03 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.59 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' HG11 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.78 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 1.13 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.35 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 14' ' ' SER . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 1.03 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 1.05 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 1.03 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.81 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 1.03 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 1.36 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 1.03 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.536 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.84 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.64 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.626 ' CG2' HG23 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 1.03 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 1.03 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.94 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.856 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.17 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.37 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.43 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 1.03 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 1.05 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.665 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.99 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.611 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.83 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.99 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.665 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.17 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.63 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.15 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 1.03 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 5' ' ' ARG . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.22 112.755 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 1.02 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.93 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 47' ' ' VAL . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 1.01 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.486 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 1.03 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.95 108.56 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 1.07 110.695 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.485 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 1.2 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 3.35 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 1.12 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 3.06 110.764 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.97 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 1.0 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 1.05 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 64' ' ' ASP . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.86 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 1.04 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.769 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 2.05 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 1.03 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.16 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.589 HD13 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 1.03 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 1.02 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.47 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.8 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.95 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.581 ' CG ' HG23 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.88 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 1.21 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.13 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 1.04 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.97 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' A' ' 84' ' ' LYS . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 1.03 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.19 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.626 HG23 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 1.0 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 1.02 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.61 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.63 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.36 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 1.08 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 1.04 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 1.46 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.24 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 110' ' ' ASP . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 1.05 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.45 -175.02 38.79 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -140.01 153.63 46.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.156 0.478 . . . . 1.18 110.116 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.48 -21.26 5.43 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.938 -0.649 . . . . 2.58 112.372 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.87 57.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 3.93 110.974 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.98 146.57 11.87 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.016 -0.611 . . . . 2.52 112.74 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 63.81 -85.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.37 0.668 . . . . 5.52 110.832 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.93 104.05 4.43 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.237 0.541 . . . . 1.4 109.857 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' OD1' ' HD2' ' A' ' 25' ' ' ARG . 3.6 m-20 -59.65 -64.64 0.87 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.719 -1.128 . . . . 2.21 111.122 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.567 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 12.1 m-20 -117.26 -5.54 11.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.634 . . . . 2.37 110.713 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 25' ' ' ARG . 1.8 mm? -75.03 164.25 26.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.824 -167.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -138.05 -33.95 0.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.24 -1.345 . . . . 1.68 109.852 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 16.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.428 -0.805 . . . . 3.87 110.733 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.109 -0.396 . . . . 9.71 112.109 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.43 -15.48 60.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.557 0.218 . . . . 9.67 111.278 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -70.09 -30.85 68.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.022 0.439 . . . . 8.44 110.081 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 74.0 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.988 -0.551 . . . . 6.12 110.184 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -81.89 59.08 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 6.53 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.42 ' HB2' ' N ' ' A' ' 46' ' ' GLY . 2.1 p -137.88 99.44 3.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.818 -0.628 . . . . 2.03 110.973 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -85.78 -61.93 1.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 2.01 112.917 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HA ' HD21 ' A' ' 48' ' ' LEU . 80.1 t 60.39 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 1.16 110.969 -171.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 48' ' ' LEU . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.76 110.425 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.747 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 1.17 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.16 116.822 172.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 65' ' ' GLN . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 1.03 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.59 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.625 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.78 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 1.13 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.35 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 1.03 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 1.05 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 1.03 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.492 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.81 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 1.03 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 1.36 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 1.03 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.84 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.64 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 1.03 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 1.03 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.94 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.17 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.37 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.43 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.768 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 1.03 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.593 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 1.05 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.99 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.522 ' OD1' ' HB1' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.83 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB1' ' OD1' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.99 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.17 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.693 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.15 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.455 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 1.03 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 6' ' ' SER . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.22 112.568 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 1.02 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.93 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 47' ' ' VAL . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 1.01 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 1.03 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.95 108.347 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 1.07 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.492 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 1.2 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 3.35 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 1.12 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 3.06 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.97 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 1.05 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 66' ' ' TYR . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.609 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.86 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 1.04 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.747 HD23 ' SD ' ' A' ' 10' ' ' MET . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 1.01 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 2.05 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG22 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 1.03 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.16 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.664 HD13 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.03 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 1.02 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.47 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' HG22 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.8 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.95 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' CG ' HG22 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 1.03 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.88 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HG3' HD21 ' A' ' 90' ' ' LEU . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 1.21 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.13 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 1.04 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.97 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD21 ' HG3' ' A' ' 84' ' ' LYS . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 1.03 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.19 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 1.02 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.61 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.693 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.36 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 1.08 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 1.04 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' HA2' HD12 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 1.46 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.24 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 1.05 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.63 178.01 36.3 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.552 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 27.2 p-10 -124.32 175.8 6.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.451 0.625 . . . . 1.18 111.145 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 140.91 3.0 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.0 -0.84 . . . . 2.58 111.0 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.44 112.2 11.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 3.93 110.907 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.03 -75.93 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.566 -0.826 . . . . 2.52 112.83 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -119.65 131.49 55.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.59 0.233 . . . . 5.52 110.787 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -65.6 118.07 8.97 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.442 0.639 . . . . 1.4 110.334 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.49 -61.17 2.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.447 -1.251 . . . . 2.21 111.842 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.4 -11.01 11.23 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.091 0.472 . . . . 2.37 111.913 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.8 mm? -88.27 158.35 18.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.473 0.654 . . . . 1.23 111.261 -166.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -162.69 -25.16 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.299 -1.319 . . . . 1.68 109.985 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.638 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p90 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.907 . . . . 3.87 111.814 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.594 -0.602 . . . . 9.71 111.594 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -91.72 -42.7 9.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.652 0.263 . . . . 9.67 110.391 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -148.02 101.5 3.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 8.44 111.249 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.1 m -98.14 123.69 42.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.497 -0.556 . . . . 6.12 109.497 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -142.19 -33.32 0.48 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.61 0.243 . . . . 6.53 111.378 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 p -143.81 95.41 2.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.547 0.689 . . . . 2.03 111.19 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 66.6 mm-40 -122.77 -59.09 1.63 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 2.01 111.009 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD22 ' A' ' 48' ' ' LEU . 84.9 t 59.73 103.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.704 -0.68 . . . . 1.16 112.403 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.44 ' O ' HD21 ' A' ' 48' ' ' LEU . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.76 109.697 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.608 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 1.17 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.16 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 65' ' ' GLN . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 1.03 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.59 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.569 ' O ' HG11 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.78 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.35 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.569 HG11 ' O ' ' A' ' 14' ' ' SER . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 1.03 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 1.05 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 1.03 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.464 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 32.9 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.81 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 1.03 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 1.36 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 1.03 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.606 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.84 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.64 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 1.03 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 1.03 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.94 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.863 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.17 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.598 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.37 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.43 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.788 ' HB1' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 1.03 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 1.05 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.99 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.466 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.83 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.99 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.627 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.15 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 1.03 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.22 112.288 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.585 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 1.02 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 8' ' ' VAL . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.93 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 47' ' ' VAL . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 1.01 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 1.03 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.95 108.417 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 1.07 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 1.2 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 3.35 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 1.12 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 3.06 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.97 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 1.0 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 1.05 109.532 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' HD23 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HB2' HD21 ' A' ' 82' ' ' LEU . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.86 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 1.04 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 1.01 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 2.05 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 1.03 111.836 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.863 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.16 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 1.03 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 1.02 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.47 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.462 ' CD1' HG22 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.8 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 41' ' ' TRP . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.95 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.88 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 1.21 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.13 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 1.04 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.97 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 1.03 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.19 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.596 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 1.0 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 1.02 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.61 106.675 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.627 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.36 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 39' ' ' SER . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 1.08 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 1.04 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA2' HD13 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 1.46 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.24 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 1.05 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.8 177.05 30.2 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.11 6.06 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.186 0.493 . . . . 1.18 110.758 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 160.09 18.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.621 -0.799 . . . . 2.58 112.06 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.46 37.94 19.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.838 0.455 . . . . 3.93 111.45 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.1 159.15 8.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.803 -0.713 . . . . 2.52 112.262 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -71.89 -51.03 24.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.048 0.451 . . . . 5.52 109.985 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.27 96.75 6.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 1.4 110.624 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -63.13 -57.16 11.51 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.461 -0.791 . . . . 2.21 110.061 173.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.82 -14.89 10.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 2.37 110.551 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.24 166.86 21.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.007 -0.997 . . . . 1.23 113.031 -160.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -159.91 -32.3 0.06 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.196 -1.82 . . . . 1.68 107.049 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.444 -1.707 . . . . 3.87 110.098 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.993 -0.443 . . . . 9.71 111.993 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -131.45 3.64 4.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.933 0.396 . . . . 9.67 110.79 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -101.09 -0.32 36.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.157 -0.474 . . . . 8.44 111.058 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -78.57 51.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.706 0.765 . . . . 6.12 111.125 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -155.59 10.86 0.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.742 -1.117 . . . . 6.53 108.885 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.454 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 10.4 p -156.29 97.55 1.78 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.45 -0.796 . . . . 2.03 111.115 -173.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 40.1 mt-10 -145.46 -48.03 0.22 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.464 -0.789 . . . . 2.01 111.857 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t 60.83 101.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 1.16 112.065 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.76 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 1.17 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.16 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 1.03 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.59 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG13 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.78 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 1.13 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.35 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 1.03 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 1.05 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 1.03 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.4 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.81 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 1.03 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 1.36 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 1.03 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.626 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.84 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.663 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.64 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.614 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 1.03 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 1.03 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.413 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.94 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.17 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.619 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.37 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.43 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 1.03 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 1.05 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.718 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.99 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.83 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.99 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.718 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.17 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.15 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.498 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 1.03 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 6' ' ' SER . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.22 112.427 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 1.02 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 8' ' ' VAL . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.93 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 47' ' ' VAL . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 1.01 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 1.03 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.95 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 1.07 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.486 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 1.2 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 3.35 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 1.12 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 3.06 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.97 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 1.0 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 1.05 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.86 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 1.04 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 1.01 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 2.05 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 1.03 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.869 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.16 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.6 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 1.03 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 1.02 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.47 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.498 ' CD1' HG23 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.8 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.503 ' CE2' ' HG3' ' A' ' 70' ' ' ARG . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.95 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 1.03 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.88 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.639 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 1.21 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.13 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 1.04 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.97 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 84' ' ' LYS . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 1.03 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.19 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.614 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 1.0 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 1.02 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.61 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.624 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.36 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 1.08 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 1.04 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 1.46 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.24 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 1.05 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.13 -176.74 27.8 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -140.56 158.62 43.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 1.18 110.835 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.49 90.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.169 -0.772 . . . . 2.58 111.169 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.89 44.51 19.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.269 0.557 . . . . 3.93 110.023 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.18 -137.63 16.18 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.032 -0.827 . . . . 2.52 111.032 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.4 m80 72.58 149.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.693 0.759 . . . . 5.52 112.202 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.23 92.57 7.79 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 115.815 -0.63 . . . . 1.4 110.443 176.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.61 -64.11 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.161 -0.927 . . . . 2.21 110.331 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -118.43 -4.07 10.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.382 -0.827 . . . . 2.37 110.08 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.2 mm? -72.48 162.1 29.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.268 -0.878 . . . . 1.23 112.077 -164.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -154.5 -30.76 0.11 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.25 -1.341 . . . . 1.68 110.235 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.977 -1.01 . . . . 3.87 111.494 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.979 -0.448 . . . . 9.71 111.979 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -71.74 -25.25 61.98 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.854 -0.204 . . . . 9.67 110.571 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm 47.19 73.02 0.21 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.725 0.641 . . . . 8.44 112.172 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -97.26 -20.46 17.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.339 0.59 . . . . 6.12 109.584 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -145.76 43.68 1.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.275 -0.875 . . . . 6.53 109.018 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -152.49 95.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 2.03 110.791 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.588 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 13.5 mm-40 -84.09 -55.66 4.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.299 -0.864 . . . . 2.01 111.8 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.5 t 48.7 90.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 1.16 111.887 -174.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.588 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.76 110.956 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.638 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 1.17 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.16 115.762 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 1.03 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.59 110.24 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.78 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 1.13 110.607 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.35 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.51 HG11 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 1.03 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 1.05 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 1.03 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.486 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.81 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 1.03 111.264 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 1.36 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 1.03 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.647 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.84 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.64 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HA ' ' HH ' ' A' ' 113' ' ' TYR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 1.03 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.717 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 1.03 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.94 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.866 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.17 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.37 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.43 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.773 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 1.03 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.617 ' HA ' ' CZ2' ' A' ' 41' ' ' TRP . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 1.05 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.654 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.99 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.83 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.99 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.745 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.17 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.72 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.15 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 1.03 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.22 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 1.02 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.93 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 47' ' ' VAL . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 1.01 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 1.03 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.95 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 1.07 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.472 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 1.2 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 3.35 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 1.12 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 3.06 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.97 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 62' ' ' THR . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 1.0 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 61' ' ' ILE . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 1.05 109.876 172.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.614 ' HA ' HD22 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 82' ' ' LEU . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.86 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 1.04 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 10' ' ' MET . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 1.01 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 2.05 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 1.03 112.589 -169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.866 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.16 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD13 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 1.03 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 1.02 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.47 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.507 ' CD1' HG23 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.8 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' HD12 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.95 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 1.03 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.88 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG3' HD23 ' A' ' 90' ' ' LEU . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 1.21 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.13 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 1.04 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.97 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 HD23 ' HG3' ' A' ' 84' ' ' LYS . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 1.03 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.19 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.596 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 1.02 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.61 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.72 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.36 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 1.08 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 1.04 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 1.46 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.24 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.4 -179.66 35.16 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -119.06 132.86 56.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.343 0.572 . . . . 1.18 110.327 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.45 -176.08 34.68 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.835 -0.906 . . . . 2.58 110.835 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 67.45 -71.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.23 0.612 . . . . 3.93 110.988 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.58 -96.76 0.11 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.544 -0.623 . . . . 2.52 111.544 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -112.11 -23.51 10.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 5.52 110.841 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -129.52 103.2 6.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.62 0.724 . . . . 1.4 111.831 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.33 -58.53 3.23 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.689 -1.141 . . . . 2.21 109.116 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 16.8 m-20 -117.46 -4.07 11.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.157 -0.928 . . . . 2.37 110.166 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 25' ' ' ARG . 2.2 mm? -74.64 168.52 19.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.229 -0.896 . . . . 1.23 111.225 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -166.52 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.103 -0.953 . . . . 1.68 110.573 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.603 ' HH ' ' HA ' ' A' ' 26' ' ' VAL . 9.4 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.931 -1.032 . . . . 3.87 111.419 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 48' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 0.45 111.518 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.41 109.993 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.695 ' SD ' HD23 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 0.89 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.1 116.878 174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 0.11 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.2 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.2 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 0.35 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.31 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 0.19 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 0.16 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 0.12 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.48 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.66 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 0.84 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 0.89 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 0.17 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.508 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.26 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.747 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.1 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 0.13 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 0.14 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.16 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.884 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.15 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.654 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.36 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.11 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 0.15 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.654 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 0.22 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.729 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.47 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.39 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.15 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.15 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.749 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.14 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 0.24 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.17 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 0.11 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD21 HD22 ' A' ' 68' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.1 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.4 mm-40 -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.766 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 0.16 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 0.13 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.18 108.22 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 0.24 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.511 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 0.9 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.55 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 2.5 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.51 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 0.12 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.417 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 0.16 109.296 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.634 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 61' ' ' ILE . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.11 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 0.07 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 0.11 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 1.74 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 0.11 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.884 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.14 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 0.11 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG23 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 0.24 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 4.6 t-20 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.889 ' HB3' HD22 ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.38 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.19 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.767 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.16 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.538 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 0.19 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.19 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 0.57 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.12 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 0.17 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.2 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 0.12 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.15 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.666 HG21 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 0.14 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 0.06 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.889 HD22 ' HB3' ' A' ' 77' ' ' ASN . 4.8 t-20 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.749 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.18 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 0.31 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 0.15 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.766 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 0.85 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.2 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 48' ' ' LEU . 21.5 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.655 0.613 . . . . 0.45 112.655 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.41 110.742 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.68 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.89 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.1 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 0.11 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.2 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 0.35 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.31 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 0.19 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 0.16 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 0.12 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.66 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 0.84 110.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 0.89 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.17 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.26 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.1 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 0.13 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 0.14 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.16 114.258 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.15 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.36 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.11 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.827 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 0.15 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.68 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 0.22 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.694 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.47 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.39 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.15 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.694 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.15 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.62 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.14 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.534 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 0.24 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.17 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 0.11 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.1 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.7 mm-40 -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.655 HD11 ' HA2' ' A' ' 98' ' ' GLY . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 0.16 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 0.13 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.18 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 0.24 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.663 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 0.9 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 2.73 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 0.55 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.454 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 2.5 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HD2' HD22 ' A' ' 90' ' ' LEU . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.51 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' OG ' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 0.12 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 0.16 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.11 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 0.07 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 80' ' ' TYR . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 0.11 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 1.74 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 27' ' ' ALA . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 0.11 112.432 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.14 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.575 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 0.11 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.24 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.2 t-20 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.38 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.19 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.16 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 0.19 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.19 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.615 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 0.57 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.12 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 0.17 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.2 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 0.12 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.15 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.643 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 0.14 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 0.06 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.15 106.671 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.62 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.18 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 0.31 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 0.15 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 0.85 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.2 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 0.12 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' HA ' HD23 ' A' ' 48' ' ' LEU . 39.0 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 0.45 113.032 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.41 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.89 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.1 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 0.11 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.2 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.2 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 0.35 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.31 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 0.19 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 0.16 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 0.12 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.66 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 0.84 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 0.89 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 0.17 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.26 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.1 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.675 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 0.13 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 0.14 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.16 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.15 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.36 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.11 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 0.15 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 0.22 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.47 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.39 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.15 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.15 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.14 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 0.24 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.17 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 0.11 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.657 HD21 HD22 ' A' ' 68' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.1 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 0.16 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 0.13 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.18 108.203 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 0.24 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.524 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 0.9 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 2.73 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.55 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 2.5 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.51 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 0.12 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 0.16 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.792 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.11 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 0.07 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 0.11 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 1.74 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 0.11 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.604 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 0.11 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 0.24 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.4 t-20 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.38 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.19 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.16 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 0.19 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.19 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 67' ' ' ILE . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 0.57 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.12 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 0.17 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.2 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 ' HD2' ' A' ' 60' ' ' TYR . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 0.12 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.591 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.15 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.675 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 0.14 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 0.06 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.15 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.18 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 0.31 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.15 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 0.85 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.2 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 0.12 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD23 ' A' ' 48' ' ' LEU . 47.5 t . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 0.45 111.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.699 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.653 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 0.89 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.1 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 0.11 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.2 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.2 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.35 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.31 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 0.19 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 0.16 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 0.12 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.7 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.66 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 0.84 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 0.89 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 0.17 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.26 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.68 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.1 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 92' ' ' THR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 0.13 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 0.14 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.16 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.15 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.36 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.813 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 0.15 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 0.22 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.83 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.47 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.432 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.39 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.15 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.83 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.15 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.14 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.24 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.17 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 0.11 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 68' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.1 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 0.16 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 0.13 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.18 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 0.24 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' HD11 ' A' ' 61' ' ' ILE . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 0.9 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 2.73 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.55 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 2.5 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' HD2' HD22 ' A' ' 90' ' ' LEU . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.51 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 0.12 111.678 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 0.16 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.794 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 0.07 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 0.11 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 1.74 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 0.11 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.873 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.14 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.643 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.11 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 0.24 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.0 t-20 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.38 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.19 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.16 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.553 ' CG ' HG21 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 0.19 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.679 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.19 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 0.57 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.12 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 0.17 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.2 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 60' ' ' TYR . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 0.12 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.15 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.65 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 0.14 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 0.06 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.15 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.691 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.18 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 0.31 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.719 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.2 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 0.12 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.6 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.301 0.572 . . . . 0.45 112.294 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.41 110.577 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.704 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.89 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.1 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 67' ' ' ILE . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 0.11 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.2 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.2 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 0.35 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.31 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.19 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 0.16 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 0.12 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.49 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.66 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 0.84 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 0.89 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 0.17 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.26 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.1 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.645 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 0.13 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 0.14 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.16 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.888 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.15 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.36 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.727 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 0.15 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.22 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.905 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.47 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.39 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.15 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.905 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.15 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.14 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 0.24 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.17 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 0.11 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.1 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.9 mm-40 -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 0.16 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 0.13 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.18 108.143 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 0.24 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' HD11 ' A' ' 61' ' ' ILE . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 0.9 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 2.73 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 0.55 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 2.5 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.525 ' HD2' HD22 ' A' ' 90' ' ' LEU . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.51 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 0.12 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 0.16 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.624 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 0.07 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 0.11 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 1.74 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 0.11 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.14 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.664 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 0.11 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 0.24 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.38 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.19 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.16 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.526 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 0.19 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.19 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 0.57 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.12 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 0.17 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.2 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.525 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 0.12 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.15 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 0.14 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 0.06 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.15 107.069 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.676 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.18 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 0.31 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 0.15 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 0.85 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.2 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 0.12 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' HD23 ' A' ' 48' ' ' LEU . 76.8 t . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 0.45 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.41 109.913 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.682 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.89 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.1 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 0.11 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.2 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.2 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 0.35 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.31 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 0.19 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 0.16 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 0.12 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.66 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 0.84 110.672 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 0.89 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.17 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.26 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.1 111.487 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 0.13 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 0.14 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.16 113.68 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.889 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.15 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.36 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.11 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 0.15 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 0.22 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.726 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.47 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.439 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.39 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.15 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.726 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.15 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.14 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.539 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 0.24 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.17 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 0.11 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 68' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.1 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.2 mm-40 -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.742 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 0.16 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 0.13 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.18 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 0.24 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 0.9 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 2.73 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 0.55 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HE ' ' HE1' ' A' ' 60' ' ' TYR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 2.5 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.564 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.51 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 0.12 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 0.16 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.784 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.11 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 0.07 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 0.11 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 1.74 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG21 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 0.11 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.889 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.14 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 0.11 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.24 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.7 t-20 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.38 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.19 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.16 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.563 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 0.19 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.19 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.62 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 0.57 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.12 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 0.17 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.2 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 0.12 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.15 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 0.14 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 0.06 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.15 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.71 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.18 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 0.31 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.15 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.742 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 0.85 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.2 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.637 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.1 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.32 0.581 . . . . 0.45 112.502 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.41 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 0.89 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.1 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 0.11 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.2 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.2 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 0.35 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.31 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 0.19 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 0.16 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 0.12 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.66 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 0.84 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 0.89 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.17 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.26 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 101' ' ' VAL . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.1 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 0.13 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 0.14 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.16 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.15 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.36 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.11 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.801 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 0.15 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 0.22 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.47 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.39 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.15 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.15 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.664 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.14 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 0.24 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.17 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 0.11 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 68' ' ' LEU . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.1 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.726 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 0.16 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 0.13 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.18 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 0.24 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 0.9 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 2.73 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 0.55 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.51 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 0.12 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 0.16 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.11 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 0.07 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 0.11 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.581 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 1.74 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 0.11 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.14 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 0.11 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 0.24 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.38 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.19 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.16 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 0.19 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.19 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 0.57 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.12 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.596 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 0.17 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.2 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 0.12 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.15 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.652 HG21 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 0.14 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.06 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.15 106.619 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.664 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.18 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 0.31 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 0.15 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.2 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 0.12 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.9 t . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 0.45 112.117 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.66 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 0.89 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.1 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 0.11 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.2 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 0.35 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.31 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 0.19 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 0.16 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 0.12 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.44 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.66 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 19' ' ' VAL . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 0.84 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 0.89 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 0.17 110.312 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.608 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.26 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.1 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG21 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 0.13 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 0.14 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.16 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.15 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.36 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.11 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 0.15 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 0.22 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.893 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.47 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.39 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.15 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.893 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.15 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.14 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 0.24 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.17 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 0.11 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 68' ' ' LEU . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.1 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.785 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 0.16 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 0.13 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.18 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 0.24 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.483 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 0.9 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 2.73 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.55 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.499 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 2.5 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.842 ' HD2' HD22 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.51 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 0.12 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 0.16 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.758 ' HA ' HD21 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 0.07 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 0.11 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.652 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 1.74 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 27' ' ' ALA . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 0.11 112.04 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.14 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.697 HD11 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 0.11 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 0.24 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.6 t-20 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.583 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.38 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.19 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.16 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 0.19 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.19 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 0.57 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.12 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 0.17 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.2 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.842 HD22 ' HD2' ' A' ' 60' ' ' TYR . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 0.12 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.15 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.14 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 0.06 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.15 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.18 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 0.31 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 0.15 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 0.85 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.2 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 0.12 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 45.7 t . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 0.45 111.867 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.41 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.71 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 0.89 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.1 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 0.11 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.2 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.2 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 0.35 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.31 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG13 HG12 ' A' ' 19' ' ' VAL . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.19 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 0.16 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 0.12 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.66 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 0.84 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 0.89 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 0.17 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.26 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.1 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.13 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 0.14 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.16 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.15 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.668 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.36 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.11 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 0.15 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 0.22 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.792 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.47 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.39 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.15 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.792 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.15 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.665 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.14 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 0.24 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.17 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 0.11 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 68' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.1 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.3 mm-40 -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 0.16 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.669 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 0.13 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.18 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.49 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 0.24 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 0.9 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 2.73 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.55 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 2.5 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.53 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.51 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 0.12 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 0.16 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 61' ' ' ILE . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.11 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 0.07 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 0.11 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 1.74 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 0.11 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.14 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.636 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 0.11 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.479 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.24 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.1 t-20 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.38 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.19 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.779 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.16 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.582 ' CG ' HG21 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 0.19 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.19 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.595 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 0.57 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.12 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 0.17 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.2 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 0.12 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.15 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.676 HG21 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 0.14 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 0.06 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.15 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.18 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 0.31 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 0.15 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 0.85 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.2 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 0.12 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.4 t . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.45 111.858 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.41 110.695 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 0.89 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.1 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 0.11 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.2 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.2 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 0.19 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.653 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 0.12 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.66 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.418 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 0.84 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 0.89 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 0.17 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.663 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.26 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.1 111.981 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 0.13 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 0.14 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.16 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.896 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.15 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.659 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.11 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 0.15 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 0.22 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.759 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.47 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.39 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.15 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.759 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.15 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.14 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 0.24 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.17 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 0.11 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.1 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.702 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 0.16 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 0.13 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.18 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 0.24 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.526 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 0.9 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 2.73 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.55 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 2.5 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.607 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.51 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 0.12 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 0.16 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.11 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 0.07 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 0.11 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.627 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 1.74 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.548 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 0.11 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.896 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.14 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.554 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 0.11 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.24 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.38 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.19 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.838 ' HB3' HD11 ' A' ' 68' ' ' LEU . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.16 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.548 ' CG ' HG21 ' A' ' 71' ' ' VAL . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.19 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 0.57 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.12 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 0.17 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.663 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.2 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.607 HD22 ' HD2' ' A' ' 60' ' ' TYR . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 0.12 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.15 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 0.14 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 0.06 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.15 107.127 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 0.31 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 0.15 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.702 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 0.85 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.2 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 0.12 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 77.0 t . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 0.45 111.881 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.41 109.879 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.707 ' SD ' HD23 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 0.89 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.1 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.629 ' HB2' HG12 ' A' ' 67' ' ' ILE . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 0.11 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.2 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.2 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 0.35 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.31 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 19' ' ' VAL . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 0.19 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 0.16 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 0.12 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.66 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 0.84 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 0.89 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 0.17 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.68 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.26 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.1 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 0.13 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 0.14 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.16 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.864 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.15 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.36 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.11 109.838 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 0.15 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 0.22 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.47 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.39 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.15 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.15 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.14 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 0.24 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.17 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 0.11 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 68' ' ' LEU . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.1 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 mm-40 -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.705 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 0.16 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 0.13 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.18 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.467 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 0.24 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 0.9 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 2.73 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 0.55 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.467 ' NE ' HG23 ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 2.5 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.51 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 0.12 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 0.16 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.11 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 0.07 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 0.11 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 1.74 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 0.11 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.864 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.14 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 0.11 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 0.24 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.8 t-20 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.38 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.19 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.16 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 0.19 107.891 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.19 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 0.57 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.12 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 0.17 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.2 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 0.12 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.15 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 0.14 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 0.06 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.15 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.18 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 0.31 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.705 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 0.85 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.2 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 0.12 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 48' ' ' LEU . 94.8 t . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 0.45 110.393 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.4 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.646 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 0.89 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.1 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 0.11 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.2 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.2 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 0.35 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.31 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 0.19 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 0.16 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 0.12 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.66 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 0.84 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 0.89 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.17 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.26 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.1 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.653 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 0.13 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 0.14 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.16 113.476 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.15 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.11 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 0.15 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 0.22 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.47 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.46 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.39 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.15 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.15 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.651 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.14 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 0.24 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.17 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 0.11 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.744 HD21 HD22 ' A' ' 68' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.1 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.6 mm-40 -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.697 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 0.16 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 0.13 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.18 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.429 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 0.9 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 2.73 110.715 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 0.55 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.429 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 2.5 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.51 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 0.12 111.7 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 0.16 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.617 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.11 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 0.07 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 0.11 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.691 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 1.74 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 0.11 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.14 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.11 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 0.24 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.2 t-20 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.38 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.19 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.845 ' HB3' HD11 ' A' ' 68' ' ' LEU . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.16 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 0.19 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.19 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 0.57 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.12 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 0.17 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.2 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 0.12 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.15 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.653 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 0.14 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 0.06 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.15 106.607 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.651 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.18 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 0.31 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 0.15 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 0.85 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.2 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 0.12 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HA ' HD23 ' A' ' 48' ' ' LEU . 75.3 t . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 0.45 111.87 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.41 110.306 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.673 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 0.89 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.1 116.53 172.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 0.11 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.2 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.2 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.35 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.31 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 0.19 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 0.16 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 0.12 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.66 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 0.84 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 0.89 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 0.17 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.529 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.26 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.1 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG21 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 0.13 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 0.14 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.16 113.213 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.879 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.15 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.36 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.11 109.994 175.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.803 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 0.15 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 0.22 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.793 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.47 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.39 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.15 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.793 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.15 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.14 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 0.24 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.17 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 0.11 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.1 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.6 mm-40 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 0.16 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.654 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 0.13 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.18 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 0.9 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.73 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 0.55 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 2.5 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.565 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 0.12 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 0.16 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.11 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 0.07 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 0.11 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 1.74 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 0.11 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.879 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.14 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 0.11 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 0.24 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.4 t-20 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.38 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.19 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.781 ' HB3' HD11 ' A' ' 68' ' ' LEU . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.16 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.566 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 0.19 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 0.57 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.12 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 0.17 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.2 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.565 HD22 ' HD2' ' A' ' 60' ' ' TYR . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 0.12 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.15 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.682 ' HB ' HG22 ' A' ' 101' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 0.14 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 0.06 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.15 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.755 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.18 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.31 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 0.15 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 0.85 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.2 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 0.12 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 0.45 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.41 110.174 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.67 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 0.89 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.1 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 0.11 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.2 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' HG12 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.2 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.35 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.31 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 19' ' ' VAL . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 0.19 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 0.16 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 0.12 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.448 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.66 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 0.84 111.217 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 0.89 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 0.17 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.629 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.26 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.628 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.1 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 92' ' ' THR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 0.13 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 0.14 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.16 114.436 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.881 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.15 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.646 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.36 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.11 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 0.15 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 0.22 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.902 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.47 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.39 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.15 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.902 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.15 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.14 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 0.24 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.17 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.11 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD21 HD22 ' A' ' 68' ' ' LEU . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.1 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.622 HD11 ' HA2' ' A' ' 98' ' ' GLY . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 0.16 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 0.13 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.18 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 0.24 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.542 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 0.9 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 2.73 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 0.55 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 2.5 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.542 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.51 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 0.12 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 0.16 109.629 172.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.62 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.11 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.07 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 0.11 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 1.74 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 0.11 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.881 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.14 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.645 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 0.11 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.24 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t-20 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 40' ' ' ALA . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.38 110.929 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.19 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.16 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 0.19 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.19 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 0.57 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.12 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 0.17 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.629 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.2 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 0.12 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.15 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 0.14 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 0.06 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.15 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.692 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.18 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 0.31 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 0.15 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.622 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 0.85 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.2 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 0.12 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t . . . . . 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 0.45 112.395 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.41 110.578 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 0.89 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.1 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 0.11 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.2 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.2 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.35 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.31 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 19' ' ' VAL . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 0.19 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 0.16 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 0.12 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 27.8 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.66 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 0.84 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.89 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 0.17 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.26 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.1 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 0.13 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 0.14 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.16 113.569 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.898 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.15 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.36 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.11 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 0.15 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 0.22 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.667 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.47 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.39 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.15 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.667 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.15 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.726 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.14 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 0.24 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.17 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 0.11 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.1 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.9 mm-40 -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.693 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 0.16 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.74 HD23 HD11 ' A' ' 82' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 0.13 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.18 108.202 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 0.24 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 0.9 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 2.73 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 2.5 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.51 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 0.12 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 0.16 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.714 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.634 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.11 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.67 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 0.07 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 80' ' ' TYR . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 0.11 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 1.74 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 0.11 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.14 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.647 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 0.11 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.4 t-20 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.38 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HD1' HG22 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.19 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.821 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.611 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.74 HD11 HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.19 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 0.57 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.12 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 0.17 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.2 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 0.12 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.15 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.638 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 0.14 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 0.06 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.15 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.726 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.18 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 0.31 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.15 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.693 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 0.85 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.2 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 0.12 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 0.45 110.326 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.563 HD21 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.41 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 0.89 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.1 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 0.11 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.2 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.524 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.2 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 0.35 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.31 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 19' ' ' VAL . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 0.19 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 0.16 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 0.12 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.66 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 0.89 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 0.17 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.26 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.1 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 0.13 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.722 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 0.14 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.16 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.15 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.36 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 0.15 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 0.22 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.47 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.39 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.15 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.15 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.14 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 0.24 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.17 112.755 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 0.11 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.1 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 mm-40 -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 0.16 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 0.13 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.18 108.56 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.403 HG23 ' NE ' ' A' ' 58' ' ' ARG . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 0.24 110.695 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 61' ' ' ILE . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 0.9 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 2.73 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 0.55 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 2.5 110.764 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.51 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 0.12 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 0.16 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.11 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 0.07 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 0.11 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 1.74 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 0.11 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.14 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 0.11 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 0.24 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.2 t-20 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.38 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.19 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.16 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.592 ' CG ' HG21 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 0.19 107.839 176.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.19 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 0.57 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.12 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.613 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 0.17 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.2 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 0.12 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.15 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 101' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 0.14 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 0.06 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.15 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.18 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 0.31 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 0.15 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.698 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 0.85 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.2 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 0.12 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.1 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 0.45 110.969 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.41 110.425 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.736 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 0.89 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.1 116.822 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB2' HG12 ' A' ' 67' ' ' ILE . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 0.11 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.2 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.2 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.31 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 0.19 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 0.16 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 0.12 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.66 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 0.84 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 0.89 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.17 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.26 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.1 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 0.13 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 0.14 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.16 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.9 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.15 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.674 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.11 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 0.15 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 0.22 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.47 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.39 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.15 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.15 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.14 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 0.24 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.17 112.568 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 0.11 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 68' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.1 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.9 mm-40 -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 0.16 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.577 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 0.13 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.18 108.347 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 0.24 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 0.9 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 0.55 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 2.5 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.51 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 0.12 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 0.16 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 61' ' ' ILE . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.11 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 0.07 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 0.11 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 1.74 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 0.11 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.14 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 0.11 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 0.24 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.38 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.19 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 0.19 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.19 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 0.57 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.12 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 0.17 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.2 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.553 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 0.12 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.15 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.671 HG21 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 0.14 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 0.06 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.15 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.718 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.18 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 0.31 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 0.15 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.675 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 0.85 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.2 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 92' ' ' THR . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 0.12 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.224 0.535 . . . . 0.45 112.403 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.41 109.697 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.89 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.1 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 ' HB2' HG12 ' A' ' 67' ' ' ILE . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 0.11 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.2 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.2 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.31 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 0.19 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 0.16 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.613 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 0.12 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 29.8 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.66 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 0.89 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 0.17 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.617 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.26 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.1 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 0.13 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 0.14 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.16 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.15 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.36 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 0.15 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 0.22 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.686 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.47 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.39 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.15 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.686 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.15 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.14 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 0.24 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.17 112.288 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.59 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 0.11 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.635 HD21 HD22 ' A' ' 68' ' ' LEU . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.1 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 0.16 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD23 HD11 ' A' ' 82' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 0.13 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.18 108.417 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 0.24 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' HD11 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 0.9 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 2.73 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.55 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 2.5 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.51 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 0.12 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 0.16 109.532 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.11 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 0.07 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 0.11 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 1.74 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 27' ' ' ALA . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 0.11 111.836 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.608 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.11 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 0.24 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.6 t-20 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.38 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.19 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.16 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 0.19 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.19 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 0.57 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.12 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 0.17 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.2 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 0.12 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.15 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.644 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 0.14 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 0.06 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.15 106.675 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.649 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.18 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 0.31 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 0.15 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 0.85 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.2 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 0.12 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 0.45 112.065 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.41 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.801 ' SD ' HD23 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 0.89 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.1 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' HG12 ' A' ' 67' ' ' ILE . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 0.11 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.2 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG12 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.2 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.31 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 0.19 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 0.16 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 0.12 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.514 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 28.2 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.66 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 0.84 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 0.89 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 0.17 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.634 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.26 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.1 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.13 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.14 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.16 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.89 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.15 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.36 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.11 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 0.15 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.744 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.47 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.39 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.15 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.744 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.14 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 0.24 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.17 112.427 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 0.11 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.68 HD21 HD22 ' A' ' 68' ' ' LEU . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.1 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.8 mm-40 -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 98' ' ' GLY . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 0.16 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 0.13 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.18 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 0.24 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 0.9 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 2.73 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 0.55 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 2.5 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' HD2' HD22 ' A' ' 90' ' ' LEU . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.51 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 0.12 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 0.16 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.625 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.11 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 0.07 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 0.11 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 1.74 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 0.11 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.89 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.14 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.599 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 0.11 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 0.24 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.5 t-20 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.38 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.19 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.774 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.16 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 0.19 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.19 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 0.57 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.12 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 0.17 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.2 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 0.12 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.15 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 0.14 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 0.06 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.15 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.648 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.18 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.31 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 0.15 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 0.85 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.2 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.619 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 0.12 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.5 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 0.45 111.887 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.41 110.956 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.708 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 0.89 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.1 115.762 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 0.11 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.2 110.24 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.2 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 0.35 110.607 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.31 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 0.19 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 0.16 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 0.12 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.66 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' HG22 ' A' ' 19' ' ' VAL . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 0.84 111.264 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 0.89 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 0.17 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.26 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.1 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 0.13 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 0.14 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.16 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.15 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.36 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.11 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 0.15 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 0.22 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.699 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.47 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.39 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.656 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.15 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.15 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.745 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.14 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 0.24 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.17 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 0.11 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.1 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.2 mm-40 -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.682 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 0.16 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 0.13 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.18 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 0.24 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' HD11 ' A' ' 61' ' ' ILE . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 0.9 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 2.73 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 0.55 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 2.5 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.51 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 55' ' ' SER . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 0.12 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 0.16 109.876 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 61' ' ' ILE . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.11 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 0.07 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 0.11 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 1.74 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' ALA . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 0.11 112.589 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.14 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 0.11 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 0.24 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.9 t-20 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.38 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.19 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.778 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.16 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 0.19 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.673 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.19 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 0.57 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.12 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 0.17 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.2 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 0.12 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.15 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.635 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 0.14 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 0.06 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.15 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.745 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 0.31 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 0.15 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 0.85 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.2 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 0.12 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.165 -0.374 . . . . 9.37 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -133.89 -58.84 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.593 0.235 . . . . 9.04 110.699 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.407 ' HG2' ' OE2' ' A' ' 7' ' ' GLU . 23.7 mmt -64.38 -68.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 8.13 111.23 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 p -170.88 -69.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.186 -0.461 . . . . 5.76 109.977 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -152.4 140.73 20.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 5.73 110.084 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.4 m 62.8 94.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.014 0.822 . . . . 1.52 111.543 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 3' ' ' MET . 41.8 mt-10 -117.86 -57.41 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.955 -1.021 . . . . 2.01 112.081 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 48' ' ' LEU . 98.2 t 62.36 107.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 0.45 111.518 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.41 109.993 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.695 ' SD ' HD23 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 0.89 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.1 116.878 174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 0.11 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.2 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.2 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 0.35 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.31 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 0.19 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 0.16 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 0.12 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.48 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.66 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 0.84 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 0.89 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 0.17 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.508 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.26 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.747 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.1 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 0.13 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 0.14 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.16 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.884 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.15 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.654 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.36 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.11 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 0.15 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.654 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 0.22 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.729 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.47 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.39 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.15 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.15 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.749 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.14 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 0.24 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.17 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 0.11 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD21 HD22 ' A' ' 68' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.1 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.4 mm-40 -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.766 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 0.16 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 0.13 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.18 108.22 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 0.24 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.511 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 0.9 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.55 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 2.5 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.51 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 0.12 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.417 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 0.16 109.296 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.634 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 61' ' ' ILE . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.11 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 0.07 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 0.11 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 1.74 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 0.11 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.884 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.14 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 0.11 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.529 HG23 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 0.24 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 4.6 t-20 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.889 ' HB3' HD22 ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.38 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.19 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.767 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.16 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.538 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 0.19 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.19 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 0.57 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.12 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 0.17 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.2 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 0.12 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.15 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.666 HG21 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 0.14 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 0.06 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.889 HD22 ' HB3' ' A' ' 77' ' ' ASN . 4.8 t-20 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.749 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.18 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 0.31 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 0.15 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.766 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 0.85 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.2 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.93 178.24 28.23 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -124.35 159.54 30.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.41 . . . . 1.18 111.039 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.19 -140.77 3.11 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.757 -0.656 . . . . 2.58 111.911 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.57 62.04 6.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.835 0.35 . . . . 3.51 111.309 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.12 49.2 73.53 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.144 -0.551 . . . . 2.3 112.609 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -136.2 157.11 47.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.466 . . . . 4.69 110.682 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -82.45 100.82 10.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.516 0.674 . . . . 0.96 110.015 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -64.45 -62.31 1.68 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.614 -1.176 . . . . 2.21 110.083 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 17.6 m-20 -117.54 3.97 12.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.623 -0.717 . . . . 2.37 110.223 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mm? -83.16 170.54 14.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.725 -0.67 . . . . 0.81 111.024 -170.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -157.76 -34.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.07 -0.968 . . . . 1.68 109.978 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 114.994 -1.003 . . . . 3.71 111.127 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.078 -0.409 . . . . 9.37 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -140.95 149.65 42.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.539 . . . . 9.04 109.543 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt 68.13 96.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.868 0.73 . . . . 8.13 110.284 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m 66.42 -175.53 0.19 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.693 -0.685 . . . . 5.76 110.533 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -150.24 130.5 13.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.315 -0.254 . . . . 5.73 110.315 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -82.0 126.49 32.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.961 -0.385 . . . . 1.52 109.961 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 41.9 mt-10 -145.04 -47.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.057 -0.52 . . . . 2.01 111.354 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 48' ' ' LEU . 21.5 t 48.12 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.25 0.62 . . . . 0.45 112.655 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.41 110.742 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.68 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.89 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.1 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 0.11 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.2 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 0.35 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.31 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 0.19 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 0.16 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 0.12 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.66 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 0.84 110.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 0.89 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.17 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.26 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.1 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 0.13 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 0.14 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.16 114.258 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.15 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.36 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.11 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.827 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 0.15 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.68 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 0.22 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.694 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.47 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.39 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.15 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.694 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.15 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.62 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.14 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.534 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 0.24 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.17 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 0.11 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.1 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.7 mm-40 -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.655 HD11 ' HA2' ' A' ' 98' ' ' GLY . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 0.16 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 0.13 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.18 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 0.24 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.663 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 0.9 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 2.73 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 0.55 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.454 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 2.5 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HD2' HD22 ' A' ' 90' ' ' LEU . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.51 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' OG ' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 0.12 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 0.16 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.11 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 0.07 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 80' ' ' TYR . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 0.11 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 1.74 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 27' ' ' ALA . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 0.11 112.432 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.14 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.575 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 0.11 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.24 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.2 t-20 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.38 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.19 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.16 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 0.19 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.19 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.615 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 0.57 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.12 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 0.17 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.2 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 0.12 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.15 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.643 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 0.14 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 0.06 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.15 106.671 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.62 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.18 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 0.31 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 0.15 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 0.85 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.2 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 0.12 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.42 -173.29 33.86 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -138.01 91.77 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.564 0.697 . . . . 1.18 111.326 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.74 -32.41 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.71 -0.757 . . . . 2.58 112.564 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.3 57.99 4.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.47 . . . . 3.51 111.382 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.06 -132.97 11.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 2.3 112.653 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -92.9 -46.97 7.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.135 0.493 . . . . 4.69 110.446 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -116.09 86.95 2.58 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.216 0.531 . . . . 0.96 111.262 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.94 -58.38 8.13 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.178 -0.919 . . . . 2.21 110.57 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.63 -14.54 11.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.115 -0.948 . . . . 2.37 110.158 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.3 mm? -73.65 162.88 28.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.616 -1.175 . . . . 0.81 112.04 -162.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -146.94 -25.96 0.4 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.501 -1.227 . . . . 1.68 110.851 -171.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 21.6 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.447 -0.787 . . . . 3.71 111.223 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.859 -0.496 . . . . 9.37 111.859 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 m170 58.48 33.07 22.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.99 0.424 . . . . 9.04 111.449 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.7 ttm -74.13 -33.94 63.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 8.13 110.559 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.41 28.82 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.75 -0.659 . . . . 5.76 110.554 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -124.37 101.29 7.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.513 0.561 . . . . 5.73 112.513 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 p 40.13 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.929 1.393 . . . . 1.52 114.315 172.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.95 -46.13 18.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.857 -1.065 . . . . 2.01 111.653 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' HA ' HD23 ' A' ' 48' ' ' LEU . 39.0 t 41.39 88.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 0.45 113.032 -176.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.41 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.89 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.1 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 0.11 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.2 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.2 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 0.35 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.31 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 0.19 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 0.16 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 0.12 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.66 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 0.84 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 0.89 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 0.17 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.26 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.1 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.712 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 0.13 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 0.14 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.16 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.15 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.36 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.11 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 0.15 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 0.22 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.47 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.39 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.15 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.15 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.14 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 0.24 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.17 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 0.11 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD21 HD22 ' A' ' 68' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.1 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 0.16 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 0.13 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.18 108.203 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 0.24 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.524 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 0.9 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 2.73 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.55 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 2.5 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.51 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 0.12 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 0.16 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.792 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.11 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 0.07 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 0.11 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 1.74 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 0.11 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.604 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 0.11 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 0.24 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.4 t-20 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.38 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.19 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.16 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 0.19 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.19 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 67' ' ' ILE . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 0.57 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.12 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 0.17 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.2 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 ' HD2' ' A' ' 60' ' ' TYR . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 0.12 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.591 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.15 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.675 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 0.14 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 0.06 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.15 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.18 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 0.31 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.15 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 0.85 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.2 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 0.12 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.84 179.53 31.48 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -124.96 171.44 10.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.253 0.526 . . . . 1.18 110.083 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.407 ' H ' ' NH2' ' A' ' 25' ' ' ARG . . . 171.71 -143.45 7.54 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.658 -0.782 . . . . 2.58 112.056 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.78 100.4 12.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 3.51 110.961 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.37 -163.92 26.34 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.816 -0.706 . . . . 2.3 112.259 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.45 -35.89 9.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.857 0.36 . . . . 4.69 111.178 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.449 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -135.69 121.85 20.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.578 . . . . 0.96 112.168 -173.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.99 -60.19 2.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.022 -0.99 . . . . 2.21 110.055 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 15.8 m-20 -114.31 -1.43 13.57 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.128 -0.942 . . . . 2.37 110.286 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.4 mm? -81.03 162.24 23.87 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.274 -0.876 . . . . 0.81 110.979 -167.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -142.3 -23.46 0.67 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.72 -1.127 . . . . 1.68 110.749 -171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.712 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p90 . . . . . 0 C--O 1.252 1.202 0 CA-C-N 115.718 -0.674 . . . . 3.71 111.008 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.235 -0.346 . . . . 9.37 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 55.07 76.78 0.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.312 0.645 . . . . 9.04 111.19 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ttt 55.22 61.57 2.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.619 -0.719 . . . . 8.13 110.535 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -68.84 154.98 41.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.465 -0.789 . . . . 5.76 110.933 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -79.31 62.1 3.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.493 -0.929 . . . . 5.73 108.493 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 m -151.26 89.93 1.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.558 -0.746 . . . . 1.52 111.07 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -96.24 -56.66 2.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 2.01 111.218 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD23 ' A' ' 48' ' ' LEU . 47.5 t 56.8 92.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 0.45 111.913 -176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.699 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.653 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 0.89 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.1 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 0.11 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.2 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.2 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.35 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.31 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 0.19 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 0.16 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 0.12 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.7 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.66 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 0.84 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 0.89 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 0.17 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.26 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.68 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.1 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 0.13 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 0.14 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.16 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.15 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.36 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.813 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 0.15 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 0.22 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.83 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.47 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.432 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.39 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.15 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.83 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.15 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.14 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.24 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.17 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 0.11 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 68' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.1 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 0.16 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 0.13 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.18 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 0.24 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' HD11 ' A' ' 61' ' ' ILE . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 0.9 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 2.73 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.55 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 2.5 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' HD2' HD22 ' A' ' 90' ' ' LEU . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.51 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 0.12 111.678 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 0.16 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.794 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 0.07 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 0.11 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 1.74 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 0.11 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.873 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.14 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.643 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.11 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 0.24 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.0 t-20 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.38 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.19 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.16 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.553 ' CG ' HG21 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 0.19 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.679 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.19 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 0.57 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.12 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 0.17 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.2 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 60' ' ' TYR . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 0.12 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.15 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.65 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 0.14 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 0.06 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.15 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.691 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.18 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 0.31 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.719 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.2 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 0.12 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.54 38.88 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -134.68 24.92 3.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.27 0.535 . . . . 1.18 110.446 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.75 85.54 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.623 -0.717 . . . . 2.58 112.346 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -78.11 -21.77 49.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.225 0.536 . . . . 3.51 110.298 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.34 -81.46 1.55 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.551 -0.75 . . . . 2.3 112.567 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -67.26 93.39 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.336 0.255 . . . . 4.69 110.465 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.451 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . 46.41 71.39 0.3 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.476 0.655 . . . . 0.96 111.261 -173.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 14.5 t70 -51.93 -55.76 18.27 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.464 -1.244 . . . . 2.21 110.415 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.425 ' H ' HD22 ' A' ' 111' ' ' LEU . 8.8 t70 -117.88 -12.99 10.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.44 -0.8 . . . . 2.37 110.007 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 108' ' ' ALA . 1.9 mm? -73.96 162.02 29.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.945 -1.025 . . . . 0.81 112.241 -161.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.93 -24.23 2.96 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.927 -1.488 . . . . 1.68 110.363 -173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 17.7 p90 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.586 -0.734 . . . . 3.71 110.608 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.321 -0.312 . . . . 9.37 112.321 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -85.6 -30.99 22.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 9.04 110.254 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 tpt -98.85 -48.93 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.126 0.488 . . . . 8.13 110.499 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -85.93 76.88 9.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.235 0.541 . . . . 5.76 109.942 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -76.87 125.98 30.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.596 -0.729 . . . . 5.73 109.918 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -143.03 88.31 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.885 0.85 . . . . 1.52 111.706 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.6 -48.3 6.15 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.431 -1.258 . . . . 2.01 111.017 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.6 t 48.97 89.02 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 123.839 0.712 . . . . 0.45 112.294 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.41 110.577 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.704 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.89 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.1 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 67' ' ' ILE . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 0.11 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.2 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.2 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 0.35 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.31 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.19 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 0.16 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 0.12 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.49 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.66 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 0.84 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 0.89 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 0.17 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.26 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.1 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.645 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 0.13 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 0.14 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.16 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.888 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.15 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.36 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.727 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 0.15 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.22 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.905 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.47 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.39 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.15 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.905 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.15 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.14 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 0.24 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.17 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 0.11 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.1 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.9 mm-40 -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 0.16 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 0.13 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.18 108.143 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 0.24 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' HD11 ' A' ' 61' ' ' ILE . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 0.9 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 2.73 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 0.55 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 2.5 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.525 ' HD2' HD22 ' A' ' 90' ' ' LEU . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.51 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 0.12 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 0.16 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.624 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 0.07 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 0.11 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 1.74 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 0.11 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.14 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.664 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 0.11 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 0.24 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.38 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.19 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.16 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.526 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 0.19 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.19 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 0.57 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.12 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 0.17 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.2 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.525 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 0.12 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.15 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 0.14 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 0.06 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.15 107.069 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.676 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.18 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 0.31 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 0.15 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 0.85 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.2 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 0.12 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -99.48 -163.19 29.32 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.49 35.77 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.545 0.688 . . . . 1.18 110.138 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.68 -31.35 7.48 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.365 -0.834 . . . . 2.58 112.276 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -80.1 -43.33 21.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 3.51 111.19 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.87 -156.46 27.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.662 -0.78 . . . . 2.3 112.087 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -52.52 -41.87 63.85 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.431 0.292 . . . . 4.69 111.655 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.504 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -120.22 75.23 1.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.648 0.737 . . . . 0.96 110.532 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 17.5 t70 -54.69 -56.56 17.93 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.354 -1.294 . . . . 2.21 109.677 173.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 9.6 m-20 -119.98 -2.84 10.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.364 -0.835 . . . . 2.37 110.42 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.2 mm? -75.89 167.36 22.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.775 -0.648 . . . . 0.81 111.475 -167.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.13 -27.32 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.16 -0.927 . . . . 1.68 110.432 -172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 23.6 p90 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.866 -1.061 . . . . 3.71 111.678 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 111.786 -0.525 . . . . 9.37 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 58.1 73.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 9.04 110.915 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptm -94.48 -10.82 31.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.764 -0.458 . . . . 8.13 109.764 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 m 67.73 117.42 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.106 -0.952 . . . . 5.76 112.123 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 36.8 mmt180 -90.51 39.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.462 0.649 . . . . 5.73 109.916 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -140.92 69.04 1.34 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.295 1.045 . . . . 1.52 110.445 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -91.64 -56.53 3.07 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.745 -1.571 . . . . 2.01 111.985 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' HD23 ' A' ' 48' ' ' LEU . 76.8 t 56.71 97.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 0.45 112.002 -173.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.41 109.913 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.682 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.89 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.1 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 0.11 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.2 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.2 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 0.35 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.31 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 0.19 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 0.16 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 0.12 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.66 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 0.84 110.672 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 0.89 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.17 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.26 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.1 111.487 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 0.13 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 0.14 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.16 113.68 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.889 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.15 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.36 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.11 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 0.15 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 0.22 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.726 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.47 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.439 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.39 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.15 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.726 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.15 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.14 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.539 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 0.24 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.17 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 0.11 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 68' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.1 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.2 mm-40 -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.742 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 0.16 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 0.13 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.18 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 0.24 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 0.9 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 2.73 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 0.55 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HE ' ' HE1' ' A' ' 60' ' ' TYR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 2.5 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.564 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.51 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 0.12 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 0.16 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.784 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.11 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 0.07 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 0.11 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 1.74 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG21 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 0.11 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.889 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.14 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 0.11 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.24 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.7 t-20 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.38 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.19 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.16 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.563 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 0.19 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.19 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.62 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 0.57 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.12 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 0.17 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.2 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 0.12 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.15 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 0.14 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 0.06 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.15 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.71 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.18 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 0.31 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.15 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.742 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 0.85 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.2 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.02 176.29 33.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.623 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 30.2 p-10 -132.44 -4.04 3.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.65 0.725 . . . . 1.18 111.889 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.93 68.53 2.25 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.24 -0.505 . . . . 2.58 113.076 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.86 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.851 0.46 . . . . 3.51 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.78 -174.58 42.87 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.715 -0.755 . . . . 2.3 111.668 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 52.48 -96.24 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.327 0.651 . . . . 4.69 112.401 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.71 125.19 4.66 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.896 0.855 . . . . 0.96 110.187 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HH21 ' A' ' 25' ' ' ARG . 51.1 t0 -83.77 -64.16 1.22 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.337 -1.301 . . . . 2.21 110.845 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -116.69 -5.3 11.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 2.37 111.226 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.24 163.65 27.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.708 0.766 . . . . 0.81 111.94 -166.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.81 -30.99 0.35 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.452 -1.249 . . . . 1.68 110.642 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 12.1 p90 . . . . . 0 C--O 1.246 0.909 0 CA-C-N 115.522 -0.763 . . . . 3.71 110.971 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.171 -0.372 . . . . 9.37 112.171 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -154.3 68.29 0.74 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.221 0.534 . . . . 9.04 109.614 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.03 -33.91 70.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 8.13 111.014 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.5 t -93.75 113.38 25.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.917 -0.583 . . . . 5.76 109.93 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 3.2 mpt_? -82.48 -38.26 24.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.439 -0.948 . . . . 5.73 108.439 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t 61.35 103.84 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.93 -1.032 . . . . 1.52 112.04 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -109.5 -42.05 4.43 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.79 -1.095 . . . . 2.01 111.018 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.637 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.1 t 46.01 86.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 123.766 0.666 . . . . 0.45 112.502 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.41 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 0.89 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.1 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 0.11 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.2 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.2 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 0.35 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.31 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 0.19 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 0.16 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 0.12 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.66 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 0.84 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 0.89 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.17 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.26 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.679 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.1 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 0.13 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 0.14 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.16 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.15 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.36 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.11 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.801 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 0.15 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 0.22 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.47 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.39 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.15 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.15 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.14 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 0.24 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.17 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 0.11 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 68' ' ' LEU . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.1 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.726 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 0.16 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 0.13 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.18 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 0.24 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 0.9 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 2.73 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 0.55 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.51 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 0.12 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 0.16 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.11 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 0.07 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 0.11 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.581 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 1.74 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 0.11 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.14 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 0.11 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 0.24 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.38 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.19 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.16 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 0.19 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.19 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 0.57 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.12 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.596 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 0.17 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.2 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 0.12 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.15 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.652 HG21 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 0.14 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.06 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.15 106.619 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.664 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.18 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 0.31 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 0.15 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.2 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 0.12 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.65 -168.34 33.85 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -138.35 178.93 6.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.171 -0.307 . . . . 1.18 110.171 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.58 -48.6 0.92 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.712 -0.756 . . . . 2.58 111.902 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.07 89.42 7.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.691 0.281 . . . . 3.51 111.146 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.45 -141.9 48.07 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 2.3 112.248 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.14 -50.32 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.817 -0.438 . . . . 4.69 109.817 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.07 87.01 5.99 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.438 0.637 . . . . 0.96 110.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -64.26 -53.3 51.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.885 -1.052 . . . . 2.21 109.916 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -115.91 -17.22 11.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.317 -0.856 . . . . 2.37 110.18 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.679 HD21 ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -80.84 167.89 19.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.901 -1.045 . . . . 0.81 112.391 -162.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -126.79 1.95 6.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.539 -1.664 . . . . 1.68 107.527 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.421 ' CZ ' HD12 ' A' ' 111' ' ' LEU . 5.4 p90 . . . . . 0 N--CA 1.438 -1.052 0 CA-C-N 113.734 -1.575 . . . . 3.71 110.615 -172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.068 -0.413 . . . . 9.37 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -86.71 112.0 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.343 -0.243 . . . . 9.04 110.343 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.4 mmm 70.15 128.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.937 0.773 . . . . 8.13 111.733 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m 62.08 88.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.334 -0.848 . . . . 5.76 111.266 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.45 110.11 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.866 -0.607 . . . . 5.73 110.043 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -128.37 92.53 3.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.552 0.691 . . . . 1.52 111.074 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.77 -49.33 11.27 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.972 -1.013 . . . . 2.01 111.159 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.9 t 42.71 79.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 0.45 112.117 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.66 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 0.89 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.1 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 0.11 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.2 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 0.35 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.31 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 0.19 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 0.16 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 0.12 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.44 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.66 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 19' ' ' VAL . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 0.84 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 0.89 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 0.17 110.312 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.608 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.26 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.1 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG21 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 0.13 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 0.14 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.16 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.15 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.36 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.11 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 0.15 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 0.22 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.893 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.47 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.39 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.15 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.893 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.15 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.14 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 0.24 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.17 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 0.11 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 68' ' ' LEU . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.1 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.785 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 0.16 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 0.13 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.18 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 0.24 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.483 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 0.9 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 2.73 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.55 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.499 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 2.5 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.842 ' HD2' HD22 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.51 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 0.12 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 0.16 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.758 ' HA ' HD21 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 0.07 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 0.11 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.652 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 1.74 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 27' ' ' ALA . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 0.11 112.04 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.14 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.697 HD11 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 0.11 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 0.24 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.6 t-20 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.583 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.38 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.19 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.16 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 0.19 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.19 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 0.57 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.12 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 0.17 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.2 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.842 HD22 ' HD2' ' A' ' 60' ' ' TYR . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 0.12 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.15 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.14 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 0.06 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.15 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.18 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 0.31 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 0.15 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 0.85 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.2 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 0.12 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.6 -118.43 0.38 Allowed Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -155.27 -68.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.628 -0.508 . . . . 1.18 109.628 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.98 -144.14 42.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.218 -0.515 . . . . 2.58 112.853 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.82 169.39 8.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.571 0.225 . . . . 3.51 110.612 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.26 34.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.83 -0.7 . . . . 2.3 112.421 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -117.84 -9.46 10.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 4.69 110.984 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -134.25 119.98 19.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.846 0.831 . . . . 0.96 112.552 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.11 -54.07 3.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.211 -1.359 . . . . 2.21 109.742 171.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 8.9 m-20 -115.85 -1.17 12.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.335 -0.848 . . . . 2.37 109.525 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.6 mm? -81.4 164.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.159 -0.928 . . . . 0.81 111.514 -165.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.38 5.46 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.586 -1.188 . . . . 1.68 109.757 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-N 114.909 -1.041 . . . . 3.71 111.344 -167.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.678 -0.569 . . . . 9.37 111.678 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 58.24 67.38 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.93 0.395 . . . . 9.04 110.747 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -79.76 119.88 23.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.872 -0.418 . . . . 8.13 109.872 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -68.54 118.89 12.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.2 -0.454 . . . . 5.76 109.81 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.01 141.39 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 5.73 111.066 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 p -96.02 87.34 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.908 0.861 . . . . 1.52 110.821 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.7 mm-40 -89.83 -61.59 1.66 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.675 -1.148 . . . . 2.01 111.997 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 45.7 t 57.69 90.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 0.45 111.867 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.41 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.71 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 0.89 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.1 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 0.11 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.2 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.2 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 0.35 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.31 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG13 HG12 ' A' ' 19' ' ' VAL . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.19 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 0.16 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 0.12 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.66 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 0.84 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 0.89 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 0.17 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.26 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.1 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.13 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 0.14 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.16 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.15 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.668 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.36 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.11 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 0.15 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 0.22 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.792 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.47 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.39 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.15 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.792 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.15 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.665 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.14 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 0.24 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.17 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 0.11 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 68' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.1 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.3 mm-40 -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 0.16 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.669 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 0.13 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.18 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.49 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 0.24 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 0.9 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 2.73 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.55 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 2.5 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.53 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.51 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 0.12 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 0.16 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 61' ' ' ILE . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.11 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 0.07 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 0.11 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 1.74 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 0.11 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.14 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.636 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 0.11 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.479 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.24 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.1 t-20 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.38 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.19 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.779 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.16 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.582 ' CG ' HG21 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 0.19 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.19 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.595 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 0.57 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.12 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 0.17 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.2 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 0.12 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.15 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.676 HG21 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 0.14 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 0.06 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.15 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.18 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 0.31 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 0.15 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 0.85 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.2 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 0.12 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.01 -159.79 23.51 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.91 -20.86 15.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.109 0.48 . . . . 1.18 109.968 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.31 -129.78 49.62 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.367 -0.833 . . . . 2.58 112.543 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.54 21.6 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.339 0.59 . . . . 3.51 109.762 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.82 158.63 14.68 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.348 -0.842 . . . . 2.3 111.943 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 62.99 -138.63 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.701 0.4 . . . . 4.69 111.233 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.07 106.68 16.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.4 0.619 . . . . 0.96 111.869 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.47 -64.15 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.191 -0.913 . . . . 2.21 110.315 171.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.527 ' H ' HD22 ' A' ' 111' ' ' LEU . 27.2 t70 -116.24 0.7 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.13 -0.941 . . . . 2.37 109.161 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 101' ' ' VAL . 1.9 mm? -85.71 175.23 8.84 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.81 112.73 -163.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.65 -30.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.595 -1.639 . . . . 1.68 106.843 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.927 0 CA-C-N 112.889 -1.959 . . . . 3.71 110.408 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.771 -0.531 . . . . 9.37 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -96.7 147.41 23.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.843 0.322 . . . . 9.04 110.329 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -120.32 154.88 34.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.175 -0.676 . . . . 8.13 109.175 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 p -94.69 144.62 25.47 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.516 -0.55 . . . . 5.76 109.516 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -82.96 -175.56 5.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.021 -0.363 . . . . 5.73 110.021 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.0 p -70.93 87.36 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.641 0.734 . . . . 1.52 110.416 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 23.1 mm-40 -85.73 -58.97 2.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.803 -1.089 . . . . 2.01 112.097 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.4 t 53.32 92.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.45 111.858 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.41 110.695 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 0.89 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.1 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 0.11 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.2 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.2 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 0.19 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.653 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 0.12 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.66 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.418 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 0.84 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 0.89 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 0.17 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.663 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.26 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.1 111.981 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.791 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 0.13 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 0.14 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.16 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.896 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.15 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.659 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.11 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 0.15 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 0.22 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.759 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.47 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.39 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.15 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.759 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.15 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.14 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 0.24 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.17 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 0.11 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.1 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.702 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 0.16 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 0.13 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.18 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 0.24 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.526 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 0.9 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 2.73 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.55 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 2.5 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.51 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 0.12 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 0.16 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.11 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 0.07 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 0.11 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.627 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 1.74 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.548 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 0.11 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.896 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.14 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.554 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 0.11 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.24 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.38 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.19 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.838 ' HB3' HD11 ' A' ' 68' ' ' LEU . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.16 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.548 ' CG ' HG21 ' A' ' 71' ' ' VAL . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.19 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 0.57 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.12 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 0.17 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.663 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.2 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.607 HD22 ' HD2' ' A' ' 60' ' ' TYR . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 0.12 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.15 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 0.14 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 0.06 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.15 107.127 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 0.31 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 0.15 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.702 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 0.85 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.2 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 0.12 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.98 179.92 27.55 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 31.7 p-10 -129.82 15.82 5.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.2 0.5 . . . . 1.18 110.861 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.94 -32.9 34.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.868 -0.682 . . . . 2.58 112.232 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.41 -29.75 62.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.918 0.39 . . . . 3.51 111.103 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.14 173.03 49.12 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 2.3 112.243 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.2 m80 57.26 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.426 0.69 . . . . 4.69 111.569 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.0 97.48 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.092 0.472 . . . . 0.96 109.845 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.96 -60.48 3.51 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.172 -0.922 . . . . 2.21 110.95 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -12.37 11.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.597 0.713 . . . . 2.37 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.4 mm? -75.84 161.57 28.88 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.81 112.262 -162.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.39 -29.1 0.16 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.93 -1.486 . . . . 1.68 110.253 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.791 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 3.6 p90 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.382 -0.827 . . . . 3.71 111.338 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.966 -0.453 . . . . 9.37 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -127.24 30.9 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 9.04 110.705 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -60.15 132.73 54.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 8.13 110.68 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 t -137.92 -99.17 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 5.76 110.082 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 5' ' ' ARG . 23.5 mtp180 56.14 -168.52 0.1 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.534 0.683 . . . . 5.73 111.719 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -135.11 91.71 2.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.619 -0.719 . . . . 1.52 109.571 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.59 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.1 mm-40 -117.07 -59.41 1.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.861 -1.063 . . . . 2.01 111.751 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 77.0 t 61.67 105.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 0.45 111.881 -175.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.41 109.879 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.707 ' SD ' HD23 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 0.89 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.1 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.629 ' HB2' HG12 ' A' ' 67' ' ' ILE . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 0.11 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.2 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.2 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 0.35 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.31 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 19' ' ' VAL . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 0.19 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 0.16 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 0.12 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.66 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 0.84 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 0.89 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 0.17 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.68 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.26 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.1 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 0.13 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 0.14 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.16 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.864 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.15 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.36 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.11 109.838 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 0.15 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 0.22 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.47 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.39 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.15 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.15 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.14 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 0.24 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.17 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 0.11 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 68' ' ' LEU . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.1 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 mm-40 -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.705 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 0.16 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 0.13 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.18 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.467 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 0.24 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 0.9 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 2.73 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 0.55 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.467 ' NE ' HG23 ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 2.5 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.51 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 0.12 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 0.16 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.11 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 0.07 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 0.11 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 1.74 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 0.11 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.864 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.14 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 0.11 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 0.24 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.8 t-20 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.38 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.19 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.16 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 0.19 107.891 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.19 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 0.57 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.12 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 0.17 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.2 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 0.12 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.15 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 0.14 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 0.06 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.15 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.18 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 0.31 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.705 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 0.85 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.2 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 0.12 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.48 -172.71 32.24 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -137.28 159.62 41.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.071 0.436 . . . . 1.18 110.328 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.72 -141.04 3.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 2.58 112.264 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.92 -13.53 55.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.83 0.348 . . . . 3.51 111.468 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.89 -158.36 30.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.843 -0.694 . . . . 2.3 112.035 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -110.59 -58.72 2.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 4.69 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -104.24 91.76 4.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.96 111.65 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.61 -61.1 2.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.694 -1.139 . . . . 2.21 109.753 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 6.3 m-20 -118.04 -5.07 10.99 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.208 -0.906 . . . . 2.37 110.21 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.9 mm? -69.5 165.07 21.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.399 -0.818 . . . . 0.81 111.657 -167.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.99 -30.55 0.12 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.81 -1.086 . . . . 1.68 110.809 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 14.6 p90 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.294 -0.866 . . . . 3.71 111.294 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.673 -0.571 . . . . 9.37 111.673 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -77.46 -57.86 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.872 -0.418 . . . . 9.04 109.872 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -68.6 111.51 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.107 -0.701 . . . . 8.13 109.107 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 m -100.25 -85.56 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 5.76 111.22 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.3 107.81 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.915 -0.402 . . . . 5.73 109.915 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m 56.61 81.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.853 0.835 . . . . 1.52 110.977 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 43.1 mt-10 -101.5 -61.36 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.828 -1.078 . . . . 2.01 113.555 -171.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 48' ' ' LEU . 94.8 t 69.08 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 0.45 110.393 -170.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.4 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.646 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 0.89 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.1 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 0.11 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.2 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.2 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 0.35 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.31 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 0.19 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 0.16 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 0.12 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.66 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 0.84 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 0.89 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.17 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.26 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.1 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.653 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 0.13 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 0.14 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.16 113.476 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.15 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.11 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 0.15 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 0.22 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.47 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.46 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.39 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.15 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.15 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.651 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.14 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 0.24 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.17 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 0.11 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.744 HD21 HD22 ' A' ' 68' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.1 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.6 mm-40 -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.697 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 0.16 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 0.13 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.18 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.429 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 0.9 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 2.73 110.715 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 0.55 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.429 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 2.5 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.51 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 0.12 111.7 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 0.16 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.617 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.11 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 0.07 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 0.11 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.691 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 1.74 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 0.11 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.14 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.11 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 0.24 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.2 t-20 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.38 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.19 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.845 ' HB3' HD11 ' A' ' 68' ' ' LEU . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.16 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 0.19 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.19 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 0.57 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.12 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 0.17 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.2 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 0.12 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.15 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.653 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 0.14 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 0.06 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.15 106.607 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.651 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.18 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 0.31 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 0.15 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 0.85 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.2 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 0.12 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.04 175.82 20.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -141.04 47.91 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.618 0.723 . . . . 1.18 109.242 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.09 -22.2 78.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.614 -0.721 . . . . 2.58 113.604 -173.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.13 6.58 5.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 3.51 111.89 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.89 79.48 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.778 -0.725 . . . . 2.3 112.065 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -117.91 158.61 24.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.349 -0.611 . . . . 4.69 109.349 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -63.86 92.47 0.07 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.52 0.676 . . . . 0.96 110.186 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.38 -62.01 2.2 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.39 -1.277 . . . . 2.21 110.337 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -117.62 0.42 12.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.529 -0.76 . . . . 2.37 110.987 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 25' ' ' ARG . 2.3 mm? -82.11 161.72 22.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.671 0.748 . . . . 0.81 111.555 -167.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.31 -33.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.295 -1.32 . . . . 1.68 110.513 -170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 10.7 p90 . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.976 -1.011 . . . . 3.71 111.708 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 CA-C-O 120.177 -0.235 . . . . 9.37 112.805 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.4 m80 60.77 43.9 11.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.621 0.368 . . . . 9.04 111.707 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.9 ttp -129.65 87.64 2.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.926 0.393 . . . . 8.13 110.415 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.6 t -74.56 112.31 10.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.47 -0.567 . . . . 5.76 109.47 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -98.65 166.94 11.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 5.73 111.163 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.8 m 65.61 77.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.132 0.968 . . . . 1.52 110.773 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -85.28 -61.35 1.79 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.037 -1.438 . . . . 2.01 112.273 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HA ' HD23 ' A' ' 48' ' ' LEU . 75.3 t 58.22 99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 0.45 111.87 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.41 110.306 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.673 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 0.89 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.1 116.53 172.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 0.11 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.2 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.2 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.35 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.31 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 0.19 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 0.16 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 0.12 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.66 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 0.84 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 0.89 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 0.17 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.529 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.26 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.1 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG21 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 0.13 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 0.14 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.16 113.213 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.879 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.15 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.36 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.11 109.994 175.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.803 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 0.15 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 0.22 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.793 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.47 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.39 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.15 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.793 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.15 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.14 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 0.24 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.17 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 0.11 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.1 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.6 mm-40 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 0.16 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.654 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 0.13 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.18 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 0.9 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.73 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 0.55 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 2.5 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.565 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 0.12 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 0.16 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.11 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 0.07 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 0.11 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 1.74 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 0.11 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.879 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.14 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 0.11 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 0.24 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.4 t-20 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.38 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.19 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.781 ' HB3' HD11 ' A' ' 68' ' ' LEU . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.16 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.566 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 0.19 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 0.57 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.12 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 0.17 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.2 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.565 HD22 ' HD2' ' A' ' 60' ' ' TYR . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 0.12 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.15 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.682 ' HB ' HG22 ' A' ' 101' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 0.14 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 0.06 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.15 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.755 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.18 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.31 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 0.15 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 0.85 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.2 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 0.12 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -102.28 176.54 25.61 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -113.67 177.5 4.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.421 0.611 . . . . 1.18 109.948 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.87 -35.69 2.07 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.698 -0.763 . . . . 2.58 112.012 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.26 -167.48 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.547 0.213 . . . . 3.51 110.87 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.45 -90.47 1.49 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.249 -0.977 . . . . 2.3 112.295 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -60.51 -51.55 68.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.624 0.25 . . . . 4.69 111.116 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -164.05 127.59 2.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.36 0.6 . . . . 0.96 111.199 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.945 -1.025 . . . . 2.21 111.055 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.3 -19.4 12.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.571 0.7 . . . . 2.37 110.432 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' OH ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -80.16 166.01 21.88 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.888 -1.051 . . . . 0.81 111.488 -166.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.86 3.51 4.11 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.01 -1.45 . . . . 1.68 108.213 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.535 ' OH ' HD12 ' A' ' 111' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 113.948 -1.478 . . . . 3.71 111.017 -175.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.442 -0.663 . . . . 9.37 111.442 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -62.34 120.33 10.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.169 -0.678 . . . . 9.04 109.169 175.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttm -71.16 80.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 8.13 111.285 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.7 m -161.83 -54.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.157 -0.929 . . . . 5.76 108.735 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.688 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 18.5 tpp180 70.76 119.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.143 0.902 . . . . 5.73 110.42 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 112.15 11.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.137 0.494 . . . . 1.52 111.916 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.09 -50.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 2.01 111.696 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t 58.49 101.08 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 0.45 112.138 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.41 110.174 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.67 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 0.89 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.1 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 0.11 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.2 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' HG12 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.2 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.35 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.31 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 19' ' ' VAL . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 0.19 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 0.16 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 0.12 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.448 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.66 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 0.84 111.217 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 0.89 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 0.17 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.629 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.26 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.628 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.1 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 0.13 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 0.14 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.16 114.436 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.881 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.15 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.646 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.36 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.11 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 0.15 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 0.22 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.902 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.47 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.39 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.15 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.902 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.15 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.14 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 0.24 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.17 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.11 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD21 HD22 ' A' ' 68' ' ' LEU . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.1 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.688 ' OE1' ' HG3' ' A' ' 5' ' ' ARG . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.622 HD11 ' HA2' ' A' ' 98' ' ' GLY . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 0.16 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 0.13 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.18 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 0.24 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.542 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 0.9 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 2.73 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 0.55 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 2.5 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.542 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.51 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 0.12 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 0.16 109.629 172.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.62 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.11 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.07 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 0.11 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 1.74 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 0.11 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.881 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.14 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.645 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 0.11 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.24 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t-20 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 40' ' ' ALA . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.38 110.929 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.19 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.16 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 0.19 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.19 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 0.57 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.12 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 0.17 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.629 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.2 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 0.12 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.15 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 0.14 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 0.06 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.15 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.692 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.18 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 0.31 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 0.15 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.622 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 0.85 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.2 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 0.12 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -93.01 -173.5 40.76 Favored Glycine 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -139.08 -170.88 2.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.598 0.699 . . . . 1.18 111.635 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.38 -128.06 1.27 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.059 -0.817 . . . . 2.58 111.059 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.48 58.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.869 0.366 . . . . 3.51 110.077 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.95 2.11 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.401 -0.904 . . . . 2.3 113.621 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.69 145.65 54.58 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.258 0.529 . . . . 4.69 110.628 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -71.39 93.77 1.18 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.14 0.495 . . . . 0.96 110.561 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.14 -63.36 1.17 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.99 -1.004 . . . . 2.21 110.693 174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.435 ' HB3' HG12 ' A' ' 101' ' ' VAL . 36.6 t70 -116.26 -12.74 11.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.5 -0.773 . . . . 2.37 110.188 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.5 mm? -68.32 160.12 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.961 -1.018 . . . . 0.81 111.827 -164.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.23 -30.92 0.92 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.032 -1.44 . . . . 1.68 110.033 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.721 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.5 p90 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.421 -0.808 . . . . 3.71 111.008 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.042 -0.423 . . . . 9.37 112.042 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -113.29 -19.18 11.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.726 -0.279 . . . . 9.04 111.082 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' SER . 53.5 tpp -86.25 -78.0 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.057 -0.349 . . . . 8.13 110.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 3' ' ' MET . 36.4 t 170.93 140.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.184 -0.673 . . . . 5.76 109.184 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -111.63 34.22 4.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.011 0.91 . . . . 5.73 109.255 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -125.64 115.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.888 -1.051 . . . . 1.52 110.417 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 46.0 mt-10 -134.45 -49.64 0.78 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.62 -0.718 . . . . 2.01 111.183 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t 54.72 92.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 0.45 112.395 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.41 110.578 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 0.89 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.1 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 0.11 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.2 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.2 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.35 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.31 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 19' ' ' VAL . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 0.19 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 0.16 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 0.12 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 27.8 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.66 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 0.84 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.89 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 0.17 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.26 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.1 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 0.13 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 0.14 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.16 113.569 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.898 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.15 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.36 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.11 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 0.15 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 0.22 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.667 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.47 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.39 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.15 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.667 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.15 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.726 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.14 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 0.24 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.17 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 0.11 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.1 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.9 mm-40 -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.693 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 0.16 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.74 HD23 HD11 ' A' ' 82' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 0.13 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.18 108.202 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 0.24 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 0.9 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 2.73 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 2.5 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.51 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 0.12 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 0.16 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.714 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.634 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.11 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.67 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 0.07 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 80' ' ' TYR . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 0.11 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 1.74 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 0.11 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.14 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.647 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 0.11 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.4 t-20 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.38 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HD1' HG22 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.19 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.821 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.611 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.74 HD11 HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.19 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 0.57 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.12 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 0.17 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.2 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 0.12 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.15 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.638 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 0.14 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 0.06 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.15 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.726 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.18 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 0.31 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.15 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.693 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 0.85 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.2 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 0.12 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.3 -176.78 36.01 Favored Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -130.18 23.16 5.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.114 0.483 . . . . 1.18 110.521 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.12 -37.39 91.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.081 -0.807 . . . . 2.58 111.081 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.01 139.57 48.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.888 -0.412 . . . . 3.51 109.888 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.7 69.46 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.835 -0.621 . . . . 2.3 113.388 -174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -131.76 -78.07 0.51 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.762 0.281 . . . . 4.69 110.574 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.33 107.5 14.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.654 0.74 . . . . 0.96 112.004 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.96 -68.83 0.34 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.578 -1.192 . . . . 2.21 110.279 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.26 0.78 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.376 1.084 . . . . 2.37 108.483 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -71.39 150.77 44.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.81 112.57 -166.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.72 -0.05 0.84 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.958 -1.474 . . . . 1.68 108.739 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' HH ' ' HE1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.436 -1.256 . . . . 3.71 110.374 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.747 -0.541 . . . . 9.37 111.747 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -124.34 74.42 1.31 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.132 0.492 . . . . 9.04 109.806 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -148.67 155.11 40.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.051 -0.522 . . . . 8.13 110.936 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -155.68 -74.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 5.76 109.753 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.436 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 74.6 mtp180 51.76 -158.45 0.12 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.18 0.514 . . . . 5.73 110.912 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -146.33 107.12 4.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.251 -0.648 . . . . 1.52 109.251 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 42.1 mt-10 -119.18 -45.93 2.53 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 2.01 110.891 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t 53.52 91.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 0.45 110.326 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.563 HD21 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.41 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 0.89 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.1 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 0.11 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.2 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.524 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.2 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 0.35 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.31 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 19' ' ' VAL . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 0.19 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 0.16 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 0.12 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.66 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 0.89 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 0.17 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.26 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.1 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 0.13 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.722 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 0.14 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.16 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.15 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.36 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 0.15 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 0.22 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.47 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.39 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.15 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.15 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.14 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 0.24 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 5' ' ' ARG . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.17 112.755 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 0.11 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.1 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 mm-40 -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.698 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 0.16 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 0.13 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.18 108.56 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.403 HG23 ' NE ' ' A' ' 58' ' ' ARG . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 0.24 110.695 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 61' ' ' ILE . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 0.9 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 2.73 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 0.55 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 2.5 110.764 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.51 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 0.12 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 0.16 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.11 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 0.07 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 0.11 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 1.74 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 0.11 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.14 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 0.11 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 0.24 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 3.2 t-20 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.38 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.19 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.16 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.592 ' CG ' HG21 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 0.19 107.839 176.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.19 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 0.57 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.12 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.613 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 0.17 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.2 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 0.12 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.15 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 101' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 0.14 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 0.06 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.15 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.18 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 0.31 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 0.15 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.698 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 0.85 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.2 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 0.12 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.45 -175.02 38.79 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 25' ' ' ARG . 28.7 p-10 -140.01 153.63 46.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.156 0.478 . . . . 1.18 110.116 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.48 -21.26 5.43 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.938 -0.649 . . . . 2.58 112.372 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.87 57.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 3.51 110.974 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.98 146.57 11.87 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.016 -0.611 . . . . 2.3 112.74 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 63.81 -85.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.37 0.668 . . . . 4.69 110.832 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -141.93 104.05 4.43 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.237 0.541 . . . . 0.96 109.857 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 25' ' ' ARG . 3.6 m-20 -59.65 -64.64 0.87 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.719 -1.128 . . . . 2.21 111.122 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 12.1 m-20 -117.26 -5.54 11.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.634 . . . . 2.37 110.713 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.527 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.8 mm? -75.03 164.25 26.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.479 -0.782 . . . . 0.81 111.824 -167.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -138.05 -33.95 0.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.24 -1.345 . . . . 1.68 109.852 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 16.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.428 -0.805 . . . . 3.71 110.733 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.109 -0.396 . . . . 9.37 112.109 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.43 -15.48 60.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.557 0.218 . . . . 9.04 111.278 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -70.09 -30.85 68.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.022 0.439 . . . . 8.13 110.081 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 74.0 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.988 -0.551 . . . . 5.76 110.184 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -81.89 59.08 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 5.73 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 46' ' ' GLY . 2.1 p -137.88 99.44 3.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.818 -0.628 . . . . 1.52 110.973 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -85.78 -61.93 1.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 2.01 112.917 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.1 t 60.39 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 0.45 110.969 -171.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.41 110.425 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.736 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 0.89 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.1 116.822 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB2' HG12 ' A' ' 67' ' ' ILE . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 0.11 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.2 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.2 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.31 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 0.19 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 0.16 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 0.12 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.66 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 0.84 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 0.89 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.17 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.26 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.1 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 0.13 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 0.14 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.16 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.9 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.15 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.674 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.11 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 0.15 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 0.22 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.47 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.39 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.15 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.15 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.14 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 0.24 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 6' ' ' SER . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.17 112.568 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 0.11 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 68' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.1 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.9 mm-40 -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 0.16 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.577 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 0.13 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.18 108.347 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 0.24 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 0.9 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 0.55 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 2.5 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.51 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 0.12 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 0.16 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 61' ' ' ILE . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.11 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 0.07 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 0.11 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 1.74 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 0.11 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.14 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 0.11 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 0.24 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.7 t-20 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.38 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.19 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 0.19 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.19 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 0.57 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.12 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 0.17 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.2 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.553 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 0.12 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.15 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.671 HG21 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 0.14 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 0.06 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.15 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.718 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.18 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 0.31 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 0.15 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.675 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 0.85 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.2 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 92' ' ' THR . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 0.12 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.63 178.01 36.3 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 27.2 p-10 -124.32 175.8 6.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.451 0.625 . . . . 1.18 111.145 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 140.91 3.0 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.0 -0.84 . . . . 2.58 111.0 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.44 112.2 11.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 3.51 110.907 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.03 -75.93 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.566 -0.826 . . . . 2.3 112.83 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -119.65 131.49 55.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.59 0.233 . . . . 4.69 110.787 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -65.6 118.07 8.97 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.442 0.639 . . . . 0.96 110.334 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.49 -61.17 2.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.447 -1.251 . . . . 2.21 111.842 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.4 -11.01 11.23 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.091 0.472 . . . . 2.37 111.913 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.8 mm? -88.27 158.35 18.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.473 0.654 . . . . 0.81 111.261 -166.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -162.69 -25.16 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.299 -1.319 . . . . 1.68 109.985 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.653 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p90 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.907 . . . . 3.71 111.814 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.594 -0.602 . . . . 9.37 111.594 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -91.72 -42.7 9.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.652 0.263 . . . . 9.04 110.391 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -148.02 101.5 3.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 8.13 111.249 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.1 m -98.14 123.69 42.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.497 -0.556 . . . . 5.76 109.497 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -142.19 -33.32 0.48 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.61 0.243 . . . . 5.73 111.378 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.7 p -143.81 95.41 2.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.547 0.689 . . . . 1.52 111.19 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.619 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 66.6 mm-40 -122.77 -59.09 1.63 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 2.01 111.009 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.9 t 59.73 103.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.704 -0.68 . . . . 0.45 112.403 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.41 109.697 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.89 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.1 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 ' HB2' HG12 ' A' ' 67' ' ' ILE . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 0.11 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.2 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.2 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.31 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 0.19 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 0.16 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.613 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 0.12 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 29.8 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.66 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 0.89 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 0.17 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.617 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.26 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.1 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 0.13 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 0.14 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.16 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.15 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.36 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 0.15 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 0.22 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.686 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.47 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.39 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.15 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.686 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.15 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.14 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 0.24 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 6' ' ' SER . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.17 112.288 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.59 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 0.11 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.635 HD21 HD22 ' A' ' 68' ' ' LEU . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.1 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.1 mm-40 -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 0.16 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD23 HD11 ' A' ' 82' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 0.13 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.18 108.417 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 0.24 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' HD11 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 0.9 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 2.73 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.55 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 2.5 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.51 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 0.12 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 0.16 109.532 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.11 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 0.07 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 0.11 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 1.74 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 27' ' ' ALA . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 0.11 111.836 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.608 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.11 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 0.24 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 2.6 t-20 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.38 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.19 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.16 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 0.19 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.19 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 0.57 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.12 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 0.17 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.2 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 0.12 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.15 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.644 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 0.14 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 0.06 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.15 106.675 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.649 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.18 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 0.31 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 0.15 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 0.85 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.2 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 0.12 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.8 177.05 30.2 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.11 6.06 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.186 0.493 . . . . 1.18 110.758 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 160.09 18.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.621 -0.799 . . . . 2.58 112.06 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.46 37.94 19.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.838 0.455 . . . . 3.51 111.45 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.1 159.15 8.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.803 -0.713 . . . . 2.3 112.262 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -71.89 -51.03 24.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.048 0.451 . . . . 4.69 109.985 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.27 96.75 6.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.96 110.624 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -63.13 -57.16 11.51 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.461 -0.791 . . . . 2.21 110.061 173.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.412 ' H ' HD22 ' A' ' 111' ' ' LEU . 10.9 t70 -116.82 -14.89 10.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 2.37 110.551 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 110' ' ' ASP . 2.1 mm? -79.24 166.86 21.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.007 -0.997 . . . . 0.81 113.031 -160.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -159.91 -32.3 0.06 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.196 -1.82 . . . . 1.68 107.049 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.444 -1.707 . . . . 3.71 110.098 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.993 -0.443 . . . . 9.37 111.993 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -131.45 3.64 4.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.933 0.396 . . . . 9.04 110.79 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -101.09 -0.32 36.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.157 -0.474 . . . . 8.13 111.058 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -78.57 51.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.706 0.765 . . . . 5.76 111.125 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -155.59 10.86 0.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.742 -1.117 . . . . 5.73 108.885 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 10.4 p -156.29 97.55 1.78 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.45 -0.796 . . . . 1.52 111.115 -173.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 40.1 mt-10 -145.46 -48.03 0.22 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.464 -0.789 . . . . 2.01 111.857 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t 60.83 101.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 0.45 112.065 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.41 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.801 ' SD ' HD23 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 0.89 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.1 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' HG12 ' A' ' 67' ' ' ILE . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 0.11 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.2 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG12 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.2 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.31 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 0.19 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 0.16 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 0.12 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.514 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 28.2 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.66 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 0.84 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 0.89 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 0.17 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.634 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.26 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.1 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.13 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.14 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.16 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.89 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.15 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.36 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.11 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 0.15 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.744 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.47 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.39 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.15 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.744 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.14 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 0.24 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 6' ' ' SER . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.17 112.427 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 0.11 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.68 HD21 HD22 ' A' ' 68' ' ' LEU . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.1 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.8 mm-40 -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 98' ' ' GLY . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 0.16 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 0.13 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.18 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 0.24 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 0.9 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 2.73 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 0.55 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 2.5 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' HD2' HD22 ' A' ' 90' ' ' LEU . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.51 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 0.12 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 0.16 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.625 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.11 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 0.07 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 0.11 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 1.74 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 0.11 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.89 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.14 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.599 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 0.11 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 0.24 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.5 t-20 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.38 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.19 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.774 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.16 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 0.19 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.19 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 0.57 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.12 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 0.17 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.2 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 0.12 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.15 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 0.14 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 0.06 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.15 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.648 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.18 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.31 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 0.15 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 0.85 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.2 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.619 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 0.12 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.13 -176.74 27.8 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -140.56 158.62 43.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 1.18 110.835 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.49 90.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.169 -0.772 . . . . 2.58 111.169 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.89 44.51 19.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.269 0.557 . . . . 3.51 110.023 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.18 -137.63 16.18 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.032 -0.827 . . . . 2.3 111.032 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.4 m80 72.58 149.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.693 0.759 . . . . 4.69 112.202 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -93.23 92.57 7.79 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 115.815 -0.63 . . . . 0.96 110.443 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.61 -64.11 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.161 -0.927 . . . . 2.21 110.331 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.459 ' HB3' HG12 ' A' ' 101' ' ' VAL . 17.9 t70 -118.43 -4.07 10.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.382 -0.827 . . . . 2.37 110.08 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.2 mm? -72.48 162.1 29.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.268 -0.878 . . . . 0.81 112.077 -164.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -154.5 -30.76 0.11 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.25 -1.341 . . . . 1.68 110.235 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.977 -1.01 . . . . 3.71 111.494 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.979 -0.448 . . . . 9.37 111.979 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -71.74 -25.25 61.98 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.854 -0.204 . . . . 9.04 110.571 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm 47.19 73.02 0.21 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.725 0.641 . . . . 8.13 112.172 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -97.26 -20.46 17.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.339 0.59 . . . . 5.76 109.584 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -145.76 43.68 1.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.275 -0.875 . . . . 5.73 109.018 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -152.49 95.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 1.52 110.791 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 13.5 mm-40 -84.09 -55.66 4.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.299 -0.864 . . . . 2.01 111.8 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.5 t 48.7 90.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 0.45 111.887 -174.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.41 110.956 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.708 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 0.89 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 9' ' ' ASN . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.1 115.762 168.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 0.11 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.2 110.24 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.2 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 0.35 110.607 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.31 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 0.19 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 0.16 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 0.12 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.66 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' HG22 ' A' ' 19' ' ' VAL . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 0.84 111.264 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 0.89 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 0.17 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.26 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.1 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 0.13 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 0.14 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.16 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.15 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.36 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.11 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 0.15 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 0.22 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.699 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.47 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.39 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.656 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.15 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.15 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.745 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.14 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 0.24 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.17 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 0.11 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.1 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.2 mm-40 -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.682 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 0.16 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 0.13 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.18 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 0.24 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' HD11 ' A' ' 61' ' ' ILE . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 0.9 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 2.73 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 0.55 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 2.5 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.51 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 55' ' ' SER . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 0.12 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 0.16 109.876 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 61' ' ' ILE . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.11 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 0.07 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 0.11 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 1.74 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' ALA . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 0.11 112.589 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.14 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 0.11 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 0.24 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.9 t-20 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.38 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.19 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.778 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.16 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 0.19 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.673 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.19 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 0.57 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.12 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 0.17 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.2 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 0.12 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.15 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.635 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 0.14 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 0.06 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.15 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.745 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 0.31 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 0.15 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 0.85 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.2 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 0.12 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.4 -179.66 35.16 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -119.06 132.86 56.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.343 0.572 . . . . 1.18 110.327 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.45 -176.08 34.68 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.835 -0.906 . . . . 2.58 110.835 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 67.45 -71.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.23 0.612 . . . . 3.51 110.988 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.58 -96.76 0.11 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.544 -0.623 . . . . 2.3 111.544 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -112.11 -23.51 10.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 4.69 110.841 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -129.52 103.2 6.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.62 0.724 . . . . 0.96 111.831 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.33 -58.53 3.23 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.689 -1.141 . . . . 2.21 109.116 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 16.8 m-20 -117.46 -4.07 11.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.157 -0.928 . . . . 2.37 110.166 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 25' ' ' ARG . 2.2 mm? -74.64 168.52 19.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.229 -0.896 . . . . 0.81 111.225 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -166.52 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.103 -0.953 . . . . 1.68 110.573 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 9.4 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.931 -1.032 . . . . 3.71 111.419 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 48' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 0.45 111.518 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.41 109.993 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.695 ' SD ' HD23 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 0.89 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.1 116.878 174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 0.11 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.2 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.2 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 0.35 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.31 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 0.19 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 0.16 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 0.12 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.48 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.66 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 0.84 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 0.89 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 0.17 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.508 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.26 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.747 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.1 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 0.13 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 0.14 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.16 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.884 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.15 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.654 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.36 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.11 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 0.15 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.654 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 0.22 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.729 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.47 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.39 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.15 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.15 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.749 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.14 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 0.24 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.17 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 0.11 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD21 HD22 ' A' ' 68' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.1 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.766 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 0.16 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 0.13 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.18 108.22 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 0.24 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.511 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 0.9 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.55 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 2.5 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.51 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 0.12 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.417 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 0.16 109.296 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.634 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 61' ' ' ILE . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.11 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 0.07 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 0.11 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 1.74 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 0.11 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.884 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.14 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 0.11 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG23 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 0.24 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t30 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.38 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.19 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.767 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.16 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.538 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 0.19 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.19 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 0.57 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.12 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 0.17 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.2 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 0.12 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.15 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.666 HG21 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 0.14 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 0.06 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.5 t30 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.749 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.18 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 0.31 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 0.15 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.766 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 0.85 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.2 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 48' ' ' LEU . 21.5 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.655 0.613 . . . . 0.45 112.655 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.41 110.742 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.68 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.89 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.1 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 0.11 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.2 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 0.35 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.31 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 0.19 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 0.16 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 0.12 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.66 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 0.84 110.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 0.89 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.17 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.26 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.1 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 0.13 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 0.14 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.16 114.258 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.15 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.36 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.11 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.827 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 0.15 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.68 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 0.22 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.694 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.47 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.39 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.15 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.694 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.15 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.62 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.14 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.534 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 0.24 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.17 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 0.11 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.1 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.655 HD11 ' HA2' ' A' ' 98' ' ' GLY . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 0.16 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 0.13 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.18 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 0.24 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.663 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 0.9 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 2.73 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 0.55 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.454 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 2.5 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HD2' HD22 ' A' ' 90' ' ' LEU . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.51 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' OG ' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 0.12 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 0.16 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.11 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 0.07 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 80' ' ' TYR . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 0.11 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 1.74 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 27' ' ' ALA . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 0.11 112.432 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.14 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.575 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 0.11 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.24 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.38 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.19 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.16 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 0.19 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.19 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.615 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 0.57 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.12 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 0.17 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.2 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 0.12 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.15 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.643 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 0.14 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 0.06 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.15 106.671 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.62 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.18 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 0.31 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 0.15 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 0.85 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.2 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 0.12 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' HA ' HD23 ' A' ' 48' ' ' LEU . 39.0 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 0.45 113.032 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.41 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.89 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.1 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 0.11 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.2 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.2 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 0.35 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.31 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 0.19 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 0.16 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 0.12 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.66 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 0.84 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 0.89 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 0.17 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.26 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.1 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.675 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 0.13 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 0.14 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.16 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.15 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.36 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.11 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 0.15 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 0.22 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.47 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.39 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.15 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.15 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.14 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 0.24 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.17 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 0.11 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.657 HD21 HD22 ' A' ' 68' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.1 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 0.16 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 0.13 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.18 108.203 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 0.24 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.524 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 0.9 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 2.73 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.55 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 2.5 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.51 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 0.12 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 0.16 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.792 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.11 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 0.07 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 0.11 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 1.74 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 0.11 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.604 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 0.11 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 0.24 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.38 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.19 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.16 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 0.19 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.19 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 67' ' ' ILE . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 0.57 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.12 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 0.17 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.2 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 ' HD2' ' A' ' 60' ' ' TYR . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 0.12 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.591 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.15 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.675 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 0.14 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 0.06 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.15 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.18 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 0.31 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.15 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 0.85 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.2 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 0.12 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD23 ' A' ' 48' ' ' LEU . 47.5 t . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 0.45 111.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.699 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.653 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 0.89 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.1 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 0.11 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.2 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.2 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.35 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.31 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 0.19 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 0.16 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 0.12 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 34.0 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.66 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 0.84 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 0.89 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 0.17 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.26 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.68 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.1 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 92' ' ' THR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 0.13 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 0.14 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.16 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.15 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.36 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.813 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 0.15 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 0.22 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.83 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.47 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.635 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.432 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.39 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.15 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.83 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.15 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.14 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.24 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.17 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 0.11 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 68' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.1 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 0.16 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 0.13 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.18 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 0.24 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' HD11 ' A' ' 61' ' ' ILE . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 0.9 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 2.73 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.55 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 2.5 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' HD2' HD22 ' A' ' 90' ' ' LEU . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.51 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 0.12 111.678 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 0.16 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.794 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 0.07 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 0.11 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 1.74 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 0.11 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.873 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.14 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.643 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.11 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 0.24 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.38 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.19 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.16 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.553 ' CG ' HG21 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 0.19 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.679 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.19 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 0.57 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.12 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 0.17 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.2 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 60' ' ' TYR . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 0.12 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.15 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.65 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 0.14 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 0.06 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.15 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.691 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.18 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 0.31 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.719 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.2 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 0.12 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.6 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.301 0.572 . . . . 0.45 112.294 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.41 110.577 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.704 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.89 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.1 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 67' ' ' ILE . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 0.11 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.2 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.2 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 0.35 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.31 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.19 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 0.16 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 0.12 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.49 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.66 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 0.84 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 0.89 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 0.17 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.26 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.1 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.645 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 0.13 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 0.14 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.16 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.888 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.15 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.36 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.727 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 0.15 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.22 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.905 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.47 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.39 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.15 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.905 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.15 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.14 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 0.24 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.17 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 0.11 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.1 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 0.16 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 0.13 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.18 108.143 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 0.24 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' HD11 ' A' ' 61' ' ' ILE . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 0.9 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 2.73 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 0.55 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 2.5 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.525 ' HD2' HD22 ' A' ' 90' ' ' LEU . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.51 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 0.12 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 0.16 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.624 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 0.07 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 0.11 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 1.74 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 0.11 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.14 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.664 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 0.11 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 0.24 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.38 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.19 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.16 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.526 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 0.19 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.19 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 0.57 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.12 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 0.17 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.2 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.525 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 0.12 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.15 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 0.14 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 0.06 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.15 107.069 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.676 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.18 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 0.31 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 0.15 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 0.85 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.2 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 0.12 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' HD23 ' A' ' 48' ' ' LEU . 76.8 t . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 0.45 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.41 109.913 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.682 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.89 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.1 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 0.11 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.2 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.2 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 0.35 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.31 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 0.19 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 0.16 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 0.12 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.66 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 0.84 110.672 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 0.89 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.17 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.26 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.1 111.487 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 0.13 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 0.14 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.16 113.68 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.889 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.15 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.36 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.11 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 0.15 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 0.22 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.726 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.47 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.439 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.39 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.15 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.726 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.15 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.14 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.539 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 0.24 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.17 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 0.11 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 68' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.1 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.742 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 0.16 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 0.13 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.18 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 0.24 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 0.9 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 2.73 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 0.55 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HE ' ' HE1' ' A' ' 60' ' ' TYR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 2.5 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.564 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.51 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 0.12 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 0.16 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.784 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.11 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 0.07 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 0.11 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 1.74 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG21 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 0.11 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.889 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.14 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 0.11 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.24 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.38 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.19 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.16 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.563 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 0.19 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.19 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.62 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 0.57 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.12 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 0.17 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.2 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 0.12 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.15 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 0.14 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 0.06 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.15 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.71 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.18 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 0.31 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.15 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.742 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 0.85 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.2 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.637 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.1 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.32 0.581 . . . . 0.45 112.502 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.41 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 0.89 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.1 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 0.11 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.2 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.2 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 0.35 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.31 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 0.19 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 0.16 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 0.12 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.66 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 0.84 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 0.89 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.17 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.26 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 101' ' ' VAL . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.1 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 0.13 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 0.14 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.16 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.15 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.36 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.11 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.801 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 0.15 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 0.22 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.47 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.644 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.644 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.39 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.15 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.15 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.664 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.14 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 0.24 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.17 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 0.11 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 68' ' ' LEU . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.1 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.726 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 0.16 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 0.13 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.18 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 0.24 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 0.9 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 2.73 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 0.55 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.51 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 0.12 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 0.16 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.11 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 0.07 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 0.11 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.581 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 1.74 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 0.11 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.14 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 0.11 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 0.24 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.38 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.19 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.16 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 0.19 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.19 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 0.57 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.12 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.596 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 0.17 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.2 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 0.12 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.15 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.652 HG21 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 0.14 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.06 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.15 106.619 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.664 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.18 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 0.31 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 0.15 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.2 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 0.12 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.9 t . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 0.45 112.117 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.66 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 0.89 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.1 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 0.11 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.2 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 0.35 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.31 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 0.19 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 0.16 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 0.12 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.44 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.66 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 19' ' ' VAL . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 0.84 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 0.89 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 0.17 110.312 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.608 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.26 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.1 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG21 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 0.13 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 0.14 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.16 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.15 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.36 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.11 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 0.15 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 0.22 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.893 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.47 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.39 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.15 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.893 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.15 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.14 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 0.24 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.17 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 0.11 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 68' ' ' LEU . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.1 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.785 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 0.16 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 0.13 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.18 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 0.24 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.483 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 0.9 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 2.73 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.55 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.499 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 2.5 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.842 ' HD2' HD22 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.51 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 0.12 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 0.16 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.758 ' HA ' HD21 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 0.07 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 0.11 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.652 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 1.74 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 27' ' ' ALA . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 0.11 112.04 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.14 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.697 HD11 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 0.11 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 0.24 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.583 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.38 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.19 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.16 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 0.19 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.19 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 0.57 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.12 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 0.17 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.2 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.842 HD22 ' HD2' ' A' ' 60' ' ' TYR . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 0.12 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.15 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.14 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 0.06 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.15 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.18 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 0.31 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 0.15 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 0.85 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.2 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 0.12 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 45.7 t . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 0.45 111.867 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.41 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.71 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 0.89 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.1 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 0.11 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.2 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.2 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 0.35 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.31 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG13 HG12 ' A' ' 19' ' ' VAL . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.19 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 0.16 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 0.12 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.66 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 0.84 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 0.89 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 0.17 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.26 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.1 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.13 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 0.14 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.16 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.15 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.668 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.36 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.11 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 0.15 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 0.22 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.792 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.47 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.62 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.62 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.39 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.15 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.792 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.15 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.665 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.14 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 0.24 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.17 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 0.11 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 68' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.1 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 0.16 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.669 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 0.13 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.18 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.49 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 0.24 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 0.9 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 2.73 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.55 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 2.5 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.53 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.51 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 0.12 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 0.16 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 61' ' ' ILE . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.11 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 0.07 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 0.11 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 1.74 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 0.11 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.14 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.636 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 0.11 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.479 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.24 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.38 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.19 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.779 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.16 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.582 ' CG ' HG21 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 0.19 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.19 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.595 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 0.57 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.12 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 0.17 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.2 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 0.12 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.15 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.676 HG21 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 0.14 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 0.06 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.15 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.18 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 0.31 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 0.15 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 0.85 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.2 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 0.12 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.4 t . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.45 111.858 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.41 110.695 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 0.89 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.1 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 0.11 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.2 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.2 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 0.19 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.653 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 0.12 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.66 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.418 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 0.84 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 0.89 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 0.17 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.663 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.26 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.1 111.981 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 0.13 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 0.14 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.16 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.896 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.15 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.659 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.11 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 0.15 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 0.22 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.759 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.47 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.61 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.39 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.15 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.759 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.15 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.14 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 0.24 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.17 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 0.11 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.1 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.702 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 0.16 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 0.13 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.18 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 0.24 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.526 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 0.9 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 2.73 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.55 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 2.5 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.607 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.51 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 0.12 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 0.16 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.11 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 0.07 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 0.11 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.627 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 1.74 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.548 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 0.11 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.896 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.14 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.554 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 0.11 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.24 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.38 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.19 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.838 ' HB3' HD11 ' A' ' 68' ' ' LEU . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.16 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.548 ' CG ' HG21 ' A' ' 71' ' ' VAL . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.19 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 0.57 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.12 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 0.17 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.663 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.2 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.607 HD22 ' HD2' ' A' ' 60' ' ' TYR . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 0.12 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.15 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 0.14 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 0.06 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.15 107.127 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 0.31 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 0.15 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.702 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 0.85 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.2 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 0.12 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 77.0 t . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 0.45 111.881 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.41 109.879 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.707 ' SD ' HD23 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 0.89 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.1 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.629 ' HB2' HG12 ' A' ' 67' ' ' ILE . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 0.11 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.2 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.2 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 0.35 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.31 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 19' ' ' VAL . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 0.19 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 0.16 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 0.12 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.66 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 0.84 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 0.89 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 0.17 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.68 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.26 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.1 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 0.13 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 0.14 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.16 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.864 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.15 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.36 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.11 109.838 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 0.15 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 0.22 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.47 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.656 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.656 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.39 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.15 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.15 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.14 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 0.24 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.17 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 0.11 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 68' ' ' LEU . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.1 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.705 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 0.16 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 0.13 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.18 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.467 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 0.24 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 0.9 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 2.73 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 0.55 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.467 ' NE ' HG23 ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 2.5 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.51 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 0.12 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 0.16 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.11 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 0.07 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 0.11 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 1.74 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 0.11 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.864 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.14 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 0.11 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 0.24 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.38 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.19 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.16 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 0.19 107.891 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.19 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 0.57 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.12 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 0.17 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.2 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 0.12 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.15 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 0.14 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 0.06 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.15 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.18 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 0.31 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.705 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 0.85 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.2 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 0.12 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 48' ' ' LEU . 94.8 t . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 0.45 110.393 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.4 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.646 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 0.89 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.1 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 0.11 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.2 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.2 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 0.35 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.31 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 0.19 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 0.16 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 0.12 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.66 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 0.84 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 0.89 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.17 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.26 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.1 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.653 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 0.13 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 0.14 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.16 113.476 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.15 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.11 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 0.15 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 0.22 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.47 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.46 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.39 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.15 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.15 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.651 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.14 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 0.24 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.17 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 0.11 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.744 HD21 HD22 ' A' ' 68' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.1 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.697 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 0.16 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 0.13 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.18 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.429 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 0.9 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 2.73 110.715 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 0.55 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.429 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 2.5 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.51 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 0.12 111.7 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 0.16 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.617 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.11 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 0.07 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 0.11 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.691 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 1.74 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 0.11 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.14 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.11 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 0.24 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.38 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.19 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.845 ' HB3' HD11 ' A' ' 68' ' ' LEU . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.16 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 0.19 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.19 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 0.57 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.12 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 0.17 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.2 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 0.12 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.15 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.653 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 0.14 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 0.06 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.15 106.607 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.651 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.18 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 0.31 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 0.15 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 0.85 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.2 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 0.12 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HA ' HD23 ' A' ' 48' ' ' LEU . 75.3 t . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 0.45 111.87 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.41 110.306 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.673 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 0.89 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.1 116.53 172.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 0.11 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.2 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.2 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.35 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.31 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 0.19 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 0.16 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 0.12 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.66 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 0.84 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 0.89 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 0.17 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.529 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.26 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.1 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG21 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 0.13 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 0.14 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.16 113.213 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.879 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.15 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.36 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.11 109.994 175.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.803 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 0.15 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 0.22 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.793 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.47 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.68 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.39 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.15 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.793 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.15 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.14 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 0.24 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.17 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 0.11 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.1 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 mm100 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 0.16 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.654 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 0.13 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.18 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 0.9 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.73 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 0.55 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 2.5 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.565 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 0.12 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 0.16 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.11 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 0.07 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 0.11 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 1.74 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 0.11 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.879 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.14 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 0.11 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 0.24 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.38 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.19 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.781 ' HB3' HD11 ' A' ' 68' ' ' LEU . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.16 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.566 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 0.19 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 0.57 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.12 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 0.17 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.2 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.565 HD22 ' HD2' ' A' ' 60' ' ' TYR . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 0.12 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.15 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.682 ' HB ' HG22 ' A' ' 101' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 0.14 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 0.06 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.15 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.755 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.18 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.31 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 0.15 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 0.85 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.2 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 0.12 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 0.45 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.41 110.174 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.67 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 0.89 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.1 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 0.11 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.2 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' HG12 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.2 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.35 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.31 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 19' ' ' VAL . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 0.19 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 0.16 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 0.12 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.448 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.66 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 0.84 111.217 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 0.89 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 0.17 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.629 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.26 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.628 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.1 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 92' ' ' THR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 0.13 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 0.14 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.16 114.436 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.881 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.15 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.646 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.36 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.11 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 0.15 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 0.22 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.902 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.47 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.39 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.15 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.902 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.15 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.14 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 0.24 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.17 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.11 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD21 HD22 ' A' ' 68' ' ' LEU . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.1 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.622 HD11 ' HA2' ' A' ' 98' ' ' GLY . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 0.16 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 0.13 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.18 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 0.24 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.542 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 0.9 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 2.73 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 0.55 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 2.5 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.542 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.51 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 0.12 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 0.16 109.629 172.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.62 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.11 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.07 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 0.11 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 1.74 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 0.11 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.881 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.14 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.645 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 0.11 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.24 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.421 HD22 ' ND2' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 40' ' ' ALA . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.421 ' ND2' HD22 ' A' ' 75' ' ' ASN . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.38 110.929 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.19 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.16 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 0.19 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.19 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 0.57 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.12 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 0.17 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.629 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.2 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 0.12 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.15 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 0.14 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 0.06 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.15 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.692 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.18 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 0.31 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 0.15 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.622 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 0.85 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.2 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 0.12 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t . . . . . 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 0.45 112.395 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.41 110.578 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 0.89 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.1 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 0.11 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.2 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.2 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.35 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.31 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 19' ' ' VAL . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 0.19 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 0.16 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 0.12 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 30.2 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.66 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 0.84 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.89 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 0.17 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.26 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.1 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 0.13 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 0.14 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.16 113.569 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.898 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.15 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.36 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.11 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 0.15 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 0.22 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.667 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.47 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.39 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.15 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.667 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.15 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.726 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.14 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 0.24 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.17 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 0.11 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.1 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.693 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 0.16 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.74 HD23 HD11 ' A' ' 82' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 0.13 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.18 108.202 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 0.24 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 0.9 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 2.73 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 2.5 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.51 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 0.12 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 0.16 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.714 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.634 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.11 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.67 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 0.07 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 80' ' ' TYR . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 0.11 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 1.74 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 0.11 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.14 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.647 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 0.11 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.38 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HD1' HG22 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.19 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.821 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.611 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.74 HD11 HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.19 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 0.57 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.12 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 0.17 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.2 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 0.12 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.15 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.638 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 0.14 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 0.06 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.15 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.726 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.18 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 0.31 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.15 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.693 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 0.85 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.2 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 0.12 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 0.45 110.326 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.563 HD21 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.41 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 0.89 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.1 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 0.11 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.2 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.524 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.2 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 0.35 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.31 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 19' ' ' VAL . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 0.19 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 0.16 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 0.12 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.66 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 0.89 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 0.17 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.26 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.1 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 0.13 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.722 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 0.14 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.16 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.15 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.36 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 0.15 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 0.22 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.47 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.65 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.39 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.15 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.15 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.14 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 0.24 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.17 112.755 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 0.11 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.1 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.698 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 0.16 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 0.13 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.18 108.56 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.403 HG23 ' NE ' ' A' ' 58' ' ' ARG . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 0.24 110.695 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 61' ' ' ILE . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 0.9 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 2.73 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 0.55 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 2.5 110.764 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.51 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 0.12 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 0.16 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.11 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 0.07 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 0.11 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 1.74 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 0.11 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.14 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 0.11 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 0.24 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.38 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.19 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.16 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.592 ' CG ' HG21 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 0.19 107.839 176.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.19 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 0.57 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.12 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.613 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 0.17 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.2 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 0.12 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.15 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 101' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 0.14 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 0.06 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.15 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.18 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 0.31 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 0.15 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.698 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 0.85 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.2 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 0.12 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.1 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 0.45 110.969 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.41 110.425 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.736 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 0.89 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.1 116.822 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB2' HG12 ' A' ' 67' ' ' ILE . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 0.11 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.2 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.2 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.31 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 0.19 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 0.16 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 0.12 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.66 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 0.84 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 0.89 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.17 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.26 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.1 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 0.13 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 0.14 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.16 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.9 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.15 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.674 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.11 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 0.15 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 0.22 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.47 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.39 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.15 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.15 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.14 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 0.24 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.17 112.568 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 0.11 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 68' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.1 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 0.16 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.577 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 0.13 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.18 108.347 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 0.24 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 0.9 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 0.55 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 2.5 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.51 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 0.12 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 0.16 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 61' ' ' ILE . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.11 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 0.07 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 0.11 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 1.74 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 0.11 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.14 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 0.11 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 0.24 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.38 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.19 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 0.19 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.19 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 0.57 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.12 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 0.17 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.2 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.553 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 0.12 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.15 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.671 HG21 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 0.14 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 0.06 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.15 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.718 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.18 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 0.31 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 0.15 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.675 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 0.85 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.2 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 92' ' ' THR . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 0.12 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.224 0.535 . . . . 0.45 112.403 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.41 109.697 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.89 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.1 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 ' HB2' HG12 ' A' ' 67' ' ' ILE . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 0.11 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.2 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.2 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.31 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 0.19 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 0.16 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.613 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 0.12 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 32.9 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.66 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 0.89 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 0.17 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.617 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.26 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.1 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 0.13 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 0.14 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.16 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.15 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.36 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 0.15 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 0.22 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.686 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.47 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.575 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.39 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.15 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.686 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.15 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.14 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 0.24 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.17 112.288 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.59 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 0.11 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.635 HD21 HD22 ' A' ' 68' ' ' LEU . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.1 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 0.16 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD23 HD11 ' A' ' 82' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 0.13 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.18 108.417 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 0.24 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' HD11 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 0.9 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 2.73 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.55 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 2.5 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.51 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 0.12 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 0.16 109.532 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.11 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 0.07 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 0.11 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 1.74 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 27' ' ' ALA . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 0.11 111.836 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.608 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.11 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 0.24 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.38 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.19 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.16 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 0.19 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.19 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 0.57 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.12 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 0.17 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.2 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 0.12 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.15 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.644 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 0.14 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 0.06 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.15 106.675 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.649 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.18 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 0.31 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 0.15 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 0.85 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.2 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 0.12 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 0.45 112.065 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.41 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.801 ' SD ' HD23 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 0.89 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.1 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' HG12 ' A' ' 67' ' ' ILE . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 0.11 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.2 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG12 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.2 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.31 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 0.19 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 0.16 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 0.12 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.514 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.4 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.66 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 0.84 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 0.89 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 0.17 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.634 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.26 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.1 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.13 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.14 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.16 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.89 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.15 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.36 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.11 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 0.15 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.744 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.47 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.591 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.39 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.15 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.744 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.14 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 0.24 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.17 112.427 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 0.11 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.68 HD21 HD22 ' A' ' 68' ' ' LEU . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.1 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 98' ' ' GLY . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 0.16 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 0.13 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.18 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 0.24 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 0.9 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 2.73 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 0.55 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 2.5 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' HD2' HD22 ' A' ' 90' ' ' LEU . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.51 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 0.12 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 0.16 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.625 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.11 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 0.07 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 0.11 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 1.74 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 0.11 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.89 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.14 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.599 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 0.11 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 0.24 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.38 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.19 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.774 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.16 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 0.19 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.19 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 0.57 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.12 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 0.17 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.2 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 0.12 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.15 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 0.14 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 0.06 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.15 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.648 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.18 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.31 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 0.15 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 0.85 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.2 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.619 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 0.12 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.5 t . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 0.45 111.887 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.412 HD22 ' HA2' ' A' ' 11' ' ' GLY . 0.9 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.41 110.956 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.708 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 0.89 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 9' ' ' ASN . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.1 115.762 168.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 0.11 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.2 110.24 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.2 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 0.35 110.607 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.31 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 0.19 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 0.16 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 0.12 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.66 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' HG22 ' A' ' 19' ' ' VAL . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 0.84 111.264 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 0.89 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 0.17 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.26 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.1 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 0.13 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 0.14 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.16 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.15 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.36 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.11 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 0.15 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 0.22 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.699 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.47 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.39 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.656 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.15 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.15 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.745 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.14 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 0.24 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.17 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 0.11 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.1 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.682 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 0.16 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 0.13 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.18 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 0.24 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' HD11 ' A' ' 61' ' ' ILE . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 0.9 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 2.73 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 0.55 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 2.5 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.51 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 55' ' ' SER . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 0.12 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 0.16 109.876 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 61' ' ' ILE . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.11 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 0.07 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 0.11 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 1.74 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' ALA . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 0.11 112.589 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.14 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 0.11 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 0.24 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.38 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.19 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.778 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.16 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 0.19 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.673 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.19 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 0.57 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.12 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 0.17 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.2 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 0.12 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.15 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.635 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 0.14 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 0.06 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.15 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.745 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 0.31 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 0.15 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 0.85 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.2 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 0.12 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.165 -0.374 . . . . 9.37 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -133.89 -58.84 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.593 0.235 . . . . 9.04 110.699 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.407 ' HG2' ' OE2' ' A' ' 7' ' ' GLU . 23.7 mmt -64.38 -68.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 8.13 111.23 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 p -170.88 -69.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.186 -0.461 . . . . 5.76 109.977 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -152.4 140.73 20.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 5.73 110.084 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.4 m 62.8 94.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.014 0.822 . . . . 1.52 111.543 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 3' ' ' MET . 41.8 mt-10 -117.86 -57.41 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.955 -1.021 . . . . 2.01 112.081 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 48' ' ' LEU . 98.2 t 62.36 107.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.168 0.508 . . . . 0.45 111.518 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -162.9 -169.18 1.97 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.106 -0.497 . . . . 1.41 109.993 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.695 ' SD ' HD23 ' A' ' 68' ' ' LEU . 23.0 mmt -100.32 -8.97 22.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.898 0.856 . . . . 0.89 110.821 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 61.47 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.7 2.095 . . . . 0.1 116.878 174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.5 mt -123.93 172.51 8.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 118.093 0.947 . . . . 0.11 109.777 169.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t -96.11 118.54 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.247 -0.888 . . . . 1.2 110.25 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.1 p -83.36 21.65 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.2 110.259 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.97 110.13 19.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.506 -0.77 . . . . 0.35 110.533 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.94 -8.81 79.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.944 -0.646 . . . . 0.31 112.275 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 19' ' ' VAL . 9.9 p -71.73 149.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.414 0.626 . . . . 0.19 111.363 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.8 74.47 5.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.172 -0.922 . . . . 0.16 109.642 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.15 136.33 23.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.5 -1.227 . . . . 0.12 112.201 -175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.48 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -83.85 100.78 11.19 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.195 -0.911 . . . . 0.66 110.262 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 2.5 mtt180 -92.44 -33.54 14.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.2 -0.455 . . . . 0.84 110.815 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -70.88 -6.94 42.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.409 0.623 . . . . 0.89 110.727 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.67 2.12 56.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.404 -0.816 . . . . 0.17 110.626 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.508 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 41.1 t -72.37 144.32 48.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.26 111.544 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.747 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.6 mmp_? -86.07 -15.42 41.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.287 -0.87 . . . . 2.1 112.1 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.8 t -130.0 150.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 0.13 109.702 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.31 132.67 48.17 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 122.029 0.919 . . . . 0.14 112.951 -173.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -70.05 45.12 0.07 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.126 1.77 . . . . 0.16 113.703 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.884 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.52 96.03 0.67 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 122.57 1.176 . . . . 0.15 110.583 -159.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.654 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 53.6 tp60 -60.96 -16.39 42.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.229 -0.896 . . . . 0.36 111.004 -171.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.7 t -75.36 -38.25 60.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.275 -0.421 . . . . 1.11 110.303 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.76 -30.02 32.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.42 -0.956 . . . . 0.15 108.42 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.654 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.1 mt -64.73 -42.76 95.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.64 -1.164 . . . . 0.22 110.033 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -80.46 -11.95 59.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.062 -0.972 . . . . 1.54 109.701 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 12.6 t70 -85.2 16.08 3.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.406 -1.27 . . . . 0.49 108.906 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.729 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 36.4 p -38.7 -19.81 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.921 1.689 . . . . 1.47 114.859 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -11.44 57.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.97 111.481 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.98 145.34 46.56 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.086 0.47 . . . . 0.82 111.161 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.6 t -77.72 -2.7 37.47 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.25 -1.018 . . . . 1.39 108.25 169.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.8 -16.79 62.14 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 109.052 -0.722 . . . . 0.15 109.052 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 85.1 m95 -97.56 -10.9 24.36 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.607 -0.724 . . . . 0.15 111.568 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.91 103.83 16.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.251 -0.648 . . . . 0.5 109.251 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.749 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -55.04 -63.57 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.484 -1.234 . . . . 0.14 111.113 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.78 -108.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.448 -1.251 . . . . 0.24 109.643 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -145.73 111.15 5.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.684 0.393 . . . . 1.82 110.718 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.96 16.93 34.26 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.285 0.381 . . . . 0.17 112.436 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -69.47 -40.02 79.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.662 0.744 . . . . 0.11 109.114 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD21 HD22 ' A' ' 68' ' ' LEU . 11.4 tp -70.69 -42.35 70.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.934 -1.03 . . . . 0.1 109.921 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.3 mt-10 -64.39 -16.08 61.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.225 -1.352 . . . . 1.49 110.215 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.42 -56.5 4.39 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.342 -1.299 . . . . 0.37 110.407 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.766 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.8 mt -60.12 -37.08 71.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 112.957 -1.928 . . . . 0.16 109.223 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 78.2 mt -71.72 -42.73 66.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.329 -1.305 . . . . 0.13 111.032 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -58.62 -38.15 77.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.388 1.089 . . . . 0.18 108.22 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.555 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.2 m -68.98 -49.48 57.52 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 113.33 -1.759 . . . . 0.24 110.647 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.511 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 48.5 m -48.96 -50.24 36.53 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.204 0.602 . . . . 0.9 111.698 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.3 mtp180 -62.05 -42.3 99.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.194 -0.457 . . . . 2.73 110.354 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 t -60.88 -40.25 92.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.55 110.906 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.1 mmm180 -66.2 -30.82 71.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.792 0.806 . . . . 2.5 110.622 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.8 19.3 15.68 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.334 -1.303 . . . . 0.24 111.128 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 34.3 m-85 -75.68 -48.49 21.81 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.544 0.688 . . . . 0.51 109.388 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.9 pt -141.28 -170.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.986 -1.006 . . . . 0.12 111.747 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.417 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.35 143.9 47.94 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.41 -1.723 . . . . 0.16 109.296 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.35 -122.58 2.53 Favored Glycine 0 C--N 1.333 0.395 0 O-C-N 123.831 0.707 . . . . 0.24 113.61 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.06 20.44 17.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 2.21 110.134 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.634 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.9 mm-40 -76.68 34.83 0.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.19 -0.914 . . . . 0.66 111.162 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HB3' HD13 ' A' ' 61' ' ' ILE . 38.6 p90 -108.17 165.8 11.22 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.851 -0.426 . . . . 0.11 109.851 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.5 mt -128.04 102.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 121.73 0.776 . . . . 0.07 109.708 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.8 tp -95.76 153.73 17.59 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.5 -0.926 . . . . 0.11 108.5 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -147.53 145.54 29.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.949 0.404 . . . . 0.93 111.816 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 2.5 mpt_? -74.03 134.83 43.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.54 -0.755 . . . . 1.74 109.88 174.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG21 ' CG ' ' A' ' 81' ' ' ASN . 50.0 t -127.29 -63.89 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.547 -0.751 . . . . 0.11 112.153 -172.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.884 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -145.64 160.84 41.09 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.333 -0.547 . . . . 0.14 112.113 -169.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' NE1' ' A' ' 41' ' ' TRP . 75.1 mt -122.07 110.82 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.705 -0.679 . . . . 0.11 109.873 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.529 HG23 ' OD1' ' A' ' 72' ' ' ASN . 44.3 t -117.17 113.07 41.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.739 -0.664 . . . . 0.24 109.209 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 t30 67.16 8.67 6.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.879 0.847 . . . . 0.39 110.162 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 84.07 17.12 65.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.053 -1.07 . . . . 0.13 112.099 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 77.1 m-20 -93.83 37.39 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.715 -0.285 . . . . 0.38 111.216 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.93 116.68 0.01 OUTLIER Glycine 0 N--CA 1.471 1.004 0 O-C-N 124.795 1.309 . . . . 0.08 115.239 -169.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.0 m-85 -93.4 137.14 32.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.554 0.693 . . . . 0.19 110.625 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.767 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.8 m-85 -123.95 137.98 54.54 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.419 -1.264 . . . . 0.16 109.701 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.538 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.1 m-20 -95.78 141.34 29.36 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.827 -0.749 . . . . 1.56 109.059 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.85 129.34 54.04 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.045 -1.094 . . . . 0.19 108.045 176.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.8 m-85 -124.22 160.0 28.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.081 -0.963 . . . . 0.19 110.21 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 84.6 mttt -79.29 165.96 44.94 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 114.939 -1.028 . . . . 0.57 109.112 172.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 26.8 Cg_exo -56.15 -19.26 26.45 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.232 1.955 . . . . 0.12 112.149 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -90.03 -7.99 52.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.297 -0.865 . . . . 1.93 109.875 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.93 60.43 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.37 -0.832 . . . . 0.11 111.894 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.8 m -65.69 121.21 14.47 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.458 -0.436 . . . . 0.17 111.641 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 81.3 t80 -56.27 128.14 34.26 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.923 0.868 . . . . 0.2 112.193 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 51.8 mt -105.1 -57.55 2.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.853 -1.522 . . . . 0.12 110.06 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -167.36 174.79 7.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.424 0.63 . . . . 0.15 112.316 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.666 HG21 ' CG2' ' A' ' 26' ' ' VAL . 90.2 m -111.54 124.97 53.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.32 -1.309 . . . . 0.14 108.722 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -114.62 163.44 15.42 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.715 0.769 . . . . 0.06 110.798 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.5 t30 -104.91 118.7 37.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.749 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.8 p -68.75 -37.4 79.37 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.513 -0.551 . . . . 0.18 109.513 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 31.8 mmtt -76.46 -13.23 60.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.297 -0.865 . . . . 0.31 111.715 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 p -129.72 -17.77 3.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.048 0.452 . . . . 0.15 110.785 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.766 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.75 14.91 75.62 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.656 -0.702 . . . . 0.13 111.71 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -73.52 161.08 30.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.952 -0.759 . . . . 0.85 108.952 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -147.56 141.35 25.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.505 0.669 . . . . 0.2 111.427 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -114.07 144.06 22.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.037 -173.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.93 178.24 28.23 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.327 -0.94 . . . . 0.49 111.59 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -124.35 159.54 30.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.41 . . . . 1.18 111.039 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.19 -140.77 3.11 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.757 -0.656 . . . . 2.58 111.911 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.57 62.04 6.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.835 0.35 . . . . 3.51 111.309 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.12 49.2 73.53 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.144 -0.551 . . . . 2.3 112.609 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -136.2 157.11 47.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.466 . . . . 4.69 110.682 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -82.45 100.82 10.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.516 0.674 . . . . 0.96 110.015 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -64.45 -62.31 1.68 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.614 -1.176 . . . . 2.21 110.083 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 17.6 m-20 -117.54 3.97 12.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.623 -0.717 . . . . 2.37 110.223 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mm? -83.16 170.54 14.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.725 -0.67 . . . . 0.81 111.024 -170.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -157.76 -34.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.07 -0.968 . . . . 1.68 109.978 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 114.994 -1.003 . . . . 3.71 111.127 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.078 -0.409 . . . . 9.37 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -140.95 149.65 42.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.539 . . . . 9.04 109.543 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt 68.13 96.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.868 0.73 . . . . 8.13 110.284 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m 66.42 -175.53 0.19 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.693 -0.685 . . . . 5.76 110.533 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -150.24 130.5 13.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.315 -0.254 . . . . 5.73 110.315 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -82.0 126.49 32.03 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.961 -0.385 . . . . 1.52 109.961 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 41.9 mt-10 -145.04 -47.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.057 -0.52 . . . . 2.01 111.354 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 48' ' ' LEU . 21.5 t 48.12 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.25 0.62 . . . . 0.45 112.655 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.33 -177.4 6.18 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.452 -0.34 . . . . 1.41 110.742 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.68 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -95.83 -8.91 32.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 0.89 111.478 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.43 -35.77 0.26 Allowed Glycine 0 C--N 1.31 -0.87 0 CA-C-N 113.355 -1.748 . . . . 0.1 116.252 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.3 mt -122.81 170.81 9.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 117.906 0.853 . . . . 0.11 109.612 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -96.02 118.99 33.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.592 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 29.7 p -84.43 22.91 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.482 0.658 . . . . 0.2 110.362 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.49 101.81 13.96 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.587 -0.733 . . . . 0.35 111.031 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.49 -10.19 64.88 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.981 -0.628 . . . . 0.31 112.077 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -70.52 148.32 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.504 0.669 . . . . 0.19 111.53 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.76 74.46 9.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.047 -0.979 . . . . 0.16 110.011 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -88.2 135.94 24.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.149 -1.387 . . . . 0.12 112.075 -175.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.5 mt-30 -87.1 100.0 12.33 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.429 -0.805 . . . . 0.66 110.607 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -89.61 -33.85 16.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.201 0.524 . . . . 0.84 110.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -64.29 -13.5 50.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.414 -0.812 . . . . 0.89 111.051 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.35 1.54 51.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.17 110.991 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 48.4 t -71.47 134.18 46.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.658 . . . . 0.26 111.091 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -70.69 -22.31 62.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.857 -1.065 . . . . 2.1 112.209 178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.2 t -127.25 151.72 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.704 -0.48 . . . . 0.13 109.704 -175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.79 134.48 46.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 122.013 0.911 . . . . 0.14 112.992 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.43 45.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.063 1.745 . . . . 0.16 114.258 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.05 97.36 0.68 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 122.64 1.209 . . . . 0.15 110.178 -161.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tp60 -61.51 -15.79 41.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.009 -0.996 . . . . 0.36 110.857 -172.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.8 t -78.0 -29.53 49.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.399 -0.364 . . . . 1.11 110.52 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.827 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -89.31 -28.9 19.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.776 -0.824 . . . . 0.15 108.776 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.68 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.7 mt -67.79 -44.16 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.647 -1.16 . . . . 0.22 109.964 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.61 -9.63 59.06 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.046 -0.979 . . . . 1.54 109.293 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.2 t70 -94.08 17.59 12.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.178 -1.374 . . . . 0.49 109.238 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.694 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.2 t -40.47 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.77 1.228 . . . . 1.47 113.627 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.43 -12.41 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.037 0.384 . . . . 0.97 112.037 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -61.17 144.79 53.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.204 0.526 . . . . 0.82 111.432 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.474 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.8 p -75.11 -3.23 31.49 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.581 -0.736 . . . . 1.39 109.145 169.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.99 -17.62 64.58 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.651 -0.704 . . . . 0.15 110.152 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.694 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.4 m95 -97.18 -10.0 26.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.15 111.99 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.9 107.92 15.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.922 -0.581 . . . . 0.5 109.885 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.62 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -61.1 -64.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.17 -0.923 . . . . 0.14 111.518 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.534 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 159.59 -116.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.576 1.151 . . . . 0.24 110.334 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.24 112.67 8.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.872 0.469 . . . . 1.82 110.934 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' CD ' ' A' ' 49' ' ' GLU . . . 52.91 28.37 31.81 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.865 -0.494 . . . . 0.17 111.865 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -78.97 -42.4 24.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 123.829 0.852 . . . . 0.11 109.344 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 8' ' ' VAL . 14.6 tp -73.07 -42.11 63.39 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.958 -1.019 . . . . 0.1 109.241 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' CD ' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp0 -65.73 -12.1 51.0 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.395 -1.73 . . . . 1.49 110.207 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -83.39 -53.19 5.9 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.031 -1.441 . . . . 0.37 110.702 174.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.655 HD11 ' HA2' ' A' ' 98' ' ' GLY . 16.2 mt -64.6 -32.65 58.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 113.395 -1.73 . . . . 0.16 108.876 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.5 mt -73.17 -43.35 61.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.871 -1.513 . . . . 0.13 110.888 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.24 75.11 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.197 0.999 . . . . 0.18 108.318 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.6 m -67.46 -56.69 8.59 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 113.536 -1.665 . . . . 0.24 110.771 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.663 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 3.4 p -49.9 -41.77 46.6 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.615 0.245 . . . . 0.9 111.616 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.8 mtp180 -65.95 -47.31 75.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.681 0.277 . . . . 2.73 110.808 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.67 -39.18 83.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.411 0.624 . . . . 0.55 110.789 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.454 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.9 mmt180 -67.76 -30.46 69.92 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.079 -0.964 . . . . 2.5 110.941 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.75 19.87 11.49 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.715 -1.129 . . . . 0.24 111.724 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HD2' HD22 ' A' ' 90' ' ' LEU . 46.5 m-85 -77.11 -48.34 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.331 0.586 . . . . 0.51 109.776 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' OG ' ' A' ' 55' ' ' SER . 8.0 pt -140.57 -170.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 122.121 0.962 . . . . 0.12 111.884 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -133.19 142.58 48.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.365 -1.743 . . . . 0.16 109.761 172.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 56' ' ' ARG . . . 41.34 -120.23 1.84 Allowed Glycine 0 C--N 1.332 0.347 0 O-C-N 124.098 0.874 . . . . 0.24 113.801 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -112.12 20.58 16.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.429 0.633 . . . . 2.21 109.971 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.2 mm-40 -79.41 34.93 0.27 Allowed 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.089 -0.96 . . . . 0.66 110.939 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -107.79 166.2 10.87 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.704 -0.48 . . . . 0.11 109.704 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 84.2 mt -128.58 101.81 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.68 0.752 . . . . 0.07 109.851 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 80' ' ' TYR . 14.7 tp -95.46 156.32 16.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.397 -0.964 . . . . 0.11 108.397 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -149.27 146.08 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.13 0.491 . . . . 0.93 111.672 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -75.91 134.82 40.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.468 -0.787 . . . . 1.74 109.99 173.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 27' ' ' ALA . 30.6 t -127.09 -66.32 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.678 -0.692 . . . . 0.11 112.432 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.2 t-20 -144.34 158.83 43.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.181 -0.608 . . . . 0.14 111.852 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.575 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.8 mt -118.85 109.29 26.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.899 -0.591 . . . . 0.11 109.906 172.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 93.9 t -113.34 107.48 23.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.24 109.473 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.62 9.13 6.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.182 0.992 . . . . 0.39 110.117 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.77 16.37 61.69 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.276 -0.964 . . . . 0.13 112.265 -171.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 48.7 m-20 -94.48 38.47 1.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.567 -0.372 . . . . 0.38 110.946 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.26 115.8 0.01 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.896 1.373 . . . . 0.08 115.094 -170.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CD1' HG21 ' A' ' 26' ' ' VAL . 10.9 m-85 -93.63 134.53 35.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.849 0.833 . . . . 0.19 110.946 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.6 m-85 -121.12 136.61 54.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 113.757 -1.565 . . . . 0.16 108.792 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 18.2 p30 -105.64 145.39 31.1 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.799 -1.161 . . . . 1.56 110.507 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -104.84 134.29 48.22 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.89 -1.05 . . . . 0.19 109.032 -176.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.1 m-85 -125.58 160.33 29.86 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.892 -1.049 . . . . 0.19 110.137 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.615 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.6 mttt -78.22 165.08 52.89 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.904 -1.043 . . . . 0.57 108.684 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.0 Cg_exo -56.34 -19.88 30.14 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 121.965 1.776 . . . . 0.12 111.975 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.79 1.27 50.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.509 -0.768 . . . . 1.93 110.314 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 93.59 1.37 66.14 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.674 -0.694 . . . . 0.11 113.293 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.4 m -65.74 121.8 15.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.668 0.734 . . . . 0.17 111.839 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.0 t80 -56.34 128.13 34.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.994 0.902 . . . . 0.2 112.438 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 84' ' ' LYS . 59.4 mt -104.41 -60.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.795 -1.548 . . . . 0.12 110.36 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 24.3 p90 -165.87 173.98 10.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.933 -0.576 . . . . 0.15 111.762 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.643 HG21 ' CG2' ' A' ' 26' ' ' VAL . 74.0 m -115.43 127.68 55.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.93 -1.032 . . . . 0.14 109.007 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -115.34 165.15 13.28 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.838 0.828 . . . . 0.06 110.92 -174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.57 121.69 44.03 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.671 -1.603 . . . . 1.15 106.671 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.62 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.5 p -71.94 -43.6 64.97 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.465 0.65 . . . . 0.18 109.549 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 39' ' ' SER . 31.8 mmtt -67.54 -25.0 65.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.745 -1.116 . . . . 0.31 111.742 -172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 p -117.01 -21.15 9.04 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.282 0.563 . . . . 0.15 110.657 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.33 14.8 81.61 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.599 -0.728 . . . . 0.13 111.326 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.24 167.56 20.15 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.869 -0.789 . . . . 0.85 108.869 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 15.8 p90 -147.53 142.92 27.4 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.591 0.71 . . . . 0.2 111.565 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -113.01 141.4 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 114.488 -1.233 . . . . 0.12 109.44 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.42 -173.29 33.86 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.366 -0.921 . . . . 0.49 111.003 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -138.01 91.77 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.564 0.697 . . . . 1.18 111.326 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.74 -32.41 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.71 -0.757 . . . . 2.58 112.564 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.3 57.99 4.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.47 . . . . 3.51 111.382 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.06 -132.97 11.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 2.3 112.653 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -92.9 -46.97 7.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.135 0.493 . . . . 4.69 110.446 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -116.09 86.95 2.58 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.216 0.531 . . . . 0.96 111.262 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.94 -58.38 8.13 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.178 -0.919 . . . . 2.21 110.57 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.63 -14.54 11.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.115 -0.948 . . . . 2.37 110.158 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.3 mm? -73.65 162.88 28.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.616 -1.175 . . . . 0.81 112.04 -162.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -146.94 -25.96 0.4 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.501 -1.227 . . . . 1.68 110.851 -171.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 21.6 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.447 -0.787 . . . . 3.71 111.223 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.859 -0.496 . . . . 9.37 111.859 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.1 m170 58.48 33.07 22.8 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.99 0.424 . . . . 9.04 111.449 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.7 ttm -74.13 -33.94 63.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.017 -0.538 . . . . 8.13 110.559 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.41 28.82 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.75 -0.659 . . . . 5.76 110.554 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -124.37 101.29 7.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.513 0.561 . . . . 5.73 112.513 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.4 p 40.13 86.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.929 1.393 . . . . 1.52 114.315 172.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.95 -46.13 18.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.857 -1.065 . . . . 2.01 111.653 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' HA ' HD23 ' A' ' 48' ' ' LEU . 39.0 t 41.39 88.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.032 0.753 . . . . 0.45 113.032 -176.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -160.65 -163.79 1.12 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.715 -0.221 . . . . 1.41 110.448 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -89.87 -13.71 35.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.89 112.136 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.47 -37.28 0.12 Allowed Glycine 0 C--N 1.31 -0.902 0 C-N-CA 125.843 1.687 . . . . 0.1 116.249 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.6 mt -123.05 172.16 8.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 118.238 1.019 . . . . 0.11 109.393 168.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 15' ' ' ALA . 70.0 p -94.95 121.66 36.78 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.629 -0.714 . . . . 1.2 110.179 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 17' ' ' VAL . 22.7 p -80.79 24.07 0.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.482 0.658 . . . . 0.2 110.085 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.07 113.21 22.62 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.416 -0.811 . . . . 0.35 110.556 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -9.99 72.61 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.028 -0.606 . . . . 0.31 112.418 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -74.01 148.35 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.571 0.7 . . . . 0.19 111.807 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.07 74.81 4.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.936 -1.029 . . . . 0.16 109.813 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -86.58 133.81 28.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.334 -1.303 . . . . 0.12 112.29 -175.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 61.1 mt-30 -82.01 100.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.36 -0.837 . . . . 0.66 110.598 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -90.24 -38.09 13.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.967 -0.56 . . . . 0.84 110.251 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -66.98 -14.16 62.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 0.89 111.344 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.24 2.01 53.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.817 -0.629 . . . . 0.17 110.869 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.1 t -71.27 138.8 49.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.26 111.639 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 8.2 mmt-85 -82.9 -11.81 57.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.26 -0.882 . . . . 2.1 111.544 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.712 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 48.7 t -129.97 149.56 33.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.342 -0.614 . . . . 0.13 109.342 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.55 132.45 47.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 122.051 0.929 . . . . 0.14 113.075 -173.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.9 46.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 126.217 1.807 . . . . 0.16 113.055 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.51 98.65 0.88 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 122.836 1.303 . . . . 0.15 110.696 -159.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.7 tp60 -63.38 -10.8 18.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.969 -1.014 . . . . 0.36 111.203 -171.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 t -81.38 -34.91 31.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.343 -0.39 . . . . 1.11 110.123 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -85.01 -29.52 24.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.948 -0.76 . . . . 0.15 108.948 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.8 mt -66.25 -43.38 91.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.696 -1.138 . . . . 0.22 110.22 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.23 -16.67 60.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.257 1.027 . . . . 1.54 108.889 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' SER . 13.3 t70 -88.17 16.49 6.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.811 -1.54 . . . . 0.49 109.426 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.9 t -46.27 -12.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.93 1.292 . . . . 1.47 113.869 -175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -11.35 60.28 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.139 -0.351 . . . . 0.97 111.143 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.05 144.36 45.59 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.27 0.557 . . . . 0.82 112.152 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -71.11 -6.22 37.6 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.311 -0.859 . . . . 1.39 109.628 168.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . . . -65.77 -17.78 64.86 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.982 -0.554 . . . . 0.15 110.305 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -97.18 -7.29 32.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.148 0.499 . . . . 0.15 111.814 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -84.05 105.17 14.71 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.811 -0.632 . . . . 0.5 109.853 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.1 m-85 -59.29 -65.01 0.74 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.621 -0.718 . . . . 0.14 111.402 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.71 -103.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.986 1.315 . . . . 0.24 109.673 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -154.27 120.35 5.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.829 -0.623 . . . . 1.82 110.033 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.96 9.68 15.53 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.916 -0.584 . . . . 0.17 112.766 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -68.43 -39.35 80.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.647 0.779 . . . . 0.11 109.092 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD21 HD22 ' A' ' 68' ' ' LEU . 12.2 tp -74.64 -40.12 61.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.609 -1.178 . . . . 0.1 109.465 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.1 mm-40 -66.04 -16.43 63.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.711 -1.586 . . . . 1.49 110.455 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.39 -55.19 5.6 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 114.41 -1.268 . . . . 0.37 110.165 175.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.4 mt -62.35 -36.86 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.885 -1.961 . . . . 0.16 109.104 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 68.3 mt -71.43 -44.32 65.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.282 -1.326 . . . . 0.13 110.737 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.69 -39.14 73.31 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.203 -1.036 . . . . 0.18 108.203 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.41 -54.34 30.04 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 113.54 -1.664 . . . . 0.24 110.248 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.524 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 37.4 m -46.68 -48.67 20.08 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.845 0.458 . . . . 0.9 111.862 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 30.7 mtt180 -65.44 -41.81 93.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 2.73 110.855 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.4 m -68.57 -31.42 70.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.55 111.628 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 54' ' ' THR . 9.7 mmt180 -70.7 -30.33 66.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.811 0.815 . . . . 2.5 110.34 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.89 20.6 11.23 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.329 -1.305 . . . . 0.24 111.483 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.4 m-85 -77.34 -47.68 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.319 0.581 . . . . 0.51 109.852 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -141.3 -170.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 122.223 1.011 . . . . 0.12 111.92 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.66 139.48 46.49 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.225 -1.807 . . . . 0.16 109.044 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.07 -129.37 2.06 Favored Glycine 0 CA--C 1.517 0.183 0 O-C-N 123.99 0.806 . . . . 0.24 113.95 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -96.66 14.85 23.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.057 0.456 . . . . 2.21 110.543 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.792 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.3 mm-40 -78.57 35.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.656 -0.702 . . . . 0.66 111.191 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 41.5 p90 -107.74 165.56 11.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.566 -0.531 . . . . 0.11 109.566 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.7 mt -128.98 101.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.778 0.799 . . . . 0.07 109.69 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.6 tp -95.97 151.43 19.44 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.824 -0.806 . . . . 0.11 108.824 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -146.32 144.02 29.52 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.083 0.401 . . . . 0.93 112.083 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 mpt_? -71.93 134.38 45.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.527 -0.76 . . . . 1.74 109.928 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.8 t -127.45 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.579 -0.737 . . . . 0.11 112.347 -172.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.7 t-20 -144.87 160.19 41.7 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.055 -169.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.604 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.0 mt -123.64 110.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.967 -0.561 . . . . 0.11 110.029 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 72.1 t -113.96 108.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.503 -0.772 . . . . 0.24 109.315 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.07 8.44 6.16 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.1 0.952 . . . . 0.39 110.178 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.41 17.16 57.67 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.025 -1.083 . . . . 0.13 112.463 -171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 91.0 m-20 -93.19 37.83 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.901 0.35 . . . . 0.38 111.079 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.93 115.18 0.02 OUTLIER Glycine 0 N--CA 1.469 0.893 0 O-C-N 124.645 1.216 . . . . 0.08 115.064 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -91.94 137.58 32.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.624 0.726 . . . . 0.19 110.759 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 47.5 m-85 -122.65 137.42 54.91 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.245 -1.343 . . . . 0.16 109.688 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' CG ' HG21 ' A' ' 71' ' ' VAL . 94.5 m-20 -95.7 142.09 28.42 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.864 -0.735 . . . . 1.56 109.232 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.31 53.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.017 -1.105 . . . . 0.19 108.017 176.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 76.6 m-85 -122.85 158.93 29.22 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.044 -0.98 . . . . 0.19 110.332 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 67' ' ' ILE . 79.3 mttt -77.48 165.59 50.4 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.801 -1.091 . . . . 0.57 108.933 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.5 Cg_exo -56.03 -18.78 23.9 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.082 1.855 . . . . 0.12 111.715 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.22 -0.49 57.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.213 -0.903 . . . . 1.93 110.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.33 1.22 84.14 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.604 -0.725 . . . . 0.11 112.247 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 9.4 m -65.11 121.71 15.36 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.295 -0.532 . . . . 0.17 111.613 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -56.44 126.7 27.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.839 0.828 . . . . 0.2 112.002 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 ' HD2' ' A' ' 60' ' ' TYR . 59.1 mt -104.21 -57.92 1.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.867 -1.515 . . . . 0.12 109.97 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.591 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 22.7 p90 -166.63 174.2 9.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.15 112.157 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.675 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -111.24 125.73 54.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.243 -1.344 . . . . 0.14 108.851 171.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -114.63 165.84 12.36 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.462 0.648 . . . . 0.06 110.454 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -105.91 124.53 49.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.02 -1.474 . . . . 1.15 107.02 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 24.4 p -75.98 -36.54 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.202 -0.666 . . . . 0.18 109.202 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 30.3 mmtt -73.81 -23.35 59.66 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.227 -0.897 . . . . 0.31 111.468 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -120.15 -19.88 7.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.15 111.092 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.0 15.65 81.23 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.259 -0.737 . . . . 0.13 111.259 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -73.01 163.21 28.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.204 -0.665 . . . . 0.85 109.204 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.3 p90 -147.13 138.87 24.23 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.586 0.708 . . . . 0.2 111.188 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -112.86 144.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.443 -1.253 . . . . 0.12 109.434 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.84 179.53 31.48 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.115 -1.04 . . . . 0.49 110.622 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -124.96 171.44 10.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.253 0.526 . . . . 1.18 110.083 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.407 ' H ' ' NH2' ' A' ' 25' ' ' ARG . . . 171.71 -143.45 7.54 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.658 -0.782 . . . . 2.58 112.056 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.78 100.4 12.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.941 0.4 . . . . 3.51 110.961 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.37 -163.92 26.34 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.816 -0.706 . . . . 2.3 112.259 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.45 -35.89 9.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.857 0.36 . . . . 4.69 111.178 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.449 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -135.69 121.85 20.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.315 0.578 . . . . 0.96 112.168 -173.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.99 -60.19 2.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.022 -0.99 . . . . 2.21 110.055 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 15.8 m-20 -114.31 -1.43 13.57 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.128 -0.942 . . . . 2.37 110.286 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.4 mm? -81.03 162.24 23.87 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.274 -0.876 . . . . 0.81 110.979 -167.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -142.3 -23.46 0.67 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.72 -1.127 . . . . 1.68 110.749 -171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.712 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p90 . . . . . 0 C--O 1.252 1.202 0 CA-C-N 115.718 -0.674 . . . . 3.71 111.008 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.235 -0.346 . . . . 9.37 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 55.07 76.78 0.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.312 0.645 . . . . 9.04 111.19 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ttt 55.22 61.57 2.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.619 -0.719 . . . . 8.13 110.535 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -68.84 154.98 41.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.465 -0.789 . . . . 5.76 110.933 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -79.31 62.1 3.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.493 -0.929 . . . . 5.73 108.493 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 m -151.26 89.93 1.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.558 -0.746 . . . . 1.52 111.07 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -96.24 -56.66 2.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 2.01 111.218 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' HD23 ' A' ' 48' ' ' LEU . 47.5 t 56.8 92.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.136 0.493 . . . . 0.45 111.913 -176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -155.27 -172.2 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.699 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.653 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -94.44 -10.79 31.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 0.89 112.071 -178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.78 -36.7 0.07 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 126.169 1.842 . . . . 0.1 116.897 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 65' ' ' GLN . 73.7 mt -122.72 172.94 8.06 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.271 1.036 . . . . 0.11 109.149 168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -96.4 118.0 32.02 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.569 -0.741 . . . . 1.2 110.665 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.7 p -82.07 20.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.343 0.592 . . . . 0.2 110.418 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.86 108.82 18.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.35 110.542 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.27 67.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.884 -0.674 . . . . 0.31 112.337 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 19' ' ' VAL . 11.4 p -68.91 148.11 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.572 0.701 . . . . 0.19 111.532 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 74.29 8.58 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.959 -1.018 . . . . 0.16 109.731 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -88.57 136.16 23.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.342 -1.299 . . . . 0.12 112.141 -175.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 34.0 mt-30 -83.77 102.2 12.13 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.385 -0.825 . . . . 0.66 110.155 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -94.1 -30.69 14.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.002 -0.544 . . . . 0.84 110.47 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -74.75 -5.1 41.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.346 0.593 . . . . 0.89 110.353 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.06 0.22 51.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.338 -0.846 . . . . 0.17 110.382 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 33.4 t -70.61 137.94 50.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.46 -0.791 . . . . 0.26 111.962 -175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.68 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -74.43 -22.07 59.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.215 -0.902 . . . . 2.1 112.739 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 39.1 t -126.62 154.28 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.78 -0.452 . . . . 0.13 109.78 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -72.11 133.39 45.18 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 122.015 0.912 . . . . 0.14 112.805 -173.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.04 45.77 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 126.313 1.845 . . . . 0.16 113.803 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 96.79 0.66 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.64 1.209 . . . . 0.15 110.64 -160.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.6 tp60 -61.74 -15.03 37.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 0.36 111.183 -171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.2 m -76.45 -39.53 53.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.275 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.813 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.33 -29.57 38.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.388 -0.967 . . . . 0.15 108.388 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 86.0 mt -67.38 -42.01 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.773 -1.103 . . . . 0.22 110.074 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.58 -10.96 59.89 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.279 1.038 . . . . 1.54 108.818 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' SER . 28.1 t70 -89.18 16.78 6.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.91 -1.495 . . . . 0.49 109.142 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.83 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.3 m -47.37 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.45 1.278 . . . . 1.47 114.45 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -70.62 -14.11 62.35 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.083 -0.386 . . . . 0.97 111.2 171.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.635 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -59.34 148.07 33.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 121.333 0.587 . . . . 0.82 111.939 -179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.432 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.5 p -76.9 -3.13 37.06 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.192 -0.913 . . . . 1.39 109.093 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -68.74 -15.87 63.64 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.51 -0.768 . . . . 0.15 110.07 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.83 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.5 m95 -100.43 -12.53 19.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.319 -0.401 . . . . 0.15 111.856 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -85.38 104.74 15.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.206 -0.665 . . . . 0.5 109.206 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.85 -64.1 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.697 -1.138 . . . . 0.14 111.159 -176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.66 -111.83 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.24 109.737 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -142.6 109.1 5.33 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.758 0.313 . . . . 1.82 111.076 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.89 16.92 57.62 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 116.018 -0.537 . . . . 0.17 112.043 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -70.37 -39.73 76.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 123.631 0.773 . . . . 0.11 109.277 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 HD22 ' A' ' 68' ' ' LEU . 11.6 tp -72.21 -41.73 66.59 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.1 109.632 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.35 -16.03 61.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.995 -1.457 . . . . 1.49 110.171 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.98 -55.31 5.23 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 114.403 -1.271 . . . . 0.37 110.534 176.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.5 mt -62.19 -36.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 112.935 -1.939 . . . . 0.16 109.105 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 74.1 mt -72.49 -43.39 63.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.396 -1.274 . . . . 0.13 111.052 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.55 71.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.299 1.047 . . . . 0.18 108.436 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.3 m -71.13 -53.91 12.9 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 113.632 -1.622 . . . . 0.24 110.324 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' HD11 ' A' ' 61' ' ' ILE . 49.4 m -46.19 -48.38 17.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.058 0.543 . . . . 0.9 111.889 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -63.6 -45.37 90.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.395 -0.366 . . . . 2.73 110.45 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 t -60.39 -34.57 74.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.55 110.996 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.3 mmt180 -73.31 -30.32 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.215 -0.902 . . . . 2.5 110.476 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.43 14.0 23.05 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.654 -1.157 . . . . 0.24 111.523 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' HD2' HD22 ' A' ' 90' ' ' LEU . 42.0 m-85 -71.92 -48.69 43.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.526 0.679 . . . . 0.51 109.617 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.3 pt -140.49 -170.21 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.026 -0.988 . . . . 0.12 111.678 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -133.56 141.32 47.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.411 -1.722 . . . . 0.16 109.537 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.49 -121.4 1.11 Allowed Glycine 0 C--N 1.332 0.348 0 O-C-N 124.095 0.872 . . . . 0.24 114.239 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -103.83 13.74 32.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.467 . . . . 2.21 110.291 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.794 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.6 mm-40 -78.36 35.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.579 -0.737 . . . . 0.66 111.273 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.0 p90 -106.77 165.01 11.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.679 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -128.35 101.79 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.697 0.76 . . . . 0.07 109.729 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.7 tp -97.7 150.55 21.07 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.851 -0.796 . . . . 0.11 108.851 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -145.64 144.51 30.48 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.93 111.606 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.12 134.36 45.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.484 -0.78 . . . . 1.74 109.801 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 81' ' ' ASN . 55.5 t -125.9 -64.94 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.703 . . . . 0.11 112.109 -172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.873 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 16.9 t-20 -145.3 158.99 43.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 120.645 -0.422 . . . . 0.14 111.851 -171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.643 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.3 mt -117.74 106.73 20.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.11 109.915 171.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 90.6 t -109.17 107.77 23.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.559 -0.746 . . . . 0.24 109.302 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.93 8.48 6.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.939 0.876 . . . . 0.39 110.372 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.97 13.92 61.56 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.024 -1.084 . . . . 0.13 112.202 -171.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 89.2 m-20 -92.89 37.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.925 0.363 . . . . 0.38 111.06 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.23 115.88 0.01 OUTLIER Glycine 0 N--CA 1.472 1.08 0 O-C-N 124.795 1.31 . . . . 0.08 115.165 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.5 m-85 -94.29 136.84 34.14 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.612 0.72 . . . . 0.19 110.609 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.8 m-85 -123.21 137.63 54.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.265 -1.334 . . . . 0.16 109.619 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.553 ' CG ' HG21 ' A' ' 71' ' ' VAL . 90.6 m-20 -95.81 141.94 28.66 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.581 -0.847 . . . . 1.56 109.055 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.985 -1.117 . . . . 0.19 107.985 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.679 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.1 m-85 -122.3 158.55 29.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.057 -0.974 . . . . 0.19 109.893 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 83.8 mttt -76.62 164.97 56.18 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.958 -1.019 . . . . 0.57 108.974 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.42 -19.94 24.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.06 1.84 . . . . 0.12 111.586 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.03 -7.57 55.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.252 -0.885 . . . . 1.93 109.933 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.75 -1.5 63.68 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.428 -0.805 . . . . 0.11 112.235 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -63.82 120.98 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.351 -0.5 . . . . 0.17 111.82 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.9 t80 -55.32 126.73 26.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 122.05 0.929 . . . . 0.2 112.299 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 60' ' ' TYR . 52.7 mt -104.28 -58.5 1.87 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.807 -1.542 . . . . 0.12 109.965 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.9 p90 -165.29 174.17 10.45 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.508 0.67 . . . . 0.15 112.069 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.65 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.1 m -112.17 122.7 48.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.262 -1.336 . . . . 0.14 108.816 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.53 165.15 12.24 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.551 0.691 . . . . 0.06 110.805 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.992 -1.484 . . . . 1.15 106.992 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.691 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 12.7 p -75.98 -38.15 57.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.914 -0.773 . . . . 0.18 108.914 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 25.1 mmtt -73.2 -19.84 61.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -1.029 . . . . 0.31 111.407 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -125.73 -17.17 5.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.099 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.719 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 72.85 15.34 78.18 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.068 -0.587 . . . . 0.13 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -75.38 164.59 26.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.7 p90 -147.54 140.81 25.23 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.706 0.765 . . . . 0.2 111.718 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -113.79 139.72 37.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.502 -1.227 . . . . 0.12 110.079 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.54 38.88 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.362 -0.923 . . . . 0.49 111.094 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -134.68 24.92 3.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.27 0.535 . . . . 1.18 110.446 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.75 85.54 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.623 -0.717 . . . . 2.58 112.346 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -78.11 -21.77 49.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.225 0.536 . . . . 3.51 110.298 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.34 -81.46 1.55 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.551 -0.75 . . . . 2.3 112.567 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -67.26 93.39 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.336 0.255 . . . . 4.69 110.465 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.451 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . 46.41 71.39 0.3 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.476 0.655 . . . . 0.96 111.261 -173.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 14.5 t70 -51.93 -55.76 18.27 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.464 -1.244 . . . . 2.21 110.415 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.425 ' H ' HD22 ' A' ' 111' ' ' LEU . 8.8 t70 -117.88 -12.99 10.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.44 -0.8 . . . . 2.37 110.007 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 108' ' ' ALA . 1.9 mm? -73.96 162.02 29.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.945 -1.025 . . . . 0.81 112.241 -161.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.93 -24.23 2.96 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.927 -1.488 . . . . 1.68 110.363 -173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 17.7 p90 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.586 -0.734 . . . . 3.71 110.608 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.321 -0.312 . . . . 9.37 112.321 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -85.6 -30.99 22.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 9.04 110.254 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 tpt -98.85 -48.93 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.126 0.488 . . . . 8.13 110.499 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -85.93 76.88 9.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.235 0.541 . . . . 5.76 109.942 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -76.87 125.98 30.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.596 -0.729 . . . . 5.73 109.918 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -143.03 88.31 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.885 0.85 . . . . 1.52 111.706 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.6 -48.3 6.15 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.431 -1.258 . . . . 2.01 111.017 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.6 t 48.97 89.02 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 123.839 0.712 . . . . 0.45 112.294 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -152.03 -171.88 4.06 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.105 -0.498 . . . . 1.41 110.577 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.704 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -98.19 -8.25 27.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.89 111.802 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.99 -36.81 0.06 OUTLIER Glycine 0 N--CA 1.469 0.878 0 C-N-CA 126.167 1.841 . . . . 0.1 116.749 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.624 ' HB2' HG12 ' A' ' 67' ' ' ILE . 74.2 mt -123.08 172.13 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 118.192 0.996 . . . . 0.11 109.619 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -95.15 116.71 29.08 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.523 -0.762 . . . . 1.2 110.709 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 17' ' ' VAL . 65.5 p -81.1 20.69 0.78 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.28 0.562 . . . . 0.2 110.686 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 114.52 23.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.87 -0.605 . . . . 0.35 110.197 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 -2.39 87.53 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.029 -0.605 . . . . 0.31 112.626 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 19' ' ' VAL . 12.1 p -76.72 147.0 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.19 111.335 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 74.34 9.86 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.05 0.929 . . . . 0.16 109.652 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -90.65 136.22 24.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.235 -1.348 . . . . 0.12 112.312 -175.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.49 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.4 mt-30 -83.9 101.18 11.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.128 -0.942 . . . . 0.66 110.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -93.06 -33.43 14.09 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.017 -0.538 . . . . 0.84 110.897 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 m -68.15 -22.21 64.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 0.89 110.519 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.16 -3.89 44.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.296 -0.866 . . . . 0.17 111.366 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.4 t -65.79 147.94 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.229 0.538 . . . . 0.26 111.567 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 1.4 mmp_? -88.39 -15.96 34.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.53 -0.759 . . . . 2.1 111.794 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.645 ' CG2' HG21 ' A' ' 92' ' ' THR . 38.8 t -129.29 154.65 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.476 -0.565 . . . . 0.13 109.476 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.3 134.26 42.59 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 121.847 0.832 . . . . 0.14 112.988 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.41 45.37 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 126.155 1.782 . . . . 0.16 113.822 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.888 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.77 95.62 0.68 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.45 1.119 . . . . 0.15 110.468 -160.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.5 tp60 -58.3 -18.38 26.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.221 -0.899 . . . . 0.36 111.263 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 16.4 m -74.85 -36.66 62.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.727 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.72 -28.85 27.98 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.279 -1.008 . . . . 0.15 108.279 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 82.6 mt -66.61 -41.94 89.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.22 110.217 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 3.2 m-20 -80.45 -7.6 59.22 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.077 0.941 . . . . 1.54 109.525 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.2 t70 -93.56 16.82 12.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.876 -1.511 . . . . 0.49 109.0 173.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.905 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 2.2 m -46.81 -7.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.148 1.166 . . . . 1.47 114.148 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.14 -7.83 54.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.234 -0.292 . . . . 0.97 111.404 172.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.35 150.71 34.3 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.221 0.534 . . . . 0.82 111.638 177.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.4 m -72.22 -10.82 60.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.438 -0.801 . . . . 1.39 109.328 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.14 -15.48 63.15 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 115.294 -0.866 . . . . 0.15 110.595 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.905 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.5 m95 -102.93 -9.37 19.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.999 0.37 . . . . 0.15 111.999 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.85 106.09 17.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.965 -0.754 . . . . 0.5 108.965 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.676 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -58.45 -65.36 0.67 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.886 -1.052 . . . . 0.14 111.647 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.57 -116.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.857 -1.065 . . . . 0.24 110.437 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.86 113.74 9.24 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.737 0.415 . . . . 1.82 110.901 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.55 22.59 25.04 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-N 116.249 -0.432 . . . . 0.17 112.34 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -73.66 -43.29 54.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.615 0.722 . . . . 0.11 109.262 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 10.4 tp -71.55 -40.49 69.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.218 -0.901 . . . . 0.1 109.751 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.2 mt-10 -67.86 -12.45 60.67 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.157 -1.383 . . . . 1.49 110.246 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.43 -58.72 2.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 114.336 -1.302 . . . . 0.37 110.132 173.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.6 mt -58.19 -37.8 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 113.079 -1.873 . . . . 0.16 109.375 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 61.5 mt -71.66 -43.64 65.7 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.429 -1.259 . . . . 0.13 111.062 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.05 -37.62 77.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.451 1.12 . . . . 0.18 108.143 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 4.1 m -68.18 -51.3 47.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.365 -1.743 . . . . 0.24 110.569 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' HD11 ' A' ' 61' ' ' ILE . 31.9 m -48.43 -49.6 34.56 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 122.981 0.512 . . . . 0.9 111.417 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 22.0 mtp180 -63.26 -42.24 99.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.99 -0.55 . . . . 2.73 110.416 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -59.82 -43.07 94.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.702 -0.681 . . . . 0.55 110.635 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.9 mmm180 -63.95 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.333 -0.848 . . . . 2.5 110.85 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.62 19.07 16.65 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.608 -1.178 . . . . 0.24 111.297 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.525 ' HD2' HD22 ' A' ' 90' ' ' LEU . 36.9 m-85 -75.16 -47.82 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.573 0.702 . . . . 0.51 109.382 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.5 pt -140.58 -171.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.859 -1.064 . . . . 0.12 111.411 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.59 143.88 47.6 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 113.491 -1.686 . . . . 0.16 109.644 173.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.8 -120.81 2.23 Favored Glycine 0 C--N 1.331 0.251 0 O-C-N 124.0 0.813 . . . . 0.24 113.647 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -110.07 16.62 21.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.21 109.739 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.624 ' HA ' HD21 ' A' ' 12' ' ' LEU . 6.6 mm-40 -76.8 35.57 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.017 -0.992 . . . . 0.66 111.265 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.1 p90 -108.15 164.46 12.28 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.0 mt -128.13 101.8 7.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.691 0.758 . . . . 0.07 109.743 175.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.5 tp -96.14 152.93 18.09 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.746 -0.835 . . . . 0.11 108.746 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -147.26 143.06 27.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.902 0.382 . . . . 0.93 111.633 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.2 mpt_? -71.42 136.52 47.73 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.623 -0.717 . . . . 1.74 109.507 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 81' ' ' ASN . 46.0 t -127.27 -65.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.594 -0.73 . . . . 0.11 112.022 -173.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.92 158.58 43.75 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.578 -0.449 . . . . 0.14 112.033 -170.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.664 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -117.54 107.5 22.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.786 -0.643 . . . . 0.11 109.867 171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 92.5 t -110.46 106.41 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.442 -0.799 . . . . 0.24 109.143 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 67.02 9.2 6.72 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.314 1.054 . . . . 0.39 110.018 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.86 15.46 61.27 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.125 -1.036 . . . . 0.13 112.319 -171.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 90.4 m-20 -91.05 37.16 0.92 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.38 110.83 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.82 114.73 0.02 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.723 1.264 . . . . 0.08 115.054 -168.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.7 m-85 -92.88 137.04 32.71 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.786 -0.707 . . . . 0.19 110.798 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.7 m-85 -122.93 137.18 55.02 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.244 -1.343 . . . . 0.16 109.569 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.526 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.3 m-20 -95.63 140.46 30.42 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.848 -0.741 . . . . 1.56 109.102 176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.76 129.19 54.01 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.852 -1.166 . . . . 0.19 107.852 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 71.1 m-85 -123.9 159.87 28.72 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.017 -0.992 . . . . 0.19 110.192 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.6 mttt -78.42 164.94 53.4 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.073 -0.967 . . . . 0.57 108.709 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 22.5 Cg_exo -56.61 -19.48 30.21 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.124 1.883 . . . . 0.12 111.863 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.07 -1.11 54.9 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.189 -0.914 . . . . 1.93 110.283 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.49 -2.22 70.3 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.751 -0.659 . . . . 0.11 113.035 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.0 m -63.18 123.34 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.22 -0.577 . . . . 0.17 111.946 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 91.5 t80 -57.82 126.17 26.25 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.992 0.901 . . . . 0.2 112.216 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.525 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.1 mt -102.5 -59.33 1.72 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.699 -1.591 . . . . 0.12 109.881 176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 23.1 p90 -165.93 173.51 10.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.561 0.695 . . . . 0.15 112.313 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CG2' ' A' ' 26' ' ' VAL . 91.4 m -111.33 121.73 46.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.238 -1.346 . . . . 0.14 108.89 172.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -111.1 165.35 11.96 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.477 0.656 . . . . 0.06 110.682 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 44.8 t-20 -105.28 127.15 52.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.069 -1.456 . . . . 1.15 107.069 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.676 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.94 -39.13 56.74 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.053 -0.721 . . . . 0.18 109.053 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.0 mmtt -70.3 -28.61 65.32 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.195 -0.911 . . . . 0.31 111.27 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.0 p -116.36 -20.33 9.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.746 -0.661 . . . . 0.15 111.014 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.07 13.62 83.03 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.561 -0.616 . . . . 0.13 111.561 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.13 162.83 28.98 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.019 -0.734 . . . . 0.85 109.019 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 25.0 p90 -146.28 138.27 24.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.677 0.751 . . . . 0.2 111.324 175.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -111.86 140.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.405 -1.271 . . . . 0.12 109.649 -173.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -99.48 -163.19 29.32 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 120.173 -1.013 . . . . 0.49 111.493 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.49 35.77 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.545 0.688 . . . . 1.18 110.138 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.68 -31.35 7.48 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.365 -0.834 . . . . 2.58 112.276 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 109' ' ' ASP . . . -80.1 -43.33 21.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 3.51 111.19 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.87 -156.46 27.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.662 -0.78 . . . . 2.3 112.087 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -52.52 -41.87 63.85 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.431 0.292 . . . . 4.69 111.655 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.504 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -120.22 75.23 1.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.648 0.737 . . . . 0.96 110.532 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 17.5 t70 -54.69 -56.56 17.93 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.354 -1.294 . . . . 2.21 109.677 173.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 9.6 m-20 -119.98 -2.84 10.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.364 -0.835 . . . . 2.37 110.42 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.2 mm? -75.89 167.36 22.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.775 -0.648 . . . . 0.81 111.475 -167.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.13 -27.32 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.16 -0.927 . . . . 1.68 110.432 -172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 23.6 p90 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.866 -1.061 . . . . 3.71 111.678 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 111.786 -0.525 . . . . 9.37 111.786 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 58.1 73.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 9.04 110.915 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptm -94.48 -10.82 31.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.764 -0.458 . . . . 8.13 109.764 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 m 67.73 117.42 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.106 -0.952 . . . . 5.76 112.123 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 36.8 mmt180 -90.51 39.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.462 0.649 . . . . 5.73 109.916 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -140.92 69.04 1.34 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.295 1.045 . . . . 1.52 110.445 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -91.64 -56.53 3.07 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.745 -1.571 . . . . 2.01 111.985 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' HD23 ' A' ' 48' ' ' LEU . 76.8 t 56.71 97.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.295 0.569 . . . . 0.45 112.002 -173.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.18 -166.83 1.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 1.41 109.913 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.682 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -98.73 -9.0 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.89 112.002 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.02 -36.72 0.07 OUTLIER Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.176 1.846 . . . . 0.1 116.75 172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 65' ' ' GLN . 69.2 mt -122.44 172.64 8.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.745 0.772 . . . . 0.11 109.489 169.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -98.31 117.32 32.45 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.422 -0.808 . . . . 1.2 110.125 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' VAL . 27.7 p -81.03 16.78 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.414 0.626 . . . . 0.2 110.52 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.46 104.92 16.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.792 -0.64 . . . . 0.35 110.316 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.56 -11.52 59.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.906 -0.664 . . . . 0.31 112.01 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -74.89 152.06 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.426 0.631 . . . . 0.19 111.226 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.35 75.35 4.54 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.001 -1.0 . . . . 0.16 109.771 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.15 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.743 -1.117 . . . . 0.12 112.019 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.465 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -85.3 100.38 11.77 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.488 -0.778 . . . . 0.66 110.361 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.3 -33.52 15.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.848 -0.615 . . . . 0.84 110.672 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -69.05 -14.68 63.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.381 0.61 . . . . 0.89 110.628 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.87 2.53 53.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.17 111.369 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.5 t -71.06 143.17 50.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.53 0.681 . . . . 0.26 112.042 -176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 9.4 mmt180 -83.14 -19.46 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.039 -0.982 . . . . 2.1 111.487 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -127.22 153.59 36.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.731 -0.47 . . . . 0.13 109.731 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.77 132.58 46.3 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 122.056 0.931 . . . . 0.14 112.85 -174.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.99 46.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 126.263 1.825 . . . . 0.16 113.68 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.889 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.32 96.92 0.69 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 122.619 1.199 . . . . 0.15 110.457 -160.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -60.93 -15.86 35.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.122 -0.944 . . . . 0.36 111.353 -171.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 46.4 t -76.11 -36.78 58.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.211 -0.45 . . . . 1.11 110.369 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.67 -29.45 27.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.572 -0.899 . . . . 0.15 108.572 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.3 mt -66.25 -43.17 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.642 -1.163 . . . . 0.22 110.29 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -74.45 -16.57 60.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.394 1.092 . . . . 1.54 108.896 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.1 t70 -87.76 17.51 4.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.692 -1.595 . . . . 0.49 109.55 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.726 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 3.1 t -41.7 -16.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.133 1.373 . . . . 1.47 113.671 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.97 112.015 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.09 143.23 52.65 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.851 0.358 . . . . 0.82 110.869 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.439 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.95 -2.28 26.36 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.519 -0.919 . . . . 1.39 108.519 169.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.62 -16.1 63.39 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 109.312 -0.625 . . . . 0.15 109.312 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.726 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.6 m95 -98.54 -9.66 24.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.15 111.552 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -88.71 104.16 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.5 109.757 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -57.26 -63.15 1.32 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 0.14 111.713 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.539 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 157.0 -121.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.128 1.371 . . . . 0.24 109.374 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -131.76 122.63 26.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.931 0.396 . . . . 1.82 111.085 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.58 19.04 5.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.786 -0.643 . . . . 0.17 112.46 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.35 -42.48 57.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.763 0.825 . . . . 0.11 109.378 -178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 68' ' ' LEU . 11.7 tp -72.04 -40.16 68.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.027 -0.988 . . . . 0.1 109.585 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.5 mm-40 -68.0 -11.99 59.93 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.136 -1.393 . . . . 1.49 110.49 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.9 -56.81 4.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.412 -1.267 . . . . 0.37 110.11 173.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.742 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -61.9 -35.17 66.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 112.781 -2.009 . . . . 0.16 109.179 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 77.4 mt -73.0 -44.61 60.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.157 -1.383 . . . . 0.13 110.646 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.62 -34.2 67.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.265 1.031 . . . . 0.18 108.423 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.8 m -74.1 -54.53 7.61 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 113.43 -1.714 . . . . 0.24 110.732 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 10.2 p -50.43 -44.19 55.22 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.201 0.445 . . . . 0.9 112.201 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 31.5 mtt180 -65.63 -41.37 92.72 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 2.73 110.19 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.4 t -62.51 -39.96 95.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.404 0.621 . . . . 0.55 110.823 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HE ' ' HE1' ' A' ' 60' ' ' TYR . 5.0 mmm180 -66.38 -31.31 72.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.278 -0.874 . . . . 2.5 110.784 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.79 16.53 21.56 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.524 -1.216 . . . . 0.24 111.162 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.564 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 37.8 m-85 -71.25 -47.7 55.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.746 -0.835 . . . . 0.51 108.746 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -140.86 -170.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.753 -1.112 . . . . 0.12 111.812 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.52 137.69 45.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.15 -1.841 . . . . 0.16 109.205 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.84 -127.43 1.92 Allowed Glycine 0 N--CA 1.453 -0.226 0 O-C-N 124.15 0.906 . . . . 0.24 114.112 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' TYR . 22.4 p-10 -96.53 10.67 37.68 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.242 -0.479 . . . . 2.21 110.66 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.784 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.9 mm-40 -76.3 35.12 0.14 Allowed 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.846 -0.615 . . . . 0.66 111.192 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.5 p90 -106.63 166.16 10.77 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.213 -0.662 . . . . 0.11 109.213 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.8 mt -129.37 102.11 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 121.857 0.837 . . . . 0.07 109.9 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 11.7 tp -95.89 152.53 18.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.856 -0.794 . . . . 0.11 108.856 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.09 143.18 28.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.998 0.428 . . . . 0.93 112.1 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.7 mpt_? -70.99 135.06 47.64 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.368 -0.833 . . . . 1.74 110.031 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG21 ' CG ' ' A' ' 81' ' ' ASN . 51.3 t -127.88 -62.91 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.665 -0.698 . . . . 0.11 112.033 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.889 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.7 t-20 -145.63 160.72 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.407 -0.517 . . . . 0.14 112.15 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.8 mt -122.44 109.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.806 -0.634 . . . . 0.11 109.807 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -114.2 109.36 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.24 109.293 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 68.02 9.36 7.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.003 0.906 . . . . 0.39 110.048 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 86.08 16.43 62.97 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.117 -1.039 . . . . 0.13 112.232 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 83.5 m-20 -93.26 37.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.629 0.372 . . . . 0.38 111.075 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.66 115.49 0.02 OUTLIER Glycine 0 N--CA 1.471 1.024 0 O-C-N 124.803 1.314 . . . . 0.08 115.184 -169.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.7 m-85 -92.64 136.35 33.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.745 -0.728 . . . . 0.19 110.647 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.23 138.72 54.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.277 -1.329 . . . . 0.16 109.593 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.563 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.9 m-20 -95.38 140.89 29.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.9 -0.72 . . . . 1.56 109.187 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.71 128.38 53.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.932 -1.136 . . . . 0.19 107.932 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.633 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 78.5 m-85 -123.36 159.48 28.8 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.049 -0.978 . . . . 0.19 110.248 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.62 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.9 mttt -78.4 164.81 54.18 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 114.929 -1.032 . . . . 0.57 108.709 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 25.6 Cg_exo -55.5 -19.39 22.84 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.147 1.898 . . . . 0.12 112.426 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.06 0.05 51.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.637 -0.71 . . . . 1.93 109.813 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.76 2.72 66.83 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.256 -0.884 . . . . 0.11 112.726 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.84 121.77 15.81 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.111 -0.64 . . . . 0.17 111.623 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 84.5 t80 -57.1 127.04 29.97 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.876 0.846 . . . . 0.2 112.089 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.1 mt -103.6 -59.84 1.66 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.911 -1.495 . . . . 0.12 110.107 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 22.3 p90 -165.36 172.98 11.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.441 0.638 . . . . 0.15 111.746 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.669 HG21 ' CG2' ' A' ' 26' ' ' VAL . 92.2 m -110.56 126.41 54.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.496 -1.229 . . . . 0.14 108.755 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -115.33 165.62 12.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.463 0.649 . . . . 0.06 110.609 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -105.01 127.68 52.97 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.14 -1.43 . . . . 1.15 107.14 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.71 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.4 p -76.65 -37.86 55.57 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.263 -0.643 . . . . 0.18 109.263 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.2 mmtt -73.19 -25.11 60.65 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.275 -0.875 . . . . 0.31 111.384 -171.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -118.56 -19.29 8.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.15 111.05 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.742 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.5 14.36 82.08 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.367 -0.693 . . . . 0.13 111.367 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -72.94 162.82 29.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.685 . . . . 0.85 109.149 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.8 p90 -148.22 138.21 22.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.825 0.821 . . . . 0.2 111.818 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -112.35 139.06 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.36 -1.291 . . . . 0.12 110.082 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.02 176.29 33.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.9 -0.88 . . . . 0.49 110.9 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.623 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 30.2 p-10 -132.44 -4.04 3.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.65 0.725 . . . . 1.18 111.889 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.93 68.53 2.25 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.24 -0.505 . . . . 2.58 113.076 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.86 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.851 0.46 . . . . 3.51 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.78 -174.58 42.87 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.715 -0.755 . . . . 2.3 111.668 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 52.48 -96.24 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.327 0.651 . . . . 4.69 112.401 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.71 125.19 4.66 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.896 0.855 . . . . 0.96 110.187 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HH21 ' A' ' 25' ' ' ARG . 51.1 t0 -83.77 -64.16 1.22 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.337 -1.301 . . . . 2.21 110.845 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -116.69 -5.3 11.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 2.37 111.226 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.24 163.65 27.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.708 0.766 . . . . 0.81 111.94 -166.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.81 -30.99 0.35 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.452 -1.249 . . . . 1.68 110.642 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 12.1 p90 . . . . . 0 C--O 1.246 0.909 0 CA-C-N 115.522 -0.763 . . . . 3.71 110.971 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.171 -0.372 . . . . 9.37 112.171 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -154.3 68.29 0.74 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.221 0.534 . . . . 9.04 109.614 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.03 -33.91 70.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 8.13 111.014 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.5 t -93.75 113.38 25.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.917 -0.583 . . . . 5.76 109.93 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 3.2 mpt_? -82.48 -38.26 24.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.439 -0.948 . . . . 5.73 108.439 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t 61.35 103.84 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.93 -1.032 . . . . 1.52 112.04 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -109.5 -42.05 4.43 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.79 -1.095 . . . . 2.01 111.018 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.637 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.1 t 46.01 86.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 123.766 0.666 . . . . 0.45 112.502 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -152.01 -175.47 5.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.016 -0.538 . . . . 1.41 109.668 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 mpt? -95.38 -7.64 37.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.305 0.574 . . . . 0.89 112.055 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.98 -36.72 0.09 OUTLIER Glycine 0 C--N 1.311 -0.834 0 C-N-CA 125.915 1.721 . . . . 0.1 116.715 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 65' ' ' GLN . 74.9 mt -121.81 172.08 8.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 117.816 0.808 . . . . 0.11 109.509 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ALA . 15.2 m -100.05 114.54 27.94 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.382 -0.826 . . . . 1.2 110.237 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 76.4 p -77.82 21.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.2 110.755 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -86.46 112.0 21.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.734 -0.666 . . . . 0.35 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.12 -8.5 79.49 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.947 -0.644 . . . . 0.31 112.19 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 19' ' ' VAL . 7.3 p -75.89 150.13 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.628 0.728 . . . . 0.19 111.565 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.63 74.9 5.06 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.933 -1.03 . . . . 0.16 109.919 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -87.11 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.428 -1.26 . . . . 0.12 111.86 -175.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.8 mt-30 -86.49 101.3 13.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.698 -0.683 . . . . 0.66 110.615 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -90.33 -30.99 17.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.063 -0.517 . . . . 0.84 110.838 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -70.84 -13.67 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.931 -0.577 . . . . 0.89 110.971 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 3.7 53.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.17 110.985 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 32.5 t -70.01 151.69 45.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.26 111.42 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.679 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.9 mmp_? -93.21 -20.61 20.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 2.1 111.476 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.652 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.0 t -127.27 152.57 35.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.879 -0.785 . . . . 0.13 108.879 -175.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.22 133.24 46.85 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.071 0.939 . . . . 0.14 113.137 -172.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.79 46.01 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.19 1.796 . . . . 0.16 113.699 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.75 95.24 0.65 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 122.7 1.238 . . . . 0.15 110.78 -160.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 35.2 tp60 -57.26 -18.94 18.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 0.36 111.366 -173.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 9.6 t -75.79 -38.29 58.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.311 -0.404 . . . . 1.11 110.363 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.801 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.78 -28.46 30.3 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.502 -0.925 . . . . 0.15 108.502 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.8 mt -65.5 -43.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.725 -1.125 . . . . 0.22 109.872 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -79.42 -13.77 59.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.994 -1.003 . . . . 1.54 109.001 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 31' ' ' SER . 7.8 t70 -82.74 16.29 2.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.127 -1.397 . . . . 0.49 108.828 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 25.6 p -42.34 -13.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.564 1.546 . . . . 1.47 114.382 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.644 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.37 -16.11 63.81 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.25 -0.281 . . . . 0.97 111.365 175.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.644 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.1 143.84 51.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.033 0.444 . . . . 0.82 111.742 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -76.83 -1.21 27.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.507 -0.923 . . . . 1.39 108.507 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.49 -17.02 62.3 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 121.312 0.577 . . . . 0.15 109.451 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 87.8 m95 -97.22 -12.59 22.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.396 -0.82 . . . . 0.15 111.663 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.06 106.77 17.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.424 0.631 . . . . 0.5 109.418 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -57.77 -63.79 1.12 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.355 -1.293 . . . . 0.14 111.471 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.69 -110.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.748 1.219 . . . . 0.24 109.772 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.59 119.75 11.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.951 -0.568 . . . . 1.82 109.954 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.41 17.16 5.69 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 115.901 -0.59 . . . . 0.17 112.757 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -72.88 -41.17 60.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 C-N-CA 123.476 0.71 . . . . 0.11 109.401 -176.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 68' ' ' LEU . 9.3 tp -70.77 -40.95 72.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.169 -0.923 . . . . 0.1 109.413 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.95 -17.35 64.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.831 -1.531 . . . . 1.49 110.014 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.35 -56.34 4.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 114.399 -1.273 . . . . 0.37 110.46 176.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.726 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.1 mt -60.8 -36.77 73.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 112.955 -1.93 . . . . 0.16 109.191 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 57.2 mt -70.81 -43.21 69.11 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.257 -1.338 . . . . 0.13 110.623 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.22 78.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.938 -1.028 . . . . 0.18 108.583 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.4 m -65.29 -52.53 53.6 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.752 -1.567 . . . . 0.24 110.364 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.1 m -48.42 -47.93 37.58 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.649 0.38 . . . . 0.9 111.902 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.99 -40.9 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.533 -0.303 . . . . 2.73 110.351 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -59.98 -43.19 95.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.506 0.669 . . . . 0.55 110.784 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.9 mmt180 -65.74 -30.6 71.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.991 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.29 24.82 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.836 -1.075 . . . . 0.24 111.118 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.8 m-85 -70.72 -47.89 57.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.464 0.649 . . . . 0.51 109.33 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.5 pt -140.27 -171.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.89 -1.05 . . . . 0.12 111.612 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.08 141.82 47.31 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.105 -1.861 . . . . 0.16 108.93 171.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.2 -123.84 1.35 Allowed Glycine 0 CA--C 1.516 0.153 0 O-C-N 124.079 0.862 . . . . 0.24 113.89 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' TYR . 18.4 p-10 -100.44 12.41 37.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.924 0.392 . . . . 2.21 110.759 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.71 34.76 0.15 Allowed 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.786 -0.643 . . . . 0.66 111.474 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.5 p90 -106.96 164.2 12.33 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.372 -0.603 . . . . 0.11 109.372 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 91.3 mt -128.91 101.77 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.722 0.773 . . . . 0.07 109.966 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.3 tp -95.97 154.4 17.26 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.92 -0.77 . . . . 0.11 108.92 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -148.95 142.72 25.6 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.93 111.815 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.581 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -71.06 137.1 48.68 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.686 -0.688 . . . . 1.74 109.726 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.517 HG21 ' CG ' ' A' ' 81' ' ' ASN . 53.2 t -127.16 -64.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.525 -0.761 . . . . 0.11 111.973 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.6 t-20 -144.78 159.83 42.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.423 -0.511 . . . . 0.14 112.035 -171.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.1 mt -119.34 108.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.746 -0.661 . . . . 0.11 109.793 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 97.3 t -112.8 107.53 23.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.871 -0.789 . . . . 0.24 108.871 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER 67.94 8.79 6.71 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.008 0.908 . . . . 0.39 110.246 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.14 14.38 60.58 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.186 -1.007 . . . . 0.13 112.201 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 44.9 m-20 -91.0 37.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.576 -0.367 . . . . 0.38 111.177 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -26.03 114.37 0.02 OUTLIER Glycine 0 N--CA 1.47 0.901 0 O-C-N 124.526 1.142 . . . . 0.08 114.77 -168.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' VAL . 24.4 m-85 -91.21 137.53 32.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.759 0.79 . . . . 0.19 111.138 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.1 m-85 -122.94 136.83 55.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.98 -1.464 . . . . 0.16 109.761 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' CG ' HG21 ' A' ' 71' ' ' VAL . 96.3 m-20 -95.96 140.15 31.13 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.999 -0.741 . . . . 1.56 108.999 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.96 129.76 54.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.135 -1.061 . . . . 0.19 108.135 176.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 77.4 m-85 -123.35 158.77 30.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.108 -0.951 . . . . 0.19 110.319 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.7 mttt -76.85 165.57 51.39 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.006 -0.997 . . . . 0.57 108.847 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 14.7 Cg_exo -57.68 -18.42 33.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.886 1.724 . . . . 0.12 111.744 177.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -94.32 -4.61 48.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.454 -0.793 . . . . 1.93 109.928 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 97.1 -2.31 61.4 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.334 -0.848 . . . . 0.11 112.769 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.596 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -61.98 121.25 12.5 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.335 -0.509 . . . . 0.17 111.479 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 87.4 t80 -56.02 129.16 38.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.785 0.802 . . . . 0.2 112.418 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD22 ' HD2' ' A' ' 60' ' ' TYR . 54.7 mt -105.88 -57.41 2.05 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.901 -1.499 . . . . 0.12 110.301 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 29.3 p90 -167.54 173.54 8.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.556 0.693 . . . . 0.15 112.431 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.652 HG21 ' CG2' ' A' ' 26' ' ' VAL . 95.3 m -111.98 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.094 -1.412 . . . . 0.14 108.917 172.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.1 163.33 14.43 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.06 111.053 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.89 120.57 41.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.619 -1.623 . . . . 1.15 106.619 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.664 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.8 p -71.34 -41.85 69.29 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.332 0.587 . . . . 0.18 109.679 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 32.6 mmtt -69.93 -21.48 63.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.98 -1.009 . . . . 0.31 111.512 -171.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 p -121.02 -21.78 6.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.044 0.45 . . . . 0.15 111.001 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.05 12.57 84.52 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.552 -0.619 . . . . 0.13 111.552 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.32 160.22 32.66 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.036 -0.727 . . . . 0.85 109.036 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 31.3 p90 -146.65 143.0 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.519 0.676 . . . . 0.2 111.462 174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -116.49 141.79 32.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.642 -1.163 . . . . 0.12 109.657 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.65 -168.34 33.85 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.377 -0.916 . . . . 0.49 111.849 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -138.35 178.93 6.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.171 -0.307 . . . . 1.18 110.171 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.58 -48.6 0.92 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.712 -0.756 . . . . 2.58 111.902 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.07 89.42 7.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.691 0.281 . . . . 3.51 111.146 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.45 -141.9 48.07 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 2.3 112.248 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.14 -50.32 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.817 -0.438 . . . . 4.69 109.817 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.07 87.01 5.99 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.438 0.637 . . . . 0.96 110.617 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -64.26 -53.3 51.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.885 -1.052 . . . . 2.21 109.916 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -115.91 -17.22 11.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.317 -0.856 . . . . 2.37 110.18 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.679 HD21 ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -80.84 167.89 19.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.901 -1.045 . . . . 0.81 112.391 -162.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -126.79 1.95 6.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.539 -1.664 . . . . 1.68 107.527 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.421 ' CZ ' HD12 ' A' ' 111' ' ' LEU . 5.4 p90 . . . . . 0 N--CA 1.438 -1.052 0 CA-C-N 113.734 -1.575 . . . . 3.71 110.615 -172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.068 -0.413 . . . . 9.37 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -86.71 112.0 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.343 -0.243 . . . . 9.04 110.343 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.4 mmm 70.15 128.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.937 0.773 . . . . 8.13 111.733 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m 62.08 88.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.334 -0.848 . . . . 5.76 111.266 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.45 110.11 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.866 -0.607 . . . . 5.73 110.043 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -128.37 92.53 3.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.552 0.691 . . . . 1.52 111.074 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.77 -49.33 11.27 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.972 -1.013 . . . . 2.01 111.159 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 48' ' ' LEU . 44.9 t 42.71 79.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.428 0.633 . . . . 0.45 112.117 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 -168.91 3.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.781 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.66 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -89.28 -11.44 43.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.512 0.672 . . . . 0.89 111.595 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.33 -36.89 0.09 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 126.178 1.847 . . . . 0.1 116.437 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 65' ' ' GLN . 76.9 mt -122.08 172.03 8.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.966 0.883 . . . . 0.11 109.31 168.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 15' ' ' ALA . 23.2 m -100.35 113.79 26.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.326 -0.852 . . . . 1.2 110.599 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 61.1 p -77.54 27.87 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.205 0.526 . . . . 0.2 111.004 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.18 108.36 18.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.024 -0.534 . . . . 0.35 110.663 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.58 -7.5 79.03 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.043 -0.598 . . . . 0.31 112.465 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 19' ' ' VAL . 13.0 p -68.96 146.85 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 121.443 0.64 . . . . 0.19 110.959 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 74.3 9.56 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 122.153 0.978 . . . . 0.16 109.621 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.21 137.11 21.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 114.189 -1.368 . . . . 0.12 111.768 -176.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.44 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 52.9 mt-30 -85.65 99.48 11.32 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.287 -0.869 . . . . 0.66 109.913 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 19' ' ' VAL . 31.5 mtt180 -94.93 -32.21 13.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.852 -0.613 . . . . 0.84 110.23 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -74.25 1.48 11.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.192 -0.913 . . . . 0.89 109.712 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.21 -0.18 28.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.873 -1.058 . . . . 0.17 110.312 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.608 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.6 t -74.61 136.01 42.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.743 -0.662 . . . . 0.26 111.377 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -76.58 -11.09 59.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.61 -0.723 . . . . 2.1 112.501 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' CG2' HG21 ' A' ' 92' ' ' THR . 37.3 t -131.6 155.27 41.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.462 -0.57 . . . . 0.13 109.462 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -74.28 133.35 42.61 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 121.896 0.855 . . . . 0.14 113.062 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.93 45.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 126.219 1.808 . . . . 0.16 114.619 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.19 95.87 0.6 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.748 1.261 . . . . 0.15 110.576 -161.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.4 tp60 -62.76 -12.55 24.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.223 -0.899 . . . . 0.36 111.177 -171.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 37.7 t -78.34 -39.06 40.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.253 -0.431 . . . . 1.11 110.006 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.72 -30.21 36.29 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.206 -1.035 . . . . 0.15 108.206 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.1 mt -66.33 -43.02 91.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.88 -1.055 . . . . 0.22 110.099 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.28 -16.8 60.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.229 1.014 . . . . 1.54 108.695 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.1 t70 -86.6 17.05 4.11 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.816 -1.538 . . . . 0.49 109.284 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.893 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.5 m -47.65 -3.49 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.076 1.139 . . . . 1.47 114.076 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -75.3 -10.56 59.57 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.237 -0.29 . . . . 0.97 110.967 171.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -61.86 146.29 50.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.049 0.452 . . . . 0.82 111.291 177.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 6.7 p -71.61 -9.2 57.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.565 -0.743 . . . . 1.39 109.097 168.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.36 -21.23 66.15 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.785 -0.643 . . . . 0.15 110.285 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.893 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 97.2 m95 -94.77 -14.18 24.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.097 -0.501 . . . . 0.15 112.114 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -82.98 106.0 14.44 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -55.24 -64.48 0.83 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.749 -1.114 . . . . 0.14 111.295 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.26 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.249 1.019 . . . . 0.24 110.3 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -147.09 108.87 4.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.263 -0.426 . . . . 1.82 110.698 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 19.86 31.92 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-O 121.452 0.473 . . . . 0.17 112.247 -176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.95 -37.33 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 123.594 0.758 . . . . 0.11 109.645 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 68' ' ' LEU . 11.9 tp -73.11 -40.65 64.79 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.902 0.858 . . . . 0.1 109.344 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 4.7 mm-40 -67.79 -13.31 62.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.601 -1.636 . . . . 1.49 110.297 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.16 -55.92 4.75 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.327 -1.306 . . . . 0.37 110.447 173.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.785 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.2 mt -61.34 -36.62 74.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 112.996 -1.911 . . . . 0.16 109.054 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.6 mt -72.49 -42.49 64.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.136 -1.393 . . . . 0.13 110.581 177.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.07 -38.14 70.25 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.186 0.993 . . . . 0.18 108.334 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -67.24 -54.77 17.9 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.274 -1.785 . . . . 0.24 110.361 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.483 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 25.9 m -47.65 -48.84 28.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.712 0.405 . . . . 0.9 111.876 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.1 mtt180 -64.88 -39.15 93.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.853 0.359 . . . . 2.73 110.67 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -64.73 -45.25 87.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.55 110.507 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.499 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.1 mmt180 -60.91 -29.58 69.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.841 -1.072 . . . . 2.5 110.656 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.92 27.33 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.24 111.493 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.842 ' HD2' HD22 ' A' ' 90' ' ' LEU . 39.2 m-85 -69.2 -48.99 60.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.51 109.592 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.3 pt -140.78 -171.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.936 -1.029 . . . . 0.12 111.774 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 138.83 45.22 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.217 -1.811 . . . . 0.16 109.336 171.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.06 -126.87 2.64 Favored Glycine 0 N--CA 1.453 -0.183 0 O-C-N 124.061 0.851 . . . . 0.24 113.764 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 6.2 p30 -98.65 12.85 34.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.06 0.457 . . . . 2.21 111.032 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.758 ' HA ' HD21 ' A' ' 12' ' ' LEU . 32.0 mm-40 -76.12 35.64 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.519 0.728 . . . . 0.66 111.827 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.66 165.87 11.22 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.32 -0.622 . . . . 0.11 109.32 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 83.5 mt -127.31 101.12 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.804 0.811 . . . . 0.07 109.646 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.2 tp -96.11 153.67 17.66 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.384 -0.969 . . . . 0.11 108.384 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -146.9 151.41 37.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.284 0.564 . . . . 0.93 111.789 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.652 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.173 -0.921 . . . . 1.74 109.06 173.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 27' ' ' ALA . 25.4 t -127.42 -64.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.779 -0.646 . . . . 0.11 112.04 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.867 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.8 t-20 -148.49 160.28 43.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.54 -0.464 . . . . 0.14 111.875 -168.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.697 HD11 ' NE1' ' A' ' 41' ' ' TRP . 80.6 mt -119.95 110.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.93 -0.577 . . . . 0.11 110.057 172.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 55.1 t -115.65 110.95 33.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 0.24 109.351 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.74 8.96 5.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.999 0.904 . . . . 0.39 110.31 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 85.5 19.03 59.2 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.261 -0.971 . . . . 0.13 112.273 -171.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.583 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 90.6 m-20 -95.2 36.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.5 0.32 . . . . 0.38 111.259 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.87 116.49 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.82 1.325 . . . . 0.08 115.059 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 26' ' ' VAL . 13.2 m-85 -92.51 136.21 33.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.19 111.04 -174.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.4 m-85 -124.71 133.67 53.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.985 -1.461 . . . . 0.16 108.958 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.1 p30 -102.56 144.75 30.58 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.122 -1.031 . . . . 1.56 110.398 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.13 132.03 51.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.071 -0.968 . . . . 0.19 108.786 -176.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.7 m-85 -123.84 160.01 28.36 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.679 -1.146 . . . . 0.19 110.13 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG3' HD21 ' A' ' 90' ' ' LEU . 88.9 mttt -78.29 165.6 49.02 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 115.072 -0.967 . . . . 0.57 109.004 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.5 Cg_exo -54.78 -20.84 23.47 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 122.17 1.913 . . . . 0.12 112.279 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.53 0.11 52.7 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.596 -0.729 . . . . 1.93 110.364 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.79 2.71 66.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.607 -0.724 . . . . 0.11 113.203 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m -63.96 121.0 13.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.481 0.641 . . . . 0.17 111.696 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 86.3 t80 -57.02 124.72 19.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.821 0.82 . . . . 0.2 112.09 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.842 HD22 ' HD2' ' A' ' 60' ' ' TYR . 76.4 mt -104.46 -57.65 2.0 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.031 -1.441 . . . . 0.12 110.617 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 33.0 p90 -164.86 176.05 9.05 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.117 -0.492 . . . . 0.15 111.88 177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.9 m -119.79 123.81 44.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.14 109.084 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -112.29 162.64 15.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.883 0.849 . . . . 0.06 111.18 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 77' ' ' ASN . 2.8 t30 -104.88 112.38 25.48 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.762 -1.563 . . . . 1.15 106.919 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.728 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.6 p -64.11 -37.9 89.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.627 -0.508 . . . . 0.18 109.627 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.8 mmtt -72.06 -18.1 61.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.282 -0.872 . . . . 0.31 111.515 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 -16.97 5.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.31 0.576 . . . . 0.15 111.04 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 71.19 17.2 75.67 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.397 -0.82 . . . . 0.13 111.478 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.08 161.52 29.94 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.664 -0.865 . . . . 0.85 108.664 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -149.1 139.93 22.79 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.451 0.644 . . . . 0.2 111.454 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.584 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.43 138.26 37.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.402 -1.272 . . . . 0.12 109.337 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.6 -118.43 0.38 Allowed Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.144 -1.027 . . . . 0.49 112.514 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -155.27 -68.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.628 -0.508 . . . . 1.18 109.628 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.98 -144.14 42.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.218 -0.515 . . . . 2.58 112.853 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.82 169.39 8.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.571 0.225 . . . . 3.51 110.612 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.26 34.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.83 -0.7 . . . . 2.3 112.421 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -117.84 -9.46 10.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 4.69 110.984 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -134.25 119.98 19.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.846 0.831 . . . . 0.96 112.552 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.11 -54.07 3.43 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.211 -1.359 . . . . 2.21 109.742 171.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 8.9 m-20 -115.85 -1.17 12.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.335 -0.848 . . . . 2.37 109.525 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 108' ' ' ALA . 2.6 mm? -81.4 164.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.159 -0.928 . . . . 0.81 111.514 -165.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.38 5.46 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.586 -1.188 . . . . 1.68 109.757 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-N 114.909 -1.041 . . . . 3.71 111.344 -167.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.678 -0.569 . . . . 9.37 111.678 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 58.24 67.38 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.93 0.395 . . . . 9.04 110.747 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -79.76 119.88 23.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.872 -0.418 . . . . 8.13 109.872 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -68.54 118.89 12.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.2 -0.454 . . . . 5.76 109.81 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -65.01 141.39 58.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 5.73 111.066 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 p -96.02 87.34 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.908 0.861 . . . . 1.52 110.821 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.7 mm-40 -89.83 -61.59 1.66 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.675 -1.148 . . . . 2.01 111.997 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 45.7 t 57.69 90.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 0.45 111.867 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -151.37 -175.89 5.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.876 -0.602 . . . . 1.41 110.485 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.71 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.3 mmt -90.76 -17.08 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.374 1.083 . . . . 0.89 111.223 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.53 -37.89 0.58 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 112.536 -2.12 . . . . 0.1 116.186 169.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 65' ' ' GLN . 80.9 mt -123.51 172.55 8.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 118.005 0.903 . . . . 0.11 109.555 168.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -96.87 118.92 34.36 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.397 -0.82 . . . . 1.2 110.185 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 37.3 p -84.08 20.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.399 0.619 . . . . 0.2 110.38 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 106.45 17.6 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.787 -0.642 . . . . 0.35 110.481 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.78 -13.88 65.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.844 -0.693 . . . . 0.31 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG13 HG12 ' A' ' 19' ' ' VAL . 10.4 p -68.84 147.86 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.19 111.309 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.48 74.33 8.57 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.014 -0.994 . . . . 0.16 109.889 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -87.85 136.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.49 -1.232 . . . . 0.12 112.357 -175.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 45.5 mt-30 -87.13 100.97 13.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.161 -0.927 . . . . 0.66 110.092 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -92.81 -25.54 18.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.77 -0.65 . . . . 0.84 110.144 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 m -74.02 -14.92 61.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.318 -0.856 . . . . 0.89 110.905 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.04 -3.3 58.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.557 . . . . 0.17 111.101 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.8 t -64.65 155.21 34.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.488 0.661 . . . . 0.26 111.33 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.6 mmp_? -95.83 -16.68 21.69 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.136 -0.938 . . . . 2.1 111.887 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 92' ' ' THR . 48.7 t -127.7 156.01 39.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.13 109.634 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -73.86 132.68 42.77 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.039 0.923 . . . . 0.14 112.793 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.52 44.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.214 1.805 . . . . 0.16 113.664 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -69.25 96.74 0.87 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 122.596 1.189 . . . . 0.15 110.707 -159.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.668 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 42.4 tp60 -61.68 -14.71 33.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 0.36 111.271 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 21.8 m -82.52 -25.8 33.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.309 -0.405 . . . . 1.11 110.916 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.811 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -90.68 -29.2 17.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.166 -1.05 . . . . 0.15 108.166 171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 88.8 mt -67.46 -45.39 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 114.626 -1.17 . . . . 0.22 110.268 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.82 -14.77 60.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.092 0.949 . . . . 1.54 108.729 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.1 t70 -86.53 16.85 4.23 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.956 -1.475 . . . . 0.49 109.191 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.792 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.9 m -44.17 -11.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.165 1.172 . . . . 1.47 114.165 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.62 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -65.55 -13.88 59.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.866 0.365 . . . . 0.97 111.366 172.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.62 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -62.68 145.49 54.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.321 0.582 . . . . 0.82 112.281 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.422 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.4 p -74.54 -3.96 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.135 -0.939 . . . . 1.39 109.352 168.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.69 -16.68 64.4 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.748 -0.66 . . . . 0.15 110.283 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.792 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 96.1 m95 -97.34 -13.76 21.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 0.15 111.832 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.65 106.14 13.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.521 -0.548 . . . . 0.5 109.521 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.665 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -56.9 -64.38 0.89 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.674 -1.148 . . . . 0.14 111.578 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.76 -105.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.393 1.077 . . . . 0.24 110.073 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.04 103.69 3.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.882 0.372 . . . . 1.82 111.514 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.3 19.77 47.98 Favored Glycine 0 N--CA 1.467 0.753 0 CA-C-N 116.111 -0.495 . . . . 0.17 112.073 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.25 -37.86 78.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 123.691 0.796 . . . . 0.11 109.223 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 68' ' ' LEU . 14.9 tp -70.82 -41.43 71.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.905 -1.043 . . . . 0.1 109.654 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 45.0 mm-40 -68.41 -12.2 60.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.783 -1.553 . . . . 1.49 110.232 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.19 -53.18 6.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.18 -1.373 . . . . 0.37 110.155 173.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.741 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.6 mt -65.51 -32.41 58.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 113.185 -1.825 . . . . 0.16 108.968 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.669 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 81.9 mt -74.18 -42.61 59.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.06 -1.427 . . . . 0.13 110.966 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.45 74.5 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 122.115 0.959 . . . . 0.18 108.518 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.49 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.3 m -70.3 -56.7 6.08 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.699 -1.592 . . . . 0.24 110.675 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.6 p -51.04 -41.53 59.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.58 0.229 . . . . 0.9 111.567 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 24.7 mtp180 -63.95 -48.52 76.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.576 0.227 . . . . 2.73 110.975 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -58.53 -40.2 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.55 110.804 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HG23 ' A' ' 54' ' ' THR . 12.2 mmt-85 -67.69 -30.48 70.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.063 -0.971 . . . . 2.5 110.653 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.32 14.34 22.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.926 -1.034 . . . . 0.24 111.802 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.53 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 48.0 m-85 -71.52 -47.02 58.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.446 0.641 . . . . 0.51 109.309 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 55' ' ' SER . 7.3 pt -141.57 -171.1 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.039 -0.982 . . . . 0.12 111.675 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.01 141.64 46.25 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.541 -1.663 . . . . 0.16 109.795 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.5 -123.51 2.3 Favored Glycine 0 C--N 1.33 0.249 0 O-C-N 124.062 0.851 . . . . 0.24 113.602 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 p-10 -105.63 19.49 20.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.216 0.532 . . . . 2.21 110.616 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.3 mm-40 -78.26 35.63 0.22 Allowed 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.66 111.669 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 61' ' ' ILE . 44.5 p90 -108.51 163.89 12.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.308 -0.627 . . . . 0.11 109.308 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 86.7 mt -126.36 101.4 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.69 0.757 . . . . 0.07 109.543 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -95.84 152.09 18.8 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.419 -0.956 . . . . 0.11 108.419 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -146.84 146.49 30.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.93 111.612 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 1.5 mpt_? -75.89 134.9 40.16 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.364 -0.834 . . . . 1.74 109.596 175.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.1 t -127.43 -63.85 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.916 -0.583 . . . . 0.11 112.165 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -144.64 160.74 40.69 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.132 -0.627 . . . . 0.14 112.221 -170.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.636 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.9 mt -121.67 111.43 31.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.712 . . . . 0.11 109.799 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.479 HG23 ' OD1' ' A' ' 72' ' ' ASN . 67.8 t -117.03 111.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.24 109.398 177.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.57 8.42 5.1 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.992 0.901 . . . . 0.39 110.282 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 87.33 16.37 60.7 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.007 -1.092 . . . . 0.13 112.174 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 79.4 m-20 -93.52 38.09 1.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.551 0.34 . . . . 0.38 111.043 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.94 116.56 0.01 OUTLIER Glycine 0 N--CA 1.47 0.908 0 O-C-N 124.848 1.342 . . . . 0.08 115.172 -170.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.6 m-85 -94.92 137.01 34.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.583 0.706 . . . . 0.19 110.703 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.779 ' HB3' HD11 ' A' ' 68' ' ' LEU . 50.6 m-85 -123.57 137.99 54.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.378 -1.283 . . . . 0.16 109.698 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.582 ' CG ' HG21 ' A' ' 71' ' ' VAL . 87.5 m-20 -96.02 140.82 30.2 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.874 -0.787 . . . . 1.56 108.874 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD12 ' CZ ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -105.92 127.37 53.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.983 -1.118 . . . . 0.19 107.983 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 72.5 m-85 -121.64 159.64 26.09 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.029 -0.987 . . . . 0.19 109.75 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.595 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.3 mttt -78.72 165.76 47.24 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 115.109 -0.95 . . . . 0.57 108.95 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.74 -20.52 28.57 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 C-N-CA 122.021 1.814 . . . . 0.12 112.191 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.1 0.26 54.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.614 -0.721 . . . . 1.93 110.073 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 92.73 -0.72 70.58 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.35 -0.841 . . . . 0.11 112.878 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 3.4 m -63.29 120.65 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.385 0.592 . . . . 0.17 111.517 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.8 t80 -56.35 129.6 41.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.979 0.895 . . . . 0.2 111.936 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 84' ' ' LYS . 49.5 mt -106.51 -57.68 2.02 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.846 -1.525 . . . . 0.12 110.081 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 24.9 p90 -167.33 172.05 10.1 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.428 0.632 . . . . 0.15 112.451 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.676 HG21 ' CG2' ' A' ' 26' ' ' VAL . 98.8 m -110.99 121.11 44.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.409 -1.268 . . . . 0.14 108.66 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.92 164.48 12.55 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.57 0.7 . . . . 0.06 110.889 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -103.57 126.49 50.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.949 -1.5 . . . . 1.15 106.949 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.7 p -74.83 -39.49 61.59 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.051 -0.722 . . . . 0.18 109.051 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 31.5 mmtt -74.34 -20.99 59.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.124 -0.943 . . . . 0.31 111.671 -170.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 p -120.01 -21.06 7.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.23 0.538 . . . . 0.15 110.825 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.741 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.95 17.36 79.38 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.697 -0.683 . . . . 0.13 111.479 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -78.55 165.82 23.28 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.794 -0.817 . . . . 0.85 108.794 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.0 p90 -148.37 139.27 23.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.991 0.9 . . . . 0.2 111.918 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.5 m -110.91 138.95 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.147 -1.388 . . . . 0.12 109.805 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.01 -159.79 23.51 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.461 -0.876 . . . . 0.49 111.818 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -99.91 -20.86 15.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.109 0.48 . . . . 1.18 109.968 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.31 -129.78 49.62 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.367 -0.833 . . . . 2.58 112.543 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.54 21.6 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.339 0.59 . . . . 3.51 109.762 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.82 158.63 14.68 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.348 -0.842 . . . . 2.3 111.943 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 62.99 -138.63 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.701 0.4 . . . . 4.69 111.233 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.07 106.68 16.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.4 0.619 . . . . 0.96 111.869 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.47 -64.15 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.191 -0.913 . . . . 2.21 110.315 171.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.527 ' H ' HD22 ' A' ' 111' ' ' LEU . 27.2 t70 -116.24 0.7 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.13 -0.941 . . . . 2.37 109.161 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 101' ' ' VAL . 1.9 mm? -85.71 175.23 8.84 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.81 112.73 -163.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.65 -30.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.595 -1.639 . . . . 1.68 106.843 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.927 0 CA-C-N 112.889 -1.959 . . . . 3.71 110.408 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.771 -0.531 . . . . 9.37 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -96.7 147.41 23.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.843 0.322 . . . . 9.04 110.329 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -120.32 154.88 34.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.175 -0.676 . . . . 8.13 109.175 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 p -94.69 144.62 25.47 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.516 -0.55 . . . . 5.76 109.516 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -82.96 -175.56 5.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.021 -0.363 . . . . 5.73 110.021 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.0 p -70.93 87.36 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.641 0.734 . . . . 1.52 110.416 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 23.1 mm-40 -85.73 -58.97 2.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.803 -1.089 . . . . 2.01 112.097 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' HD23 ' A' ' 48' ' ' LEU . 49.4 t 53.32 92.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.45 111.858 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -156.46 -168.69 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.087 -0.506 . . . . 1.41 110.695 178.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -91.66 -18.55 23.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.951 0.882 . . . . 0.89 111.278 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 -36.91 0.5 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 113.031 -1.895 . . . . 0.1 115.605 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 65' ' ' GLN . 72.8 mt -122.79 171.85 8.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 117.57 0.685 . . . . 0.11 109.381 167.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 t -92.51 121.5 34.03 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.291 -0.868 . . . . 1.2 110.662 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 51.4 p -88.26 22.62 2.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.511 0.672 . . . . 0.2 110.441 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.44 18.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.416 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 -8.24 80.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.764 -0.731 . . . . 0.31 112.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 19' ' ' VAL . 11.8 p -70.2 147.48 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-O 121.627 0.727 . . . . 0.19 111.428 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.32 74.25 10.02 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.565 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.653 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -88.99 133.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.467 -1.242 . . . . 0.12 112.179 -175.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.2 mt-30 -82.62 100.98 10.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.333 -0.849 . . . . 0.66 110.511 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.418 HH12 ' CD ' ' A' ' 69' ' ' GLU . 2.9 mmt180 -91.31 -35.74 14.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.95 -0.568 . . . . 0.84 110.804 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 m -65.4 -18.72 65.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.244 0.545 . . . . 0.89 111.062 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.71 -2.69 57.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.695 -0.684 . . . . 0.17 111.349 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.663 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.4 t -70.24 148.32 48.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.351 0.596 . . . . 0.26 111.74 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 2.7 mmt180 -87.91 -13.41 41.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.123 -0.944 . . . . 2.1 111.981 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.791 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 47.7 t -130.3 151.21 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.885 -0.413 . . . . 0.13 109.885 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -68.21 133.11 48.33 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.082 0.944 . . . . 0.14 113.062 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -71.16 45.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.056 1.742 . . . . 0.16 113.514 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.896 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.48 95.63 0.64 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 122.565 1.174 . . . . 0.15 110.447 -159.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.659 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.0 tp60 -59.9 -16.06 26.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.192 -172.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 15.7 m -78.92 -31.77 45.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.464 . . . . 1.11 110.943 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.86 -28.64 22.73 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.743 -0.836 . . . . 0.15 108.743 173.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 81.1 mt -66.73 -42.54 89.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.723 -1.126 . . . . 0.22 110.249 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.433 1.111 . . . . 1.54 108.896 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' SER . 11.1 t70 -89.4 17.49 6.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.728 -1.578 . . . . 0.49 109.084 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.759 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.2 t -44.31 -15.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.605 1.162 . . . . 1.47 113.41 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -62.8 -16.37 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.623 0.231 . . . . 0.97 111.623 174.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.61 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -59.6 144.46 47.6 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.192 0.52 . . . . 0.82 111.464 177.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.495 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 4.5 t -76.7 -1.93 30.33 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.353 -0.98 . . . . 1.39 108.353 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.7 -15.3 58.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.457 -0.571 . . . . 0.15 109.457 174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.759 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 88.2 m95 -99.48 -8.37 24.76 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.68 -0.691 . . . . 0.15 111.403 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.59 101.51 10.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 0.5 109.728 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.4 m-85 -56.09 -63.78 1.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.34 -0.845 . . . . 0.14 111.215 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.25 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.67 1.188 . . . . 0.24 110.261 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.49 110.54 4.8 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.667 0.387 . . . . 1.82 110.488 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.2 17.75 32.22 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-O 121.294 0.386 . . . . 0.17 112.301 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.48 -38.39 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 123.731 0.812 . . . . 0.11 109.383 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -72.46 -42.85 64.51 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.838 -1.073 . . . . 0.1 109.839 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.6 mm-40 -65.53 -15.16 62.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.11 -1.405 . . . . 1.49 110.629 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -76.16 -56.27 4.8 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.414 -1.266 . . . . 0.37 110.25 174.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.702 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.0 mt -61.43 -37.05 76.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.808 -1.996 . . . . 0.16 109.143 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.8 mt -71.56 -42.24 68.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.331 -1.304 . . . . 0.13 110.605 177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -57.09 -40.44 76.97 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 122.466 1.127 . . . . 0.18 108.151 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 3.0 m -66.44 -49.88 65.23 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.091 -1.868 . . . . 0.24 110.648 174.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.526 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.3 m -48.98 -50.92 33.4 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.818 0.447 . . . . 0.9 111.859 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 23.2 mtt180 -63.78 -39.52 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.769 0.319 . . . . 2.73 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.7 t -61.91 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.55 110.981 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 54' ' ' THR . 6.7 mmm180 -62.96 -31.72 72.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.115 -0.948 . . . . 2.5 110.821 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.89 22.39 10.97 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.324 -1.307 . . . . 0.24 111.07 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.4 m-85 -77.25 -48.3 17.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.511 0.672 . . . . 0.51 109.572 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.8 pt -141.86 -170.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 122.317 1.056 . . . . 0.12 111.813 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.17 139.34 45.79 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.051 -1.886 . . . . 0.16 109.387 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.99 -128.35 2.67 Favored Glycine 0 CA--C 1.517 0.192 0 O-C-N 123.875 0.734 . . . . 0.24 113.917 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' TYR . 5.7 p-10 -97.3 13.95 27.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.953 0.406 . . . . 2.21 110.7 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.637 ' HA ' HD21 ' A' ' 12' ' ' LEU . 35.2 mm-40 -76.73 36.01 0.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.527 0.731 . . . . 0.66 111.793 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.5 p90 -108.21 165.94 11.12 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.848 -0.614 . . . . 0.11 109.41 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.3 mt -128.57 102.69 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.805 0.812 . . . . 0.07 109.84 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.4 tp -98.74 152.53 19.57 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.1 -0.704 . . . . 0.11 109.1 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.2 mm-40 -149.81 142.26 24.34 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.93 111.804 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.627 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -67.85 136.28 53.84 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.62 -0.718 . . . . 1.74 110.387 172.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.548 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.1 t -127.55 -64.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.949 -1.023 . . . . 0.11 112.344 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.896 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 19.6 t-20 -144.74 160.09 41.78 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.707 -0.397 . . . . 0.14 111.853 -170.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.554 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -120.41 105.87 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.955 -0.566 . . . . 0.11 110.142 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.8 t -108.89 108.46 25.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.24 109.262 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 65.97 8.45 5.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.895 0.855 . . . . 0.39 110.168 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.22 15.17 61.06 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.099 -1.048 . . . . 0.13 112.542 -172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 92.4 m-20 -92.79 37.78 1.02 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.136 0.468 . . . . 0.38 110.831 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.83 115.13 0.01 OUTLIER Glycine 0 N--CA 1.468 0.809 0 O-C-N 124.948 1.405 . . . . 0.08 115.243 -169.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 26' ' ' VAL . 12.5 m-85 -91.44 137.51 32.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.615 0.722 . . . . 0.19 110.927 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.838 ' HB3' HD11 ' A' ' 68' ' ' LEU . 42.4 m-85 -122.59 139.08 54.32 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.284 -1.325 . . . . 0.16 109.895 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.548 ' CG ' HG21 ' A' ' 71' ' ' VAL . 92.3 m-20 -95.58 141.16 29.42 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.664 -0.814 . . . . 1.56 108.975 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.26 128.96 54.35 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 176.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.1 m-85 -123.7 160.1 27.95 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.11 -0.95 . . . . 0.19 110.419 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.0 mttt -78.01 164.53 56.51 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.832 -1.076 . . . . 0.57 108.873 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 32.3 Cg_exo -55.01 -19.86 21.35 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 122.305 2.003 . . . . 0.12 111.817 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -91.43 -4.35 55.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.804 -1.089 . . . . 1.93 110.11 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.38 0.1 67.82 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.456 -0.793 . . . . 0.11 112.338 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 10.1 m -65.41 121.92 15.97 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.303 -0.528 . . . . 0.17 111.771 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.663 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.5 t80 -57.18 127.72 33.38 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.839 0.828 . . . . 0.2 112.372 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.607 HD22 ' HD2' ' A' ' 60' ' ' TYR . 58.9 mt -104.64 -58.06 1.94 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.922 -1.49 . . . . 0.12 110.078 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -165.77 175.04 9.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.496 0.665 . . . . 0.15 112.05 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -112.22 124.33 52.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.433 -1.258 . . . . 0.14 108.66 171.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -112.34 165.79 11.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.537 0.684 . . . . 0.06 110.823 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -103.79 126.52 50.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.127 -1.435 . . . . 1.15 107.127 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 15.2 p -77.06 -38.8 51.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 39.0 mmtt -74.78 -22.17 58.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.288 -0.869 . . . . 0.31 111.639 -170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -118.76 -21.33 7.88 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.179 -0.464 . . . . 0.15 110.685 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.702 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.37 9.36 87.06 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.881 -0.6 . . . . 0.13 111.647 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -70.56 165.12 23.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.15 -0.685 . . . . 0.85 109.15 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.5 p90 -145.39 138.54 26.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.652 0.739 . . . . 0.2 111.114 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.44 140.78 28.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.491 -1.232 . . . . 0.12 109.651 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.98 179.92 27.55 Favored Glycine 0 C--N 1.312 -0.756 0 C-N-CA 120.127 -1.035 . . . . 0.49 110.946 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 31.7 p-10 -129.82 15.82 5.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.2 0.5 . . . . 1.18 110.861 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.94 -32.9 34.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.868 -0.682 . . . . 2.58 112.232 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.41 -29.75 62.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.918 0.39 . . . . 3.51 111.103 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.14 173.03 49.12 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 2.3 112.243 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.2 m80 57.26 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.426 0.69 . . . . 4.69 111.569 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.0 97.48 2.9 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.092 0.472 . . . . 0.96 109.845 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.96 -60.48 3.51 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.172 -0.922 . . . . 2.21 110.95 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -12.37 11.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.597 0.713 . . . . 2.37 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.4 mm? -75.84 161.57 28.88 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.81 112.262 -162.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.39 -29.1 0.16 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.93 -1.486 . . . . 1.68 110.253 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.791 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 3.6 p90 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.382 -0.827 . . . . 3.71 111.338 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.966 -0.453 . . . . 9.37 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -127.24 30.9 5.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 9.04 110.705 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -60.15 132.73 54.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 8.13 110.68 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 t -137.92 -99.17 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 5.76 110.082 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 5' ' ' ARG . 23.5 mtp180 56.14 -168.52 0.1 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.534 0.683 . . . . 5.73 111.719 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -135.11 91.71 2.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.619 -0.719 . . . . 1.52 109.571 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.59 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 77.1 mm-40 -117.07 -59.41 1.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.861 -1.063 . . . . 2.01 111.751 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.571 ' HA ' HD23 ' A' ' 48' ' ' LEU . 77.0 t 61.67 105.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.589 . . . . 0.45 111.881 -175.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -161.68 -171.39 2.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.756 -0.656 . . . . 1.41 109.879 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.707 ' SD ' HD23 ' A' ' 68' ' ' LEU . 22.9 mmt -99.58 -10.09 22.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.894 0.854 . . . . 0.89 110.646 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 -37.18 0.06 OUTLIER Glycine 0 N--CA 1.466 0.689 0 C-N-CA 126.763 2.125 . . . . 0.1 116.65 174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.629 ' HB2' HG12 ' A' ' 67' ' ' ILE . 76.5 mt -124.26 171.73 9.64 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.103 0.951 . . . . 0.11 109.678 168.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -95.9 117.09 29.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.315 -0.857 . . . . 1.2 110.532 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 17' ' ' VAL . 34.3 p -80.57 14.94 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.38 0.609 . . . . 0.2 110.45 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.94 102.15 13.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.86 -0.609 . . . . 0.35 110.665 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.51 -4.31 58.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.861 -0.685 . . . . 0.31 111.875 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 19' ' ' VAL . 10.7 p -79.17 149.67 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 121.572 0.701 . . . . 0.19 111.16 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.98 74.46 8.93 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.965 -1.016 . . . . 0.16 109.493 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -88.61 136.76 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.468 -1.242 . . . . 0.12 112.212 -175.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.5 mt-30 -82.05 101.54 10.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.197 -0.91 . . . . 0.66 109.847 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -94.13 -32.19 13.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.908 -0.587 . . . . 0.84 110.719 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -74.54 -15.63 60.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.695 . . . . 0.89 110.499 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -1.68 54.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.329 -0.851 . . . . 0.17 111.237 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.68 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.2 t -69.16 152.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.37 0.605 . . . . 0.26 111.526 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.3 mmp_? -90.64 -14.53 32.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.347 -0.842 . . . . 2.1 112.381 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.66 ' CG2' HG21 ' A' ' 92' ' ' THR . 45.9 t -130.34 155.69 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.472 -0.566 . . . . 0.13 109.472 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.66 132.35 44.46 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.88 0.848 . . . . 0.14 112.74 -173.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.61 44.91 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 126.131 1.772 . . . . 0.16 113.309 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.864 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.09 96.17 0.61 Allowed 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 122.759 1.266 . . . . 0.15 110.542 -158.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.1 tp60 -63.05 -8.89 8.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.154 -0.93 . . . . 0.36 111.112 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 22.7 t -79.76 -42.98 23.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.838 -0.43 . . . . 1.11 109.838 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -79.04 -28.67 43.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.758 -0.83 . . . . 0.15 108.758 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 83.2 mt -66.9 -41.12 87.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.873 -1.058 . . . . 0.22 109.792 177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.88 -16.19 59.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.207 1.004 . . . . 1.54 108.723 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 4.3 t70 -87.32 16.84 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.824 -1.535 . . . . 0.49 108.986 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.0 OUTLIER -43.31 -12.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.366 1.247 . . . . 1.47 114.366 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.656 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -68.94 -16.69 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.215 -0.303 . . . . 0.97 111.442 173.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.656 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -57.23 142.04 44.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.342 -0.39 . . . . 0.82 111.241 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -71.61 -4.43 27.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.864 -0.791 . . . . 1.39 108.864 169.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.4 -15.85 61.28 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.038 0.446 . . . . 0.15 109.937 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 92.7 m95 -98.37 -11.95 21.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.645 -0.707 . . . . 0.15 111.706 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.06 103.52 12.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.5 109.348 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.9 m-85 -55.56 -64.34 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.06 -0.973 . . . . 0.14 111.252 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.02 -106.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.481 1.112 . . . . 0.24 109.995 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -144.74 110.99 5.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.666 0.386 . . . . 1.82 110.473 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.49 19.43 26.55 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.292 0.384 . . . . 0.17 112.421 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.03 -38.2 74.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.042 -0.725 . . . . 0.11 109.042 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 68' ' ' LEU . 14.2 tp -73.11 -44.22 60.59 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.1 110.107 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 5.4 mm-40 -66.53 -12.72 59.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.204 -1.362 . . . . 1.49 110.48 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.02 -55.17 5.51 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.398 -1.274 . . . . 0.37 110.578 173.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.705 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.8 mt -61.8 -36.74 75.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 112.895 -1.957 . . . . 0.16 108.877 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 67.0 mt -71.7 -43.02 66.67 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.298 -1.319 . . . . 0.13 110.611 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -56.42 -37.17 69.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.289 1.042 . . . . 0.18 108.448 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.467 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -68.3 -55.39 12.27 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 113.268 -1.787 . . . . 0.24 110.1 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 39.4 m -47.14 -48.33 23.32 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.832 0.453 . . . . 0.9 111.928 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtt180 -65.98 -39.04 90.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.408 -0.36 . . . . 2.73 110.675 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.4 t -67.74 -37.49 82.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.454 0.645 . . . . 0.55 110.671 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.467 ' NE ' HG23 ' A' ' 54' ' ' THR . 10.2 mmt180 -68.45 -30.45 69.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.12 -0.946 . . . . 2.5 110.837 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.16 21.16 11.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.529 -1.214 . . . . 0.24 111.381 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.575 ' HD2' HD22 ' A' ' 90' ' ' LEU . 43.7 m-85 -76.03 -48.07 22.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.397 0.618 . . . . 0.51 109.401 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -141.54 -171.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.154 0.978 . . . . 0.12 112.013 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.04 141.94 47.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.088 -1.869 . . . . 0.16 109.257 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 38.26 -131.35 1.58 Allowed Glycine 0 C--N 1.331 0.292 0 O-C-N 124.171 0.92 . . . . 0.24 113.801 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' TYR . 38.7 m-20 -97.22 14.93 24.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.01 0.433 . . . . 2.21 110.123 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.5 mm-40 -75.6 33.59 0.11 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.66 110.741 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -108.44 164.33 12.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.425 -0.583 . . . . 0.11 109.425 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.5 mt -127.5 101.54 7.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.877 0.846 . . . . 0.07 109.723 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.5 tp -95.81 153.89 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.378 -0.971 . . . . 0.11 108.378 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -148.91 144.35 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.827 0.346 . . . . 0.93 111.757 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -72.91 135.79 45.14 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.633 -0.712 . . . . 1.74 109.778 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' ASN . 44.9 t -126.66 -64.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.588 -0.733 . . . . 0.11 112.293 -172.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.864 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 20.4 t-20 -146.02 159.47 43.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.557 -0.457 . . . . 0.14 112.004 -171.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.601 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -119.84 109.09 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.92 -0.582 . . . . 0.11 110.183 172.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 79.2 t -112.67 107.7 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.294 -0.632 . . . . 0.24 109.294 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.71 8.37 5.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.051 0.929 . . . . 0.39 110.253 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 16.19 58.3 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.84 -1.172 . . . . 0.13 112.404 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 76.3 m-20 -93.07 37.45 1.03 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.814 0.307 . . . . 0.38 110.643 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.67 115.68 0.02 OUTLIER Glycine 0 N--CA 1.468 0.823 0 O-C-N 124.819 1.324 . . . . 0.08 115.037 -169.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.3 m-85 -93.04 137.34 32.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.19 110.656 -175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.6 m-85 -123.45 137.56 54.77 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.331 -1.304 . . . . 0.16 109.775 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 85.7 m-20 -95.92 141.19 29.65 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.677 -0.809 . . . . 1.56 109.115 175.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.13 129.41 54.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.891 -1.152 . . . . 0.19 107.891 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.691 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.3 m-85 -123.86 158.8 31.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.092 -0.958 . . . . 0.19 110.126 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.0 mttt -76.76 165.73 50.26 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.892 -1.049 . . . . 0.57 108.724 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 16.3 Cg_exo -58.08 -17.4 31.4 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 121.933 1.755 . . . . 0.12 111.683 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.06 -6.37 55.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.095 -0.957 . . . . 1.93 109.678 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 94.41 1.66 64.2 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.257 -0.883 . . . . 0.11 111.93 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 15.5 m -67.29 121.37 15.55 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.326 -0.514 . . . . 0.17 111.813 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.5 t80 -56.09 127.4 30.39 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.971 0.891 . . . . 0.2 112.233 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.575 HD22 ' HD2' ' A' ' 60' ' ' TYR . 57.5 mt -105.62 -57.54 2.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.732 -1.576 . . . . 0.12 110.006 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 19.6 p90 -166.55 173.67 9.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.366 0.603 . . . . 0.15 112.454 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 26' ' ' VAL . 97.3 m -112.03 119.88 39.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.364 -1.289 . . . . 0.14 108.793 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -108.87 164.36 12.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.533 0.682 . . . . 0.06 110.581 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.3 125.66 50.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.951 -1.5 . . . . 1.15 106.951 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 25.5 p -75.09 -37.42 61.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.336 -0.616 . . . . 0.18 109.336 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.2 mmtt -74.99 -22.05 58.77 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.196 -0.911 . . . . 0.31 111.804 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -120.63 -18.94 7.62 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.796 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.705 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.1 14.45 81.82 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.568 -0.613 . . . . 0.13 111.568 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -75.81 164.89 25.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.232 -0.655 . . . . 0.85 109.232 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 34.1 p90 -146.67 141.02 26.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.402 0.62 . . . . 0.2 111.503 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.2 m -115.65 140.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.625 -1.17 . . . . 0.12 110.216 -173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -98.48 -172.71 32.24 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.642 -0.79 . . . . 0.49 111.607 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -137.28 159.62 41.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.071 0.436 . . . . 1.18 110.328 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.72 -141.04 3.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 2.58 112.264 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.92 -13.53 55.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.83 0.348 . . . . 3.51 111.468 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.89 -158.36 30.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.843 -0.694 . . . . 2.3 112.035 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -110.59 -58.72 2.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 4.69 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -104.24 91.76 4.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.96 111.65 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.61 -61.1 2.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.694 -1.139 . . . . 2.21 109.753 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 6.3 m-20 -118.04 -5.07 10.99 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.208 -0.906 . . . . 2.37 110.21 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.9 mm? -69.5 165.07 21.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.399 -0.818 . . . . 0.81 111.657 -167.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.99 -30.55 0.12 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.81 -1.086 . . . . 1.68 110.809 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 14.6 p90 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.294 -0.866 . . . . 3.71 111.294 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.673 -0.571 . . . . 9.37 111.673 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -77.46 -57.86 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.872 -0.418 . . . . 9.04 109.872 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -68.6 111.51 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.107 -0.701 . . . . 8.13 109.107 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.1 m -100.25 -85.56 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 5.76 111.22 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.3 107.81 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.915 -0.402 . . . . 5.73 109.915 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m 56.61 81.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.853 0.835 . . . . 1.52 110.977 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 43.1 mt-10 -101.5 -61.36 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.828 -1.078 . . . . 2.01 113.555 -171.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 48' ' ' LEU . 94.8 t 69.08 104.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.102 0.477 . . . . 0.45 110.393 -170.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -155.45 179.6 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.4 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.646 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.18 -13.03 23.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.772 0.796 . . . . 0.89 111.275 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.46 -36.54 0.1 OUTLIER Glycine 0 C--N 1.31 -0.882 0 CA-C-N 113.03 -1.895 . . . . 0.1 116.502 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 65' ' ' GLN . 81.3 mt -122.85 172.45 8.46 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.152 0.976 . . . . 0.11 109.921 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -96.7 118.31 32.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.141 -0.936 . . . . 1.2 110.099 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 17' ' ' VAL . 49.8 p -82.17 15.32 2.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.2 110.154 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.43 12.4 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.077 -0.511 . . . . 0.35 110.416 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.22 -8.08 52.63 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.866 -0.606 . . . . 0.31 111.983 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 9.0 p -76.67 148.34 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.645 0.736 . . . . 0.19 111.478 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.16 74.54 7.11 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.896 -1.047 . . . . 0.16 109.93 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -86.52 135.94 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.597 -1.183 . . . . 0.12 112.197 -175.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 60.2 mt-30 -81.9 102.1 10.66 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.073 -0.967 . . . . 0.66 109.806 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -94.59 -33.41 13.03 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.632 -0.713 . . . . 0.84 110.946 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -76.83 -10.2 59.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.517 0.675 . . . . 0.89 110.274 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.0 -3.59 58.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.17 110.473 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 34.9 t -66.62 147.59 53.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.531 -0.759 . . . . 0.26 111.786 -176.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.9 mmp_? -86.55 -16.92 35.39 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.447 -0.797 . . . . 2.1 111.944 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.653 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.1 t -129.23 151.81 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 0.13 109.809 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.19 133.81 47.45 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.916 0.865 . . . . 0.14 112.987 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.92 45.76 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 126.24 1.816 . . . . 0.16 113.476 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.882 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.39 97.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.569 1.176 . . . . 0.15 110.373 -159.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.3 tp60 -59.76 -16.46 27.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.035 -172.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.8 t -74.14 -41.82 60.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.23 -0.441 . . . . 1.11 110.042 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.64 -29.87 36.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.765 -0.828 . . . . 0.15 108.765 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 78.4 mt -64.62 -42.94 96.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.768 -1.105 . . . . 0.22 110.2 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -13.96 59.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.835 -1.075 . . . . 1.54 109.053 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' SER . 5.7 t70 -89.81 17.29 6.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.868 -1.515 . . . . 0.49 109.049 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 18.1 t -40.49 -18.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.078 1.351 . . . . 1.47 113.995 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -65.84 -11.74 48.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.119 -0.363 . . . . 0.97 111.84 176.019 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -60.43 143.51 53.14 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.255 0.55 . . . . 0.82 111.953 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.46 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.5 p -70.31 -8.08 47.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.169 -0.923 . . . . 1.39 109.193 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.95 -18.01 65.05 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.647 -0.706 . . . . 0.15 110.298 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 86.4 m95 -96.89 -9.49 28.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.041 -0.527 . . . . 0.15 111.904 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.92 108.36 18.76 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.31 -0.626 . . . . 0.5 109.31 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.651 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.1 m-85 -59.86 -64.22 1.02 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.939 -1.028 . . . . 0.14 111.012 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.87 -107.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.678 -1.147 . . . . 0.24 110.057 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.21 113.1 5.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.82 110.78 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.83 18.28 31.83 Favored Glycine 0 N--CA 1.468 0.792 0 CA-C-O 121.42 0.456 . . . . 0.17 112.126 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -71.26 -41.73 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 123.809 0.843 . . . . 0.11 109.16 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.744 HD21 HD22 ' A' ' 68' ' ' LEU . 11.3 tp -70.95 -41.69 70.79 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.725 -1.125 . . . . 0.1 109.868 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.65 -19.05 63.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.07 -1.423 . . . . 1.49 109.751 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.64 -56.33 4.61 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.481 -1.236 . . . . 0.37 110.649 177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.697 HD11 ' HA2' ' A' ' 98' ' ' GLY . 21.7 mt -59.19 -37.25 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.97 -1.923 . . . . 0.16 109.16 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 65.7 mt -71.23 -43.82 66.55 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.189 -1.368 . . . . 0.13 110.899 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.86 73.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.138 0.971 . . . . 0.18 108.403 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.429 HG23 ' NE ' ' A' ' 58' ' ' ARG . 1.7 m -66.59 -53.21 36.88 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.388 174.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.0 m -48.17 -47.64 35.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.887 0.475 . . . . 0.9 111.972 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 26.4 mtt180 -67.65 -35.86 79.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 2.73 110.715 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.0 t -68.42 -39.37 81.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.502 0.668 . . . . 0.55 110.512 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.429 ' NE ' HG23 ' A' ' 54' ' ' THR . 9.6 mmt180 -66.59 -30.58 70.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.969 -1.014 . . . . 2.5 110.715 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.45 18.77 15.51 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.519 -1.219 . . . . 0.24 111.326 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -74.23 -47.28 36.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.319 0.58 . . . . 0.51 109.687 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.7 pt -142.19 -170.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 122.099 0.952 . . . . 0.12 111.7 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.218 -1.81 . . . . 0.16 108.97 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 37.63 -130.95 1.34 Allowed Glycine 0 C--N 1.331 0.269 0 O-C-N 123.917 0.76 . . . . 0.24 114.065 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 4.1 m-20 -97.21 17.39 17.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.92 0.39 . . . . 2.21 110.251 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.617 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.6 mm-40 -75.6 33.22 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.815 -0.63 . . . . 0.66 110.463 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 36.4 p90 -109.25 165.73 11.4 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.11 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 92.4 mt -128.96 106.29 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.545 0.688 . . . . 0.07 109.858 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.2 tp -102.83 148.1 26.06 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.08 -0.711 . . . . 0.11 109.08 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.65 144.38 32.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.85 0.357 . . . . 0.93 111.782 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.691 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -70.01 131.51 44.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 1.74 109.939 169.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.5 t -123.55 -62.84 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.354 -0.839 . . . . 0.11 112.075 -172.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.882 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.8 t-20 -144.94 158.95 43.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.626 -0.43 . . . . 0.14 112.034 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 78.0 mt -119.66 108.17 22.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.11 110.031 171.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 94.1 t -110.65 106.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.123 -0.695 . . . . 0.24 109.123 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 67.07 7.51 5.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.01 0.91 . . . . 0.39 110.455 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 90.45 15.28 57.29 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.976 -1.106 . . . . 0.13 112.048 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 68.4 m-20 -91.6 37.42 0.96 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 122.426 0.29 . . . . 0.38 110.676 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.28 114.39 0.02 OUTLIER Glycine 0 N--CA 1.469 0.861 0 O-C-N 124.749 1.281 . . . . 0.08 114.853 -167.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' HG21 ' A' ' 26' ' ' VAL . 16.1 m-85 -91.75 135.76 33.66 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.67 0.748 . . . . 0.19 110.7 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.845 ' HB3' HD11 ' A' ' 68' ' ' LEU . 38.9 m-85 -122.02 136.95 54.96 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.107 -1.406 . . . . 0.16 109.696 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -96.1 142.1 28.69 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.559 -0.856 . . . . 1.56 109.458 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.15 128.36 53.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.064 -1.087 . . . . 0.19 108.064 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.8 m-85 -122.93 158.4 30.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.923 -1.035 . . . . 0.19 110.036 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.4 mttt -76.5 166.18 46.9 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.967 -1.015 . . . . 0.57 109.012 171.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 18.6 Cg_exo -57.52 -17.98 30.18 Favored 'Trans proline' 0 CA--C 1.518 -0.285 0 C-N-CA 122.009 1.806 . . . . 0.12 111.761 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.4 -5.21 54.78 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.395 -0.82 . . . . 1.93 109.59 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 19' ' ' VAL . . . 94.03 1.58 65.05 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.155 -0.929 . . . . 0.11 112.018 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.6 m -65.69 121.95 16.15 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.38 -0.482 . . . . 0.17 111.721 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 84.1 t80 -56.72 127.33 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.085 0.945 . . . . 0.2 112.116 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.3 mt -105.13 -58.69 1.86 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.781 -1.554 . . . . 0.12 109.865 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 26.2 p90 -164.84 174.24 10.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.487 0.661 . . . . 0.15 112.061 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.653 HG21 ' CG2' ' A' ' 26' ' ' VAL . 86.6 m -113.12 124.93 53.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.157 -1.383 . . . . 0.14 108.535 172.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -113.28 162.87 15.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.846 0.831 . . . . 0.06 110.952 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.2 118.56 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.607 -1.627 . . . . 1.15 106.607 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.651 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 17.7 p -69.55 -41.69 75.57 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.392 0.615 . . . . 0.18 109.595 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 36.0 mmtt -70.72 -21.99 62.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.806 -1.088 . . . . 0.31 111.932 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -119.89 -18.9 8.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.534 -0.466 . . . . 0.15 110.856 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.47 15.53 80.36 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.671 -0.695 . . . . 0.13 111.612 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -74.98 166.08 24.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.404 -0.591 . . . . 0.85 109.404 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.1 p90 -149.65 138.58 21.1 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.406 0.622 . . . . 0.2 111.252 175.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -110.0 146.18 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.543 -1.208 . . . . 0.12 109.561 -174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.04 175.82 20.82 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.973 -1.108 . . . . 0.49 112.929 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -141.04 47.91 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.618 0.723 . . . . 1.18 109.242 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.09 -22.2 78.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.614 -0.721 . . . . 2.58 113.604 -173.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.13 6.58 5.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 3.51 111.89 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.89 79.48 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.778 -0.725 . . . . 2.3 112.065 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -117.91 158.61 24.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.349 -0.611 . . . . 4.69 109.349 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -63.86 92.47 0.07 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.52 0.676 . . . . 0.96 110.186 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.38 -62.01 2.2 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.39 -1.277 . . . . 2.21 110.337 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -117.62 0.42 12.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.529 -0.76 . . . . 2.37 110.987 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 25' ' ' ARG . 2.3 mm? -82.11 161.72 22.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.671 0.748 . . . . 0.81 111.555 -167.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.31 -33.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.295 -1.32 . . . . 1.68 110.513 -170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 10.7 p90 . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.976 -1.011 . . . . 3.71 111.708 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 CA-C-O 120.177 -0.235 . . . . 9.37 112.805 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.4 m80 60.77 43.9 11.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.621 0.368 . . . . 9.04 111.707 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.9 ttp -129.65 87.64 2.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.926 0.393 . . . . 8.13 110.415 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.6 t -74.56 112.31 10.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.47 -0.567 . . . . 5.76 109.47 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -98.65 166.94 11.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 5.73 111.163 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.8 m 65.61 77.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.132 0.968 . . . . 1.52 110.773 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -85.28 -61.35 1.79 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.037 -1.438 . . . . 2.01 112.273 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HA ' HD23 ' A' ' 48' ' ' LEU . 75.3 t 58.22 99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.183 0.516 . . . . 0.45 111.87 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -159.32 -170.62 3.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.146 -0.479 . . . . 1.41 110.306 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.673 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.5 mpt? -97.38 -11.35 24.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.407 0.622 . . . . 0.89 111.795 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 63.69 -36.55 0.08 OUTLIER Glycine 0 C--N 1.311 -0.859 0 C-N-CA 125.888 1.709 . . . . 0.1 116.53 172.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 66.1 mt -122.84 172.15 8.67 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 117.931 0.865 . . . . 0.11 109.271 169.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -99.14 117.51 33.8 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.433 -0.803 . . . . 1.2 110.122 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 67' ' ' ILE . 23.5 p -82.42 20.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.339 0.59 . . . . 0.2 110.594 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.22 100.58 12.78 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.72 -0.673 . . . . 0.35 110.558 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.13 -1.88 59.39 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.747 -0.74 . . . . 0.31 112.114 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 19' ' ' VAL . 10.9 p -78.82 149.89 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.311 0.577 . . . . 0.19 111.31 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.48 74.12 7.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.059 0.933 . . . . 0.16 109.774 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -89.07 135.28 26.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.276 -1.329 . . . . 0.12 112.504 -174.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.8 mt-30 -82.47 100.6 10.16 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.314 -0.857 . . . . 0.66 109.969 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -92.82 -36.08 13.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.149 -0.478 . . . . 0.84 110.757 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -71.07 -12.64 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.469 0.652 . . . . 0.89 110.311 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.6 1.5 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.124 -0.944 . . . . 0.17 111.034 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.529 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 42.0 t -72.89 148.13 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.26 111.769 -175.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 1.1 mmt180 -92.78 -11.21 34.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.303 -0.862 . . . . 2.1 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG21 ' A' ' 92' ' ' THR . 58.7 t -129.7 148.74 33.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.17 -0.678 . . . . 0.13 109.17 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -67.78 132.95 48.39 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 121.977 0.894 . . . . 0.14 113.405 -171.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.26 45.11 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 126.295 1.838 . . . . 0.16 113.213 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.879 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.65 96.71 0.74 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 122.695 1.236 . . . . 0.15 110.641 -159.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.5 tp60 -61.53 -13.69 23.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.017 -0.992 . . . . 0.36 111.286 -171.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 24.2 t -77.31 -39.93 46.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.32 -0.4 . . . . 1.11 109.994 175.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.803 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.63 -29.48 36.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.817 -0.808 . . . . 0.15 108.817 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 84.4 mt -65.87 -42.67 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.684 -1.144 . . . . 0.22 109.691 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.8 -12.9 60.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.106 0.955 . . . . 1.54 109.046 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' SER . 9.5 t70 -87.92 16.28 6.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.104 -1.407 . . . . 0.49 109.22 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.793 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.6 m -46.53 -6.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.304 1.224 . . . . 1.47 114.304 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.68 -17.12 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.97 110.964 171.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.68 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.7 OUTLIER -60.86 145.36 50.36 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.854 -0.612 . . . . 0.82 112.081 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.6 0.64 29.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.535 -0.913 . . . . 1.39 108.535 168.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.69 -17.1 62.62 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.137 -0.69 . . . . 0.15 109.137 173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.793 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.0 m95 -98.48 -11.83 21.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.521 -0.763 . . . . 0.15 112.078 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -89.86 95.61 10.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.562 0.22 . . . . 0.5 110.459 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.8 m-85 -48.78 -65.72 0.52 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.021 0.826 . . . . 0.14 112.723 -167.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 166.25 -107.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.891 -1.05 . . . . 0.24 110.499 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -144.93 108.41 4.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.641 0.258 . . . . 1.82 111.242 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.38 21.27 33.08 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-O 121.546 0.525 . . . . 0.17 111.874 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.76 -39.76 68.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 123.583 0.753 . . . . 0.11 109.431 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.29 -39.62 68.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.064 -0.971 . . . . 0.1 109.489 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.64 -16.18 62.38 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.827 -1.533 . . . . 1.49 110.297 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 mm100 -79.03 -53.84 6.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.583 -1.19 . . . . 0.37 110.364 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 98' ' ' GLY . 15.1 mt -64.51 -32.47 57.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 112.74 -2.027 . . . . 0.16 109.083 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.654 ' HA ' ' OG ' ' A' ' 55' ' ' SER . 80.4 mt -74.6 -43.4 55.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.082 -1.417 . . . . 0.13 111.136 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.38 71.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.275 1.036 . . . . 0.18 108.373 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -75.48 -55.01 6.1 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.477 -1.692 . . . . 0.24 110.897 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.654 ' OG ' ' HA ' ' A' ' 52' ' ' LEU . 1.7 p -49.96 -44.26 50.54 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 117.911 0.323 . . . . 0.9 111.648 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.7 mtp180 -62.08 -47.44 84.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.778 0.323 . . . . 2.73 110.66 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 t -59.76 -37.99 80.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.8 -0.636 . . . . 0.55 111.087 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 54' ' ' THR . 2.3 mmp_? -66.91 -31.86 72.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.789 0.804 . . . . 2.5 110.798 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.29 18.5 13.2 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.315 -1.311 . . . . 0.24 111.162 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.565 ' HD2' HD22 ' A' ' 90' ' ' LEU . 35.7 m-85 -75.05 -48.49 23.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -140.6 -171.16 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.038 0.923 . . . . 0.12 111.525 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.23 142.67 46.04 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.547 -1.66 . . . . 0.16 109.939 172.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.86 -119.67 1.5 Allowed Glycine 0 C--N 1.332 0.318 0 O-C-N 123.866 0.729 . . . . 0.24 113.837 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 66' ' ' TYR . 3.5 p30 -107.33 15.13 25.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.982 0.42 . . . . 2.21 110.533 176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.9 mm-40 -76.9 34.81 0.15 Allowed 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.758 -0.655 . . . . 0.66 111.404 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.5 p90 -107.23 164.12 12.44 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.341 -0.615 . . . . 0.11 109.341 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 88.6 mt -127.12 101.86 8.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.816 0.817 . . . . 0.07 109.512 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 80' ' ' TYR . 10.4 tp -95.92 152.23 18.69 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.541 -0.911 . . . . 0.11 108.541 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -147.33 144.31 28.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.895 0.379 . . . . 0.93 111.741 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -70.97 134.2 46.99 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.671 -0.695 . . . . 1.74 109.621 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' A' ' 81' ' ' ASN . 61.9 t -127.11 -62.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.737 -0.665 . . . . 0.11 111.811 -173.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.879 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.3 t-20 -144.65 160.44 41.18 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.524 . . . . 0.14 112.013 -170.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' NE1' ' A' ' 41' ' ' TRP . 74.0 mt -121.88 107.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.747 -0.661 . . . . 0.11 109.408 170.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 61.5 t -106.24 103.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.652 . . . . 0.24 109.278 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.1 7.82 5.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.947 0.879 . . . . 0.39 110.496 -179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 95.09 12.77 54.62 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.143 -1.027 . . . . 0.13 112.486 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.5 m-20 -92.37 37.03 0.99 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.95 0.375 . . . . 0.38 111.159 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.28 115.86 0.01 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.734 1.271 . . . . 0.08 115.541 -169.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.6 m-85 -96.14 134.87 38.69 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.762 0.791 . . . . 0.19 110.807 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.781 ' HB3' HD11 ' A' ' 68' ' ' LEU . 44.7 m-85 -121.25 139.2 53.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.873 -1.512 . . . . 0.16 109.522 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.566 ' CG ' HG21 ' A' ' 71' ' ' VAL . 98.7 m-20 -95.51 141.61 28.84 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.832 -0.747 . . . . 1.56 109.211 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.19 128.81 54.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.899 -1.148 . . . . 0.19 107.899 176.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 74.5 m-85 -124.22 160.19 28.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.288 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 88.5 mttt -79.06 165.26 50.13 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.976 -1.011 . . . . 0.57 108.973 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 31.2 Cg_exo -56.12 -18.75 24.33 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.206 1.937 . . . . 0.12 111.975 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -92.38 -5.28 52.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.681 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 95.34 0.78 62.88 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.281 -0.872 . . . . 0.11 112.353 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.8 m -64.7 121.89 15.58 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.299 -0.53 . . . . 0.17 111.73 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 88.1 t80 -57.48 125.79 24.43 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.829 0.823 . . . . 0.2 111.947 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.565 HD22 ' HD2' ' A' ' 60' ' ' TYR . 45.8 mt -101.27 -59.63 1.67 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.913 -1.494 . . . . 0.12 109.694 176.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 21.3 p90 -166.19 172.91 10.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.599 0.714 . . . . 0.15 112.163 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.682 ' HB ' HG22 ' A' ' 101' ' ' VAL . 86.5 m -107.25 128.07 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.152 -1.386 . . . . 0.14 108.868 172.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.7 pp -118.28 164.83 14.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.407 0.622 . . . . 0.06 110.838 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 77' ' ' ASN . 47.6 t-20 -103.82 129.3 51.25 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.256 -1.387 . . . . 1.15 107.256 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.755 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 8.5 p -78.32 -37.63 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.187 -0.671 . . . . 0.18 109.187 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.1 mmtt -73.47 -24.71 60.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.31 111.246 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.2 p -119.13 -21.19 7.72 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.88 -0.6 . . . . 0.15 111.151 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 76.72 12.64 84.3 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.353 -0.699 . . . . 0.13 111.353 -177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.18 164.32 24.48 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.396 -0.594 . . . . 0.85 109.396 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 28.8 p90 -149.94 142.5 24.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.555 0.693 . . . . 0.2 111.612 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -119.76 141.44 39.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.504 -1.225 . . . . 0.12 109.537 -174.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -102.28 176.54 25.61 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.429 -0.891 . . . . 0.49 110.899 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -113.67 177.5 4.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.421 0.611 . . . . 1.18 109.948 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.87 -35.69 2.07 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.698 -0.763 . . . . 2.58 112.012 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.26 -167.48 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.547 0.213 . . . . 3.51 110.87 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.45 -90.47 1.49 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.249 -0.977 . . . . 2.3 112.295 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -60.51 -51.55 68.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.624 0.25 . . . . 4.69 111.116 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -164.05 127.59 2.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.36 0.6 . . . . 0.96 111.199 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.945 -1.025 . . . . 2.21 111.055 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.3 -19.4 12.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.571 0.7 . . . . 2.37 110.432 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' OH ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -80.16 166.01 21.88 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.888 -1.051 . . . . 0.81 111.488 -166.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.86 3.51 4.11 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.01 -1.45 . . . . 1.68 108.213 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.535 ' OH ' HD12 ' A' ' 111' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 113.948 -1.478 . . . . 3.71 111.017 -175.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.442 -0.663 . . . . 9.37 111.442 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -62.34 120.33 10.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.169 -0.678 . . . . 9.04 109.169 175.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttm -71.16 80.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 8.13 111.285 -174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.7 m -161.83 -54.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.157 -0.929 . . . . 5.76 108.735 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.688 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 18.5 tpp180 70.76 119.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.143 0.902 . . . . 5.73 110.42 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -132.32 112.15 11.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.137 0.494 . . . . 1.52 111.916 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.09 -50.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 2.01 111.696 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.5 t 58.49 101.08 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.178 0.513 . . . . 0.45 112.138 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -156.35 -177.66 6.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 1.41 110.174 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.67 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mpt? -96.53 -12.82 23.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.656 0.741 . . . . 0.89 111.399 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.0 -36.73 0.24 Allowed Glycine 0 C--N 1.306 -1.092 0 CA-C-N 113.094 -1.867 . . . . 0.1 116.019 170.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' GLN . 75.9 mt -122.86 171.9 8.87 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 117.841 0.821 . . . . 0.11 109.587 168.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -97.21 118.03 32.75 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.411 -0.813 . . . . 1.2 110.585 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' HG12 ' A' ' 17' ' ' VAL . 53.9 p -80.08 17.22 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.311 0.577 . . . . 0.2 110.726 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.63 110.92 20.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.35 110.369 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 -9.28 73.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.002 -0.618 . . . . 0.31 112.495 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 19' ' ' VAL . 7.9 p -77.6 151.1 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.443 0.64 . . . . 0.19 111.351 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.52 74.55 4.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 122.017 0.913 . . . . 0.16 109.729 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -86.08 136.14 23.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.344 -1.298 . . . . 0.12 112.302 -174.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.448 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 59.2 mt-30 -84.71 99.74 11.03 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.514 -0.766 . . . . 0.66 110.622 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -90.31 -30.61 17.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.218 -0.447 . . . . 0.84 111.217 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -73.39 -9.37 58.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.546 0.689 . . . . 0.89 110.462 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.24 -0.891 . . . . 0.17 110.93 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.629 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 46.6 t -70.57 135.38 48.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.23 0.538 . . . . 0.26 111.243 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.628 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -76.33 -17.15 59.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.327 -0.851 . . . . 2.1 112.309 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HA ' ' OH ' ' A' ' 113' ' ' TYR . 27.3 t -126.76 151.25 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.822 -0.436 . . . . 0.13 109.822 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.01 132.8 45.69 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 121.966 0.889 . . . . 0.14 113.015 -173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.91 46.16 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.109 1.764 . . . . 0.16 114.436 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.881 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.34 96.51 0.67 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 122.532 1.158 . . . . 0.15 110.413 -161.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.646 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 46.6 tp60 -60.38 -16.45 35.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.352 -0.84 . . . . 0.36 111.054 -171.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.5 t -72.6 -44.31 62.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.072 -0.513 . . . . 1.11 109.942 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.806 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -78.71 -29.69 45.56 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.542 -0.91 . . . . 0.15 108.542 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.646 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.4 mt -65.94 -42.95 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.728 -1.123 . . . . 0.22 109.902 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.194 0.997 . . . . 1.54 109.015 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 31' ' ' SER . 19.2 t0 -87.48 15.75 6.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.882 -1.508 . . . . 0.49 109.356 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.902 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.4 m -49.17 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.876 1.436 . . . . 1.47 114.876 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -6.59 51.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.864 -0.522 . . . . 0.97 110.552 171.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.6 147.25 53.3 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.476 0.655 . . . . 0.82 112.029 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 3.3 p -73.32 -7.57 52.15 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.1 -0.955 . . . . 1.39 109.253 168.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -66.11 -16.55 64.04 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 115.844 -0.616 . . . . 0.15 109.996 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.902 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.4 m95 -100.64 -7.72 23.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.051 0.453 . . . . 0.15 111.82 -176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.12 108.72 19.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.174 -0.676 . . . . 0.5 109.174 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.4 m-85 -60.63 -63.77 1.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.803 -1.09 . . . . 0.14 110.865 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.94 -106.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.585 -1.188 . . . . 0.24 109.668 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -146.07 110.77 5.17 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.635 0.374 . . . . 1.82 110.499 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.17 17.92 39.77 Favored Glycine 0 N--CA 1.464 0.546 0 CA-C-O 121.411 0.45 . . . . 0.17 112.381 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -70.08 -39.17 76.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.55 0.74 . . . . 0.11 109.093 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD21 HD22 ' A' ' 68' ' ' LEU . 12.3 tp -71.83 -43.22 65.93 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.874 -1.057 . . . . 0.1 109.95 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.688 ' OE1' ' HG3' ' A' ' 5' ' ' ARG . 1.3 mt-10 -63.82 -17.1 62.78 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 1.49 109.942 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.2 -56.72 4.32 Favored 'General case' 0 CA--C 1.491 -1.327 0 CA-C-N 114.394 -1.276 . . . . 0.37 110.382 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.622 HD11 ' HA2' ' A' ' 98' ' ' GLY . 23.4 mt -60.31 -36.59 69.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 112.953 -1.93 . . . . 0.16 109.131 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 73.5 mt -72.28 -43.1 64.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.449 -1.25 . . . . 0.13 111.162 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.38 -39.78 76.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.885 -1.154 . . . . 0.18 107.885 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 2.4 m -66.88 -53.97 26.98 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.486 -1.688 . . . . 0.24 110.43 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.542 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 49.3 m -45.23 -48.62 12.68 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.028 0.531 . . . . 0.9 111.689 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 20.5 mtp180 -63.62 -47.19 82.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.259 -0.428 . . . . 2.73 110.793 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -59.06 -35.7 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.707 . . . . 0.55 111.05 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 54' ' ' THR . 4.7 mmt180 -71.01 -31.18 67.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.154 -0.93 . . . . 2.5 110.614 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.76 19.46 13.27 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 114.554 -1.203 . . . . 0.24 111.446 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.542 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 43.0 m-85 -75.4 -49.99 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.007 -0.738 . . . . 0.51 109.007 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 66' ' ' TYR . 8.0 pt -139.84 -171.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.008 -0.996 . . . . 0.12 111.728 -176.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.1 m -134.87 144.89 47.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.458 -1.701 . . . . 0.16 109.629 172.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.42 -122.86 2.65 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.83 0.706 . . . . 0.24 113.717 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' TYR . 1.6 m-20 -108.0 18.9 20.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.116 0.484 . . . . 2.21 110.058 173.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.62 ' HA ' HD21 ' A' ' 12' ' ' LEU . 5.7 mm-40 -75.31 34.04 0.11 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.566 -0.743 . . . . 0.66 110.881 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' HB3' HD13 ' A' ' 61' ' ' ILE . 36.1 p90 -107.93 165.29 11.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.441 -0.578 . . . . 0.11 109.441 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.0 mt -129.15 101.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.07 109.681 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 80' ' ' TYR . 13.7 tp -96.84 152.85 18.29 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.478 -0.934 . . . . 0.11 108.478 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 5.1 mm-40 -147.33 144.97 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.237 0.541 . . . . 0.93 111.62 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.3 mpt_? -72.57 136.1 45.71 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.33 -0.85 . . . . 1.74 110.019 172.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.0 t -126.85 -65.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.232 -0.895 . . . . 0.11 112.124 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.881 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.1 t-20 -145.86 159.05 43.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.576 -0.45 . . . . 0.14 111.867 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.645 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.8 mt -119.97 111.11 31.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.626 -0.715 . . . . 0.11 109.604 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.8 t -108.42 101.1 12.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.928 -0.578 . . . . 0.24 109.572 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.421 HD22 ' ND2' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 65.02 7.25 3.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.911 0.862 . . . . 0.39 110.581 -178.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 40' ' ' ALA . . . 99.63 14.02 36.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.008 -1.092 . . . . 0.13 112.868 -173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.421 ' ND2' HD22 ' A' ' 75' ' ' ASN . 40.4 m-80 -91.57 36.9 0.95 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 117.261 0.53 . . . . 0.38 110.929 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.53 115.26 0.02 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 124.513 1.133 . . . . 0.08 115.067 -168.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 26' ' ' VAL . 20.0 m-85 -93.76 136.23 34.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.782 0.801 . . . . 0.19 110.861 -175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -124.12 132.74 53.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.941 -1.481 . . . . 0.16 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.3 p30 -102.07 143.76 31.5 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.712 -1.195 . . . . 1.56 110.325 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -105.22 132.01 51.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.894 -1.048 . . . . 0.19 108.615 -175.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -123.36 159.86 27.99 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.87 -1.059 . . . . 0.19 110.284 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.9 mttt -77.57 166.36 44.56 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.729 -1.123 . . . . 0.57 108.973 171.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.0 Cg_exo -57.6 -18.44 32.71 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.136 1.89 . . . . 0.12 111.462 175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -88.82 -7.03 56.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.88 -1.055 . . . . 1.93 109.833 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.99 3.12 68.28 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.231 -0.895 . . . . 0.11 111.706 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.1 m -67.95 121.69 16.61 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.301 -0.529 . . . . 0.17 111.617 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.629 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 80.3 t80 -55.69 128.69 35.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.988 0.899 . . . . 0.2 112.42 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 60' ' ' TYR . 53.7 mt -105.84 -59.09 1.82 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.737 -1.574 . . . . 0.12 110.139 175.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.8 p90 -165.57 176.06 8.44 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.821 -0.627 . . . . 0.15 111.597 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.641 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.4 m -116.34 123.85 48.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.016 -0.993 . . . . 0.14 108.633 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -110.67 164.44 12.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.628 0.728 . . . . 0.06 110.223 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -103.84 126.58 51.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.801 -1.555 . . . . 1.15 106.801 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.692 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.9 p -75.14 -38.66 60.92 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.895 -0.78 . . . . 0.18 108.895 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 33.8 mmtt -72.94 -22.53 60.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.874 -1.057 . . . . 0.31 111.609 -171.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p -119.62 -22.01 7.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.15 0.5 . . . . 0.15 110.853 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.622 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.5 12.33 84.63 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.771 -0.649 . . . . 0.13 111.576 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.98 165.53 24.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.919 -0.771 . . . . 0.85 108.919 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 24.9 p90 -144.97 137.69 26.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.786 0.803 . . . . 0.2 111.768 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.1 m -109.29 139.72 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.309 -1.314 . . . . 0.12 110.242 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -93.01 -173.5 40.76 Favored Glycine 0 C--N 1.313 -0.704 0 N-CA-C 110.429 -1.069 . . . . 0.49 110.429 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -139.08 -170.88 2.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.598 0.699 . . . . 1.18 111.635 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.38 -128.06 1.27 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.059 -0.817 . . . . 2.58 111.059 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.48 58.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.869 0.366 . . . . 3.51 110.077 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.95 2.11 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.401 -0.904 . . . . 2.3 113.621 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.69 145.65 54.58 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.258 0.529 . . . . 4.69 110.628 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -71.39 93.77 1.18 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.14 0.495 . . . . 0.96 110.561 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.14 -63.36 1.17 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.99 -1.004 . . . . 2.21 110.693 174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.435 ' HB3' HG12 ' A' ' 101' ' ' VAL . 36.6 t70 -116.26 -12.74 11.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.5 -0.773 . . . . 2.37 110.188 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.5 mm? -68.32 160.12 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.961 -1.018 . . . . 0.81 111.827 -164.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.23 -30.92 0.92 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.032 -1.44 . . . . 1.68 110.033 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.721 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 8.5 p90 . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.421 -0.808 . . . . 3.71 111.008 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.042 -0.423 . . . . 9.37 112.042 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -113.29 -19.18 11.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.726 -0.279 . . . . 9.04 111.082 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' SER . 53.5 tpp -86.25 -78.0 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.057 -0.349 . . . . 8.13 110.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 3' ' ' MET . 36.4 t 170.93 140.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.184 -0.673 . . . . 5.76 109.184 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -111.63 34.22 4.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.011 0.91 . . . . 5.73 109.255 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -125.64 115.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.888 -1.051 . . . . 1.52 110.417 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 46.0 mt-10 -134.45 -49.64 0.78 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.62 -0.718 . . . . 2.01 111.183 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.7 t 54.72 92.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.338 0.589 . . . . 0.45 112.395 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.0 -179.93 8.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.008 -0.542 . . . . 1.41 110.578 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -88.4 -16.14 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.753 0.787 . . . . 0.89 111.789 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.13 -36.78 0.31 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 113.196 -1.82 . . . . 0.1 116.431 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.6 mt -122.55 172.05 8.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.394 1.097 . . . . 0.11 110.089 168.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 m -93.2 117.38 30.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.042 -0.981 . . . . 1.2 110.656 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' VAL . 52.6 p -81.62 15.73 2.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.498 0.666 . . . . 0.2 110.277 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 107.74 16.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.35 110.479 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.24 -1.5 70.03 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.87 -0.681 . . . . 0.31 112.376 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 19' ' ' VAL . 8.8 p -81.85 148.22 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.629 0.728 . . . . 0.19 111.673 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 74.71 7.35 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.92 -1.036 . . . . 0.16 109.655 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -87.61 134.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.343 -1.299 . . . . 0.12 111.769 -175.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 30.2 mt-30 -85.17 101.67 12.66 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.497 -0.774 . . . . 0.66 110.134 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -93.95 -30.7 14.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.566 -0.743 . . . . 0.84 111.057 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.1 m -73.43 -15.24 61.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.89 110.304 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.04 -4.65 57.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.317 -0.856 . . . . 0.17 110.85 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 81' ' ' ASN . 45.6 t -64.82 147.71 52.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.26 112.026 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 5.1 mmp_? -92.16 -14.77 28.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.1 -0.955 . . . . 2.1 111.714 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.638 ' CG2' HG21 ' A' ' 92' ' ' THR . 46.7 t -129.12 152.42 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.271 -0.64 . . . . 0.13 109.271 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.73 133.98 45.95 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.943 0.877 . . . . 0.14 113.06 -172.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.83 45.6 0.07 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.297 1.839 . . . . 0.16 113.569 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.898 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.28 97.07 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 122.726 1.251 . . . . 0.15 110.624 -160.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 47.9 tp60 -61.13 -16.59 46.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.89 -1.05 . . . . 0.36 110.878 -171.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -75.69 -38.74 58.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.915 -0.584 . . . . 1.11 110.291 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.792 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -81.54 -29.69 33.41 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.482 -0.932 . . . . 0.15 108.482 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 80.3 mt -65.75 -41.69 90.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.541 -1.208 . . . . 0.22 110.146 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' SER . 19.8 t70 -77.53 -16.32 58.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.109 0.957 . . . . 1.54 109.176 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.43 17.45 3.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.631 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.667 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.2 p -39.52 -19.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.272 1.429 . . . . 1.47 114.308 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.59 -9.35 42.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.94 0.348 . . . . 0.97 111.94 177.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.73 144.04 55.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.041 0.448 . . . . 0.82 111.576 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -75.81 -3.35 34.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.569 -0.9 . . . . 1.39 108.569 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -19.13 64.98 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 108.787 -0.82 . . . . 0.15 108.787 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.667 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 91.6 m95 -95.3 -12.44 26.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.297 -0.865 . . . . 0.15 111.818 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.6 104.97 17.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.352 0.596 . . . . 0.5 109.644 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.726 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.6 m-85 -56.8 -64.18 0.96 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.363 -1.29 . . . . 0.14 111.634 -174.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 165.15 -101.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.808 -1.087 . . . . 0.24 110.234 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -155.9 120.13 4.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.528 -0.76 . . . . 1.82 109.639 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.55 18.02 4.96 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 123.533 0.521 . . . . 0.17 113.215 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -73.87 -41.84 53.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 123.587 0.755 . . . . 0.11 109.347 -177.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 68' ' ' LEU . 16.6 tp -72.18 -38.91 68.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.81 -1.086 . . . . 0.1 109.671 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.6 mm-40 -65.48 -15.24 62.45 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.74 -1.573 . . . . 1.49 110.239 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.45 -51.6 8.13 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 114.392 -1.276 . . . . 0.37 110.344 176.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.693 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.5 mt -67.26 -31.35 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.129 -1.85 . . . . 0.16 109.149 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.74 HD23 HD11 ' A' ' 82' ' ' LEU . 72.5 mt -74.23 -41.94 60.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.888 -1.505 . . . . 0.13 110.988 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.81 78.7 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.202 -1.036 . . . . 0.18 108.202 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -66.74 -52.77 40.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.635 -1.62 . . . . 0.24 110.919 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 61' ' ' ILE . 8.4 t -48.08 -47.85 33.87 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.836 0.454 . . . . 0.9 111.294 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.5 mtp180 -64.11 -42.65 96.79 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.938 0.399 . . . . 2.73 110.494 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 t -61.33 -36.84 81.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.9 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -67.96 -27.63 66.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.275 -0.875 . . . . 2.5 110.64 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.85 26.72 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 114.454 -1.248 . . . . 0.24 110.579 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 90' ' ' LEU . 20.6 m-30 -76.93 -50.28 13.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.375 -0.912 . . . . 0.51 109.976 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.7 pt -137.03 -172.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.825 -1.079 . . . . 0.12 111.235 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 143.13 45.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.457 -1.702 . . . . 0.16 109.448 172.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 42.84 -121.22 2.88 Favored Glycine 0 CA--C 1.518 0.219 0 O-C-N 123.932 0.77 . . . . 0.24 113.643 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.12 15.4 26.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.11 0.481 . . . . 2.21 110.711 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.714 ' HA ' HD21 ' A' ' 12' ' ' LEU . 38.1 mm-40 -75.74 35.25 0.12 Allowed 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.652 0.781 . . . . 0.66 111.992 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.634 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.6 p90 -106.98 164.35 12.21 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.478 -0.564 . . . . 0.11 109.478 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.67 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 94.5 mt -128.41 101.64 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.733 0.778 . . . . 0.07 109.541 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 80' ' ' TYR . 9.4 tp -98.32 147.63 24.47 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.772 -0.825 . . . . 0.11 108.772 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -142.95 150.65 40.0 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.2 -0.6 . . . . 0.93 112.439 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -72.69 135.29 45.37 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.851 -1.068 . . . . 1.74 109.266 174.066 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG21 ' CG ' ' A' ' 81' ' ' ASN . 64.8 t -127.59 -61.56 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.956 -0.566 . . . . 0.11 111.851 -174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.898 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.1 t-20 -146.18 160.21 42.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.232 -0.587 . . . . 0.14 112.067 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.647 HD11 ' NE1' ' A' ' 41' ' ' TRP . 77.2 mt -121.48 106.33 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.801 -0.636 . . . . 0.11 109.543 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 84.0 t -107.66 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER 67.52 8.29 6.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.909 0.861 . . . . 0.39 110.299 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.71 12.82 57.66 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.995 -1.098 . . . . 0.13 112.508 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 93.4 m-20 -91.74 37.53 0.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.666 -0.314 . . . . 0.38 110.928 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -21.38 116.47 0.01 OUTLIER Glycine 0 N--CA 1.472 1.086 0 O-C-N 124.679 1.237 . . . . 0.08 115.219 -169.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' HD1' HG22 ' A' ' 92' ' ' THR . 20.7 m-85 -95.86 135.33 37.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.669 0.747 . . . . 0.19 110.896 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.821 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.1 m-85 -122.67 136.13 54.79 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.921 -178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.611 ' CG ' HG21 ' A' ' 71' ' ' VAL . 21.2 m-20 -95.55 138.35 33.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.268 -0.641 . . . . 1.56 109.268 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.74 HD11 HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -106.16 129.23 54.27 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 177.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 79.6 m-85 -122.42 158.15 30.35 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.722 -1.126 . . . . 0.19 109.882 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.2 mttt -75.75 166.87 41.72 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 114.987 -1.006 . . . . 0.57 108.597 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 19.2 Cg_exo -57.7 -17.98 31.44 Favored 'Trans proline' 0 CA--C 1.517 -0.368 0 C-N-CA 121.815 1.677 . . . . 0.12 111.563 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.97 -6.92 56.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.968 -1.014 . . . . 1.93 110.026 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 93.91 -0.69 67.29 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.689 -0.687 . . . . 0.11 111.831 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 7.2 m -65.43 119.9 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.261 -0.552 . . . . 0.17 111.632 -177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 90.6 t80 -56.03 125.8 23.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.951 0.882 . . . . 0.2 112.145 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 60' ' ' TYR . 71.3 mt -101.38 -62.32 1.26 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.75 -1.568 . . . . 0.12 109.329 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HD12 ' A' ' 82' ' ' LEU . 20.0 p90 -161.59 173.37 14.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.15 112.562 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.638 HG21 ' CG2' ' A' ' 26' ' ' VAL . 99.0 m -110.94 120.48 42.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.18 -1.373 . . . . 0.14 108.698 172.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -109.77 164.7 12.32 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.565 0.697 . . . . 0.06 110.896 -175.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -103.62 125.79 50.35 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.113 -1.44 . . . . 1.15 107.113 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.726 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 7.9 p -74.81 -36.75 62.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.878 -0.786 . . . . 0.18 108.878 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HG2' ' SG ' ' A' ' 95' ' ' CYS . 37.1 mmtt -75.89 -18.45 59.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.047 -0.979 . . . . 0.31 111.809 -170.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -124.81 -19.73 5.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.15 110.81 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.693 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 74.86 15.94 80.66 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.348 -0.701 . . . . 0.13 111.348 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.4 168.48 19.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.831 -0.803 . . . . 0.85 108.831 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.0 p90 -151.23 139.43 20.23 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.7 0.762 . . . . 0.2 111.774 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -110.84 137.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.399 -1.273 . . . . 0.12 109.754 -174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.3 -176.78 36.01 Favored Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.506 -0.854 . . . . 0.49 111.261 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -130.18 23.16 5.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.114 0.483 . . . . 1.18 110.521 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.12 -37.39 91.55 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.081 -0.807 . . . . 2.58 111.081 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.01 139.57 48.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.888 -0.412 . . . . 3.51 109.888 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.7 69.46 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.835 -0.621 . . . . 2.3 113.388 -174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -131.76 -78.07 0.51 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.762 0.281 . . . . 4.69 110.574 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.33 107.5 14.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.654 0.74 . . . . 0.96 112.004 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.96 -68.83 0.34 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.578 -1.192 . . . . 2.21 110.279 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.26 0.78 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.376 1.084 . . . . 2.37 108.483 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -71.39 150.77 44.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.81 112.57 -166.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.72 -0.05 0.84 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.958 -1.474 . . . . 1.68 108.739 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' HH ' ' HE1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.436 -1.256 . . . . 3.71 110.374 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.747 -0.541 . . . . 9.37 111.747 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -124.34 74.42 1.31 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.132 0.492 . . . . 9.04 109.806 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -148.67 155.11 40.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.051 -0.522 . . . . 8.13 110.936 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -155.68 -74.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 5.76 109.753 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.436 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 74.6 mtp180 51.76 -158.45 0.12 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.18 0.514 . . . . 5.73 110.912 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -146.33 107.12 4.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.251 -0.648 . . . . 1.52 109.251 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 42.1 mt-10 -119.18 -45.93 2.53 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 2.01 110.891 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 48' ' ' LEU . 26.2 t 53.52 91.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.856 0.836 . . . . 0.45 110.326 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.563 HD21 ' HA2' ' A' ' 11' ' ' GLY . 8.6 t30 -143.11 155.88 44.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.759 -1.11 . . . . 1.41 109.341 -165.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 68' ' ' LEU . 26.0 mmt -92.15 -12.25 33.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.33 1.062 . . . . 0.89 110.061 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 9' ' ' ASN . . . 66.01 -38.46 0.15 Allowed Glycine 0 N--CA 1.465 0.615 0 C-N-CA 127.155 2.312 . . . . 0.1 116.818 171.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.9 mt -124.83 172.2 9.53 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 118.336 1.068 . . . . 0.11 109.95 169.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' ALA . 4.0 m -98.23 114.23 26.41 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.361 -0.836 . . . . 1.2 110.516 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.524 ' O ' HG12 ' A' ' 17' ' ' VAL . 37.3 p -77.85 20.4 0.35 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.437 0.636 . . . . 0.2 110.863 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' SER . . . -87.19 101.65 13.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.811 -0.631 . . . . 0.35 110.59 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.4 -4.79 58.53 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.747 -0.739 . . . . 0.31 112.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 19' ' ' VAL . 8.5 p -78.49 151.65 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 121.479 0.656 . . . . 0.19 111.276 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 75.21 4.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.992 -1.003 . . . . 0.16 109.823 175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -87.79 136.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.711 -1.131 . . . . 0.12 112.534 -174.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.516 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 63.0 mt-30 -82.68 100.72 10.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.325 -0.852 . . . . 0.66 110.544 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -94.17 -33.01 13.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.288 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 t -71.67 -15.69 62.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.5 0.667 . . . . 0.89 110.05 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.79 3.66 44.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.064 -0.971 . . . . 0.17 111.109 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 36.5 t -73.51 142.0 46.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.337 0.589 . . . . 0.26 111.756 -175.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.7 mmp_? -81.53 -15.57 54.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.449 -0.796 . . . . 2.1 112.318 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 52.7 t -130.65 153.43 39.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.302 -0.629 . . . . 0.13 109.302 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.722 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.78 133.07 45.31 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.78 0.8 . . . . 0.14 112.955 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.19 45.18 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 126.17 1.788 . . . . 0.16 113.519 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.877 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.36 96.88 0.7 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 122.576 1.179 . . . . 0.15 110.52 -159.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 45.3 tp60 -62.49 -10.79 12.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.243 -0.889 . . . . 0.36 110.822 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 35.5 t -76.46 -43.5 39.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.044 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -80.15 -28.29 38.89 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.919 -0.771 . . . . 0.15 108.919 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 85.2 mt -67.37 -41.44 86.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.746 -1.116 . . . . 0.22 110.003 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.07 -11.07 59.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.297 1.046 . . . . 1.54 109.032 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 31' ' ' SER . 8.0 t70 -92.04 17.1 9.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.847 -1.524 . . . . 0.49 108.921 175.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.697 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 9.3 t -45.49 -13.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.558 1.143 . . . . 1.47 113.502 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -63.64 -15.01 57.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.638 0.256 . . . . 0.97 111.601 174.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.65 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -61.0 145.74 49.61 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.181 0.515 . . . . 0.82 111.524 177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 t -81.82 2.03 32.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.239 -1.023 . . . . 1.39 108.239 169.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -64.03 -16.8 62.46 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 109.258 -0.645 . . . . 0.15 109.258 172.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.9 m95 -96.19 -9.68 29.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.178 -0.919 . . . . 0.15 111.8 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -80.47 107.05 12.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.503 -0.554 . . . . 0.5 109.503 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 3.0 m-85 -58.65 -64.59 0.88 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.214 -0.903 . . . . 0.14 111.084 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 163.63 -109.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.611 -1.177 . . . . 0.24 109.649 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -144.33 113.26 6.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.138 -0.483 . . . . 1.82 110.471 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 5' ' ' ARG . . . 54.06 21.68 18.42 Favored Glycine 0 N--CA 1.466 0.647 0 CA-C-N 116.055 -0.52 . . . . 0.17 112.755 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -72.23 -42.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 123.575 0.75 . . . . 0.11 109.289 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 68' ' ' LEU . 12.5 tp -69.5 -43.16 73.69 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.806 -1.088 . . . . 0.1 110.114 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 62.7 mm-40 -68.39 -11.82 60.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.772 -1.558 . . . . 1.49 110.338 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.79 -55.48 4.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.097 -1.41 . . . . 0.37 110.352 172.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.698 HD11 ' HA2' ' A' ' 98' ' ' GLY . 19.6 mt -61.22 -36.85 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.241 -1.8 . . . . 0.16 108.983 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 63.4 mt -70.89 -43.79 67.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.285 -1.325 . . . . 0.13 110.847 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLU . . . -59.54 -36.71 76.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.87 -1.059 . . . . 0.18 108.56 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.403 HG23 ' NE ' ' A' ' 58' ' ' ARG . 2.0 m -69.64 -52.14 28.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.576 -1.647 . . . . 0.24 110.695 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 61' ' ' ILE . 48.7 m -47.48 -47.04 27.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.053 0.541 . . . . 0.9 111.454 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' CZ ' ' HA2' ' A' ' 63' ' ' GLY . 14.1 mtp180 -63.58 -45.69 89.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.125 -0.489 . . . . 2.73 110.805 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -62.0 -35.52 78.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.418 0.628 . . . . 0.55 110.938 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 9.0 mmt180 -70.57 -30.17 66.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 2.5 110.764 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.73 21.88 10.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.498 -1.228 . . . . 0.24 111.342 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' HD1' ' HA ' ' A' ' 55' ' ' SER . 41.5 m-85 -78.46 -47.98 16.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.299 0.571 . . . . 0.51 109.707 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 66' ' ' TYR . 7.4 pt -140.93 -170.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 122.082 0.944 . . . . 0.12 111.672 -175.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.18 142.33 47.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.597 -1.638 . . . . 0.16 109.74 172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.05 -120.49 1.79 Allowed Glycine 0 C--N 1.331 0.25 0 O-C-N 124.098 0.874 . . . . 0.24 113.659 175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' TYR . 25.6 p-10 -107.73 14.99 25.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 2.21 110.218 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.763 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.0 mm-40 -76.58 34.96 0.14 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.709 -0.678 . . . . 0.66 111.503 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.0 p90 -107.84 164.1 12.55 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.183 -0.673 . . . . 0.11 109.183 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 96.6 mt -126.66 101.55 8.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.783 0.801 . . . . 0.07 109.784 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 80' ' ' TYR . 8.3 tp -96.36 149.32 21.82 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.642 -0.873 . . . . 0.11 108.642 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.17 144.91 29.31 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.93 110.989 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.74 137.01 47.39 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.557 -0.747 . . . . 1.74 109.954 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG21 ' CG ' ' A' ' 81' ' ' ASN . 48.3 t -127.07 -64.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.407 -0.815 . . . . 0.11 112.168 -172.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.877 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -144.92 158.33 43.84 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 0.14 112.18 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.59 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.9 mt -119.71 106.72 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.699 -0.682 . . . . 0.11 109.872 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 96.3 t -107.47 105.26 18.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.021 -0.733 . . . . 0.24 109.021 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.1 t30 65.97 7.99 5.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.906 0.86 . . . . 0.39 110.656 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' A' ' 40' ' ' ALA . . . 92.59 16.08 50.46 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.915 -1.136 . . . . 0.13 112.524 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.9 m-20 -95.38 37.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.835 0.318 . . . . 0.38 110.539 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -24.13 117.49 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 O-C-N 124.723 1.265 . . . . 0.08 115.298 -168.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 17.6 m-85 -94.74 136.64 34.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.618 0.723 . . . . 0.19 111.114 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.789 ' HB3' HD11 ' A' ' 68' ' ' LEU . 45.2 m-85 -122.52 137.55 54.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.247 -1.342 . . . . 0.16 109.652 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.592 ' CG ' HG21 ' A' ' 71' ' ' VAL . 93.6 m-20 -96.62 141.74 29.52 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.586 -0.845 . . . . 1.56 109.138 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.55 128.47 54.14 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.839 -1.171 . . . . 0.19 107.839 176.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.0 m-85 -122.23 158.92 28.39 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.094 -0.957 . . . . 0.19 110.226 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 91.8 mttt -77.43 166.46 44.04 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.015 -0.993 . . . . 0.57 108.795 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.8 Cg_exo -56.75 -19.96 33.14 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.909 1.739 . . . . 0.12 111.345 174.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.67 -2.92 58.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.111 -0.949 . . . . 1.93 109.918 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 88.87 -0.21 82.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.465 -0.789 . . . . 0.11 111.839 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.613 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 6.7 m -64.63 121.72 15.14 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.303 -0.527 . . . . 0.17 111.719 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 76.1 t80 -57.04 125.91 24.81 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.768 . . . . 0.2 112.126 175.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.7 mt -102.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.944 -1.48 . . . . 0.12 109.74 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.6 p90 -163.89 172.69 13.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.642 -0.708 . . . . 0.15 111.86 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 101' ' ' VAL . 90.2 m -110.71 120.86 43.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.279 -1.328 . . . . 0.14 108.642 171.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -108.28 162.61 13.93 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.709 0.766 . . . . 0.06 110.525 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -102.84 124.45 48.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.739 -1.578 . . . . 1.15 106.739 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.653 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 21.7 p -73.58 -38.64 65.08 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.075 -0.713 . . . . 0.18 109.075 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 39.8 mmtt -74.37 -18.96 60.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.406 -0.815 . . . . 0.31 111.619 -170.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -123.2 -21.48 5.39 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.109 -0.496 . . . . 0.15 110.935 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.698 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 77.52 13.5 83.45 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.407 -0.677 . . . . 0.13 111.407 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -70.57 160.81 31.82 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.935 -0.765 . . . . 0.85 108.935 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 26.9 p90 -145.31 136.29 24.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.844 0.831 . . . . 0.2 111.279 173.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -109.17 137.53 40.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.201 -1.363 . . . . 0.12 110.152 -172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.45 -175.02 38.79 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 120.311 -0.947 . . . . 0.49 110.774 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 25' ' ' ARG . 28.7 p-10 -140.01 153.63 46.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.156 0.478 . . . . 1.18 110.116 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.48 -21.26 5.43 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.938 -0.649 . . . . 2.58 112.372 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.87 57.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 3.51 110.974 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.98 146.57 11.87 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.016 -0.611 . . . . 2.3 112.74 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 63.81 -85.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.37 0.668 . . . . 4.69 110.832 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -141.93 104.05 4.43 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.237 0.541 . . . . 0.96 109.857 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 25' ' ' ARG . 3.6 m-20 -59.65 -64.64 0.87 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.719 -1.128 . . . . 2.21 111.122 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 12.1 m-20 -117.26 -5.54 11.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.634 . . . . 2.37 110.713 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.527 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.8 mm? -75.03 164.25 26.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.479 -0.782 . . . . 0.81 111.824 -167.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -138.05 -33.95 0.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.24 -1.345 . . . . 1.68 109.852 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 16.4 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.428 -0.805 . . . . 3.71 110.733 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.109 -0.396 . . . . 9.37 112.109 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.43 -15.48 60.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.557 0.218 . . . . 9.04 111.278 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -70.09 -30.85 68.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.022 0.439 . . . . 8.13 110.081 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -81.66 74.0 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.988 -0.551 . . . . 5.76 110.184 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -81.89 59.08 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 5.73 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 46' ' ' GLY . 2.1 p -137.88 99.44 3.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.818 -0.628 . . . . 1.52 110.973 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -85.78 -61.93 1.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 2.01 112.917 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.1 t 60.39 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.124 0.488 . . . . 0.45 110.969 -171.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -151.02 -172.36 4.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.984 -0.553 . . . . 1.41 110.425 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.736 ' SD ' HD23 ' A' ' 68' ' ' LEU . 24.1 mmt -92.56 -14.32 28.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.782 0.801 . . . . 0.89 111.651 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 66.43 -36.67 0.16 Allowed Glycine 0 N--CA 1.468 0.833 0 C-N-CA 126.375 1.941 . . . . 0.1 116.822 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB2' HG12 ' A' ' 67' ' ' ILE . 78.9 mt -123.61 172.93 8.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 118.139 0.969 . . . . 0.11 110.015 168.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -98.14 118.5 34.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.186 -0.916 . . . . 1.2 110.037 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 17' ' ' VAL . 63.5 p -81.74 13.17 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.562 0.696 . . . . 0.2 110.06 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.62 103.28 13.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.78 -0.645 . . . . 0.35 110.361 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -6.81 52.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.055 -0.593 . . . . 0.31 112.008 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 14' ' ' SER . 9.1 p -80.75 154.87 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.496 0.665 . . . . 0.19 111.696 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.66 75.15 2.43 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.84 -1.073 . . . . 0.16 109.927 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -85.73 134.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.507 -1.224 . . . . 0.12 112.368 -175.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.499 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 60.4 mt-30 -81.5 101.38 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.256 -0.884 . . . . 0.66 110.375 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -93.54 -33.97 13.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.579 -0.737 . . . . 0.84 110.769 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.1 m -70.3 -15.75 62.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.432 0.634 . . . . 0.89 110.201 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.12 2.84 48.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.17 111.293 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 30.0 t -75.16 143.3 43.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.26 111.897 -176.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 103' ' ' ASN . 7.0 mmt180 -80.98 -20.61 41.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.258 -0.883 . . . . 2.1 111.838 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' A' ' 92' ' ' THR . 42.8 t -126.41 151.18 32.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.176 -0.465 . . . . 0.13 109.906 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -70.14 132.95 46.59 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.906 0.86 . . . . 0.14 113.089 -173.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.42 44.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.327 1.851 . . . . 0.16 113.48 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.9 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.69 97.61 0.82 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.623 1.201 . . . . 0.15 110.69 -159.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 51.8 tp60 -61.15 -18.05 56.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.226 -0.897 . . . . 0.36 111.068 -171.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.674 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 51.7 m -76.46 -33.75 58.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.35 -0.387 . . . . 1.11 110.787 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -84.56 -31.04 24.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.599 -0.889 . . . . 0.15 108.599 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 76.4 mt -63.21 -43.5 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.745 -1.116 . . . . 0.22 109.983 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' SER . 21.6 t70 -81.79 -12.37 58.57 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.763 -1.108 . . . . 1.54 109.338 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.2 t70 -85.9 14.76 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.19 -1.368 . . . . 0.49 109.01 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.752 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 37.4 p -34.52 -29.46 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.936 1.694 . . . . 1.47 114.935 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -1.46 8.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.895 0.331 . . . . 0.97 111.895 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ALA . 2.0 t-20 -56.26 -31.25 63.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.82 112.57 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.2 m 66.66 -0.09 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.867 -1.06 . . . . 1.39 110.19 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 38' ' ' ASN . . . -60.36 -17.63 44.8 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 108.02 -1.104 . . . . 0.15 108.02 164.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.752 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 95.0 m95 -89.38 -15.95 32.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.967 -1.47 . . . . 0.15 112.16 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.14 101.78 8.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.5 109.813 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.0 m-85 -52.78 -64.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.79 -1.095 . . . . 0.14 111.623 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 160.21 -115.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.409 -1.269 . . . . 0.24 109.653 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.66 116.03 11.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.317 -0.402 . . . . 1.82 110.997 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 6' ' ' SER . . . 56.89 15.33 12.67 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.862 -0.608 . . . . 0.17 112.568 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -67.17 -40.76 85.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 123.848 0.859 . . . . 0.11 109.185 -178.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 68' ' ' LEU . 12.4 tp -73.04 -41.92 63.68 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.479 -1.237 . . . . 0.1 110.008 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.31 -18.86 62.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.001 -1.454 . . . . 1.49 110.212 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -78.59 -53.74 6.87 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.346 -1.297 . . . . 0.37 110.668 177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' HA2' ' A' ' 98' ' ' GLY . 22.3 mt -62.44 -36.74 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 112.998 -1.91 . . . . 0.16 108.827 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.577 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.2 mt -71.0 -42.15 70.0 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.199 -1.364 . . . . 0.13 110.72 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.37 78.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.305 1.05 . . . . 0.18 108.347 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.2 m -66.59 -52.52 44.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.478 -1.692 . . . . 0.24 110.454 174.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 47.5 m -48.48 -46.9 38.73 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.866 0.466 . . . . 0.9 111.677 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 14.3 mtp180 -65.65 -43.08 90.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.479 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -61.3 -40.71 95.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.51 0.671 . . . . 0.55 110.74 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -66.43 -30.21 70.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.125 -0.943 . . . . 2.5 110.779 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.3 17.24 18.38 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.722 -1.126 . . . . 0.24 111.213 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.4 m-85 -73.95 -49.8 22.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.452 0.644 . . . . 0.51 109.28 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 55' ' ' SER . 7.9 pt -139.79 -171.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.034 -0.985 . . . . 0.12 111.731 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.63 142.34 46.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.229 -1.805 . . . . 0.16 109.77 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 41.92 -123.12 3.05 Favored Glycine 0 C--N 1.331 0.25 0 O-C-N 123.98 0.8 . . . . 0.24 113.787 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.22 17.17 23.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.249 0.547 . . . . 2.21 109.896 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.642 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.6 mm-40 -78.3 35.14 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.42 -0.809 . . . . 0.66 110.879 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 61' ' ' ILE . 42.9 p90 -108.15 163.33 13.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.596 -0.52 . . . . 0.11 109.596 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 12' ' ' LEU . 92.9 mt -126.38 102.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.731 0.777 . . . . 0.07 109.659 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 80' ' ' TYR . 7.0 tp -95.89 151.17 19.66 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.507 -0.923 . . . . 0.11 108.507 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.276 0.56 . . . . 0.93 112.073 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . 1.1 mpt_? -80.99 135.41 35.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.952 -1.022 . . . . 1.74 109.349 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 81' ' ' ASN . 47.9 t -127.27 -64.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 116.075 -0.511 . . . . 0.11 112.335 -172.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.9 t-20 -144.28 160.77 40.43 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.631 -0.427 . . . . 0.14 111.699 -170.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.1 mt -119.47 108.33 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.96 -0.564 . . . . 0.11 110.049 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 88.0 t -109.76 107.22 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.57 -0.741 . . . . 0.24 109.29 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.23 8.69 5.76 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.901 0.858 . . . . 0.39 110.565 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 88.95 19.05 52.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.088 -1.054 . . . . 0.13 112.22 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 81.7 m-20 -98.93 37.5 1.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 122.49 0.316 . . . . 0.38 111.128 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -17.66 116.63 0.01 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 124.644 1.215 . . . . 0.08 115.407 -170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.3 m-85 -95.78 136.17 36.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.619 0.723 . . . . 0.19 110.485 -175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.787 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.4 m-85 -123.3 137.8 54.77 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.185 -1.37 . . . . 0.16 109.787 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' CG ' HG21 ' A' ' 71' ' ' VAL . 97.5 m-20 -96.02 141.9 28.88 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.775 -0.77 . . . . 1.56 109.146 176.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -106.17 127.77 53.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.761 -1.199 . . . . 0.19 107.761 176.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 75.4 m-85 -122.83 159.32 28.38 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.978 -1.01 . . . . 0.19 110.196 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 82.3 mttt -78.18 166.51 42.7 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 114.836 -1.074 . . . . 0.57 108.934 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 23.7 Cg_exo -57.44 -17.58 27.91 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.261 1.974 . . . . 0.12 111.672 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.43 -6.17 56.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.166 -0.924 . . . . 1.93 109.758 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.47 2.62 70.1 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.209 -0.905 . . . . 0.11 111.558 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 14.2 m -65.83 120.82 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.432 -0.452 . . . . 0.17 111.582 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 72.7 t80 -56.39 126.72 27.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.882 0.848 . . . . 0.2 112.148 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.553 HD22 ' HD2' ' A' ' 60' ' ' TYR . 56.6 mt -104.58 -56.14 2.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.058 -1.428 . . . . 0.12 110.137 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 18.8 p90 -167.27 174.49 8.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.368 0.604 . . . . 0.15 111.741 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.671 HG21 ' CG2' ' A' ' 26' ' ' VAL . 80.1 m -110.23 124.39 51.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.39 -1.277 . . . . 0.14 108.663 171.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.5 pp -112.07 163.12 14.65 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.661 0.744 . . . . 0.06 110.788 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -102.11 122.95 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.908 -1.516 . . . . 1.15 106.908 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.718 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 22.6 p -74.79 -38.61 62.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.249 -0.648 . . . . 0.18 109.249 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 40.5 mmtt -73.38 -22.88 60.16 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.34 -0.845 . . . . 0.31 111.637 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 p -117.21 -23.9 7.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.125 -0.488 . . . . 0.15 110.759 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.675 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 78.9 16.69 78.58 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.638 -0.71 . . . . 0.13 111.75 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -78.8 169.48 18.17 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.295 -0.632 . . . . 0.85 109.295 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 35.1 p90 -150.01 140.68 22.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.707 0.765 . . . . 0.2 111.545 175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 92' ' ' THR . 0.9 OUTLIER -112.22 140.11 33.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 114.144 -1.389 . . . . 0.12 109.687 -173.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -94.63 178.01 36.3 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 120.273 -0.965 . . . . 0.49 110.728 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 27.2 p-10 -124.32 175.8 6.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.451 0.625 . . . . 1.18 111.145 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 140.91 3.0 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.0 -0.84 . . . . 2.58 111.0 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.44 112.2 11.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.777 0.322 . . . . 3.51 110.907 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.03 -75.93 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.566 -0.826 . . . . 2.3 112.83 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -119.65 131.49 55.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.59 0.233 . . . . 4.69 110.787 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -65.6 118.07 8.97 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.442 0.639 . . . . 0.96 110.334 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.49 -61.17 2.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.447 -1.251 . . . . 2.21 111.842 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.4 -11.01 11.23 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.091 0.472 . . . . 2.37 111.913 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 1.8 mm? -88.27 158.35 18.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.473 0.654 . . . . 0.81 111.261 -166.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -162.69 -25.16 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.299 -1.319 . . . . 1.68 109.985 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.653 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p90 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.196 -0.907 . . . . 3.71 111.814 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.594 -0.602 . . . . 9.37 111.594 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -91.72 -42.7 9.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.652 0.263 . . . . 9.04 110.391 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -148.02 101.5 3.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.898 0.38 . . . . 8.13 111.249 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.1 m -98.14 123.69 42.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.497 -0.556 . . . . 5.76 109.497 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -142.19 -33.32 0.48 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.61 0.243 . . . . 5.73 111.378 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.7 p -143.81 95.41 2.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.547 0.689 . . . . 1.52 111.19 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.619 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 66.6 mm-40 -122.77 -59.09 1.63 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 2.01 111.009 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.59 ' HA ' HD23 ' A' ' 48' ' ' LEU . 84.9 t 59.73 103.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.704 -0.68 . . . . 0.45 112.403 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -165.66 -168.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.62 . . . . 1.41 109.697 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.667 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -100.98 -6.84 23.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.89 112.005 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.33 -36.23 0.05 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 126.029 1.776 . . . . 0.1 117.097 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 ' HB2' HG12 ' A' ' 67' ' ' ILE . 82.2 mt -123.18 171.92 8.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 118.25 1.025 . . . . 0.11 109.668 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -96.24 119.59 35.01 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.159 -0.928 . . . . 1.2 110.302 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 17' ' ' VAL . 44.6 p -83.55 14.71 3.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.518 0.675 . . . . 0.2 110.255 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.17 104.35 15.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.35 110.498 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.52 -9.94 55.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.099 -0.572 . . . . 0.31 112.093 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 19' ' ' VAL . 7.5 p -78.38 153.21 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.436 0.636 . . . . 0.19 111.523 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.41 75.05 3.88 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.987 -1.006 . . . . 0.16 109.767 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.613 HG12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -87.38 134.47 27.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.398 -1.273 . . . . 0.12 112.324 -174.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 32.9 mt-30 -84.82 100.69 11.71 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.722 -0.672 . . . . 0.66 110.659 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -90.11 -34.66 15.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.541 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -70.0 -5.89 29.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.696 -0.684 . . . . 0.89 110.849 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.28 4.0 46.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.685 -0.688 . . . . 0.17 110.77 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.617 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 38.9 t -74.21 133.54 42.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.22 0.533 . . . . 0.26 111.227 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -74.79 -13.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.314 -0.857 . . . . 2.1 112.444 178.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.644 ' CG2' HG21 ' A' ' 92' ' ' THR . 47.7 t -130.63 152.76 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.343 -0.614 . . . . 0.13 109.343 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.06 133.05 45.99 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 122.074 0.94 . . . . 0.14 113.052 -171.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.93 45.58 0.07 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 126.172 1.789 . . . . 0.16 114.059 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.72 96.62 0.74 Allowed 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 122.565 1.174 . . . . 0.15 110.367 -161.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 49.9 tp60 -59.71 -17.88 38.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.371 -0.831 . . . . 0.36 111.313 -171.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 28.3 t -76.08 -35.36 59.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.389 -0.369 . . . . 1.11 110.509 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -83.94 -29.61 26.94 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.506 -0.924 . . . . 0.15 108.506 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 77.8 mt -65.25 -43.63 95.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.691 -1.141 . . . . 0.22 109.978 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 36' ' ' SER . 22.3 t70 -78.21 -14.32 59.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.35 1.071 . . . . 1.54 109.027 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 t0 -84.06 17.09 2.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.894 -1.503 . . . . 0.49 108.836 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.686 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 50.1 p -41.19 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.502 1.521 . . . . 1.47 114.388 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -72.27 -11.52 60.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.738 0.273 . . . . 0.97 111.738 176.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.575 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -60.46 144.27 51.55 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.82 111.84 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 5.1 p -69.8 -8.78 51.13 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.233 -0.894 . . . . 1.39 109.252 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.07 -18.63 65.46 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.781 -0.645 . . . . 0.15 110.24 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.686 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 90.2 m95 -95.98 -10.79 27.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.219 -0.446 . . . . 0.15 111.882 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -85.27 108.97 18.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.017 -0.538 . . . . 0.5 109.612 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.5 m-85 -61.6 -65.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.209 -0.905 . . . . 0.14 111.504 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 162.13 -111.8 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.651 1.18 . . . . 0.24 110.141 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.12 111.11 6.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.547 0.339 . . . . 1.82 111.032 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 6' ' ' SER . . . 57.74 19.47 35.96 Favored Glycine 0 N--CA 1.466 0.675 0 CA-C-O 121.45 0.472 . . . . 0.17 112.288 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.59 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -70.54 -42.02 78.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.784 0.802 . . . . 0.11 109.113 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.635 HD21 HD22 ' A' ' 68' ' ' LEU . 14.0 tp -71.0 -41.17 71.27 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.704 -1.135 . . . . 0.1 110.101 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.4 mm-40 -62.97 -16.73 60.58 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.154 -1.384 . . . . 1.49 110.441 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -80.08 -51.28 9.21 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.259 -1.337 . . . . 0.37 110.523 177.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HA2' ' A' ' 98' ' ' GLY . 13.1 mt -67.73 -31.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 113.08 -1.873 . . . . 0.16 108.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD23 HD11 ' A' ' 82' ' ' LEU . 72.4 mt -72.9 -42.4 63.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.899 -1.501 . . . . 0.13 110.621 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.74 -38.28 78.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.417 -0.957 . . . . 0.18 108.417 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.1 m -64.94 -54.65 27.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.796 -1.547 . . . . 0.24 110.319 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' HD11 ' A' ' 61' ' ' ILE . 7.1 t -48.42 -48.25 37.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.88 0.472 . . . . 0.9 111.216 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 22.8 mtp180 -65.19 -38.72 91.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.868 0.366 . . . . 2.73 110.659 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -64.68 -40.82 96.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.55 110.639 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' THR . 5.5 mmt180 -63.12 -28.74 70.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.851 -1.068 . . . . 2.5 110.482 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.36 19.3 23.61 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.374 -1.284 . . . . 0.24 110.812 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 90' ' ' LEU . 21.2 m-30 -77.41 -49.27 15.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.601 -0.8 . . . . 0.51 109.998 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 55' ' ' SER . 7.6 pt -138.9 -171.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 114.733 -1.121 . . . . 0.12 111.22 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 65' ' ' GLN . 1.2 m -135.33 145.28 47.28 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.377 -1.738 . . . . 0.16 109.532 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.01 -118.99 1.12 Allowed Glycine 0 C--N 1.331 0.255 0 O-C-N 123.983 0.802 . . . . 0.24 113.76 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -110.3 19.02 19.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.485 0.659 . . . . 2.21 109.965 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.626 ' HA ' HD21 ' A' ' 12' ' ' LEU . 4.2 mm-40 -78.37 35.34 0.22 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.249 -0.887 . . . . 0.66 111.173 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 61' ' ' ILE . 39.0 p90 -108.16 166.45 10.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.899 -0.408 . . . . 0.11 109.899 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 90.6 mt -129.66 102.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-O 121.548 0.69 . . . . 0.07 109.668 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.808 HD11 ' HB3' ' A' ' 80' ' ' TYR . 15.1 tp -98.18 153.88 18.16 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.874 -0.787 . . . . 0.11 108.874 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -147.13 143.53 28.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.138 0.494 . . . . 0.93 111.734 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -71.61 136.27 47.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.356 -0.838 . . . . 1.74 109.826 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 27' ' ' ALA . 40.4 t -127.5 -63.72 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.343 -0.844 . . . . 0.11 111.836 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.9 t-20 -146.32 159.89 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.483 -0.487 . . . . 0.14 112.095 -168.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.608 HD11 ' NE1' ' A' ' 41' ' ' TRP . 79.0 mt -122.17 109.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.11 109.904 171.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 76.7 t -114.99 111.79 37.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.894 -0.78 . . . . 0.24 108.894 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER 67.53 9.15 6.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.991 0.9 . . . . 0.39 110.279 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 83.23 17.62 66.49 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.075 -1.06 . . . . 0.13 112.144 -170.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 34.6 m-20 -93.06 37.75 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.707 0.403 . . . . 0.38 110.792 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -23.58 115.11 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 O-C-N 124.823 1.327 . . . . 0.08 114.849 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 26' ' ' VAL . 18.0 m-85 -92.19 133.23 35.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.987 0.899 . . . . 0.19 111.016 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 68' ' ' LEU . 46.5 m-85 -120.58 134.86 55.23 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.498 -1.683 . . . . 0.16 108.742 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 23.8 p30 -104.6 145.03 30.89 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.722 -1.191 . . . . 1.56 110.106 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -105.37 134.85 47.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.028 -0.987 . . . . 0.19 108.962 -176.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 68.2 m-85 -123.75 158.47 31.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.787 -1.097 . . . . 0.19 110.117 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 90.4 mttt -75.28 163.99 64.08 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.774 -1.103 . . . . 0.57 108.621 170.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 24.0 Cg_exo -55.57 -17.61 17.69 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.071 1.847 . . . . 0.12 112.084 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -88.36 -10.12 50.44 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.327 -0.851 . . . . 1.93 110.18 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 96.46 1.39 60.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.274 -0.875 . . . . 0.11 111.762 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 4.8 m -67.41 120.2 13.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.149 -0.618 . . . . 0.17 111.666 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 81.4 t80 -53.3 129.44 31.72 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.83 0.824 . . . . 0.2 112.437 174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 60' ' ' TYR . 80.5 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.862 -1.517 . . . . 0.12 110.06 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 25.9 p90 -161.65 175.12 12.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.682 -0.69 . . . . 0.15 112.115 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.644 HG21 ' CG2' ' A' ' 26' ' ' VAL . 72.1 m -115.1 126.38 54.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.667 -1.151 . . . . 0.14 108.867 171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.57 165.22 13.0 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.838 0.827 . . . . 0.06 111.006 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.95 119.91 39.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.675 -1.602 . . . . 1.15 106.675 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.649 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 19.3 p -71.02 -42.44 69.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.286 0.565 . . . . 0.18 109.492 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 35.8 mmtt -67.54 -29.56 68.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.891 -1.05 . . . . 0.31 111.527 -172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.0 p -114.56 -18.04 11.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.006 0.432 . . . . 0.15 110.893 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 73.34 14.79 79.11 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.812 -0.631 . . . . 0.13 111.833 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -76.54 167.31 22.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.133 -0.692 . . . . 0.85 109.133 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 22.7 p90 -149.01 142.47 25.28 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.535 0.683 . . . . 0.2 111.312 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -112.94 140.82 30.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.72 -1.127 . . . . 0.12 109.658 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.8 177.05 30.2 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.384 -0.912 . . . . 0.49 111.374 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -127.11 6.06 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.186 0.493 . . . . 1.18 110.758 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 160.09 18.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.621 -0.799 . . . . 2.58 112.06 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.46 37.94 19.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.838 0.455 . . . . 3.51 111.45 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.1 159.15 8.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.803 -0.713 . . . . 2.3 112.262 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -71.89 -51.03 24.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.048 0.451 . . . . 4.69 109.985 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.27 96.75 6.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.96 110.624 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -63.13 -57.16 11.51 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.461 -0.791 . . . . 2.21 110.061 173.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.412 ' H ' HD22 ' A' ' 111' ' ' LEU . 10.9 t70 -116.82 -14.89 10.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 2.37 110.551 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 110' ' ' ASP . 2.1 mm? -79.24 166.86 21.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.007 -0.997 . . . . 0.81 113.031 -160.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -159.91 -32.3 0.06 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.196 -1.82 . . . . 1.68 107.049 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.444 -1.707 . . . . 3.71 110.098 171.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.993 -0.443 . . . . 9.37 111.993 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -131.45 3.64 4.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.933 0.396 . . . . 9.04 110.79 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -101.09 -0.32 36.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.157 -0.474 . . . . 8.13 111.058 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -78.57 51.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.706 0.765 . . . . 5.76 111.125 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -155.59 10.86 0.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.742 -1.117 . . . . 5.73 108.885 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 10.4 p -156.29 97.55 1.78 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.45 -0.796 . . . . 1.52 111.115 -173.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 40.1 mt-10 -145.46 -48.03 0.22 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.464 -0.789 . . . . 2.01 111.857 -175.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 48' ' ' LEU . 88.1 t 60.83 101.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.546 0.689 . . . . 0.45 112.065 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.57 179.23 9.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.554 -0.748 . . . . 1.41 109.676 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.801 ' SD ' HD23 ' A' ' 68' ' ' LEU . 21.9 mmt -95.72 -12.44 25.44 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.121 0.963 . . . . 0.89 110.682 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.95 -37.09 0.19 Allowed Glycine 0 C--N 1.311 -0.845 0 CA-C-N 112.509 -2.132 . . . . 0.1 116.206 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' HG12 ' A' ' 67' ' ' ILE . 79.6 mt -123.83 171.68 9.47 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.852 0.826 . . . . 0.11 109.538 168.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -96.26 119.72 35.26 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.152 -0.931 . . . . 1.2 110.279 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.597 ' O ' HG12 ' A' ' 17' ' ' VAL . 78.5 p -81.38 14.45 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.225 0.536 . . . . 0.2 110.556 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.26 110.23 17.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.404 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.42 -18.97 56.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.31 112.391 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 14' ' ' SER . 7.7 p -68.68 148.85 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 121.502 0.668 . . . . 0.19 111.794 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.64 75.02 8.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.848 -1.069 . . . . 0.16 109.86 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -87.57 136.7 22.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.649 -1.16 . . . . 0.12 112.021 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.514 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 31.4 mt-30 -85.94 100.76 12.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.681 -0.69 . . . . 0.66 110.38 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 3.4 mtt180 -90.41 -36.28 14.68 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.139 -0.482 . . . . 0.84 111.304 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.7 m -72.56 -18.04 61.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.326 0.584 . . . . 0.89 110.654 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.88 4.23 17.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.366 -0.833 . . . . 0.17 111.106 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.634 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 40.5 t -77.17 148.99 35.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.355 0.598 . . . . 0.26 111.488 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.5 mmp_? -84.77 -11.81 54.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.298 -0.865 . . . . 2.1 112.533 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.5 t -132.51 151.49 34.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.13 109.96 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -69.9 133.52 47.42 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.14 113.091 -173.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CZ ' ' HD3' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -70.48 44.73 0.08 Allowed 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 126.121 1.768 . . . . 0.16 113.692 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.89 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.25 98.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.664 1.221 . . . . 0.15 110.66 -159.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 50.2 tp60 -63.49 -14.27 49.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.102 -0.953 . . . . 0.36 110.694 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 26.1 m -76.2 -38.25 56.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.312 -0.404 . . . . 1.11 110.308 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -82.39 -28.49 31.43 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.531 -0.914 . . . . 0.15 108.531 176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.662 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 87.0 mt -67.92 -42.63 85.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.043 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.0 -14.25 59.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.297 1.046 . . . . 1.54 108.803 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 31' ' ' SER . 23.8 t0 -88.27 16.36 6.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.713 -1.585 . . . . 0.49 109.285 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.744 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 1.7 m -45.51 -11.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.003 1.112 . . . . 1.47 114.003 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -67.51 -13.39 62.0 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.14 -0.35 . . . . 0.97 111.256 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.591 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -62.4 145.23 54.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.232 0.539 . . . . 0.82 111.547 177.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 1.4 m -79.0 -0.11 29.83 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.199 -1.037 . . . . 1.39 108.199 169.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -63.84 -15.54 59.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 109.254 -0.646 . . . . 0.15 109.254 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.744 ' CD1' ' HA ' ' A' ' 36' ' ' SER . 93.7 m95 -98.96 -9.68 23.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.15 111.71 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.53 103.14 13.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 0.5 109.665 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 2.2 m-85 -55.78 -63.79 1.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.677 -1.147 . . . . 0.14 111.46 -176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 161.04 -108.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.607 1.163 . . . . 0.24 110.213 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -142.59 109.88 5.65 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.375 . . . . 1.82 110.594 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 6' ' ' SER . . . 55.49 20.35 22.98 Favored Glycine 0 N--CA 1.468 0.781 0 CA-C-O 121.426 0.459 . . . . 0.17 112.427 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.99 -41.47 81.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.75 0.785 . . . . 0.11 109.066 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.68 HD21 HD22 ' A' ' 68' ' ' LEU . 12.8 tp -70.7 -42.98 69.92 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.794 -1.094 . . . . 0.1 110.374 176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 1.7 mm-40 -64.02 -17.17 63.08 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.347 -1.297 . . . . 1.49 110.085 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.43 -56.09 4.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 114.401 -1.272 . . . . 0.37 110.49 176.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 98' ' ' GLY . 24.8 mt -60.53 -36.72 71.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 113.03 -1.896 . . . . 0.16 109.078 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 71.9 mt -71.07 -43.54 67.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.08 -1.418 . . . . 0.13 110.917 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.89 78.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.277 -1.009 . . . . 0.18 108.277 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.7 m -64.97 -53.65 42.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.61 -1.632 . . . . 0.24 110.254 173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HA ' ' HD1' ' A' ' 60' ' ' TYR . 40.4 m -47.25 -48.99 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.645 0.378 . . . . 0.9 111.939 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 29.1 mtt180 -66.03 -38.33 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 2.73 110.664 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.48 -41.15 96.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.548 0.689 . . . . 0.55 110.442 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 54' ' ' THR . 8.3 mmt180 -67.22 -30.52 70.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.874 -1.057 . . . . 2.5 110.922 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.99 24.12 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.724 -1.126 . . . . 0.24 111.592 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' HD2' HD22 ' A' ' 90' ' ' LEU . 41.8 m-85 -70.35 -46.95 63.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.408 0.623 . . . . 0.51 109.889 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 66' ' ' TYR . 6.2 pt -142.77 -171.04 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 122.224 1.011 . . . . 0.12 111.771 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -134.15 141.62 47.16 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.008 -1.906 . . . . 0.16 109.233 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 40.02 -128.19 2.68 Favored Glycine 0 C--N 1.332 0.328 0 O-C-N 123.837 0.71 . . . . 0.24 114.052 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 m-20 -101.54 19.32 18.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.138 0.494 . . . . 2.21 109.877 176.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.625 ' HA ' HD21 ' A' ' 12' ' ' LEU . 3.2 mm-40 -79.4 34.22 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.626 -0.716 . . . . 0.66 110.429 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 40.2 p90 -109.73 165.49 11.64 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.353 -0.61 . . . . 0.11 109.353 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 97.1 mt -127.94 102.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-O 121.822 0.82 . . . . 0.07 109.977 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD23 ' SD ' ' A' ' 10' ' ' MET . 8.0 tp -97.75 149.34 22.41 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.879 -0.786 . . . . 0.11 108.879 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -145.23 145.54 31.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.931 0.396 . . . . 0.93 111.41 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 1.5 mpt_? -74.82 135.36 41.64 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.573 -0.74 . . . . 1.74 110.336 174.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG21 ' CG ' ' A' ' 81' ' ' ASN . 45.0 t -127.05 -65.87 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.463 -0.79 . . . . 0.11 112.381 -171.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.89 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 17.5 t-20 -143.57 159.54 42.25 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.447 -0.501 . . . . 0.14 112.085 -170.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.599 HD11 ' NE1' ' A' ' 41' ' ' TRP . 76.5 mt -120.25 107.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.862 -0.608 . . . . 0.11 109.915 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 98.2 t -110.38 107.76 23.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.654 -0.703 . . . . 0.24 109.285 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER 66.55 8.38 5.77 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.957 0.884 . . . . 0.39 110.291 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 89.37 15.61 58.43 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.063 -1.065 . . . . 0.13 112.247 -171.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 86.6 m-20 -93.88 37.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.413 0.285 . . . . 0.38 111.133 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -22.08 116.43 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 O-C-N 124.653 1.221 . . . . 0.08 115.226 -169.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 m-85 -93.91 138.31 32.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.619 0.723 . . . . 0.19 110.983 -175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.774 ' HB3' HD11 ' A' ' 68' ' ' LEU . 51.1 m-85 -123.72 138.14 54.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.319 -1.31 . . . . 0.16 109.836 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' CG ' HG21 ' A' ' 71' ' ' VAL . 91.7 m-20 -95.72 140.58 30.32 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.817 -0.809 . . . . 1.56 108.817 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -105.72 125.62 51.2 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.763 -1.199 . . . . 0.19 107.763 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 73.4 m-85 -119.68 159.13 25.05 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.961 -1.018 . . . . 0.19 110.368 -176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 49.8 mttp -76.72 165.26 53.92 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 114.56 -1.2 . . . . 0.57 108.645 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 17.4 Cg_exo -57.95 -17.75 32.11 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.159 1.906 . . . . 0.12 111.396 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.44 -5.69 57.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.764 -1.107 . . . . 1.93 109.659 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 91.07 -0.62 76.11 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.241 -0.891 . . . . 0.11 111.76 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 5.4 m -68.31 119.45 12.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.311 -0.523 . . . . 0.17 111.342 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 78.3 t80 -51.86 132.76 32.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.934 0.873 . . . . 0.2 112.578 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.0 mt -109.38 -57.51 2.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.988 -1.46 . . . . 0.12 109.919 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 20.4 p90 -165.27 174.37 10.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.385 0.612 . . . . 0.15 112.014 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.672 HG21 ' CG2' ' A' ' 26' ' ' VAL . 93.1 m -112.27 122.58 48.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.558 -1.201 . . . . 0.14 108.707 172.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.4 pp -110.8 165.12 12.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.569 0.7 . . . . 0.06 110.719 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -104.89 126.07 51.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.005 -1.48 . . . . 1.15 107.005 176.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.648 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 20.2 p -75.53 -39.79 57.87 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.204 -0.665 . . . . 0.18 109.204 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 34.0 mmtt -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.31 111.497 -171.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.5 p -114.82 -21.04 10.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.014 -0.539 . . . . 0.15 110.774 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.07 16.65 80.47 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.235 -0.746 . . . . 0.13 111.235 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -78.35 167.07 21.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.97 -0.752 . . . . 0.85 108.97 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 27.6 p90 -147.33 140.9 25.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.481 0.657 . . . . 0.2 111.284 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.619 HG22 ' HB ' ' A' ' 92' ' ' THR . 1.3 m -113.43 141.4 29.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.501 -1.227 . . . . 0.12 109.852 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.13 -176.74 27.8 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.444 -0.884 . . . . 0.49 111.465 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -140.56 158.62 43.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 1.18 110.835 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.49 90.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.169 -0.772 . . . . 2.58 111.169 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 57.89 44.51 19.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.269 0.557 . . . . 3.51 110.023 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.18 -137.63 16.18 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.032 -0.827 . . . . 2.3 111.032 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.4 m80 72.58 149.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.693 0.759 . . . . 4.69 112.202 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -93.23 92.57 7.79 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 115.815 -0.63 . . . . 0.96 110.443 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.61 -64.11 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.161 -0.927 . . . . 2.21 110.331 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.459 ' HB3' HG12 ' A' ' 101' ' ' VAL . 17.9 t70 -118.43 -4.07 10.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.382 -0.827 . . . . 2.37 110.08 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 25' ' ' ARG . 1.2 mm? -72.48 162.1 29.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.268 -0.878 . . . . 0.81 112.077 -164.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -154.5 -30.76 0.11 Allowed 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.25 -1.341 . . . . 1.68 110.235 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.585 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.977 -1.01 . . . . 3.71 111.494 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.979 -0.448 . . . . 9.37 111.979 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -71.74 -25.25 61.98 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.854 -0.204 . . . . 9.04 110.571 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm 47.19 73.02 0.21 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.725 0.641 . . . . 8.13 112.172 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -97.26 -20.46 17.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.339 0.59 . . . . 5.76 109.584 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -145.76 43.68 1.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.275 -0.875 . . . . 5.73 109.018 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -152.49 95.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 1.52 110.791 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 13.5 mm-40 -84.09 -55.66 4.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.299 -0.864 . . . . 2.01 111.8 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 48' ' ' LEU . 41.5 t 48.7 90.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.076 0.465 . . . . 0.45 111.887 -174.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -152.88 -174.64 5.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.367 -0.378 . . . . 1.41 110.956 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.708 ' HA ' ' HB3' ' A' ' 68' ' ' LEU . 1.4 mpt? -87.43 -16.46 34.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.834 0.826 . . . . 0.89 110.991 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 9' ' ' ASN . . . 71.08 -36.55 0.52 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 113.083 -1.871 . . . . 0.1 115.762 168.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 65' ' ' GLN . 79.3 mt -122.24 172.85 7.99 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.888 0.844 . . . . 0.11 109.465 167.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -96.49 115.77 27.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.219 -0.901 . . . . 1.2 110.24 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' VAL . 13.2 p -81.0 23.9 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.399 0.619 . . . . 0.2 110.632 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 108.67 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.65 -0.705 . . . . 0.35 110.607 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.73 83.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.843 -0.694 . . . . 0.31 112.337 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 19' ' ' VAL . 9.7 p -72.3 148.99 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-O 121.467 0.651 . . . . 0.19 111.092 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.13 74.41 6.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.967 0.889 . . . . 0.16 109.798 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -86.51 134.76 26.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.438 -1.255 . . . . 0.12 112.06 -175.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.483 ' O ' ' HE1' ' A' ' 83' ' ' TYR . 56.9 mt-30 -86.16 99.67 11.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.355 -0.839 . . . . 0.66 110.337 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' HG22 ' A' ' 19' ' ' VAL . 2.0 mtt180 -90.77 -35.46 14.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 0.84 111.264 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -67.58 -17.13 64.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.439 0.638 . . . . 0.89 110.337 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.34 -7.1 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.015 -0.993 . . . . 0.17 111.045 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 47.3 t -64.71 138.34 58.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.329 0.585 . . . . 0.26 111.039 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -77.01 -17.05 59.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.358 -0.837 . . . . 2.1 112.082 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG21 ' A' ' 92' ' ' THR . 43.0 t -127.7 151.9 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.397 -0.594 . . . . 0.13 109.397 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . -71.35 133.11 45.75 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.957 0.884 . . . . 0.14 113.204 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.45 44.91 0.06 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.379 1.872 . . . . 0.16 114.294 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -68.49 95.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.553 1.168 . . . . 0.15 110.482 -159.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 52.5 tp60 -61.14 -15.95 39.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.206 -0.906 . . . . 0.36 111.208 -170.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 32.3 m -79.81 -30.38 40.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.442 -0.344 . . . . 1.11 110.748 177.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.793 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . . . -86.47 -30.15 22.24 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.287 -1.005 . . . . 0.15 108.287 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 30' ' ' GLN . 79.0 mt -65.48 -43.28 94.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.949 -1.023 . . . . 0.22 110.167 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 36' ' ' SER . 23.7 t70 -78.52 -13.84 59.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.174 0.988 . . . . 1.54 109.045 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 31' ' ' SER . 27.0 t0 -81.51 15.0 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.141 -1.39 . . . . 0.49 108.613 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.699 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.0 p -40.36 -22.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.156 1.782 . . . . 1.47 114.762 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -10.85 37.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.64 -0.424 . . . . 0.97 111.094 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 140.06 58.34 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.229 -0.441 . . . . 0.82 110.891 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 2.0 m -73.84 -0.75 16.85 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.689 -0.856 . . . . 1.39 108.689 169.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.656 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.18 -18.78 62.0 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 109.102 -0.703 . . . . 0.15 109.102 172.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 70' ' ' ARG . 92.4 m95 -97.65 -12.51 22.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.15 112.01 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 106.77 18.35 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.335 -0.616 . . . . 0.5 109.335 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.745 ' CG ' ' HB2' ' A' ' 95' ' ' CYS . 1.7 m-85 -56.57 -64.37 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.289 -1.323 . . . . 0.14 111.422 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' N ' HG11 ' A' ' 47' ' ' VAL . . . 164.0 -108.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.75 -1.114 . . . . 0.24 110.033 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.15 108.02 4.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.782 0.325 . . . . 1.82 110.934 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.77 20.75 48.93 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.499 0.499 . . . . 0.17 111.972 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -71.93 -39.52 67.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 123.372 0.669 . . . . 0.11 109.319 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 68' ' ' LEU . 13.4 tp -72.61 -40.17 66.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.1 109.586 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 1.2 mm-40 -66.23 -13.79 60.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.789 -1.55 . . . . 1.49 110.105 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.4 -54.87 5.1 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.291 -1.322 . . . . 0.37 110.49 175.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.682 HD11 ' HA2' ' A' ' 98' ' ' GLY . 20.0 mt -62.4 -35.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 113.166 -1.834 . . . . 0.16 109.138 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 72.4 mt -72.34 -42.53 65.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.348 -1.297 . . . . 0.13 110.921 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.92 81.08 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.191 -1.04 . . . . 0.18 108.191 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 1.9 m -63.79 -54.23 38.48 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.464 -1.698 . . . . 0.24 110.365 173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' HD11 ' A' ' 61' ' ' ILE . 43.3 m -48.15 -48.59 34.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.687 0.395 . . . . 0.9 111.689 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 16.8 mtp180 -64.49 -43.22 94.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.286 -0.416 . . . . 2.73 110.347 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -61.2 -38.4 86.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.655 -0.702 . . . . 0.55 110.705 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' THR . 7.8 mmt180 -69.49 -31.34 69.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.148 -0.933 . . . . 2.5 110.638 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.92 17.71 13.81 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.661 -1.154 . . . . 0.24 111.479 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 90' ' ' LEU . 38.8 m-85 -75.71 -48.43 21.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.428 0.632 . . . . 0.51 109.863 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 55' ' ' SER . 8.1 pt -140.47 -170.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.114 0.959 . . . . 0.12 111.626 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -133.83 141.44 47.43 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.391 -1.731 . . . . 0.16 109.876 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 56' ' ' ARG . . . 40.59 -120.66 1.67 Allowed Glycine 0 C--N 1.33 0.228 0 O-C-N 124.182 0.926 . . . . 0.24 114.028 174.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.5 13.87 27.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.239 -0.48 . . . . 2.21 110.325 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HA ' HD21 ' A' ' 12' ' ' LEU . 7.1 mm-40 -77.65 35.72 0.2 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.525 0.73 . . . . 0.66 111.486 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 61' ' ' ILE . 45.7 p90 -106.94 164.04 12.46 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.579 -0.526 . . . . 0.11 109.579 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 83' ' ' TYR . 93.2 mt -126.99 100.75 6.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.753 0.787 . . . . 0.07 109.264 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 80' ' ' TYR . 6.1 tp -95.83 152.73 18.22 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.771 -0.826 . . . . 0.11 108.771 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 2.7 mm-40 -146.2 142.94 28.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.591 0.71 . . . . 0.93 111.452 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -76.9 135.38 38.81 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.455 -1.248 . . . . 1.74 108.713 174.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' ALA . 38.8 t -125.93 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.589 0.589 . . . . 0.11 112.589 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 18.6 t-20 -145.19 159.02 43.64 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.506 -0.477 . . . . 0.14 111.382 -168.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 ' NE1' ' A' ' 41' ' ' TRP . 69.2 mt -117.46 106.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.708 -0.678 . . . . 0.11 109.618 171.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 85.1 t -108.27 105.17 18.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.41 -0.813 . . . . 0.24 109.056 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER 66.61 8.36 5.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.763 0.792 . . . . 0.39 110.365 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 96' ' ' LYS . . . 92.39 14.16 56.12 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.219 -0.991 . . . . 0.13 112.447 -172.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 94.4 m-20 -94.45 37.54 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.981 0.39 . . . . 0.38 111.267 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 40' ' ' ALA . . . -20.69 117.82 0.01 OUTLIER Glycine 0 N--CA 1.476 1.326 0 O-C-N 124.498 1.124 . . . . 0.08 115.199 -170.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 26' ' ' VAL . 11.6 m-85 -97.21 135.38 39.23 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.615 0.722 . . . . 0.19 110.449 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.778 ' HB3' HD11 ' A' ' 68' ' ' LEU . 48.4 m-85 -123.9 133.31 53.77 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.166 -1.379 . . . . 0.16 109.227 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 10.9 p30 -102.01 145.66 28.97 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.206 -0.998 . . . . 1.56 110.131 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -104.93 130.05 53.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.904 -1.044 . . . . 0.19 108.654 -177.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.673 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 69.0 m-85 -119.59 158.72 25.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.879 -1.055 . . . . 0.19 109.958 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 88' ' ' THR . 87.4 mttt -76.03 166.04 48.3 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.0 -1.0 . . . . 0.57 108.899 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 35.7 Cg_exo -55.6 -19.4 23.53 Favored 'Trans proline' 0 CA--C 1.519 -0.234 0 C-N-CA 121.945 1.763 . . . . 0.12 111.773 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.66 -0.08 57.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.52 -0.764 . . . . 1.93 110.595 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . 87.24 1.34 84.22 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.941 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 84' ' ' LYS . 11.3 m -67.32 119.97 13.06 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.438 -0.448 . . . . 0.17 111.619 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 24' ' ' SER . 85.4 t80 -55.23 128.47 34.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.748 0.785 . . . . 0.2 112.536 176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 60' ' ' TYR . 44.3 mt -106.57 -58.35 1.94 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.913 -1.494 . . . . 0.12 110.342 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 30.0 p90 -164.38 175.21 10.2 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.937 -0.574 . . . . 0.15 112.066 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.635 HG21 ' CG2' ' A' ' 26' ' ' VAL . 88.9 m -116.43 126.53 53.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.75 -1.114 . . . . 0.14 109.046 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 2.6 pp -114.6 165.59 12.62 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.538 0.685 . . . . 0.06 110.634 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -103.64 125.05 49.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.858 -1.534 . . . . 1.15 106.858 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.745 ' HB2' ' CG ' ' A' ' 43' ' ' PHE . 13.8 p -75.08 -40.16 60.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 28.1 mmtt -68.8 -27.98 66.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.989 -1.005 . . . . 0.31 111.061 -170.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 p -118.36 -17.76 9.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.08 -0.509 . . . . 0.15 111.212 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 51' ' ' ILE . . . 75.32 15.09 81.37 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.881 -0.676 . . . . 0.13 111.669 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -72.09 164.77 25.59 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.963 -0.754 . . . . 0.85 108.963 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 23.5 p90 -150.44 138.34 20.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.563 0.697 . . . . 0.2 111.703 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 1.1 m -111.82 144.02 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.522 -1.217 . . . . 0.12 109.338 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . -96.4 -179.66 35.16 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.082 -1.056 . . . . 0.49 111.251 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -119.06 132.86 56.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.343 0.572 . . . . 1.18 110.327 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.45 -176.08 34.68 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.835 -0.906 . . . . 2.58 110.835 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 67.45 -71.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.23 0.612 . . . . 3.51 110.988 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.58 -96.76 0.11 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.544 -0.623 . . . . 2.3 111.544 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -112.11 -23.51 10.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 4.69 110.841 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -129.52 103.2 6.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.62 0.724 . . . . 0.96 111.831 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.33 -58.53 3.23 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.689 -1.141 . . . . 2.21 109.116 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 16.8 m-20 -117.46 -4.07 11.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.157 -0.928 . . . . 2.37 110.166 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 25' ' ' ARG . 2.2 mm? -74.64 168.52 19.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.229 -0.896 . . . . 0.81 111.225 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -166.52 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.103 -0.953 . . . . 1.68 110.573 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.618 ' OH ' ' HA ' ' A' ' 26' ' ' VAL . 9.4 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.931 -1.032 . . . . 3.71 111.419 -175.284 . . . . . . . . 1 1 . 1 stop_ save_